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 Abstract 
This thesis describes the synthesis of different cyclic imines and the exploration of their 
reactivity with cyclopropenones and 1,3-dipoles, as well as an investigation of the chemistry 
of the products. The synthesis of biologically and pharmaceutically important heterocyclic 
natural product analogues, such as the pyrroloazepines, indolizidines and pyrrolizidines has 
been achieved using a cycloaddition reaction between cyclic imidates and cyclopropenones. 
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A new route to pyridines has been developed using the generation of a proposed 3-
azacyclopentadienone as the key step. The 3-azacyclopentadienones are generated by using 
boiling toluene to induce a [2+2]-cycloreversion in a series of azabicyclo[3.2.0]hept-2-en-4-
ones. Regiospecific Diels-Alder reaction of the intermediate 3-azacyclopentadienone with a 
styrene is followed by chelotropic extrusion of carbon monoxide and loss of hydrogen to give 
the pyridine.  
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The process is similar to the well-known process by which benzenes are accessed from 
cyclopentadienones. The azabicyclo[3.2.0]hept-2-en-4-ones were available from the reaction 
of cyclopropenones with 1-azetines, where cyclopropenones behave as an all carbon 1,3-
dipole equivalents. Using the same methodology 1,3-dipolar cycloaddition of nitrile oxides to 
4-aryl-2-alkylthio-1-azetines afforded a series of oxadiazabicyclo[3.2.0]heptenes as single 
diastereoisomers. Heating these cycloadducts in toluene resulted in an overall [2+2]-
cycloreversion to give 5-alkylthio-3-aryl-1,2,4-oxadiazoles.  
 
 N
SR
Ar
N
SR
Ar
N
O
Ar
Et2O
+
O
N
Ar
N
N
O
Ar
Ph
RS
+heat
 
Cycloaddition reactions of a series of benzodiazepines were also studied. The 
benzodiazepines were formed using literature methods and converted to cyclic  imines with 
the help of εeerwein’s reagent. Reactions between such cyclic  imines and cyclopropenones 
and 1,3-dipoles were attempted to produce tricyclic and tetracyclic benzodiazepine 
analogues.  
 
 
 
 
 
Finally, some multicomponent reactions of aryl aldehydes with cyanides and 1,3-dicarbonyl 
compounds were investigated to produce fully substituted heterocyclic compounds like 
dihydropyridines and pyrans with substituents suitable for intramolecular cyclization and 
imine formation. The main substituent of interest was the azide group as this had been used in 
section 2.3.3.1.2 & 2.3.3.1.3 in this thesis. 
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1. Introduction 
This thesis will describe new approaches to the synthesis of 1,2,4-oxadiazoles and pyridines, 
an attempt to use benzodiazepines as cyclic imines and the use of o-azidobenzaldehyde in 
multicomponent reactions. Short introductions to 1,2,4-oxadiazoles, pyridines and 
multicomponent reactions of aryl aldehydes are therefore included.  
1.1 1,2,4-oxadiazoles 
Oxadiazoles are five-membered heterocycles containing two carbon atoms, two nitrogen 
atoms and one oxygen atom. These compounds are of considerable importance in different 
areas of pesticide and medicinal chemistry as well as polymer and material sciences1. 
Oxadiazoles have been proved to have a large impact on multiple drug discovery 
programmes across different disease areas including cancer2, inflammation3, diabetes4, 
obesity5 and infection6. Raltegravir 1, an oxadiazole containing compound and antiretroviral 
drug for the treatment of HIV infection7, has been recently launched into the market. 
Furthermore, a number of compounds containing an oxadiazole ring are at the final stage of 
clinical trials e.g. zibotentan 2 as an anticancer agent8 and ataluren 3 for the treatment of 
cystic fibrosis9. 
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There are several reasons behind the introduction of oxadiazoles into the drug discovery 
programmes. They have been used as a replacement of carbonyl compounds like esters, 
amides, carbamates and hydroxamic esters. Oxadiazoles have been used as a vital part of the 
pharmacophore, contributing towards ligand binding10, and in some cases they act as a flat 
aromatic linker to place substituents in appropriate orientations11. These moieties have also 
been used to modulate molecular properties by placing them in the periphery of the 
molecule12.                
Oxadiazole rings can exist in three different regioisomeric forms as 1,2,4-oxadizole 4, 1,3,4-
isomer 5 and the 1,2,5-isomer 6. This thesis will focus only on 1,2,4-oxadiazoles.     
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1.1.1. Bioactivity of 1,2,4-oxadiazoles 
1.1.1.1. Antiinflammatory and antiasthmatic agents 
1,2,4-Oxadiazoles are known to show antiinflammatory properties and one example is 5-
methyl-3-phenyl-1,2,4-oxadiazole which shows properties similar to phenylbutazone13. Some 
other compounds like dual cyclooxygenase/5-lypoxygenase, coumarin and 3-phenyl-1,2,4-
oxadiazole-5-carbohydrazide derivatives have been reported3,14,15 to show antiinflammatory 
activities. A new class of interleukin-8 antagonists containing a 3,5-diaryl-1,2,4-oxadiazole 7 
has been introduced16 as potential antiinflammatory agents. 1,2,4-oxadiazoles having a fatty 
acid chain at C (5) 8 as isosters of palmitic acid derivatives show inhibition to fatty acid 
amide hydrolase (FAAH), with activity similar to aspirin and ibuprofen17. The introduction of 
a long chain hydrocarbon to the oxadiazole ring increases the hydrophobicity of these 
molecules which allows them to enter the cells more quickly and leave more slowly than 
3 
 
shorter alkyl chain derivatives, hence, increasing the anti-inflammatory activity of these 
compounds.      
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Some α-keto 1,2,4-oxadiazoles 9 have been found as inhibitors of human mast cell tryptase, 
an enzyme that is linked with immediate and long term effects of asthma18.  
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1.1.1.2 Anti-tumoral activity 
Cancer is in fact a condition consisting of more than one hundred different diseases, all 
causing uncontrolled growth and spread of abnormal cells. For the discovery of anti-cancer 
drugs, the identification of compounds acting as apoptosis inducers is of considerable 
interest. It has been proved by high throughput screening (HTS) assays that 1,2,4-oxadiazoles 
like 10 can act as apoptosis agents2. Moreover, structure activity relationship (SAR) of 3,5-
diaryl-1,2,4-oxadiazoles has shown that changing the para-substituent of the aryl group has 
no effect on the activity of the compound. 3,5-Diaryl-1,2,4-oxadiazoles have been shown to 
induce apoptosis selectively in breast and colorectal cancer without affecting the primary 
4 
 
normal cells19. A series of 1,2,4-oxadiazoles carboxamides 11 have also been examined for 
inhibition to glycogen synthase kinase-3 (GSK-3) which is an important regulator of 
differentiation and proliferation of cells.  
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1,2,4-Oxadiazole-5-thione and 1,2,4-oxadiazole-5-one are considered good bioisoesters in the 
hydrophilic pharmacophore of known non-steroidal androgen receptor antagonists for the 
treatment of prostate cancer20. Sulfonyl and sulfide derivatives of 1,2,4-oxadiazoles have also 
been tested by MTT assay on prostate cancer cells, DU-145. These compounds showed good 
activity on androgen independent cells PC-3 whereas on androgen dependent cells LNCaP, 
showed moderate activity21. 1,2,4-Oxadiazoles which are thiol-linked and contain electron 
withdrawing aryl substituents have been found active against androgen independent prostrate 
cancer cell-lines21. 1,2,4-Triazol-3-ylsulfanylmethyl-3-phenyl-1,2,4-oxadiazoles antagonize 
Wnt signalling and are inhibitors of tankyrases (TNKS1 and 2) that show no activity against 
PARP1 and 2 (poly ADPribose polymerase domains). The dysregulation of the Wnt pathway 
is the cause of several diseases including some cancer developments22.     
 
1.1.1.3. Immunosuppressors 
Sometimes, the immune system of the body needs to be suppressed, such as in preparation for 
organ transplantation to avoid the rejection of donor tissue, or in treatment of auto-immune 
diseases such as Crohn’s disease and rheumatoid arthritis. 1,2,4-Oxadiazoles have been found 
to be efficient mimetics for monophosphorylated tetrapeptide sequences found in SH2 
domains of ZAP-70 (zeta chain associated protein kinase-70 which plays a key role in T-cell 
activation by its SH2 domains) and might be potential immunosuppressors23. Sphingosine-1-
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phosphate (S1P1) receptors have been identified as targets of immunosuppressant drugs and 
compound 12 has shown properties as S1P1 agonist24. Compound 12 is an excellent S1P1 
selective modulator that suppresses the development of auto-immune diseases such as 
multiple sclerosis and adjuvant-induced arthritis models25.   
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1.1.1.4. Neuroprotective agents 
Sirtuins are proteins (S1RT 1-7) which are important in age-related diseases, and a number of 
1,2,4-oxadiazole carbonylaminourea derivatives 13 have shown good affinity for S1RT1 and 
S1RT2 in virtual based screening proving their importance for inhibitory activity in such 
diseases26. Development of new dopamine agonists represents a new approach towards 
therapy for Parkinson’s disease. A series of γ-(5-bromo-2,3-dimethoxyphenyl)-1,2,4-
oxadiazoles have been synthesized and tested as dopamine agonists and showed good 
results27. The 1,2,4-oxadiazole system has the advantage that it can replace the amide group 
in a series of benzamide analogues with high affinity for dopamine receptors. Another 
common neurodegenerative disease is Alzheimer’s disease. Development of probes for in 
vivo imaging of ȕ-amyloid plaques, formed in the brain during the early stages of disease, is 
an emerging research area. A series of 3,5-diaryl-1,2,4-oxadiazoles have been designed as 
potential probes for ȕ-amyloid plaques and compound 14 has shown good affinity for these 
plaques1. However,  these compounds have an unfavourable in vivo pharmacokinetic profile 
due to non-specific bonding, therefore, some structure modifications are needed to reduce the 
lipophilicity of these 1,2,4-oxadiazole derivatives11.   
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1.1.1.5. Non-sense mutation readthrough promoters 
An alteration in genetic code due to changes in a nucleotide is called a non-sense mutation. It 
can convert an amino acid encoding codon to a translational stop codon (UAA, UAG or 
UGA) in the protein coding region of mRNA which can cause premature interruption of 
mRNA translation and production of truncated proteins. Such mutations are responsible for 
diseases like cystic fibrosis (CF) and Duchenne muscular dystrophy (DMD)28,29. It is of 
considerable importance to search for compounds which can promote the readthrough of 
premature stop codons and allow the synthesis of functional proteins. Ataluren, 3-[5-(2-
fluorophenyl)-[1,2,4]-oxadiazole-3-yl]-benzoic acid 3, also known as PTC-124, has been 
found to promote suppression of UGA stop codon and to correct the processing of the gene in 
patients who are affected by non sense mutations30-32. It allows the ribosome to continue the 
translation process to make a full length and functional protein chain, through bypassing the 
premature mRNA stop codon and not affecting the correct stop codons in mRNA.    
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1.1.1.6. Antidiabetic activity 
Inhibition of glycogen phosphorylase (GP), which is responsible for the release of glucose-1-
phosphate from glycogen, is considered as an efficient approach for the treatment of diabetes. 
A number of 3-ȕ-D-glucopyranosyl-1,2,4-oxadiazoles 15 have shown inhibition against GP33. 
Inhibition of dipeptidyl peptidase-IV (DPP-IV) is another approach for treatment of diabetes, 
and 5-oxo-1,2,4-oxadiazole 16 has been found a potent inhibitor towards DPP-IV34.  
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1.1.1.7. Antimicrobial activity 
1,2,4-Oxadiazoles show anti-microbial activity, for example, compound 17 is one of a series 
of 1,2,4-oxadiazoles that have been found as potent ethionamide boosters due to their ability 
to act as EthR inhibitors in the treatment of tuberculosis35. 
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3-Methyl-1,2,4-oxadiazole-5-yl has been used as a hydrolysis resistant grouping in HIV-1 
non-nucleoside reverse transcriptase inhibitors (NNRTs) and has proved itself as the best 
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bioisosteric replacement for compounds with a methyl ester group expressing anti-HIV 
activity with submicromolar EC50 values36. 
 
1.1.1.8. Importance of 1,2,4-oxadiazoles in materials 
1,2,4-Oxadiazoles have also been found useful in materials research1. The recent synthesis of 
bent-core37, bent-rod like38 and H-bond induced liquid crystals39 like compound 18 which are 
stable over broad temperature ranges are examples of their importance. 3-Nitro-5-substituted 
1,2,4-oxadiazoles such as compound 19 have been reported as energetic, insensitive high 
explosives (IHEs)40. Pyridyl-1,2,4-oxadiazoles41 and bis-1,2,4-oxadiazole42 have been used as 
chelating ligands in the synthesis of NiII, CuII, ZnII and PdII complexes, whereas, bis(pyridyl)-
1,2,4-oxadiazole Cu (II) complexes have shown good activity as DNA groove binders43. 
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1.1.2. Synthesis of 1,2,4-oxadiazoles 
1,2,4-Oxadiazoles are easy to make using 1,3-dipolar cycloaddition reactions between nitriles 
20 and nitrile oxides 21, or from the reactions of amidoximes 23 (made from nitrile reaction 
with hydroxylamine) with a carboxylic acid derivative 2444-46.     
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The synthesis of phidianidines A and B 33, the first 1,2,4-oxadiazole containing natural 
product (from the marine opistho branch mollusc, Phidiana militaris), has been reported 
recently as an example of the reaction of nitrile derived amidoxime with a carboxylic acid 
derivative. Lindsley and co-workers47 (scheme 1.2) reported the synthesis of phidianidine A 
and B, starting from 1,5-diaminopentane, converting it to the amidoxime and then reacting 
with indole acetic acid to give phidianidine A and B in 39.9 % and 21 % respectively. 
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                                                        Scheme  1.2 
 
Snider et al. (scheme 1.3) have used a similar strategy to synthesize phidianidine A and B in 
19 % overall yield. They reacted a substituted indole-3-acetyl chloride with N-5-azidopentyl-
N’-hydroxyguanidine (obtained from 1,5-diazidopentane) to produce 3-(5-
azidopentylamino)-5-((indole-3-yl)-methyl)-1,2,4-oxadiazole. The azide was reduced with 
zinc and ammonium formate to afford the corresponding amine which was elaborated to 
guanidine, completing the synthesis of phidianidine A and B48.   
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                                                             Scheme  1.3 
1,2,4-Oxadiazoles substituted with a heteroatom will form part of the discussion of this 
thesis. A brief survey of such systems is given here.
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1.1.2.1. Keto- and amino-1,2,4-oxadiazoles 
3-Keto-1,2,4-oxadiazoles 44 have been synthesized by using amidoxime route. The carbonyl 
group was formed by liberating TBS-protected alcohol followed by oxidation with Dess-
Martin periodinane49. An alternative method involves the synthesis of 3-acyl-1,2,4-
oxadiazoles as a result of a reaction of nitrile with methyl ketone in the presence of iron (III)  
nitrate, a reaction similar to the Mukaiyama-Hoshino method50. The mechanism involves the 
α-nitration of ketone and loss of water to form nitrile oxide in situ which cyclises with the 
nitrile to produce the product50. An example of a 5-keto-1,2,4-oxadiazole 45 has been 
recently reported as an anti-inflammatory agent18.  
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Several methods have been used for the synthesis of amino-1,2,4-oxadiazoles. Aromatic 
nucleophilic substitution (SNAr) of 5-trichloromethyl-1,2,4-oxadiazole51,52 and cyclization of 
amidoximes with carbodiimides53 are considered as the most convenient methods. 
Photochemical reaction of 3-acylamino-1,2,5-oxadiazole54 in the presence of amines also 
produces 3-amino-1,2,4-oxadiazoles 46, whereas, 3,5-diamino derivatives 47 have been 
reported as a result of reaction of 3-cyanoisothioureas with hydroxylamine55.   
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1.1.2.2. Ethoxycarbonyl and carbamoyl-1,2,4-oxadiazoles 
Synthesis of 3-ethoxycarbonyl derivatives 48 has been done by reacting amidoxime with 
anhydrides56 or N-acylamidoxime57. 3-Carbamoyl derivatives 49 are prepared from anhydride 
reaction with amidoximes derived from nitroisoxazolone58. Reaction of amidoxime with ethyl 
oxalyl chloride produces 5-ethoxycarbonyl-1,2,4-oxadiazoles59 which can be converted to 5-
carbamoyl-1,2,4-oxadiazoles 50 after aminolysis59. These are important compounds for 
further modifications of side chains. 
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                                                             Fig.  1.13 
1.1.2.3. Sugar linked and fluorinated 1,2,4-oxadiazoles 
The linking of a carbohydrate moiety to bioactive oxadiazoles can increase their 
pharmacological properties e.g. increase their water solubility. Sugar cyanohydrins, being 
easily accessible, are used as 1,2,4-oxadiazole synthons to do cycloaddition with nitrile 
oxides to produce 5-glycosyl derivatives 51 60, or to produce amidoxime which produce 3-
glycosyl-1,2,4-oxadiazoles33. Sugar linked 1,2,4-oxadiazoles have also been synthesized from 
azidoglycosides or azidophenyl-1,2,4-oxadiazles through a 1,2,3-triazole ‘’click’’ spacer61,62.  
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Fluorinated azoles have shown their importance in pharmaceutical industry as well as in 
material sciences. There have been several reports on the synthesis of fluorinated 1,2,4-
oxadiazoles63. Fluorinated 1,2,4-oxadiazoles 52 have been used as reagents in the presence of 
sodium dithionite, to introduce the difluoromethylene group into organic compounds64. The 
attachment of fluorinated moieties to macromolecules65,66 and polymers67,68, has been 
performed by using 5-pentafluorophenyl-1,2,4-oxadiazoles 53 as fluorinated oxadiazole 
arylating reagent (FOXARs)69. Hemming and co-workers have reported the synthesis of 5-
(β’-fluoro-2,3-dimethylbutan-3-yl) substituted 1,2,4-oxadiazoles 55 through 
fluorodesulfurization of 5-ethylthio-6,6,7,7-tetramethyl-4-oxa-1,3-diazabicyclo[3.2.0]-hept-2-
enes 54 with silver tetrafluoroborate70. 
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1.1.2.4. Heterocyclic linked 1,2,4-oxadiazoles 
A heterocycle can be linked to a 1,2,4-oxadiazole system to increase its physiochemical or 
biological properties. Many such systems have been reported in the literature1, for example, 
1,2,4-oxadiazole ring has been introduced in 3-[(1,2,4-oxadiazole-3-yl)-methyl]-3,4-
dihydropyrimidine-2(1H)-ones as a bioisostere of esters and amides. These compounds have 
been synthesized by ionic liquid-phase organic synthesis (IoLiPOS)71. Synthesis of bis (1,2,4-
oxadiazoles) has been reported including one involving several spaced bis[(1,2,4-
oxadiazole)-benzaldehyde] building blocks 56 72and another involving N, N’-protected bis(5-
aminoalkyl-1,2,4-oxadiazol-3-yl)methane73. Similarly the tris (heterocycle) 57 has been 
synthesized consisting of 1,2,3-triazole, 1,2,4- and 1,2,5-oxadiazole rings74. Such poly 
(heterocycles) can be useful as metal ligands in metal organic frameworks.  
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1.1.2.5. Metal complexes of 1,2,4-oxadiazoles 
Coordination complexes containing 1,2,4-oxadiazole systems have been reported46, 
particularly complexes with the oxadiazole acting as a monodentate ligand with Cu(II), 
Co(II), Zn(II), pd(II), Pt(II)75. Some Pd and Pt complexes containing 1,2,4-oxadiazoles have 
been synthesized by 1,3-dipolar cycloaddition of nitrile oxide and nitrile metal complexes76. 
1,2,4-Oxadiazol-3-yl-bipyridine chelate iron and copper and show similar features to 
terpyridyl complexes77. γ,γ’-Bis[1,2,4-oxadiazol] 58 synthesized by Moussebois and Eloy78 
has been identified as a ligand for palladium and silver complexes42. The Cu (II) complex of 
5-(β’-oxyphenyl)-3-phenyl-1,2,4-oxadiazole 59 has been observed as fluorescent at room 
temperature79. 3,5-Bis(β’-pyridyl)-1,2,4-oxadiazole 60 complexes of copper, nickel and zinc 
have been synthesized and evaluated for their DNA-binding interactions80. 
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In our strategy, 1-azetines were synthesized and reacted with different nitrile oxides to afford 
a series of oxadiazabicyclo[3.2.0]-hept-2-enes. Heating these bicyclic adducts in toluene 
16 
 
resulted in an overall [2+2]-cycloreversion to produce 5-alkylthio-3-aryl-1,2,4-oxadiazoles. 
This work was a continuation of the earlier fluoro-work shown above where compound 54 
gives compound 55.  
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                                                 Scheme  1.5 
1.2 Pyridines  
Pyridines 65 are a class of heterocyclic compounds which are similar to benzene in structure 
with one CH group replaced by nitrogen atom. Pyridine has been found important in the 
understanding of the chemistry of many biological systems. It is useful in the catalysis of 
both chemical and biological systems. In living organisms many enzymes contain the 
pyridine nucleotide (NADP) that is involved in many oxidation-reduction processes81. A brief 
and selective survey of pyridines is given below.  
1.2.1. Biological importance of pyridines 
Pyridine’s importance in biological systems is shown by important vitamins such as niacin 66 
and pyridoxine 67 (which is involved in, for example, the production of red blood cells) and 
also in highly toxic alkaloids such as nicotine 6882 . 
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A well known naturally occurring pyridine is epibatidine 69, an alkaloid, which was 
originally found in the skin of a neotropical poisonous frog, Epipedobates tricolor , found in 
Ecuador. 
                                 
N
68
Nicotine
N
H
Me
                   
NCl H
N
69
Epibatidine
 
                                                             Fig.  1.18 
In the pharmaceutical industry, pyridines are involved in the synthesis of over 7000 drugs83-
86
. Some of them are shown below. 
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Pyridines are also found in many agrochemicals,83,87 some of which are shown below. 
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1.2.2.  Synthesis of pyridines 
Since the discovery of pyridines, several methods have been used for its synthesis. The more 
commonly used methods involve the condensation of amine and carbonyl compounds. Such 
methods are characterized by the number of atoms in each fragment contributing to the 
heterocyclic ring. Ammonia serves as a source of nitrogen in [5+1] condensation with 1,5-
dicarbonyl compounds88 followed by  oxidation for aromatization of the ring. It is also 
involved in the [2+2+1+1] Hantzsch synthesis89,90 of pyridines, a commonly used method 
first described by Hantzsch in 188289. In this reaction two equivalents of a ȕ-keto ester are 
reacted with an aldehyde in the presence of ammonia to form a dihydropyridine, and after 
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oxidation a pyridine is formed. Alkyl and vinyl amines are used in [3+3] condensation with 
1,3-dicarbonyl derivatives91 to synthesize pyridines.  
The Hantzsch synthesis is important for the synthesis of fully substituted pyridines, but is 
limited to carboxyl substituents at the 3- and 5-positions and often requires an aryl substituent 
at the 4th position92. Despite its limitations the Hantzsch synthesis has been of huge interest 
for over a century, not least because of its use in the synthesis of many dihydropyridine anti-
hypertensives. 
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                                                             Scheme  1.6 
In 196593, Kondrat’eva and Huan described a method involving addition of a dienophile to 
oxazole , where subsequent extrusion of the oxygen atom results in the formation of a 
pyridine.          
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As will be seen later, this is similar to the method developed in the work described in this 
thesis. This method has been reported regularly for the synthesis of pyridines and some 
recently reported examples are given below 94,95.   
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1.2.2.1 Recent developments in pyridine synthesis 
Pyridine synthesis continues to be of huge interest and in recent years, various new methods96 
including new cycloaddition approaches96,97 have been reported. A short review of some 
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recent methods appears below. Pyridine synthesis was reviewed in 2010, so the below reports 
synthesis methods since then.  
1.2.2.1.1 Pyridine synthesis via cycloaddition 
Historically, cycloaddition is one of the most widely used method for the pyridine synthesis 
and there are various established cycloaddition methodologies96. However, some new 
cycloaddition approaches have been reported which will be discussed here. 
Vinyl azides have been used as a three atom unit including one nitrogen to synthesize 
pyridines, by reacting it with monocyclic propanols. The reaction starts with oxidation of 
cyclopropanol to generate ȕ-carbonyl radical in the presence of Mn (III). The radical addition 
of ȕ-carbonyl to vinyl azide forms an iminyl radical which cyclises with the intramolecular 
carbonyl group to afford the pyridine98. 
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A number of substituted pyridines have been synthesized by using iron (II) acetate and 
pyridyl bisimines as catalysts for the [2+2+2] cycloaddition of alkynes and alkynylnitriles99.  
X
R
N
R1
R2 N
X
R1
R2
R
N
N N
NN OBnBnO
iPr
PriiPr
iPr
10 mol % Fe(OAc)2
13 mol %
Zn , DMf , 85 oC
+
100 101 103
102
 
                                                             Scheme  1.11 
22 
 
Coffinier et al. have reported pyridine syntheses by coupling two multicomponent processes 
involving 1-azadienes and ketenimines. 1-Azadienes were formed in situ in a one-pot 
reaction of phosphonates, nitriles and aldehydes and reacted with ketenimines prepared from 
oxalic acid monoethyl ester chloride which was in turn prepared from the corresponding 
isocyanide and trialkylphosphite. The reaction produces a dihydropyridine which is converted 
to pyridine by phosphate elimination under basic treatment with DBU100.  
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Scheme  1.12 
Hapke and co-workers have reported the synthesis of pyridines through [2+2+2] 
cycloaddition reactions of cyanodiynes101. A similar startegy was used by Danheiser and co-
workers for a polycyclic pyridine synthesis via metal free [2+2+2] cycloaddition that 
proceeds through a pericyclic cascade mechanism involving unactivated cyano groups as 
enophile and dienophiles102. 
 
O
G
H2
C
C
N
R
R N
O
G
R RToluene (0.01 M)
reflux at 160 oC
18-66 h
R = H , Me
G = SiMe3 or
G = CH2OSiMe2(t-Bu)
108 109
 
Scheme  1.13 
Regioselective bicyclic 3- and 4-aminopyridines have been synthesized through cobalt 
catalyzed [2+2+2] cycloaddition between yn-ynamides and nitriles in excellent yields, with 
high regioselectivity in the products103, as shown in scheme 1.14.  
23 
 
R1
N
R2
N R3Ts
n
+
CpCo(CO) (dmfu)
     (10 mol %)
NN
Ts
R2
R3
R1
n n = 2-4
R1 = H , Ph , TMS
R2 = H , Ph
R3 = Alk , Bn , Ar,
        heteroAr , N(Alk)2
dmfu = dimethylfumarate
110 111 112
 
Scheme  1.14 
Cycloaddition of azoenamines with acetylendicarboxylates has resulted in the synthesis of 
pyridines. Azoenamines are produced from reaction of α-ketohydrazones with secondary 
amines104 in the presence of diethyl acetylenedicarboxylate.                
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Scheme  1.15 
Ellman has used rhodium as a catalyst for C-H activation during a one-pot 
alkenylation/electrocyclization/aromatization process to synthesize substituted pyridines from 
alkynes and α,ȕ-unsaturated imines105. 
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Scheme  1.16 
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Liebeskind has adopted an approach involving the copper catalyzed reaction of 
alkenylboronic acids and α,ȕ-unsaturated oxime O-carboxylates for the synthesis of 
substituted pyridines106.  
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                                                       Scheme  1.17 
Barluenga and his co-workers 107,108 have presented two different approaches for the synthesis 
of substituted pyridines. The first involves the gold catalyzed intermolecular hetero-dehydro-
Diels-Alder reaction between dienynes and nitriles, which leads to the regioselective 
formation of tetrasubstituted pyridines. In the second approach they used Pd as a catalyst for 
a multicomponent, one-pot synthesis of trisubstituted pyridines, and this occurs via cross-
coupling/cross-coupling/cycloaddition and proceeds through 2-azadiene intermediates. 
             
Ar
Br NH
O Ar2
Br
TMS
N
Ar1
+ + +
N
Ar2
Ar1
ArPd2(dba)2/Davephos
NaOtBu, Yb(OTf)3
47-62 %
MeO2C
R
OMe
+ R1 CN
CO2Me
R1 N OMe
R
AuClPEt3/AgSbF6
5 mol %, DCE, 85 oC
55-75 %
121 123
124 125 126 127 128
122
 
Scheme  1.18 
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1.2.2.1.2 Other methods for pyridine synthesis  
 
Rovis and co-workers have recently reported a Rh (III) catalyzed regioselective synthesis of 
pyridines by coupling α,ȕ-unsaturated O-pivaloyl oximes to alkenes. The reaction involves 
reversible C-H activation followed by alkene insertion and in the next step C-N bond 
formation/ N-O bond cleavage completes the pyridine formation109.  
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Scheme  1.19 
Park has used the reaction of 2H-azirines with vinyl diaza compounds and shown that this 
yields pyridines in the presence of a Rh catalyst. The reaction is believed to proceed through 
a carbenoid intermediate and DDQ oxidation of a non-isolated dihydropyridine110. 
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Scheme  1.20 
Synthesis of 1,4-dihydropyridines and pyridines through a general method that includes 
lithiation/isomerisation/intramolecular carbolithiation of readily available N-allyl ynamides 
has been developed111. 
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Scheme  1.21 
Pyridines can also be synthesized by one step Rh catalyzed C-H bond functionalization of 
α,ȕ-unsaturated ketoximes and terminal alkynes. This regioselective synthesis of pyridines 
proceeds through the use of triisopropyl phosphate as a ligand that suppresses the undesired 
dimerization of terminal alkynes to enynes112.  
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Scheme  1.22 
Polysubstituted 3-H, 3-F and 3-trifluoromethyl pyridines 142 (X = H, F or CF3) have been 
synthesized on the basis of C-F bond breaking of anionically activated fluoroalkyl groups. 
This is a high yielding process for the synthesis of 2,6-disubstituted 4-aminopyridines113.  
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Scheme  1.23 
Three component reaction of trifluoroacetoacetate, aldehydes and ammonium acetate results 
in the synthesis of 2-trifluoromethyl-6-difluoromethylpyridine-3,5-dicarboxylates in the 
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presence of potassium carbonate under solvent free conditions. The reaction proceeds via 
Hantzsch reaction/dehydration/dehydrofluorination in a one-pot reaction114.  
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Scheme  1.24 
 
Chiba and Wang have developed a Mn (III) mediated reaction of cyclopropanols and vinyl 
azides to synthesize tetrahydropyridines which undergo dehydration and oxidation in the 
presence of excess Mn (III), AcOH and oxygen to produce pyridines115. 
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Scheme  1.25 
 
Beauchemin and co-workers116 successfully synthesized pyridines from an intramolecular 
Cope-type hydroamination reaction starting with alkynyl oximes and proceeding through 
isomerisation and aromatization. 
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Scheme  1.26 
Banerjee and Sereda adopted a silica catalysed approach for the the synthesis of pyridines 
from aldehydes, malononitrile and thiols under mild and near neutral conditions117. 
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Scheme  1.27 
Cheng has reported the synthesis of fully substituted pyridines with the help of α,ȕ-ketoximes 
and alkynes, where C-H activation of α,ȕ-ketoximes occurred with rhodium catalyzed 
chelation118. 
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Scheme  1.28 
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Davies and co-workers have reported a one pot synthesis of highly functionalised pyridines 
which involves the Rh-catalyzed reaction of isoxazoles with diazoacetates that proceeds 
through carbenoid induced ring expansion followed by a rearrangement, oxidation 
sequence119. 
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Scheme  1.29 
Zhang, Liu et al. have used a novel temperature-controlled methodology for the synthesis of 
substituted pyridines, where (5C+1N) annulations of 1,1-bisalkylthio-1,4-pentanedienes with 
ammonium acetate results in two different pyridine products at two different temperatures. 
Reaction at 120 0C gave 3,5-dinitrile pyridines while the reaction at 65 0C gave 2-amino-3-
alkylthio-pyridines120. 
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Scheme  1.30 
In our strategy, azabicyclo[3.2.0]hept-2-en-4-ones were synthesized from the reaction 
between 4-aryl-1-azetines and readily available cyclopropenones, where the cyclopropenones 
behave as all carbon 1,3-dipole equivalents. Heating the azabicyclic adduct in toluene 
produced pyridines through a proposed azacyclopentadienone intermediate generated as a 
result of [2+2]-cycloreversion. Diels-Alder reaction between the proposed intermediate 
azacyclopentadienone and styrene followed by chelotropic extrusion of carbon monoxide and 
loss of hydrogen gives pyridines.  
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Scheme  1.31 
 
1.3 Multicomponent reactions of aryl aldehydes 
Multicomponent reactions are a class of domino reactions involving at least three substrates 
to form a product that contains a portion of each component. These reactions achieve 
multibond formation in a one-pot reaction and form complex products from simple starting 
materials. These multicomponent reactions are highly flexible, convergent, chemoselective 
and atom efficient as they avoid protecting groups and isolation of intermediates. 
Multicomponent reactions were first reported in the 19th century by Strecker, Hantzsch and 
Biginelli but it is after the more recent work of Ugi and co-workers that this strategy 
evolved121-123.  
1.3.1. Multicomponent Strecker reactions 
The Strecker reaction is a three component coupling between a carbonyl derivative, amine 
and a cyanide source to produce the corresponding α-aminonitriles. It was first reported in 
1850124 and is one of the most commonly used methods for the synthesis of α-aminonitriles 
that can be hydrolysed to α-amino acids125-129. The reaction proceeds through an initial 
formation of imine by the condensation of carbonyl and amine components followed by the 
addition of cyanide to the imine intermediate to form the product. A recent example of a  
Strecker reaction has been reported by James and co-workers130 for the synthesis of 
enantiopure α-arylglycines through an asymmetric three component reaction of 
arylaldehydes, sodium cyanide in solution and (S)-1-(4-methoxyphenyl)-ethylamine as the 
easily removed chiral auxiliary.  
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Scheme  1.32 
1.3.2. Multicomponent Hantzsch reaction  
The Hantzsch reaction was first reported in 188289 for the synthesis of 1,4-dihydropyridines 
from the reaction of enamine, aldehyde and a 1,3-dicarbonyl compound. A recent example of 
Hantzsch milticomponent reaction for pyridine synthesis has been described in the previous 
section of this chapter.  
1.3.3. Multicomponent Mannich reaction  
The classic Mannich reaction involves ammonia (or a primary or secondary amine), a 
nonenolizable aldehyde or ketone and an enolizable carbonyl compound to form ȕ-amino-
carbonyl products131-133. It was first reported in 1912134 and since then, use of various chiral 
starting materials for this asymmetric multicomponent reaction have been reported including 
enantioselective catalytic Mannich reactions135. Yang et al. have recently reported a  
stereoselective approach to chiral 6-alkylated 2-piperidinones on the basis of three 
component vinylogous Mannich reaction involving a chiral amine136, which acts as an 
auxiliary and is removed by hydrogenation. 
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Scheme  1.33 
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1.3.4. Multicomponent reactions intiated by Michael addition 
Several multicomponent reactions intiated by Michael addition of carbon nucleophiles have 
been reported. An asymmetric three component domino reaction intiated by aza-Michael 
addition has been reported by Node and co-workers137. The reaction of N-benzylamine-2(R)-
methoxy-(+)-10-bornylamine with benzaldehyde and di-tert-butyl 2,6-octadiene-1,8-dioate in 
the presence of n-BuLi afforded a highly functionalized domino product in a good yield. The 
mechanism involves aza-Michael/Michael/aldol reactions in a domino process. 
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Scheme  1.34 
Wang and co-workers138 have reported a convenient synthesis of heterocycles 177 through 
aza-Michael addition reaction. The pyridyl group of a chiral amino amide 175 activated the 
Michael acceptor 176 under acidic conditions, and acted as a directing group to place the 
enone and secondary amine in a favourable position for aza-Michael addition.  
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1.3.5. Multicomponent Ugi reactions 
The Ugi reaction was first described in 1959 and has been more widely studied and used than 
any other multicomponent reactions121. It is a four component reaction of carbonyl compound 
(usually an aldehyde), amine, an isocyanide and a carboxylic acid (or alcohol) to produce α-
amino acid derivatives. The reaction generally proceeds through in situ formation of the 
imine from aldehyde or ketone and primary amine and is followed by the α-addition of 
isocyanide to this imine and reaction with the carboxylic acid. Subsequent rearrangement 
affords the α-amino acid derivatives. 
An interesting route to highly fuctionalized chiral dihydroisoquinolines and isoindoles was 
reported by Dyker et al. based on asymmetric four component Ugi reaction involving an 
amino acid such as L-valine as a chiral auxiliary139. The reaction between L-valine, methanol, 
a benzaldehyde (carrying an alkyne) and t-butyl isocyanide gave highly fuctionalised amines. 
Gold-catalysed intramolecular hydroamination of these products afforded the isoindoles and 
dihydroisoquinolines. 
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Scheme  1.36 
 
Guanti and co-workers140 have used optically pure (-)-N-allyl-3-amino-7-oxa-[2.2.1]-
bicyclohept-5-en-2-carboxylic acid 181 in a four component Ugi reaction. The reaction of 
acid with aldehydes and isocyanides in methanol at room temperature for 48-72 h resulted in 
the synthesis of corresponding Ugi products 182. Subsequent ring opening/ring closing 
metathesis afforded a series of enantiopure highly functionalised products.     
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Scheme  1.37 
The same group has also reported the synthesis of two families of regioisomeric 
polyfunctionalised cyclohexenols141 from other oxabicycloheptene based ȕ-amino acids by 
combining four component Ugi reaction with subsequent Pd-catalyzed ring opening reaction.    
A series of ȕ-amino acids have been used in a three component Ugi reaction with isocyanides 
and aldehydes to construct ȕ-lactam libraries142,143. Water as a solvent has been used in these 
reactions which showed better reactivity than methanol as a solvent and, with the final 
products 184 being water insoluble, made the purification easy by simple filtration. 
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Scheme  1.38 
 
1.3.6. Multicomponent reactions initiated by allylation reaction  
Stereoselective allylation of aldehydes is useful because the resulting chiral homoallylic 
ethers are important building blocks in the synthesis of a number of biologically active 
natural products. Tietze et al. have developed a stereoselective synthesis of such ethers 
through a domino three component allylation reaction of aldehydes and allyl trimethyl silane 
using trimethylsilyl ether 185 as a chiral auxiliary 144-147.  
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Scheme  1.39 
 
1.3.7. Miscellaneous multicomponent reactions 
1.3.7.1. Metal catalyzed multicomponent reactions 
A Rh(II) catalyzed diastereoselective three component reactions of chiral α-
methylbenzylimines, benzaldehyde and ethyl diazoacetate has been used to furnish 
oxazolines148. The oxazolines can be hydrolyzed with TsOH to form syn-α-hydroxy-ȕ-amino 
esters. These compounds can be used in the synthesis of different chiral ligands149 and also 
constitute important building blocks in the synthesis of natural products and other 
biologically active compounds150,151. 
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Scheme  1.40 
Sato and co-workers have reported a nickel catalyzed asymmetric synthesis of Ȗ-
siloxyenamides 192152. The reaction involves the diastereoselective coupling of chiral 
oxazolidinone derived ynamides, aldehydes and triethylsilane.  
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Garner et al. have reported a copper catalyzed synthesis of highly functionalized pyrrolidines 
195 through a three component process153. The mechanism involves the reaction between a 
chiral sultam 193 and aldehyde to form an imine which forms a azomethine ylide which 
undergoes 1,3-dipolar cycloaddition with activated alkenes to form the products. 
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Scheme  1.42 
Che and co-workers have used gold(III) as a catalyst in an asymmetric three component 
coupling of chiral prolinol derivatives, aldehydes and alkynes to form chiral propargylamines 
in good yields154,155. 
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Scheme  1.43 
 
1.3.7.2. Multicomponent reaction of a chiral diamine  
Rodriguez and co-workers have reported a multicomponent reaction in which ȕ-ketoamides 
199, aryl aldehydes and cyclic or acyclic 1,2-diamines give 1,4-diazepines in good yields 
with high diastereoselectivity156. In some cases simple heating of the substrate mixture at 120 
oC without solvent gave a better result than heating in toluene at reflux. The authors used the 
same methodology for ȕ-ketoesters in reaction with aryl aldehydes and 1,2-diamines to 
furnish other 1,4-diazepine derivatives.   
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Scheme  1.44 
As a result of some interesting results with aryl azides (see later), we decided to explore some 
multicomponent reactions of 2-azidobenzaldehyde, with a particular focus on using the azide 
to perform further chemistry. 
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2. Results and Discussion 
2.1   Aim of the work and outline of discussion 
Cyclic imines are known to be reactive towards cyclopropenones157-160 and 1,3-dipoles70,161 to 
form the bicyclic adducts. Some work in the Hemming group has already been done to 
investigate the reactivity of different cyclic imines towards cyclopropenones and 1,3-dipoles. 
Based on previous observations in the group the overall aim of this project is to further 
develop cyclopropenones, which are 1,3-dipole equivalents, and other 1,3-dipoles and to look 
at their reactions with cyclic imines. For this purpose different cyclic imines will be used and 
different cyclopropenones and 1,3-dipoles will be tried. The first part of this thesis will 
describe the synthesis of simple 7-, 6- and 5-membered cyclic imines and the exploration of 
their reactivity with cyclopropenones, as well as an investigation of the chemistry of their 
products. The general process is summarised below. 
N N
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+ ?
nn
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Scheme  2.1 
The second part of the discussion will describe the synthesis of four and three membered 
cyclic imines and their reactivity with cyclopropenones and/or 1,3-dipoles. The reactivity of 
the  bicyclic adducts made from four membered cyclic imines (1-azetines) and 
cyclopropenones and 1,3-dipoles will also be described. 
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Scheme  2.2 
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The third part of the discussion will deal with a class of cyclic imines made from 
benzodiazepines and the reactivity of these towards cyclopropenones and 1,3-dipoles with the 
goal to convert them into pyrrolobenzodiazepines and oxadiazolobenzodiazepines, 
respectively.  
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This section of the work will also deal with the use of pyrrolobenzodiazepines themselves as 
starting materials for the synthesis of tetracyclic benzodiazepines: 
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Scheme  2.4 
 
In all of these reactions, the cyclopropenone, although not a 1,3-dipole, is behaving as if it 
was an all-carbon 1,3-dipole. Therefore, this thesis will also look at the reactions of several of 
the above cyclic imines with 1,3-dipoles such as nitrile oxides and nitrile imines. One of the 
nitrile oxides discussed is 2-azidobenzonitrile oxide, and azide chemistry is a strong theme in 
the group. 
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The last part of the discussion will follow this interest and will describe the chemistry of 2-
azidobenzaldehyde in multicomponent reactions with cyanides and dicarbonyl compounds, 
where the presence of azide, carbonyl and nitrile groups in the product can lead to different 
possibilities such as Staudinger-aza-Wittig sequences to form cyclic imines or azide-nitrile 
intramolecular cyclization to form a tetrazole ring. An example is shown in scheme 2.5:  
                  
N3
H
O
R1 R2
O O
CN
Amine
+ +
+
O
R1OC
R2 R
CN
N3
210 211 212
R
 
Scheme  2.5 
 
2.2 Synthesis and reactivity of 7-, 6- and 5-membered cyclic imines 
 
As the major part of this thesis revolves around the investigation of the reactivity of different 
cyclic imines with cyclopropenones and 1,3-dipoles, the first task was to synthesize 7-, 6- and 
5-membered cyclic imnes and react them with cyclopropenones to give pyrroloazepine, 
indolizidine and pyrrolizidine respectively as products and to further investigate the reactivity 
of these products. 
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Scheme  2.6 
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The reason for selecting these systems was that pyrroloazepines, indolizidines and 
pyrrolizidines are naturally occurring alkaloids which exhibit pharmacological properties and 
have attracted attention of synthetic chemists 162-164. Pyrroloazepines such as bicyclic lactams 
216 are believed to have potential to be used as protease inhibitors which are implicated in a 
range of diseases such as rheumatoid arthritis and cystic fibrosis165,166. Indolizidines and 
pyrrolizidines are potentially important in the treatment of viral infections (such as HIV), 
diabetes (type II), cancer lines and of several neurological disorders.   
 
                                                             
N
R
AcHN
CO2HO
216  
Fig.   2.1 
 
Syntheses of pyrroloazepines, indolizidines and pyrrolizidines have been reported frequently 
in the literature. For example, Marsden and co-workers167 have reported the synthesis of 
indolizidines and pyrroloazepines via an intramolecular Schmidt reaction of azido 1,3-
diketones which were prepared from 2-methylcyclopentane 1,3-dione or cyclohexane 1,3-
dione, as shown below.   
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Scheme  2.7 
 
Tamayo and co-workers have reported the synthesis of pyrrolizidines 227 and 
polyhydroxylated indolizidines 228 via pyrroloisoxazolidines 226 produced as a result of 1, 
3-dipolar cycloaddition of nitrones with 3-buten-1,2-diol derivatives which were prepared 
chemoenzymatically. N-O cleavage by using Zn/AcOH and deprotection of protecting groups 
gave the target molecules168. 
Li et al. have also used aza-sugar nitrones to produce indolizidines containing an amino 
group, using an intramolecular cycloamidation169.  
 
44 
 
N
O N
N
N
O
OBn
OBn
OBn
OBnH H
OH
OHOBn
H
OPG
GPO
OBn OH
HO
OH
HO
HO
H OH
OH
HO
GPO
OPG
225 226 227
228
Scheme 2.8 
In our approach, based on the previous work done in the group, pyrroloazepines, 
indolizidines and pyrrolizidines were accessed via reaction of cyclic imines and 
cyclopropenones. This approach would produce the compounds of general structure 229-231, 
which have been made once before in the group, but whose chemistry had not been explored. 
The first task of this PhD project was to resynthesize these compounds, optimize the 
reactions and explore the chemistry of the adducts 229-231. 
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Fig.  2.2 
This necessitated the synthesis of the cyclic imines 232-234 shown in figure 2.3 below, which 
are accessible from the readily available corresponding lactams. 
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Fig.  2.3 
2.2.1.  Synthesis of 7-, 6- and 5-membered cyclic imines 
Synthesis of these imines started with the thionation of corresponding lactams i.e. İ-
caprolactam, valerolactam and 2-pyrrolidone respectively. 
 
2.2.1.1.  Thionation of lactams   
Thionation of the lactams was achieved using δawesson’s reagent, which has been widely 
used since 1978170-172 as a thionating reagent. It requires only mild conditions, gives high 
yields and is commercially available. There is another reagent, phosphorus pentasulfide170, 
which has been used for thionation but recently Bergman173 et al. reported a P4S10.pyridine 
complex as a thionating reagent which can be used in more polar solvents like DMSO, DMF 
and at higher temperatures, with an easy non-chromatographic work-up. This complex will be 
discussed in detail in a later part of this discussion. 
İ-Caprolactam was thiated with δawesson’s reagent, the reaction yielded the corresponding 
thiolactam in 95 % yield.  
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Scheme  2.9 
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δawesson’s reagent produces a ylidic intermediate as a result of breaking the sulfur-
phosphorus bond at higher temperature. This specie, acting as a nucleophile, attacks the 
carbonyl of the lactam and after rearrangement via a four membered complex yields the 
thiolactam.  
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Scheme  2.10 
The structure of İ-caprothiolactam was confirmed by IR and NMR. 1H NMR showed signals 
in ratio of 2:2:2:2:2:1 for five sets of CH2 and one NH which appeared at 9.19 ppm. 13C NMR 
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showed the distinctive peak of C=S at 210.31 while IR showed the thiocarbonyl signal at 
1552 cm-1 confirming the product as thiolactam.   
Valerolactam was thionated by using the same method as for İ-caprolactam to get the 
valerothiolactam as white crystals in 84 % yield.  
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Scheme  2.11 
Spectroscopic analysis showed the secondary thioamide peak at 9.53 ppm and the CH2 
neighbouring C=S at 2.82 ppm as a triplet, with the rest of the protons for the other CH2 
groups appearing as multiplets. 13C NMR peaks for the four CH2s appeared in the region 
between 20-45 ppm while the C=S peak appeared at 202.11 ppm to confirm the thionation of 
the valerolactam. 
 
  
Pyrrolidine-2-one was thionated with δawesson’s reagent in THF to get the product in 90 % 
yield as white crystals.  
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Scheme  2.12    
The product showed the expected spectroscopic characteristics, for example, the presence of 
a broad signal at 3139 cm-1 in the IR spectrum with a broad peak at 8.74 ppm in the 1H NMR 
spectrum to confirm the presence of the thioamide group. A triplet at 3.63 ppm in the 1H 
NMR spectrum confirms the CH2 neighbouring the thioamide and a triplet at 2.92 ppm 
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confirmed the CH2 next to C=S. 13C NMR showed a peak at 206.07 ppm to confirm the 
presence of the thiocarbonyl.  
 
2.2.2. Reactivity of 7-, 6- and 5-membered cyclic imines with 
cyclopropenones.  
Thiolactams were alkylated with dimethyl sulfate to give the crude cyclic imines which were 
used directly in reaction with cyclopropenones. These cyclic imines were found to be volatile 
and unstable so, it was decided to not purify them and use them directly for reaction with 
cyclopropenones. It is worth noting at this point that the alkoxy compounds, whilst stable, 
were unreactive. This thesis focuses entirely on alkylthio compounds. 
 
2.2.2.1 Synthesis of 2-methylthio-1-azepan and its reactivity with 
diphenylcyclopropenone. 
Alkylation of azepan-2-thione with dimethyl sulfate resulted in the synthesis of the desired 
cyclic imine. Work up was done with potassium carbonate, and diphenylcyclopropenone was 
added to a solution of the imine in acetonitrile. Compound 249, the desired bicyclic adduct 
was isolated in 59 % yield, a significant improvement on the previous results in the group 
which had used εeerwein’s reagent to alkylate with attempted isolation of the imine.    
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Scheme  2.13 
Spectroscopic analysis confirmed the synthesis of compound 249. The 1H NMR spectrum 
showed ten aromatic protons in the region between 7.53-6.98 as four sets of multiplets 
confirming the presence of two phenyl groups. The ten protons of the five aliphatic ring CH2s 
appeared between 3.82-1.01 while disappearance of the thioamide proton and appearance of a 
49 
 
singlet at 1.97 integrating for three hydrogens confirmed the presence of thiomethyl moiety in 
the molecule.  
The 13C NMR spectrum showed six CH carbons and four quaternary carbons between 
113.21-174.29, and a peak at 197.63 ppm for the presence of carbonyl group. Five peaks for 
CH2s appeared between 43.32 to 23.95 ppm while a peak at 11.56 confirmed the presence of 
methyl group. A consistent HRMS measurement confirmed the assignment.  
Alkylation of thiolactam involves an attack from the thiolactam sulfur to dimethyl sulfate to 
form the imine. The presence of the electron donating thiomethyl group increases the 
nucleophilicity of the nitrogen; as a result nucleophilic attack from nitrogen to 
cyclopropenone, which is behaving as a Michael acceptor, allows an intermediate 254 to be 
proposed. The enolate of intermediate 254 undergoes an intramolecular attack on the 
electrophilic carbon followed by ring expansion of the cyclopropenone to form the product 
255.   
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Scheme  2.14 
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After confirming the product as 7-methylthio-9,10-diphenyl-1-azabicyclo[5.3.0]dec-9-en-8-
one, the next step was to investigate its reactivity.  
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Scheme  2.15 
On the basis of a previous observation in the group, it was envisaged that this compound 
might undergo a heat promoted reaction, but when it was subjected to boiling toluene or 
xylene it was found to be very stable and no product could be found even after 72 hours of 
heating. Heating in other solvents such as dichlorobenzene similarly showed no reaction.   
2.2.2.2 Synthesis of 2-methylthio-1-piperidine and its reactivity with 
diphenylcyclopropenone. 
Valerothiolactam was alkylated with dimethyl sulfate using the same method as for the 
synthesis of 7-membered cyclic imines described in section 2.2.2.1 and 
diphenylcyclopropenone was added to the mixture of imine to form the product, 6-
methylthio-8,9-diphenyl-1-azabicyclo[4.3.0]non-8-en-7-one, in 55 % yield. 
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Scheme  2.16 
The product showed the expected spectroscopic characteristics; for example the presence of 
ten aromatic protons between 7.00-7.52 ppm and eight protons of four CH2s between 3.65-
1.29 ppm in the 1H NMR spectrum. A singlet at 1.98 showed the three protons of SCH3, 
whereas the thioamide NH group had disappeared. 13C NMR spectroscopy confirmed the 
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eight aromatic signals between 125.23 to 131.65 and the quaternary carbon of the bridgehead 
was seen at 72.19 ppm. A peak at 198.75 ppm confirmed the presence of the carbonyl which 
was also confirmed by the IR spectrum with a peak at 1655 cm-1. Mass spectrometry 
confirmed the exact mass of the compound. 
Next, the reactivity of the adduct 257 was explored by heating it in boiling toluene as other 
workers in the group had observed a one-spot to one-spot transformation under such 
conditions. However, on this occasion, the compound 257 was found to be very stable and the 
starting material was fully recovered after purification with column chromatography. Heating 
in the higher boiling xylene gave similar results, whilst even higher boiling solvents e.g. 
dichlorobenzene resulted in degradation of compound 257.   
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Scheme  2.17 
 
In another attempt, also showed in scheme 2.17, above, adduct 257 was mixed with DMAD 
and heated in toluene in order to investigate its potential [2+2] cycloaddition reactivity with 
DMAD. However, no product was observed and the starting material was recovered after the 
purification. This concept builds on the work of Stanovnik174 who has shown that acyclic 
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enaminones 260 and cyclic enaminones 262 react with DMAD to form ring expanded 
products 261 and 263 in 70 and 73 % after [2+2] cycloaddition, as shown in scheme 2.18.  
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Scheme  2.18 
It was assumed that alkene of compound 257 is unreactive because of it being in a more 
conjugated and stable system. For this reason, a non-phenyl substituted system was 
synthesized using the parent cyclopropenone rather that DPP, as described below.  
 
2.2.2.3 Synthesis of 5-(methylthio)-3,4-dihydro-2H-pyrrole and its reactivity with 
cyclopropenone. 
The alkylation of pyrrolidine-2-thione was performed with εeerwein’s reagent in DCM and 
work up was done with aqueous potassium carbonate to release the imine from its HBF4 salt. 
This imine was also found volatile and was used as crude for cycloaddition with 
cyclopropenone.  Crude cyclopropenone acetal (available from another worker in the group) 
was treated with Amberlyst 15 in acetone to perform a deprotection and generate 
cyclopropenone. After 30 min. of stirring, deprotection was completed, as monitored by TLC, 
and confirmed by IR spectroscopy. The resulting mixture was added to the mixture of 2-
methylthio-1-pyrroline in dry acetonitrile to give the product 7a-(methylthio)-5,6,7,7a-
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tetrahydro-pyrrolizin-1-one 265 in 18 % yield as a yellow oil. Some attempts were made to 
get a better yield but due to the unstability of both the cyclopropenone and the imine, it was 
impossible to improve the yield. 
Me3OBF4
N
S
H
CH3CN
N
SMe
N
SMe O
O
247 264 265
 
Scheme  2.19 
The structure of the product 265 was confirmed by spectroscopic analysis. The 1H NMR 
spectrum shows signals for the protons at ȕ and α positions of the unsaturated carbonyl at 
7.77 and 5.35 ppm respectively, both as doublets with a coupling constant 3.5 Hz. The signals 
for six aliphatic protons appeared between 1.85 to 3.56 ppm whilst one singlet at 1.96 ppm 
integrated as three protons confirming the presence of the thiomethyl moiety. 
The 13C NMR spectrum showed the carbonyl signal at β0γ.54 ppm and signals for ȕ and α 
carbon of the unsaturated carbonyl at 169.00 and 105.24 ppm, respectively. Three peaks for 
the CH2s appear between 48.46 to 27.07 ppm and a peak at 11.84 confirmed the thiomethyl 
moiety. The IR spectrum confirmed the presence of carbonyl with a peak at 1681 cm-1.      
It was anticipated that our system, now lacking phenyl groups, might react with DMAD to do 
the cycloaddition shown below, as precedented by the work shown in scheme 2.18, above, 
developed by Stanovnik. 
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Scheme  2.20 
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So, compound 265 was mixed with DMAD in acetonitrile and heated at reflux for 12 hours; 
however, no product was formed although starting material could not be recovered because of 
its decomposition. The failure of 5-, 6- and 7-membered cyclic imine cyclopropenone adducts 
to react meant that a change of direction was taken. Next, we turned our focus towards 
smaller ring systems like 1-azetines and 1-azirines, 4-membered and 3-membered cyclic 
imines respectively. Explored was their reactivity against cyclopropenones and 1,3-dipoles 
and the chemistry  of the products (bicyclic systems) that were expected to be formed once 
the 1-azetines and 1-azirines had reacted was also investigated.   
2.3  Synthesis and reactivity of 4- and 3-membered cyclic imines. 
2.3.1 Synthesis of 1-azetines 
Several synthetic routes to 1-azetines have been described in the literature. Treatment of 
phosgene 268 with dimethylamides 267 in the presence of triethylamine gives α-
chloroenamines 271 which upon forming benzhydryl imines produce 2-dimethylamino-1-
azetines 275 after ion exchange, hydrogenation and basification175.  
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Some photochemical syntheses176,177 of 1-azetines have been reported via photocyclization of 
substituted alpha-dehydrophenylalanines but this has got some limitations. Nucleophilic 
addition of trichloromethyllithium to 1-azirine 276 has resulted in the synthesis of 2,3-
dichloro-1-azetine 280 after the basification with potassium tert-butoxide whereas treatment 
with sodium methoxide resulted in the synthesis of 2-methoxy-1-azetines 281178,179.            
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Scheme  2.22 
Thermal rearrangement of 1-(alkylthio)-cyclopropyl azides leads to 2-alkylthio-1-azetines180 
whereas thermal ring expansion of cyclopropyl azides led to simple alkyl and aryl-1-
azetines181,182. 1-Azetines are formed as a result of O-alkylation and S-alkylation of azetidine-
2-one and azetidine-2-thione (formed after thionation of azetidine-2-one) with trialkylfluoro 
tetraborates followed by basification 183-186, a route used successfully by other workers in the 
group. 
Keeping in view the previous studies, it was decided to adopt the latter route for the synthesis 
of 1-azetines.   
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2.3.1.1 Synthesis of 4-aryl-1-azetines 
2.3.1.1.1 Synthesis of 4-aryl-azetidinones 
 
As a first step towards the synthesis of 4-aryl-1-azetines, it was necessary to first synthesize 
4-aryl-1-azetidine-2-ones which were easily accessed using a literature method 187-190. A 
[2+2] cycloaddition between a styrene and chlorosulfonyl isocyanate resulted in the synthesis 
of a  chlorosulfonyl ȕ-lactam which was reduced by sodium sulfite and sodium carbonate to 
the 4-aryl-1-azetidine-2-one.   
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Scheme  2.23 
Spectroscopic characteristics of the compounds 285a-c evidenced the structures of the 
azetidinones. 4-Phenyl-1-azetidine-2-one was obtained in 79 % yield as a white solid. 
The 1H NMR spectrum of 285a showed five aromatic protons at 7.34 ppm as a multiplet and 
a broad peak at 6.97 ppm confirming the amide group in the compound, other peaks 
confirmed the ring formation showing the benzylic proton as a doublet of doublets at 4.67 
ppm with J = 5.2 and 2.3 Hz confirming the coupling with both hydrogens of CH2 in the ring. 
Two signals at 3.38 and 2.80 ppm respectively confirmed two protons of CH2 of the ring with 
a geminal coupling constant J = 14.8 Hz. The 13C NMR spectrum showed a peak at 168.48 
ppm for the carbonyl group, four aromatic signals, a peak at 50.15 for CH and a peak at 47.60 
for CH2. The IR spectrum showed a peak at 1705 cm-1 to confirm the carbonyl group and 
mass spectrometry further confirmed the structure of the compound. 
Compound 285b was produced in 83 % yield as a white solid showed the expected 
spectroscopic characteristics. The 1H NMR spectrum showed four aromatic protons as two 
doublets between 7.20-7.27 ppm. A broad peak at 6.74 confirmed the NH and a doublet of 
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doublets at 4.69 ppm confirmed the benzylic proton of the ring. Two signals at 3.42 and 2.84 
ppm respectively confirmed two protons of CH2 of the ring and a singlet at 2.37 ppm 
integrating to three protons confirmed the methyl of tolyl moiety. The 13C NMR spectrum 
evidenced the presence of a carbonyl group with a peak at 168.63 ppm and tolyl group with 
four aromatic peaks and a peak at 21.19 ppm for methyl group. Ring formation was 
evidenced by the presence of a signal at 50.37 for CH and another at 47.93 for CH2. The IR 
and MS data further confirmed the structure of 4-tolyl-azetidinone. 
Spectroscopic analysis of 4-naphthyl-1-azetidine-2-one 285c (obtained in 64 % yield as a 
white solid), confirmed the structure of the compound. The 1H NMR spectrum showed 
signals for seven aromatic protons and a broad signal at 6.69 ppm for the amide moiety. A 
doublet of doublets at 4.85 ppm confirmed the presence of the benzylic proton, whereas the 
two protons of CH2 were evidenced by two different signals at 3.52 and 2.84 ppm 
respectively. In the 13C NMR spectrum the carbonyl group was evidenced by a peak at 168.4 
ppm and ten signals in aromatic region confirmed the naphthyl moiety. Peaks at 50.58 ppm 
and 47.90 ppm respectively confirmed the CH and CH2 of the ring. The IR spectrum showed 
a peak at 1709 cm-1 to further confirm the presence of a carbonyl group. 
2.3.1.1.2 Synthesis of 4-aryl-1-azetidine-2-thiones 
To convert azetidines to 1-azetines it was necessary to do the thionation of azetidines first 
and then do thioalkylation to produce 1-azetines. Alkoxy azetines are known to be less stable 
than thioalkyl azetines157 and hence it was decided to thionate the azetidines. δawesson’s 
reagent was selected to use for thionation. Although there are some other thionating reagents 
in use which will be discussed later in this thesis, δawesson’s reagent was selected because of 
its commercial availability and high yields.    
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Scheme  2.24 
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Thionation was conducted in dry THF and thionation of 4-phenyl-1-azetidine-2-one gave 48 
% yield of thiolactam as a white solid. The structure of 4-phenyl-1-azetidine-2-thione was 
confirmed by IR and NMR spectroscopic analysis. The 1H NMR spectrum showed a shift in 
the amide peak from 6.97 ppm to 8.28 ppm while the presence of the four-membered ring 
was confirmed by the doublet of doublets at 5.18 ppm indicating the benzylic proton. Two 
signals at 3.51 and 3.02 ppm showed the two protons of CH2. In the 13C NMR spectrum, the 
main evidence was provided by the shifting of (C=O) peak from 168.48 ppm to (C=S) peak at 
204.42 ppm which was also confirmed by a shift in absorption in the IR spectrum from 1705 
cm-1 to 1486 cm-1. 
Compound 286 b & c gave spectroscopic data that similarly confirmed successful 
thionations.  
2.3.1.1.3 Alkylation of 4-aryl-1-azetidine-2-thiones : Synthesis of 4-aryl-1-
azetines 
Thiolactams were converted to 1-azetines through alkylation with dimethyl sulfate or 
εeerwein’s reagent (trimethyl or triethyl oxonium tetrafluoroborate). There are many 
alkylating reagents available but εeerwein’s reagent was selected because of its good yields 
in O- or S-alkylations as well as its success in regioselective alkylation of similar ȕ-lactams 
and ȕ-thiolactams157,161,191, whereby species such as ȕ-lactams, ȕ-thiolactams, thiocyanates 
and pyridine-2-one might undergo N-alkylation as well. Halides192,193, diazomethane194,195, 
diazoethane196, tosylates197 and dimethyl sulfate198 are other commonly used alkylating 
reagents for such species.   
In our strategy, dimethyl sulfate was used first for the alkylation of thiolactams but due to 
low yields this was not pursued with and alkylation of all thiolactams was performed with 
Meerwein’s salts in dry DCM and worked up with potassium carbonate as a base to form 
imines. The volatility of these compounds and difficulty in isolation often resulted in low 
yields (Table 2.1), sometimes due to hydrolysis which reformed the original lactam.  
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No Product  Ar  R % Yield  
1 A  Phenyl  Me 43 
2 B  Phenyl  Et 54 
3 C  Tolyl  Me 41 
4 D  Tolyl  Et 38 
5 E  Naphthyl  Me 40 
 
Table. 2.1 Substituents of 1-azetines 287 
2-Methylthio-4-phenyl-1-azetine 287a was obtained as an orange oil in 43 % yield; the 
formation of imine was evidenced by appearance of a singlet at 2.48 ppm in the 1H NMR 
spectrum integrating for the three protons of the thiomethyl moiety, and the disappearance of 
the broad singlet of the amide at 8.28 ppm. A doublet of doublets at 5.25 with J = 4.3 and 1.9 
Hz confirmed the benzylic proton, and two signals at 3.56 and 2.95 ppm evidenced the two 
protons of the CH2. The 13C NMR spectrum showed a peak at 11.51 ppm for SMe and a shift 
of the peak at 204.42 ppm (C=S) to 183.31 ppm (C=N), which was also confirmed by IR 
spectroscopy, where a shift in absorption from 1486 cm-1 to 1655 cm-1 confirmed the S-
alkylation. MS data further confirmed the structure of compound 287a. 
Compound 287b showed the expected spectroscopic characteristics. The IR spectrum of the 
compound showed no bands for the thioamide but instead showed a new peak at 1655 cm-1 
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confirming (C=N). The 1H NMR spectrum showed the presence of ethyl group with a quartet 
at 3.06 ppm and a triplet at 1.40 ppm, with disappearance of the thioamide NH peak further 
confirming the S-alkylation. The loss of C=S peak in the 13C NMR spectrum and appearance 
of new quaternary carbon at 183.56 ppm confirmed that S-alkylation had occurred and not N-
alkylation. High resolution mass spectroscopy data was also consistent with the assigned 
structure. 
S-alkylation of 4-tolyl-1-azetidine-2-thione resulted in the synthesis of 2-methylthio-4-tolyl-
1-azetine as an orange oil in 41 % yield. Spectroscopic analysis of the compound again 
confirmed the structure.  
Compound 287d yielded in 38 % as an orange oil, showed spectroscopic characteristics 
consistent with the assigned structure.  
2-Methylthio-4-naphthyl-1-azetine was synthesized as an orange oil in 40 % yield. The 
evidence of the structure was provided by spectroscopic analysis. The main evidence was 
provided by the appearance of a singlet at 2.41 ppm in the 1H NMR spectrum for the three 
protons of the thiomethyl moiety and loss of the thioamide NH peak at 7.34 ppm. The 
presence of the ring was confirmed by a doublet of doublets at 5.07 ppm showing the 
benzylic proton and two more doublets of doublets at 3.51 and 2.94 ppm confirming the 
presence of the two protons of the CH2. The 13C NMR spectrum provided further evidence of 
S-alkylation with a peak at 183.35 ppm for C=N and loss of the C=S signal from 204.41 ppm, 
whilst the IR spectrum showed a peak at 1609 cm-1 confirming the S-alkylation as a result of 
the formation of the 1-azetine. HRMS data was also consistent with the assigned structure.        
Synthesis of the 1-azetines proceeds through the following proposed mechanism: 
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Scheme  2.26 
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It was observed that 2-methylthio-4-naphthyl-1-azetine was unstable at room temperature and 
underwent quantitative conversion to 2-methylthio-benzoquinoline after 24 hours. The 
structure was assigned to the product after spectroscopic analysis. 1H NMR spectrum showed 
one singlet at 2.83 ppm confirming the presence of the thiomethyl moiety with the rest of the 
signals showing as eight aromatic protons indicating the emergence of a new aromatic ring. 
This was further confirmed by loss of the three doublets of doublets at 5.07, 3.51 and 2.94 
ppm, respectively. The 13C NMR spectrum showed one signal at 13.26 ppm for thiomethyl 
group, together with five quaternary carbons and eight CH signals between 120.87 and 
158.51 which confirmed the presence of three aromatic rings and the loss of the four 
membered ring of the azetine. HRMS data was also consistent with the assigned structure. It 
showed a mass of 226.0684 for a calculated mass of 226.0692 confirming the product as 2-
methylbenzoquinoline, a process that involves loss of two hydrogen atoms. 
It is proposed that a [2 +2] ring opening occurred to form a vinylic imine which undergoes an 
intramolecular rearrangement and aromatisation via loss of hydrogen to form the 
benzoquinoline.  Other examples of this type of rearrangement have recently been observed 
by other workers in the group, but this is the only example observed in this work.    
 
N
SMe
N SMe N
SMe
N
H H H
N
SMeSMe
-H2
aromatisation
289 290 291
292 293
 
Scheme  2.27 
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2.3.1.2 Synthesis of 3,3,4,4-tetramethyl-1-azetines 
2.3.1.2.1 Synthesis of 3,3,4,4-tetramethyl-1-azetidine-2-one 
The same protocol was followed as above. Thus, the ȕ-lactam ring was formed as a result of 
[2+2]-cycloaddition of 2,3-dimethylbut-2-ene with chlorosulfonyl isocyanate after which 
reduction with sodium sulfite and sodium carbonate afforded the ȕ-lactam in 71 % yield.  
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Scheme  2.28 
 
2.3.1.2.2 Synthesis of 3,3,4,4-tetramethyl-1-azetidine-2-thione 
Thionation of ȕ-lactam was conducted with δawesson’s reagent in dry THF to yield a white 
solid in 47 % as the thiolactam. The reaction proceeded with the same mechanism as 
described before. 
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Scheme  2.29 
The evidence of thionation was provided by IR spectroscopy with a shift in absorption from 
1703 cm-1 (C=O) to 1492 cm-1 (C=S) and was also confirmed by 13C NMR spectroscopy with 
a peak at 212.27 ppm for C=S and loss of the C=O peak from 174.91 ppm. 1H NMR 
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spectroscopy also showed a shift in NH peak from 6.02 to 8.23 ppm, a feature seen in all of 
the thionations reported above. 
 
2.3.1.2.3 Synthesis of 2-methylthio-3,3,4,4-tetramethyl-1-azetine 
Conversion of the thiolactam to the 1-azetine was performed by S-alkylation by using 
εeerwein’s reagent as described before to get β-methylthio-3,3,4,4-tetramethyl-1-azetine as a 
yellow oil in 31 % yield. Due to volatility and instability it proved hard to achieve a better 
yield. The structure of the compound was confirmed with NMR spectroscopy.  
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Scheme  2.30 
The 1H NMR spectrum showed three singlets altogether in a ratio of 2:2:1 confirming the five 
methyl groups of the compound. Two singlets at 1.26 and 1.12 ppm respectively integrated 
for six protons confirming two sets of methyl groups while a third singlet at 1.97 ppm 
evidenced the SMe confirming the S-alkylation of the azetidine-thione. The 13C NMR 
spectrum further provided evidence for azetine formation with a peak at 182.96 ppm for C=N 
and with the loss of the C=S peak from 212.27 ppm. Two quaternary carbons at 69.82 ppm 
and 51.34 ppm confirmed the presence of the remaining carbons. 
 
2.3.1.2.4 Synthesis of 2-ethylthio-3,3,4,4-tetramethyl-1-azetine 
εeerwein’s reagent was used to form 2-ethylthio-3,3,4,4-tetramethyl-1-azetine in 30 % yield 
as a yellow oil.  
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Scheme  2.31 
Spectroscopic analysis confirmed the structure, with the presence of ethyl group evidenced 
by a quartet at 2.96 and a triplet at 1.33 ppm in the 1H NMR spectrum. Four methyl groups 
were confirmed by two singlets at 1.25 ppm and 1.13 ppm. The structure was further 
confirmed by the 13C NMR spectrum with a shift in peak from 212.29 to 186.96 ppm 
establishing that it was S-alkylation and not N-alkylation.  
 
2.3.2 Reactivity of 1-azetines with cyclopropenones 
Based on the known reactivity of electron rich imines with cyclopropenones157,159,160, it was 
envisaged that the reaction of 1-azetines with cyclopropenones will give bicyclic compounds 
with the structure shown below. Such bicyclic systems might produce interesting results upon 
heating. 
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Scheme  2.32 
The chemistry and applications of cyclopropenones 199-201 and their acetals/ketals 202-204 has 
gained momentum in recent years and there have been several other reports of imines 
reacting with cyclopropenones157,159,205-208. The topic of 3-carbon 1,3-dipole equivalents is 
itself an important area due to the potential of such processes to provide access to 5-
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membered rings in [3+2]-cycloaddition reactions209-215, and it should be noted that the 
cyclopropenone is acting as an all-carbon 1,3-dipole equivalent in this reaction. 
The reaction of 2-methylthio-4-phenyl-1-azetine with diphenylcyclopropenone afforded the 
5-methylthio-2,3,7-triphenyl-1-azabicyclo[3.2.0]hept-2-en-4-one 301 as a yellow oil in 59 % 
yield as a mixture of diastereoisomers in a 4/5 ratio. 
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Scheme  2.33 
 
Spectroscopic analysis confirmed the structure of the product. The 1H NMR spectrum 
confirmed fifteen aromatic protons in the range of 6.81-7.51 ppm as a series of multiplets. All 
three protons of the four-membered ring appeared as two sets of signals showing the product 
as a mixture of diastereoisomers. Two sets of doublets of doublets at 5.58 and 4.25 ppm (J = 
8.1, 8.1 and 5.5, 9.6 Hz), respectively, confirmed the benzylic CH protons. The two protons 
of the CH2 appeared as four sets of doublets of doublets confirming the product as a mixture 
of diastereoisomers. One set of doublet of doublets appeared at 3.18 and 2.50 ppm (J = 9.6, 
12.6 and 5.5, 12.9 Hz) for one proton of CH2, whereas another set of doublet of doublets 
appeared at 2.97 and 3.03 (J = 8.1, 12.9 and 8.1, 12.6 Hz) to confirm the second proton of 
CH2. Two peaks at 2.14 and 2.08 evidenced the thiomethyl moiety and further indicated that 
the formation of the product occurred as a diastereomeric mixture. 
The 13C NMR spectrum further confirmed the formation of two diasteroisomers by showing 
double signals. For example, the signals for carbonyl appeared at 202.89 and 202.56 ppm. 
The unsaturated carbons of the enone appeared at 177.64 and 175.38 and at 126.33 and 
124.03 ppm. The benzylic CH of the ring appeared at 66.63 and 66.16 ppm, and the CH2 of 
the ring appeared at 31.29 and 29.90; the carbon of the thiomethyl was found at 11.92 and 
11.69 ppm. 
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In the next step, the reactivity of 5-methylthio-2,3,7-triphenyl-1-azabicyclo[3.2.0]hept-2-en-
4-one was investigated by heating it in boiling toluene. This resulted in the complete 
consumption of the starting material and formation of a new product identified as a 
tetrasubstituted pyridine as the only product, formed in 71 % yield as white crystals. 
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Scheme  2.34 
Spectroscopic analysis was performed to assign a structure to the product. The 1H NMR 
spectrum showed a singlet at 2.7 ppm integrating to three protons indicating the presence of 
the thiomethyl group; the rest of signals were in the aromatic region only. There were no 
signals to indicate the presence of the four membered ring which means loss of the four 
membered ring of the bicyclic adduct has occurred. In the aromatic region, signals ranging 
from 6.87 to 7.35 ppm confirmed the presence of sixteen protons which indicates the 
presence of three phenyl groups and one more proton which appeared as a singlet at 7.23 ppm 
confirming that it could belong to the pyridine ring. The formation of the pyridine ring was 
further evidenced by the 13C NMR spectrum showing the loss of carbonyl group from 202.89 
and 202.56 ppm, and loss of the carbon peaks of the four-membered ring. The presence of ten 
CH peaks and seven quaternary carbons in the aromatic region indicated that three phenyl 
groups are substituted to a tetrasubstituted pyridine ring; the fourth substituent is SMe which 
appeared at 13.39 ppm in 13C NMR spectrum. IR spectroscopy and HRMS further confirmed 
the structure of the product as 2,3,4-triphenyl-6-methylthio-1-pyridine. 
After the characterization of the product as a tetrasubstituted pyridine and keeping in mind 
the structure of the starting material, it is suggested that formation of this pyridine occurred 
through the reaction mechanism shown below. 
67 
 
        
N
O
R2
R1
RS
Ar
N
Ar
R2
R1RS
N
O
R2
R1
Ar
RS
+
N
Ar
R2
R1
RS
O- CO, - H2
303 304 305
306307
retro [2+2]
 
Scheme  2.35 
 
The first step of the suggested mechanism involves [2+2] cycloreversion of the bicyclic 
compound 303 to generate a styrene and an intermediate azacyclopentadienone 305. These 
two species then undergo a regioselective [4+2] cycloaddition to form the intermediate 306. 
Chelotropic extrusion of carbon monoxide and aromatization by loss of hydrogen results in 
the synthesis of the pyridine, as shown in scheme 2.35.  
The synthesis of the pyridine through this mechanism is equivalent to a well known process 
216-221
 by which the corresponding all carbon diene, cyclopentadienone, is used to access the 
benzene ring. The azacyclopentadienone ring is rare due to the difficulties in accessing this 
elusive system in a stable form, but its formation and use are known 222-225. Of particular 
relevance to our work is specie 308.  
                                                                           
N
O
308                                                                           
                                                               Fig.  2.4 
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This has been generated from a polymeric 5-sulfonate of 3-pyrrolin-2-one and shown to act 
as a diene toward a polymer supported alkyne, allowing access to one example of a pyridine 
ring226.                                    
Based upon the result shown in scheme 2.35 with compound 303a with compound 301, it 
was decided to explore this reaction fully. This necessitated the syntheses of some other 
azabicyclo[3.2.0]hept-2-en-4-ones 303b-g to act as potential pyridine precursors. For this the 
series of 1-azetines 287a-e discussed above were reacted smoothly with cyclopropenones to 
give the azabicyclo[3.2.0]hept-2-en-4-ones 303b-g as shown in Table 2.2 below. These were 
found to be unstable mixtures of diastereoisomers, which were made and used within 24 
hours. 
 
Entry 
 
Product 
(303) 
 
Ar 
 
R 
 
R1 
 
R2 
 
% yield 
(303)  
1 a Ph Me Ph Ph 62 
2 b Ph Et Ph Ph 63 
3 c Ph Me H Ph 52 
4 d 4-Tol Me Ph Ph 63 
5 e 4-Tol
 
Et Ph Ph 66 
6 f 2-Naphth Me Ph Ph 51 
7 g Ph Et n-Bu n-Bu 58 
 
             Table 2.2. Synthesis of azabicyclo[3.2.0]hept-2-en-4-ones 303.  
 
Diphenylcyclopropenone was commercially available, phenylcyclopropenone was 
synthesized by another worker in the group by the cyclization of 1-bromo-3-chloro-3-phenyl 
acetone acetal227 and dibutylcyclopropenone was synthesized from the reaction of 
dichlorocarbene with 5-decyne and subsequent hydrolysis228. Each of the 
azabicyclo[3.2.0]hept-2-en-4-ones 303b-g gave the desired pyridines 307b-g when heated in 
xylene or toluene, as shown in the table below, in good to reasonable yields.   
69 
 
 
Entry 
 
Pyridine 
(307) 
 
Ar 
 
R 
 
R1 
 
R2 
 
% yield 
(307) 
1 a Ph Me Ph Ph 71 
2 b Ph Et Ph Ph 75 
3 c Ph Me H Ph 62 
4 d 4-Tol Me Ph Ph 79 
5 e 4-Tol
 
Et Ph Ph 72 
6 f 2-Naphth Me Ph Ph 69 
7 g Ph Et n-Bu n-Bu 73 
  
Table 2.3.  Synthesis of pyridines 307a-g from azabicyclo[3.2.0]hept-2-en-4-ones 303a-g. 
 
The synthesis of these azabicyclo[3.2.0]hept-2-en-4-ones and subsequent conversion into 
pyridines will be discussed in detail below. 
2.3.2.1 Synthesis and reactivity of 5-methylthio-3,7-diphenyl-1-
azabicyclo[3.2.0]hept-2-en-4-one. 
2-Methylthio-4-phenyl-1-azetine was reacted with phenylcyclopropenone, which was 
synthesized in the group using the method described above227, to give 5-methylthio-3,7-
diphenyl-1-azabicyclo[3.2.0]hept-2-en-4-one in 52 % yield as a yellow oil and as a mixture 
of diastereoisomers in a ~5/6 ratio. Phenylcyclopropenone gave only the 3-phenyl-1-
azabicyclo[3.2.0]hept-2-en-4-one regioisomer, possibly due to the 1-azetine attacking the 
least hindered cyclopropenone carbon.     
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Scheme  2.36 
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The spectroscopic analysis allowed us to assign a structure to the product. 1H NMR showed 
two singlets at 8.36 and 7.76 ppm to confirm the presence of the alkene proton of the five 
membered ring. Ten aromatic protons in the range of 7.26-7.85 ppm as a series of multiplets 
evidenced the presence of two phenyl groups. All three protons of the four-membered ring 
appeared as two sets of signals confirming that the product was a mixture of 
diastereoisomers. Two sets of doublet of doublets at 5.66 and 4.65 ppm with coupling 
constants J = 7.6, 9.6 and 5.2, 10.5 Hz, respectively, are consistent with a benzylic CH 
proton. The two protons of the CH2 of the ring appeared as four sets of doublets of doublets 
as expected for a mixture of diastereoisomers. One set of these doublets of doublets appeared 
at 3.06 and 3.00 ppm (J = 9.6, 12.6 and 9.6, 12.4 Hz) for one proton of CH2, whereas another 
set appeared at 2.83 and 2.48 ppm (J = 7.6, 12.4 and 5.2, 12.6 Hz). Two peaks at 2.04 and 
2.03 for the thiomethyl moiety completed the assignment of the 1H NMR spectrum. 
The structure of the product was further confirmed with a 13C NMR spectrum which showed 
double signals for the carbons as expected with two diasteroisomers. Signals for the carbonyl 
appeared at 203.13 and 201.74 ppm whereas peaks for the carbons of the alkene appeared at 
177.64, 175.38 and 126.33, 124.03 ppm, respectively. Double peaks for the four membered 
ring carbons and thiomethyl moiety completed a consistent assignment. The regiochemistry 
of the product was confirmed with the help of HMBC spectrum, which showed a clear CH to 
CH cross peak.  
Keeping in mind the successful thermolysis (scheme 2.35) of the azabicyclic adduct 303 to 
produce the pyridine 307, azabicyclic compound 310 was also treated with boiling toluene 
until disappearance of starting material. The process again afforded the pyridine 311, on this 
occasion as white crystals in 62 % yield, shown in scheme 2.37.  
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Scheme  2.37 
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Spectroscopic analysis provided the evidence for the structure of the product. The IR 
spectrum showed no carbonyl to be present. In the 1H NMR spectrum a singlet at 8.1 ppm 
showed one proton of the pyridine ring, whereas two multiplets between 7.31-7.12 evidenced 
eleven protons confirming two phenyl groups and one more proton of the pyridine ring. 
There were no signals to indicate the presence of the four membered ring confirming its loss. 
A peak at 2.68 ppm confirmed the presence of SMe. Pyridine ring formation was further 
evidenced by 13C NMR spectrum showing the loss of carbonyl group from 203.13 and 201.74 
ppm (compound 310 was a mixture of diastereoisomers), and loss of the carbon peaks of the 
four-membered ring. The presence of eight CH peaks and five quaternary carbons in the 
aromatic region was consistent with two phenyl groups substituted to the pyridine ring. The 
methyl of the third substituent SMe appeared at 13.48 ppm.  
HRMS further confirmed the structure of the product as 3,4-diphenyl-6-methylthio-1-pyridine 
with a mass of 278.1000 for a required mass of 278.0998. 
 
2.3.2.2 Synthesis of other pyridines.  
With two successful examples demonstrated, it was the next task to show that a series of 
azabicyclo[3.2.0]hept-2-en-4-ones could be made and converted into pyridines. 
Diphenylcyclopropenone was reacted with 2-ethylthio-4-phenyl-1-azetine in acetonitrile at 
room temperature to afford 5-ethylthio-2,3,7-triphenyl-1-azabicyclo[3.2.0]hept-2-en-4-one as 
a yellow oil in 61 % yield as a mixture of diastereoisomers in a 3:5 ratio. 
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Scheme  2.38 
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The structure of the product 312 was confirmed by spectroscopic analysis. 1H NMR 
confirmed all three protons of the four-membered ring which appeared as two sets of signals 
showing the product to be a mixture of diastereoisomers. Two sets of doublet of doublets at 
5.60 and 4.28 ppm (J = 8.3, 8.3 and 5.5, 9.6 Hz) respectively confirmed the benzylic CH 
protons. The two protons of the CH2 of the ring appeared as doublets of doublets and 
multiplets confirming the product was a mixture of diastereoisomers. Two triplets between 
1.30-1.23 ppm (2 x diastereo, 3H, t, J = 7.2 Hz) evidenced the thioethyl moiety with the CH2 
of the SEt appearing at ~ 3.0 and ~ 2.6 ppm as complex multiplets. Fifteen aromatic protons 
in the range of 6.81-7.51 ppm as a series of multiplets confirmed the presence of three phenyl 
groups. 
The 13C NMR spectrum confirmed the presence of two diasteroisomers by showing double 
signals in all cases. For example, the signals for carbonyl appeared at 202.86 and 202.46 
ppm. The unsaturated carbon of the enone ȕ position appeared at 176.99 and 174.85 ppm 
whereas the α carbon of the enone appeared at 1β6.14 and 123.79 ppm. The benzylic CH of 
the ring appeared at 66.62 and 65.98 ppm, whilst the CH2 of the ring appeared at 35.14 and 
31.86 ppm, and the carbons of thioethyl group were found at 23.70, 23.59, 14.59 and 14.24 
ppm. 
The reactivity of 5-ethylthio-2,3,7-triphenyl-1-azabicyclo[3.2.0]hept-2-en-4-one 312 was 
investigated by heating it in toluene until the complete consumption of the starting material 
was observed by TLC. The formation of the 2,3,4-triphenyl-6-ethylthio-1-pyridine 313 was 
observed as the only product in 75 % yield, isolated as white crystals after chromatography, 
when the bicyclic precursor was heated overnight in toluene. 
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Scheme  2.39 
The structure of the product was assigned as a result of spectroscopic analysis which 
confirmed the synthesis of a pyridine with three phenyl groups and one thioethyl group as 
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substituents. Different signals ranging from 6.91 to 7.34 ppm in the 1H NMR spectrum 
confirmed the presence of sixteen protons which indicates the presence of three phenyl 
groups and one more proton that belongs to the pyridine ring. A quartet at 3.32 and triplet at 
1.51 ppm with coupling constant of 7.3 Hz evidenced the presence of the thioethyl moiety. 
There were no signals to indicate the presence of a four-member ring which confirms its loss. 
The formation of the pyridine ring was further evidenced by 13C NMR spectrum showing the 
loss of carbonyl group from 202.86 and 202.46 ppm, and loss of carbon peaks characteristic 
of the four-member ring. The presence of ten CH peaks and seven quaternary carbons in the 
aromatic region was consistent with three phenyl groups substituted on the pyridine ring, 
whereas the fourth substituent is SEt which shows signals at 24.52 and 15.00 ppm, 
respectively, for the CH2 and CH3 group.  
IR and HRMS further confirmed the structure of the product as 2,3,4-triphenyl-6-ethylthio-1-
pyridine, with IR showing loss of the carbonyl group and HRMS showing the mass (m/z) of 
368.1460 for a required mass of 368.1467. 
It was next decided to try a dialkylcyclopropenone to investigate the reactivity of 1-azetines 
with dialkylcyclopropenones. For this purpose, we selected dibutylcyclopropenone, which 
had been synthesized elsewhere in the group by reacting dichlorocarbene with 5-decyne and 
subsequent hydrolysis228. Reaction of dibutylcyclopropenone with 2-ethylthio-4-phenyl-1-
azetine (Scheme 2.40) afforded 5-ethylthio-2,3-dibutyl-7-phenyl-1-azabicyclo[3.2.0]hept-2-
en-4-one 315 as a dark yellow oil in 58 % yield as a mixture of diastereoisomers in a 1/1.5 
ratio. 
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Scheme  2.40 
 
The spectroscopic analysis provided the evidence for the structure of the product. The phenyl 
group was confirmed with three different signals integrating for five protons in the aromatic 
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region on the 1H NMR spectrum. The three protons of the four-membered ring appeared as 
the characteristic two sets of signals showing the product as a mixture of diastereoisomers, 
with, for example two sets of doublet of doublets at 5.48 and 4.30 ppm (J = 8.5, 8.5 and 5.4, 
8.7 Hz) for the benzylic CH proton. The twelve protons of the alkyl CH2 groups and the two 
protons of the thioethyl group appeared in a series of multiplets. Two triplets between 1.17-
1.21 with coupling constant of J = 7.4 Hz, confirmed the CH3 of thioethyl moiety, and four 
triplets 0.94-0.77 ppm evidenced the presence of two CH3 of alkyl chains in a mixture of 
diastereoisomers.  
It was further confirmed with 13C NMR spectroscopy that the bicyclic adduct was formed as 
a diasteromeric mixture with the characteristic doubling of each carbon signal. For example, 
the signals for the carbonyl appeared at 205.44 and 204.96 ppm. The signals for unsaturated 
ȕ-carbon of the enone appeared at 182.78 and 180.98 ppm whereas, the α carbon of the enone 
appeared at 126.22 and 127.26 ppm. The CH2 of the four-membered ring appeared at 64.98 
and 64.58 whereas the benzylic CH of the ring appeared at 75.45 and 75.11 ppm. Fourteen 
CH2 and six CH3 peaks confirmed the diastereomeric mixture of the desired product.  
The treatment of 5-ethylthio-2,3-dibutyl-7-phenyl-1-azabicyclo[3.2.0]hept-2-en-4-one 315 in 
boiling toluene afforded 2,3-dibutyl-4-phenyl-6-ethylthio-1-pyridine 316 as the only product 
in 73 % yield as a clear oil after full consumption of starting material. 
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Scheme  2.41 
 
Spectroscopic analysis was used to assign a structure to the product. The 1H NMR spectrum 
confirmed the presence of one phenyl group and one proton of the pyridine ring which 
appeared as a singlet at 6.84 ppm. Eighteen protons of two alkyl chains confirmed the two 
butyl groups. A quartet at 3.2 and triplet at 1.4 ppm with coupling constant of 7.3 Hz 
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evidenced the presence of thioethyl moiety. Furthermore, there were no signals to indicate the 
presence of the four-membered ring which confirms its loss. IR spectroscopic analysis 
confirmed the loss of carbonyl group. The 13C NMR spectrum showed the loss of the 
carbonyl group from 202.86 and 202.46 ppm and loss of the carbon peaks of the four-
membered ring. The presence of seven CH2 and three methyl peaks confirmed the presence 
of the two butyl chains and thioethyl moiety.   
HRMS further confirmed the structure of the product as 2,3-dibutyl-4-phenyl-6-methylthio-1-
pyridine 316, by showing the mass (m/z) of 328.2086 for a required mass of 328.2093. 
With the ability of different cyclopropenones to give adducts, and then pyridines, from 4-
phenyl-2-thioalkyl-1-azetines established, it was next decided to look at some other 4-aryl-2-
thioalkyl-1-azetines. Thus, the reaction of 2-methylthio-4-tolyl-1-azetine with 
diphenylcyclopropenone afforded 5-methylthio-2,3-diphenyl-7-tolyl-1-azabicyclo[3.2.0]hept-
2-en-4-one 317 as a yellow oil in 63 % yield as a mixture of diastereoisomers in a 1/1.5 ratio, 
as shown in Scheme 2.42. 
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Scheme  2.42 
 
Spectroscopic analysis again confirmed the structure of the product as a mixture of 
diastereoisomers. The 1H NMR spectrum confirmed ten aromatic protons for the two phenyl 
rings in the range of 7.12-7.53 ppm as a series of multiplets. The four aromatic protons of the 
tolyl group appeared as four doublets between 7.25-6.75 ppm consistent with the 
diastereomeric mixture. All three protons of the four-membered ring appeared as two sets of 
signals further showing the product was a mixture of diastereoisomers. Thus, two sets of 
doublet of doublets at 5.54 and 4.27 ppm were seen for the benzylic CH protons. The two 
protons of the CH2 of the ring appeared as four sets of doublets of doublets with one set at 
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3.16 and 2.49 ppm (2 x diastereo, 1H, J = 9.6, 12.8 and 5.1, 12.8 Hz) and another set of 
doublet of doublets at 2.95 and 3.02 ppm (2 x diastereo, 1H, J = 8.1, 12.8 and 8.5, 12.8 Hz). 
Four singlets between 2.41-2.07 ppm evidenced the ArMe and SMe moieties, and confirm the 
formation of the product as a diastereomeric mixture. 
The 13C NMR spectrum showed the characteristic double signals for each carbon. For 
example, the signals for the carbonyl appeared at 202.83 and 202.46 ppm. The ȕ-carbon of 
the enone was at 177.56 and 177.52 whereas, the α-carbon of the enone appeared at 126.21 
and 123.75 ppm. Peaks at 66.38 and 65.92 ppm were seen for the benzylic CH of the ring 
whereas the CH2 of the ring appeared at 34.35 and 31.01 ppm. Four methyl signals for the 
ArMe and SMe further confirmed the product as a diastereomeric mixture. 
The reactivity of 5-methylthio-2,3-diphenyl-7-tolyl-1-azabicyclo[3.2.0]hept-2-en-4-one 317 
was investigated by heating it in boiling toluene which resulted in the complete consumption 
of the starting material and formation of the tetrasubstituted pyridine 318 as the only product 
in 74 % yield as white crystals, as shown in Scheme 2.43. 
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Scheme  2.43 
Spectroscopic analysis was performed to assign a structure to the product. The 1H NMR 
spectrum showed the four aromatic protons of the tolyl group as the characteristic two 
doublets at 7.02 and 6.96 ppm respectively with coupling constants of J = 8.1 Hz for each. 
Eleven more aromatic protons between 7.34-6.88 confirmed the presence of two phenyl 
groups and one proton of the pyridine ring. Two singlets at 2.68 and 2.31 ppm integrating for 
three protons each confirmed the SMe and ArMe respectively.   
The 13C NMR spectrum showed the loss of carbonyl signals from 202.83 and 202.46 ppm, 
and loss of the carbon peaks of the four-membered ring. The presence of nine CH signals and 
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eight quaternary carbons in the aromatic region indicated that three aryl groups were 
substituted on the pyridine ring whereas the fourth substituent is SMe which appeared at 
13.42 ppm. A peak at 21.18 ppm confirmed the presence of ArMe.  
HRMS showed the mass (m/z) of 368.1468 required for 368.1467. On this occasion, the use 
of the tolyl group allowed us to confirm the regiochemistry of the product with X-ray 
crystallographic studies, which showed the structure with two phenyl groups at positions 2 
and 3 of the pyridine, the tolyl group at position 4 and the thiomethyl at the 6 position. 
(Crystallographic data have been deposited at the Cambridge Crystallographic data Centre as 
a CIF deposit with file number 847593. Copies of these data can be obtained free of charge 
on application to CCDC, email deposit@ccdc.cam.ac.uk.).     
 
                            
                              Fig.  2.5    2,3-diphenyl-4-tolyl-6-methylthio-1-pyridine 318. 
 
Diphenylcyclopropenone was also reacted with 2-ethylthio-4-tolyl-1-azetine to afford 5-
ethylthio-2,3-diphenyl-7-tolyl-1-azabicyclo[3.2.0]hept-2-en-4-one 319 as a yellow oil in 66 
% yield as a mixture of diastereoisomers in a 1/1.5 ratio. The product had fully consistent 1H 
and 13C spectra which were very similar to those discussed above for the SMe compound. 
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Scheme  2.44 
 
In the 1H NMR spectrum a multiplet between 2.70-2.47 ppm and two triplets at 1.30 and 1.28 
ppm with coupling constant J = 7.3 Hz evidenced the additional presence of the thioethyl 
belonging to each diastereoisomer. The 13C NMR spectrum showed the signals of the 
thioethyl group at 23.70, 23.57, 14.63 and 14.60 ppm. 
As expected, 5-ethylthio-2,3,7-triphenyl-1-azabicyclo[3.2.0]hept-2-en-4-one 319 gave 2,3-
diphenyl-4-tolyl-6-ethylthio-1-pyridine 320 when heated overnight in toluene. The product 
was isolated in 75 % as a white crystalline solid after chromatographic purification. 
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Scheme  2.45 
 
The 1H NMR spectrum confirmed the presence of fifteen aromatic protons which indicates 
the presence of the three aryl groups and the pyridine ring. The four aromatic protons of the 
tolyl moiety were evidenced by two doublets at 7.02 and 6.97 ppm with coupling constants J 
= 8.2 Hz each. A quartet at 3.32 and triplet at 1.51 ppm both with coupling constants of 7.3 
Hz evidenced the presence of the thioethyl moiety. The 13C NMR spectrum showed the loss 
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of the carbonyl group, confirmed by IR as well as loss of the carbon peaks of the four-
membered ring. The presence of nine CH peaks and eight quaternary carbons in the aromatic 
region indicated that two phenyl and one tolyl groups are substituted to the pyridine. The 
fourth substituent this time is SEt which appeared at 24.52 (CH2) and 14.99 (CH3) ppm. 
HRMS further confirmed the structure of the product as 2,3-diphenyl-4-tolyl-6-ethylthio-1-
pyridine by showing the mass (m/z) of 382.1624 for a required mass of 382.1624. 
2-Methylthio-4-naphthyl-1-azetine was also reacted with diphenylcyclopropenone to afford 
5-methylthio-2,3-diphenyl-7-naphthyl-1-azabicyclo[3.2.0]hept-2-en-4-one 321 in 51 % yield 
as a yellow oil and as a mixture of diastereoisomers in a 1/1.5 ratio.  
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Scheme  2.46 
 
The 1H NMR spectrum showed a series of multiplets and three doublets of doublets between 
7.98-6.72 ppm integrating as seventeen aromatic protons. All three protons of the four-
membered ring appeared as two sets of signals showing the product as a mixture of 
diastereoisomers. Two sets of doublets of doublets at 5.74 and 4.48 ppm indicated the 
benzylic CH proton. One set of doublet of doublets appeared at 3.26 and 3.18 ppm for one 
proton of the CH2, whereas another set of doublet of doublets appeared at 3.06 and 2.59. Two 
peaks at 2.13 and 2.07 evidenced the thiomethyl moiety and indicated the formation of the 
product as a diastereomeric mixture. 
The structure of the product was further confirmed with 13C NMR spectrum which showed 
double signals for carbons to confirm the presence of two diasteroisomers. Signals for the 
carbonyl appeared at 202.78 and 202.40 ppm whereas peaks for the alkene carbons of the 
enone appeared at 177.43, 175.45 and 126.00, 123.95 ppm. All other signals were consistent 
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with the assigned structure, including an extremely complex aromatic region that shows the 
expected number of CH and quaternary carbons for the diastereoisomeric mixture.    
The naphthyl-substituted azabicyclic compound 321 was also heated in boiling toluene until 
disappearance of starting material had occurred. The pyridine 322 was isolated as white 
crystals in 64 % yield, after column chromatography.  
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                                                            Scheme  2.47 
Spectroscopic analysis provided the evidence for the structure of the product. IR spectrum 
showed there is no peak for the carbonyl which was present in the starting material. In the 1H 
NMR spectrum a singlet at 2.7 ppm integrating to three protons showed the presence of the 
thiomethyl moiety. The rest of the signals were found in the aromatic region, most of them as 
multiplets confirming the eighteen protons of two phenyl, one naphthyl group and one proton 
of the pyridine ring. Pyridine ring formation was further evidenced by the 13C NMR spectrum 
showing the loss of a carbonyl group from 202.78 and 202.40 ppm, also confirmed by IR 
spectroscopy, and loss of the carbon peaks of the four-membered ring. The presence of 
fourteen CH peaks and nine quaternary carbons in the aromatic region indicated that two 
phenyl groups and one naphthyl are substituted to the tetra-substituted pyridine ring whereas 
the fourth substituent SMe appeared at 13.42 ppm.  
HRMS further confirmed the structure of the product as 2,3-diphenyl-4-naphthyl-6-
methylthio-1-pyridine with a mass of 404.1479 for a required mass of 404.1467. 
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2.3.2.3 Reactivity of 2-methylthio-3,3,4,4-tetramethyl-1-azetine with 
diphenylcyclopropenone : synthesis of 5-methylthio-2,3-diphenyl-6,6,7,7-
tetramethyl-1-azabicyclo[3.2.0]hept-2-en-4-one. 
After the successful reactivity of different 4-aryl-1-azetines with different cyclopropenones 
and subsequently converting the bicyclic adducts to pyridines, it was decided to investigate 
the reactivity of non-aryl azetines with cyclopropenones. Further exploration of the 
thermolyte reactivity of their products if they were found to produce bicyclic adducts similar 
to aryl azetines would then be carried out. Thus, 2-methylthio-3,3,4,4-tetramethyl-1-azetine 
298, which was synthesized from 2,3-dimethyl-but-2-ene, was reacted with 
diphenylcyclopropenone to afford 5-methylthio-2,3diphenyl-6,6,7,7-tetramethyl-1-
azabicyclo[3.2.0]hept-2-en-4-one 323 in 51 % yield as a yellow solid.  
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Scheme  2.48 
To confirm the structure of the product, spectroscopic analysis of the compound was 
performed. Five singlets between 0.73-1.95 ppm in the 1H NMR spectrum, all integrating to 
three protons each, inferred the presence of the one thiomethyl and four methyl groups. Ten 
aromatic protons showed the presence of two phenyl groups.  
The 13C NMR spectrum showed signals for five methyl groups between 10.60-27.96 ppm. 
The carbonyl peak appeared at 202.31 ppm whereas peaks for the unsaturated alkene carbons 
of the enone appeared at 175.63 and 123.57 ppm, respectively. The quaternary carbons of the 
four membered ring were evidenced by peaks at 41.93 and 70.30 ppm with the sp3 
bridgehead carbon at 83.79 ppm confirming the product as a bicyclic adduct. IR and HRMS 
further confirmed the structure of the product.    
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2.3.2.4 Reactivity of 5-methylthio-2,3-diphenyl-6,6,7,7-tetramethyl-1-
azabicyclo[3.2.0]hept-2-en-4-one.  
Based upon the successful thermolysis of other azabicyclic adducts to produce pyridines, this 
azabicyclic compound was also heated at elevated temperatures for 24 hours. However, no 
product was formed using a variety of solvents: indeed the compound was stable even after 
heating for 72 hours at 150 oC in xylene. 
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Scheme  2.49 
The corresponding 5-ethylthio adduct 325, formed from diphenylcyclopropenone and 2-
ethylthio-3,3,4,4-tetramethyl-1-azetine, was found to be similarly stable and was also 
recovered unchanged after 72 h in xylene at reflux, as shown in Scheme 2.50.          
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Scheme  2.50 
Interestingly, another worker in the group found in previous work that azabicyclic 
compounds produced from aliphatic substituted azetines behaved quite differently229 with 5-
ethylthio-2,3-diphenyl-6,6,7,7-tetramethyl-1-azabicyclo[3.2.0]hept-2-en-4-one 325 producing 
a bipyrrolinone through loss of alkene followed by dimerization with the loss of sulfur when 
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heated at ~180 oC in boiling dichlorobenzene, a product whose formation (see Scheme 2.51) 
is consistent with the formation of intermediate 328. Attempts to reproduce this reaction in 
this work were unsuccessful.   
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Scheme  2.51 
 
2.3.2.5 Attempts to trap the proposed intermediate azacyclopentadienone 
To find evidence for our proposed mechanism for the synthesis of pyridines from 
azabicyclo[3.2.0]hept-2-en-4-ones via the formation synthesis of an azacyclopentadienone, 
some experiments were done in order to attempt to trap the intermediate 
azacyclopentadienone 332.  
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Scheme  2.52 
Earlier work done in the group (see Scheme 2.52, above) showed successful trapping of the 
azacyclopentadienone by introducing p-tolyl styrene into the reaction mixture to get two 
different pyridines as shown in the figure above. This reaction was successfully repeated but 
attempts to use other styrenes, such as the p-chlorostyrene 334 (shown below), were 
unsuccessful, with only a single pyridine being formed and no incorporation of the p-chloro 
substituent.  
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Scheme  2.53 
In the next attempt to trap the azacyclopentadienone 332, 5-ethylthio-2,3,7-triphenyl-1-
azabicyclo[3.2.0]hept-2-en-4-one 312 was reacted with diphenylacetylene 335 in boiling 
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toluene to afford the pyridine 336 with three phenyl groups and no thioethyl group as 
substituents, in 50 % yield.  
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Scheme  2.54 
 
Alkynes are known to react with thiols to make alkenyl sulfides230, and it is possible that the 
alkyne has promoted desulfurisation (as opposed to loss of hydrogen) of the expected 
dihydropyridine intermediate rather than reacted with the proposed azacyclopentadienone.     
The spectroscopic analysis provided evidence for the structure of the product 336. The 1H 
NMR spectrum showed only signals in the aromatic region, with no signals for the ethyl 
moiety. Two doublets at 8.75 and 7.36 ppm with coupling constants of 7.3 Hz each 
confirmed the two protons of the pyridine ring. Fifteen other aromatic protons between 7.30-
6.90 confirmed the presence of three phenyl groups. The 13C NMR spectrum further 
confirmed the structure with the three phenyl substituents and tri-substituted pyridine 
showing seventeen signals between 158.38-123.69 ppm, with eleven CH signals and six 
quaternary carbons.  
 
5-Ethylthio-2,3,7-triphenyl-1-azabicyclo[3.2.0]hept-2-en-4-one was also heated with DMAD 
258, because of its ability to act as dienophile in [4+2] cycloaddition reactions231, and also 
with methylfuroate 337 (this time to act as a diene and trap the azacyclopentadienone as a 
dienophile)232-235 in two different attempts to trap the intermediate azacyclopentadienone but 
in  both cases the only product formed was the expected pyridine and in all cases no other 
product could be identified (Scheme 2.55).  
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Scheme  2.55 
 
Based on the reactivity of p-benzoquinone 338 as a dienophile, it was investigated whether or 
not it may react with the proposed azacyclopentadienone. The reaction of 1,4-benzoquinone 
with 5-methylthio-2,3,7-triphenyl-1-azabicyclo[3.2.0]hept-2-en-4-one afforded two products: 
one was the expected pyridine 302 of adduct 301 in 65% yield, whereas the second product is 
an unknown, tentatively assigned compound 339, as shown in Scheme 2.56, below. 
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Scheme  2.56 
 
Assuming the tentatively assigned structure is 339, a singlet at 7.28 ppm in the 1H NMR 
spectrum corresponds to the isolated CH alkene and the C=CH-CH2 moiety might explain a 
doublet (2H) at 3.77 ppm and a doublet of doublets at 6.12 ppm, signals that are clearly 
coupled. Five aromatic protons appear at 7.23-6.74 ppm and a singlet at 2.23 ppm appears for 
SMe. In the 13C NMR spectrum, two carbonyls appear at 187.7 and 187.4 ppm. Five other 
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quaternary carbons and five CH peaks appear between 126 and 148 ppm. The CH2 is at 32.64 
and CH3 at 19.40 ppm. IR and HRMS are also consistent with this tentative assignment.  
It is possible to suggest several other structures 339b-339d that fit the spectroscopic data. 
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Scheme  2.57 
 
However, only 339a has a sensible mechanism, which, although again tentative is suggested 
below. 
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Scheme  2.58 
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This is the most obvious way for Ph, C and N to be lost. It is then suggested that intermediate 
342 rearranges as follows, a process for which literature precedent exists 236-238. 
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Scheme  2.59 
This interesting observation requires more work-unfortunately all attempts to crystallise the 
product for crystallographic analysis have been unsuccessful.    
 
2.3.3 Reactivity of 1-azetines with 1,3-dipoles  
After successfully showing that 1-azetines undergo reaction with cyclopropenones to form 
bicyclic adducts and that these bicyclic adducts can also be subjected to further reaction to 
produce tetrasubstituted pyridines, it was envisaged that 1-azetines might undergo reaction 
with 1,3-dipoles like nitrile oxides to form bicyclic adducts which can undergo [2+2] 
cycloreversion on heating. It was anticipated that a heterocycle formed as a result of 
cycloreversion would, in the case of a nitrile oxide, be a 1,2,4-oxadiazole which would be 
isolable and not undergo the further reaction that was undergone by the proposed 
azacyclopentadienone, above.     
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2.3.3.1 Reactivity of 1-azetines with nitrile oxides. 
Nitrile oxides were produced in situ from corresponding hydroximoylchlorides after 
dehydrochlorination239-241 with triethylamine. Hydroximoylchlorides were formed as a result 
of chlorination239 of aldoximes which in turn were produced from the corresponding 
aldehydes. 
2.3.3.1.1 Reactivity of 2-methylthio-4-phenyl-1-azetine with p-
methoxybenzohydroximoyl chloride : Synthesis of 2-(p-methoxy-phenyl)-5-(methylthio)-
7-phenyl-4-oxa-1,3-diazabicyclo[3.2.0]hept-2-ene. 
2-Methylthio-4-phenyl-1-azetine 287a was reacted with p-methoxybenzohydroximoyl 
chloride 346 to afford 2-(p-methoxy-phenyl)-5-(methylthio)-7-phenyl-4-oxa-1,3-
diazabicyclo-[3.2.0]-hept-2-ene 347 in 43 % as yellow oil. p-Methoxy-phenyl nitrile oxide 
was generated in situ from p-methoxy-benzohydroximoyl chloride, with drop-wise addition 
of triethylamine to the reaction mixture. Triethylamine was added to produce nitrile oxide 
slowly to improve its reactivity with 1-azetine and to avoid nitrile oxide dimerisation which 
results in the formation of furoxans with only low yields of the desired oxadiazabicyclic 
adducts.   
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Scheme  2.60 
 
The mechanism involved for the synthesis of nitrile oxide and its reaction with 1-azetine is 
shown in Scheme 2.61 below.  
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Scheme  2.61 
 
The structure of the product 347 was deduced with the help of spectroscopic techniques. The 
1H NMR spectrum indicated the presence of two aromatic rings by showing nine aromatic 
protons. The three protons of the four membered ring appeared as three doublets of doublets. 
The proton of the benzylic CH appeared as a doublet of doublets at 4.83 ppm with coupling 
constant 5.3 and 9.3 Hz indicating its coupling with both protons of CH2 of the ring. Two 
more doublets of doublets at 3.67 and 2.72 ppm with J = 9.3, 13.2, 13.2 and 5.3 respectively 
confirmed the coupling of two other protons of the ring with the benzylic CH proton.   Two 
singlets at 3.8 and 2.2 ppm both integrating three protons each confirmed the presence of 
methoxy and thiomethyl moieties. The product was a single stereoisomer. 
The 13C NMR spectrum further confirmed the structure by showing carbon of N=C-N at 
161.7 ppm, three quaternary and five CH carbons in the aromatic region and the bridgehead 
quaternary carbon at 114.4 ppm confirming the bicyclic structure with two aromatic groups. 
Signals for the other four membered ring carbons appeared at 66.5 ppm and 44.6 ppm, 
whereas two peaks at 55.3 and 10.3 ppm confirmed methoxy and thiomethyl groups. IR and 
HRMS were also consistent with the assigned structure. It is notable that the product was a 
single diastereoisomer. There was no doubling up of peaks as was seen with the 
cyclopropenone adducts. NOESY experiments inferred the structure to have the cis 
stereochemistry between the phenyl and SMe groups, possibly as a result of the incoming 
1,3-dipole approaching the 1-azetine trans to the existing phenyl group, thus forcing the SMe 
group cis to the phenyl substituent.         
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2.3.3.1.2 Reactivity of 2-(p-methoxy-phenyl)-5-(methylthio)-7-phenyl-4-oxa-1,3-
diazabicyclo[3.2.0]hept-2-ene : Synthesis of 3-(p-methoxy-phenyl)-5-(methylthio)-1,2,4-
oxadiazole. 
As discussed above, thermolysis of the bicyclic adducts from 1-azetines and cyclopropenones 
produced interesting results. Thus adduct 347 was also heated in refluxing toluene to 
investigate if further interesting reactions could be discovered. The reaction was monitored 
by TLC which showed the disappearance of the starting material to afford the stable and 
isolable 1,2,4-oxadiazole 350a as the only product in 88 % yield, produced via a formal 
overall [2+2] cycloreversion of the bicyclic adduct. 
                         
N
SMe
Ph
N
O
OMe
toluene
reflux
N
N
OMeS
OMe347
350 a
- Ph=CH2
 
Scheme  2.62 
Spectroscopic analysis was performed to confirm the structure of the product. The 1H NMR 
spectrum confirmed the presence of the p-substituted aromatic ring by showing two doublets 
at 7.99 and 6.98 ppm with a coupling constant of 8.0 Hz, integrating as two protons each. It 
also confirmed the loss of the four membered ring and of one phenyl group. Two singlet 
peaks at 3.85 and 2.78 confirmed the presence of OCH3 and SMe, respectively. The 13C 
NMR spectrum further confirmed the structure of the product by showing the C=N peak at 
168.33 and sp2 carbon connected to SMe at 178.05, whereas the SMe and OMe peaks 
appeared at 14.20 and 55.38 respectively. Two quaternary carbons and two CH peaks in the 
aromatic region completed the assignment of the structure of the product. 
HRMS data confirmed the structure of the product by showing the mass (m/z) of 245.0350 
required for 245.0355. 
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1,2,4-Oxadiazoles are most commonly constructed using 1,3-dipolar cycloadditions between 
nitrile oxides and nitriles242,243 or from the reactions of a nitrile-derived amidoxime with a 
carboxylic acid derivative244,245 as described in the introduction part of this thesis. In our 
methodology, the 1-azetine can be seen to be acting as an equivalent for the nitrile species 
RS–CN, known as either an alkyl thiocyanate or an alkyl thiocyanic ester. Based upon this 
result, it was decided to explore this reaction fully. This needed the synthesis of some other 
oxadiazabicyclo[3.2.0]hept-2-enes to act as precursors for 1,2,4-oxadiazoles. For this, a series 
of 1-azetines were reacted smoothly with nitrile oxides generated in situ from the 
corresponding benzohydroximoyl chlorides to give four other oxadiazabicyclo[3.2.0]hept-2-
enes 351 as shown in the table below. These were also found to be single diastereoisomers 
having cis stereochemistry between SR and Ar1 groups. 
 
                                                          
N
N
O
Ar1
Ar2
351
SR
   
 
No. product Ar1 R Ar2 Bicycle  
% yield 
 
1 347 phenyl Me 4-MeO-
C6H4- 
 43  
2 351a 4-tolyl Me 4-MeO-
C6H4- 
 72  
3 351b 4-tolyl Et 4-MeO-
C6H4- 
 48  
4 351c 2-naphthyl Me 4-MeO-
C6H4- 
 44  
5 351d 2-naphthyl Me 2-N3-C6H4-  44  
 
   
  
Table 2.4.  Synthesis of oxadiazabicycles. 
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All of the required oxadiazabicycles were produced with the same methodology: 1,3-dipolar 
cycloaddition of the 1-azetines (see previous sections for synthesis) to a nitrile oxide that was 
generated from the corresponding hydroximoyl chloride by triethylamine induced 
dehydrochlorination. All adducts were formed as single diastereoisomers and all showed the 
same characteristics by NMR spectroscopy as described before: the CH2CH coupling in the 
ring, the characteristic bridgehead carbon that has the SR substituent.  
The four new bicyclic systems 352a-d (see Table 2.4) were heated in toluene at reflux and 
produced the corresponding 1,2,4-oxadiazoles in yields of 82, 81, 87 and 68 %, respectively. 
The NMR spectra of the newly formed 1,2,4-oxadiazoles [351b-e: see experimental] were as 
expected and full details of these and the oxadiazabicycles are given in the experimental. 
HRMS and the IR spectra were also fully consistent.  
 
2.3.3.1.3  Reactivity of 2-methylthio-3,3,4,4-tetramethyl-1-azetine with 2-
azidobenzohydroximoyl chloride : Synthesis of 2-(2-azidophenyl)-5-(methylthio)-6,6,7,7-
tetramethyl-4-oxa-1,3-diaza-bicyclo-[3.2.0]-hept-2-ene.  
The successful reactivity of aryl azetines with nitrile oxides to produce interesting results lead 
us to think about using other azetines with aliphatic substituents, to investigate if they can 
also produce something interesting. 2-Methylthio-3,3,4,4-tetramethyl-1-azetine was therefore 
reacted with 2-azidobenzohydroximoyl chloride in the presence of triethylamine to yield the 
corresponding cycloadduct 353 in 52 % as a yellow oil. The azide was chosen due to the 
interesting chemistry of the azide group246 and potential for further reactions. 
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                                                                                     Scheme  2.63 
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1H NMR spectroscopy confirmed the four protons of aromatic ring with four signals at 7.14, 
7.25, 7.43 and 7.66 ppm. The four methyl groups attached to the four membered ring 
appeared as singlets at 0.97, 1.26, 1.32 and 1.50 ppm whereas the thiomethyl group was 
confirmed as a singlet at 2.1 ppm. 
13C NMR spectroscopy further confirmed the structure of the product. Two quaternary and 
four CH aromatic carbon signals appeared at 138.36, 118.80, 131.54, 130.77, 124.68, 119.83 
ppm. The sp2 carbon (C=N) attached to the aromatic ring appeared at 157.36 ppm whereas 
the sp3 quaternary bridgehead carbon appeared at 117.14 ppm. The two remaining quaternary 
carbons of the four membered ring appeared at 71.85 and 52.75 ppm, and the four methyl 
groups attached to the four membered ring and thiomethyl group were confirmed with CH3 
signals at 26.65, 21.09, 20.52, 20.13 and 9.69 ppm.   
The IR spectrum confirmed the presence of the azide moiety, and the MS data showed the 
expected relative molecular mass assigned to the structure of the product. 
 
2.3.3.1.4 Reactivity of 2-(2-azidophenyl)-5-(methylthio)-6,6,7,7-tetramethyl-4-oxa-1,3-
diazabicyclo[3.2.0]hept-2-ene with DMAD : Synthesis of dimethyl 2-(2-azidophenyl)-6,6-
dimethyl-1-(methyl-2´[methyl-3´-oxopropan-2´-yl]thiocarboxylate)-1,6-dihydropyrimidine-
4,5-dicarboxylate. 
The thermolysis of bicyclic adducts made from 1-azetines produces interesting results as 
detailed above. Simple heating of compound 353 in toluene or xylene at reflux produced no 
results. It was therefore decided to investigate the reactivity of bicyclic compound 353 in the 
presence of DMAD. With the azide group present in the bicyclic adduct 353, it was 
envisaged that DMAD being a good dipolarophile would add to the azide, allowing the 
synthesis of triazolo-oxadiazolo substituted benzenes. The reaction was performed in 
refluxing toluene overnight to afford a complex unexpected product as a yellow oil to which 
structure 354 was assigned in 36 % yield.  
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Scheme  2.64 
The structure of the product was assigned by spectroscopic analysis. The 1H NMR spectrum 
showed four signals for four aromatic protons between 8.26-7.27 ppm indicating the presence 
of the aromatic ring. Two singlets at 4.01 and 3.74 both integrating to three protons indicated 
the presence of two methoxy groups, whereas a singlet at 2.25 confirmed the presence of the 
thiomethyl group. Two peaks at 1.46 and 1.31 integrating to six protons each indicated the 
the presence of four methyl groups.  
The 13C NMR spectrum showed a signal at 204.66 ppm for the carbonyl connected to SMe, 
with two more carbonyl signals at 160.43 and 158.20 ppm for the carbonyls of the methyl 
esters. A quaternary carbon at 165.18 indicated the N-C=N carbon. 13C NMR spectoscopy 
confirmed the presence of six aromatic carbons, two sp3 carbons connected to the dimethyls 
at 64.77 and 55.51 ppm respectively, and two methoxy signals at 53.30 and 52.71 ppm. The 
signal for the SMe appeared at 12.08 ppm and the final two quaternary carbons of the 
pyrimidine appeared at 133.07 and 131.96 ppm. The IR spectrum confirmed the presence of 
an azide group, confirming it had not reacted with DMAD, with absorption at 2129 cm-1 and 
a strong carbonyl peak at 1732 cm-1. Mass spectrometry further supported the structure with 
measured mass (m/z) of 482.1472 for required mass of 482.1468. 
The suggested mechanism for this reaction proceeds via a [2+2] cycloreversion of the 
bicyclic adduct to produce a heterodiimine which then undergoes [4+2] hetero-Diels-Alder 
reaction with DMAD to form a six membered ring, and then a [3,3] sigmatropic 
rearrangement leading to the synthesis of the final product. 
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Scheme  2.65 
This reaction has also found to be successful with the SEt analogue, producing a second 
example of the pyrimidine, this time as the ethyl thiocarboxylate247. 
 
2.3.3.2 Reactivity of a 1-azetine with a nitrile imine 
After successfully exploring the reactivity of 1-azetines with nitrile oxides, it was decided to 
investigate the reactivity of 1-azetines with nitrile imines and the further reactivity of their 
bicyclic adducts if an initial model study produced anything interesting. 
The 1-azetine was synthesized by the method described above and the nitrile imine was 
generated in situ from α-chlorobenzaldehyde phenylhydrazine as a result of 
dehydrohalogenation with triethyl amine. α-Chlorobenzaldehyde phenylhydrazine was 
produced as a result of chlorination of ȕ-benzoyl phenylhydrazine 358 which was in turn was 
made from phenylhydrazine.  
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2.3.3.2.1 Reactivity of 2-ethylthio-4-phenyl-1-azetine with α-chlorobenzaldehyde 
phenylhydrazine : Synthesis of 2,4,7-phenyl-5-(ethylthio)-1,3,4-triazabicyclo[3.2.0]hept-2-
ene.  
The reaction of 1-azetine 287b with α-chlorobenzaldehyde phenylhydrazine in the presence 
of TEA afforded the bicyclic adduct 359 in 20 % as a yellow oily solid.  
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Scheme  2.66 
The structure of compound 359 was confirmed by spectroscopic analysis. The 1H NMR 
spectrum confirmed the presence of fifteen aromatic protons for the three phenyl groups. The 
proton of the four membered ring CH appeared as a doublet of doublets at 4.54 with coupling 
constant of 9.3 and 5.3 Hz. The two other protons of this ring appeared as a multiplet at 3.37 
ppm. A doublet of quartets at 3.37 ppm indicated the presence of the two diastereotopic 
protons of the thioethyl methylene with a triplet at 1.15 ppm with coupling constant of 7.3 Hz 
for the methyl. The 13C NMR spectrum confirmed the structure by showing three quaternary 
and nine CH carbon signals for the presence of the three phenyl groups. The signal for the 
C=N appeared at 161.58 ppm with the CH2 and CH of the four membered ring appearing at 
48.01 and 33.85 ppm. Two peaks at 25.54 and 14.39 ppm completed the spectrum and 
confirmed the presence of thioethyl group. MS data was fully consistent with the assigned 
structure.    
The compound was a single diastereoisomer, but the relative stereochemistry was not 
determined. 
Based on the previous results obtained from the thermolysis of bicyclic adducts made from 1-
azetines, it was hoped that bicyclic adduct 359 would behave in the same way to produce a 
triazole and a styrene as a result of [2+2] cycloreversion of the compound. Unfortunately, no 
such reaction was observed under a variety of conditions, including up to 3 days in xylene at 
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reflux. The failure of this model system meant that other nitrilimine adducts were not 
explored. 
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Scheme  2.67 
 
 2.4 Synthesis and reactivity of 2H-azirines 
The successful investigation of the chemistry of 1-azetines with cyclopropenones and 1,3-
dipoles prompted us to turn our focus to 3-membered cyclic imines, 2H-azirines. 2H-Azirines 
have been extensively studied due to their potential in the synthesis of N-containing 
heterocycles and functionalized amino derivatives248-250.  
Among the synthetic strategies (Scheme 2.68) for the preparation of 2H-azirines248-251, the 
most widely used route is the Neber process which is an intramolecular reaction of N-
functionalized imines 363249,252; other routes include pyrolysis or photolysis of vinyl azides 
362249,253,254, and ring contractions of isoxazoles 369255,256, oxazophospholes257,258 and azete 
derivatives259 368. Elimination reaction260,261 or Swern oxidation of aziridine derivatives262,263 
361 can also produce 2H-azirines. 2H-Azirines can also be synthesized via intermolecular 
reactions between nitriles and carbenes264-266 or nitrenes and acetylenes267,268. Synthesis of 
2H-azirines has been performed by using various substituted enamine derivatives 364 in the 
presence of phenyliodine (III) diacetate (PIDA)269 and in a recently reported strategy, free 
carbenes produced from α-diazo oxime ethers have been used to produce 2-alkyl/aryloxy 2H-
azirines270. 
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Scheme  2.68 
 
2.4.1 Synthesis of 2-methyl-3-phenyl-1-azirine 
For the purpose of this work, 2-methyl-3-phenyl-1-azirine was synthesized using the Neber 
reaction271, starting with phenylacetone which was converted to the oxime by using 
hydroxylamine hydrochloride and sodium acetate. Methanesulfonyl chloride was used to 
make the ketoxime mesylate which was converted into the 2H-azirine with the help of DBU 
in 55 % yield and isolated as colourless oil.  
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Scheme  2.69 
100 
 
Spectroscopic analysis and comparison to literature data [254] confirmed the structure of the 
product. The 1H NMR spectrum showed a singlet integrating to three protons to confirm the 
presence of the methyl group and another singlet integrating to one proton which confirmed 
the CH of the ring. Five aromatic protons showed the presence of the aromatic ring. The 13C 
NMR spectrum was consistent with the structure of the product showing the C=N signal at 
164.44 ppm, one quaternary and three CH signals in the aromatic region. A peak at 12.85 
ppm confirmed a methyl group and a signal at 33.39 ppm confirmed the CH of the ring.   
The mechanism of the reaction involves synthesis of a ketoxime mesylate, which after 
basification (DBU) forms a carbanion which substitutes the mesylate group in a nucleophilic 
displacement reaction to form the azirine ring. 
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Scheme  2.70 
 
2.4.2 Reactivity of 2-methyl-3-phenyl-1-azirine with 
diphenylcyclopropenone : Synthesis of 2,5-dimethyl-3,6-diphenylpyrazine 
and 2-methyl-3,5,6-triphenylpyridine-4-(1H)-one. 
As the aim of this project was to investigate the reactivity of cyclic imines with 
cyclopropenones and 1,3-dipoles, the 1-azirine was mixed with diphenylcyclopropenone, a 
process reported to produce a pyridine derivative by Hassner272 sometime ago, but unexplored 
since. 2-Methyl-3-phenyl-1-azirine was mixed with DPP in toluene at reflux to afford, in fact, 
two products. One was 2-methyl-3,5,6-triphenylpyridine-4-(1H)-one 377 (Scheme 2.71) 
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isolated in 5 % yield as a yellow solid and the second was characterized as 2,5-dimethyl-3,6-
diphenylpyrazine 376 in 19 % yield as a yellow solid. The minor product was that expected 
from the work of Hassner, although in much lower yield, and the major product was 
unexpected but, as described below, predictable.  
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                                                      Scheme  2.71 
Spectroscopic analysis of 2,5-dimethyl-3,6-diphenylpyrazine. 
The 1H NMR spectrum showed a singlet at 2.64 ppm integrating to six protons which 
confirmed the presence of two methyl groups. A multiplet centred on 7.42 ppm showed the 
presence of six aromatic protons and this together with a doublet at 7.63 ppm integrating for 
four protons, showed the presence of the two phenyl groups. In the 13C NMR spectrum a 
signal at 22.69 ppm confirmed two methyl groups whereas four signals in aromatic region 
confirmed two phenyl groups. One signal at 151.08 ppm appeared for C=N with another 
quaternary carbon at 147.84 ppm which confirmed the formation of pyrazine. Mass 
spectrometric data further confirmed the structure of the product. 
The mechanism of the reaction most likely involves the dimerization of the azirine ring to 
form a four membered ring 378 followed by the ring opening to form the pyrazine ring. 
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Scheme  2.72 
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When this reaction was repeated without DPP, no product was formed even after five days of 
refluxing the azirine in toluene. It would therefore appear that DPP acts as a catalyst for the 
synthesis of the pyrazine. The use of DPP as a catalyst for some reactions has gained recent 
interest273,274 in the literature. On the basis of these reports, it is possible that the 
cyclopropenone activates the azirine to dimerisation as shown below. 
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Scheme  2.73 
 
Spectroscopic analysis of 2-methyl-3,5,6-triphenylpyridine-4-(1H)-one.  
The 1H NMR spectrum and the work of Hassner allowed us to assign the structure to the 
product 377 in Scheme 2.71. A singlet at 2.63 ppm integrating to three protons and a broad 
singlet at 7.95 confirmed the presence of methyl and amine groups respectively. The rest of 
signals appeared in the aromatic region showing the presence of fifteen protons to confirm 
three phenyl groups. In the 13C NMR spectrum a quaternary carbon at 172.64 ppm indicated 
the presence of carbonyl moiety and a signal at 25.66 presented evidence for the methyl 
group. The presence of seven additional quaternary carbons and nine CH signals in the region 
123.91-166.97 ppm confirmed the presence of three phenyl groups and formation of pyridone 
ring. The product was identical to that isolated by Hassner272.    
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 The proposed mechanism of the reaction involves nucleophilic attack of the azirine nitrogen 
on the electrophilic cyclopropenone ring followed by an intramolecular Cope cyclization to 
form the pyridine-4-one ring272.   
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Scheme  2.74 
Further examples of this process are being sought in the group, but time limits prevented 
further exploration in this work. 
 
2.5 Synthesis and reactivity of benzodiazepines 
The aim of this part of the PhD project was to explore the reactivity of the imine function of a 
series of relevant benzothiadiazepines and benzodiazepines towards cyclopropenones and 
nitrile oxides. So, the first target was to develop a method for the synthesis of the required 
benzodiazepines and then convert them to imines using either the thionation and S-alkylation 
process already discussed or direct O-alkylation. It was anticipated as part of this strategy that 
cyclic imines made from benzodiazepines in this way would react with cyclopropenones to 
form highly sought pyrrolobenzodiazepines275-277 as shown below. However, a wide range of 
other benzodiazepines and benzothiadiazepines based imines was also targeted.  
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Scheme  2.75 
In another goal it was hoped to use a series of pyrrolobenzodiazepines themselves as starting 
materials for the synthesis of tetracyclic pyrrolobenzodiazepines: 
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Scheme  2.76 
In the same way such imines can be used to form oxadiazolobenzodiazepines and 
oxadiazolopyrrolobenzodiazepines by reacting with nitrile oxides, rather than 
cyclopropenones.  
 
2.5.1 Synthesis of benzodiazepines 
Benzodiazepines have attained much attention in recent years as an important class of 
heterocycles due to their important biological and pharmaceutical activities, such as anti-
inflammatory, antianxiety, sedative, anticonvulsant, hypnotic and antidepressive activities. 
The pyrrolobenzodiazepines (PBDs) are a class of antitumor antibiotics which act as DNA 
interacting agents275. There are many methods available for the synthesis of PBDs275. 
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Intramolecular aza-Wittig reaction has been used to synthesize the natural DC-81 antibiotic 
starting from o-azidobenzoyl chloride and L-prolinol. As a result of this, the imine bond was 
formed directly and the cyclization occurred under mild reaction conditions276. PBDs have 
also been synthesized from 2-nitrobenzoic acid and (2S)-proline followed by amide 
formation and use of tetra-n-propylammonium peruthenate (TPAP) for conversion of 
secondary amine to its imine form277.  
As a first step to synthesize a wide range of benzodiazepines with a useful imine function for 
PBD analogue synthesis an attempt was made to synthesize a 1,2,5-benzothiadiazepine by 
using a method described by Whitehead and Traverso278. 2-Sulfamoylfluorobenzene was 
reacted with aminoacetaldehyde diethylacetal to afford 2-sulfamoyl-N-ȕ,ȕ-
diethoxyethylaniline in 42 % yield. After confirming the structure of the product, it was 
treated with 6N HCl in order to liberated the aldehyde and allow subsequent cyclization. 
Unfortunately, this latter reaction was unsuccessful and the desired benzothiadiazepine (394) 
could not be isolated.  
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Scheme  2.77 
A straightforward one-step method developed by Wright and Brabander279 was used to 
synthesize benzodiazepinones which can be turned into imines after thionation and 
alkylation. Thus isatoic anhydride was heated with different amino acids and amino acid 
esters and different benzodiazepines were formed as a result of a condensation reaction. By 
using pipecolic acid and thiazoline-4-carboxylic acid, tricyclic PBD analogues were formed, 
while using other amino acid esters some more benzodiazepines were formed with different 
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substitutents in good yield. All these compounds had their structures confirmed by NMR 
spectroscopy, and all have already been reported in the literature and synthesized using this 
exact method280.      
N
H
N
O
O
O
H
N
O
O
+ DMSO
100 oC
R
R / R1= -CH2CH2CH2CH2 - (66%) ,  -CH2SCH2 - (94%)
or R1 = H and  R =    H (79%), CH3 (6%),  CH2CH(CH3 )2 (66%)
    Bn (57%)
R1
R
OH
O
N
H R1
395 396 397
 
Scheme  2.78 
The mechanism of the reaction involves the nucleophilic attack of the amino group of the 
amino acid to the carbonyl group of isatoic anhydride followed by elimination of water and 
cyclisation to form the benzodiazepine ring. 
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Scheme  2.79 
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A 1,4-benzodiazepine-3-one was made from 2-aminobenzylamine which was reacted with 
ethyl 2-oxo-4-phenylbutyrate in refluxing toluene by using a Dean-Stark apparatus and, as a 
result of a condensation reaction, formed a tetrahydroquinazoline. Reduction of the 
quinazoline 402 with triethylsilane in TFA and 1,2-dichloroethane through the intermediate 
amino ester resulted in the formation of the desired 1,4-benzodiazepine-3-one 403. It was 
hoped that compound 403 would be easily converted into an imine for reaction with DPP and 
PBD synthesis. 
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Scheme  2.80 
Tetrahydroquinazoline 402 formation was confirmed by spectroscopic analysis and the 
product was then converted into the 1,4-benzodiazepine-3-one. Spectroscopic analysis of 
compound 403 provided the evidence of the structure. The 1H NMR spectroscopy showed 
two signals at 6.65 and 6.71 ppm to confirm two amide protons. Signals from 1.90 to 4.87 
ppm confirmed the presence of four protons of the phenylethyl chain and three protons of the 
diazepine ring, whereas other signals showing nine aromatic protons confirmed the presence 
of two phenyl rings. The 13C NMR spectrum further confirmed the structure of the product by 
showing a peak at 172.62 ppm for carbonyl, together with seven CH and three quaternary 
carbon signals between 117.65-145.43 ppm. IR and HRMS data was also consistent with the 
assigned structure, and all data was fully consistent with that reported in the literature281.       
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2.5.2 Thionation of benzodiazepines 
Direct O-alkylation was not attempted as this was the project of another student. However, 
these attempted O-alkylations were shown to lead to mixtures of O- & N-alkylated product 
and gave imines that were extremely unstable, either hydrolysing back to the amide or 
rearranging to the N-alkyl compound. Thioamides, however, as seen above in this work, have 
been shown to be easy to S-alkylate and form imines that are stable enough to undergo 
reactions. Thus, the next reaction to be explored was thiation of these benzodiazepines. A 
number of reagents have been developed for the thionation of amides but the most widely 
used method for thionation of carbonyl compounds is by using δawessen’s reagent (LR). The 
thionating properties of what is now called Lawesson’s reagent were first studied by 
Schumacher173,282 and later on its utility was brought to general attention by others283,284. 
Amongst the large number of methods used for thionation of amides are variants of LR like 
Davey’s reagent, Belleau’s reagent, Heimgartner’s reagent, and fluorous variants of LR285-289. 
LR has also been used in combination with microwave and ultrasound radiations to increase 
its reactivity290. P4S10 has also been used with different modifications like the addition of 
bases e.g. Na2CO3 (Brillon’s reagent), NaHCO3 (Scheeren’s reagent), (TMS)2O, R-Li or 
silicon oil286,290-297.  P4S10 has also been used with alumina298,299 and silica in combination 
with microwave radiation300.  
δawesson’s reagent is often more selective than other reagents like P4S10, and is more 
effective in the case of primary amides because of less nitrile formation. Easy work up, 
commercial availability and high yields mean that it is often the preferred reagent to use for 
thionation of numerous species including benzodiazepines. However, we found δawesson’s 
reagent expensive, difficult to work-up and separate and also very smelly.   
To solve this problem another thionating reagent, the P2S5-pyr. complex, was synthesized. 
This has been reported recently by Bergman173 and co-workers as a very good thionating 
reagent which can be used with solvents like acetonitrile, pyridine and DMSO. This complex 
is formed by reacting P4S10 with refluxing pyridine to form a zwitterionic reagent. This 
complex has been used in past for thionation of carbonyl compounds but its structure has 
been recently determined by Bergman, and its use more widely discussed301. 
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This complex is particularly useful because it is inexpensive, odourless, can be used at high 
temperatures and is easily crystallised by lowering the temperature and filtering. It is also 
claimed that it can be used to do thionation selectively if there are two carbonyl groups. Thus 
using just 0.25 eq. of reagent in acetonitrile can give good yield of monothionated product, 
and using 0.5 eq. of reagent in pyridine two carbonyls can be successfully thionated when 
two are present. Degradation products of this complex are water soluble, so working up with 
water followed by filtration gives pure products, without the need for chromatographic 
purification. 
All of the compounds in this section were thionated using either δawesson’s reagent or the 
Bergman reagent.       
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Compound 397a was thionated using δawesson’s reagent to afford two products 405a and 
406, one in 50 % yield as a monothionated adduct and second in 22 % yield as a dithionated 
adduct.  
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Scheme  2.82 
The structures of the products were confirmed by spectroscopic analysis. Compound 405a 
showed a broad peak in IR spectrum at 3246 cm-1 to confirm NH whereas two peaks at 1636 
and 1599 respectively infered C=O and C=S groups. A shift in absorption from 1697 to 1599 
cm-1 confirmed the thionation of one carbonyl only. In the 1H NMR spectrum one proton of 
amide was confirmed by a singlet at 12.3 whereas in the 13C NMR spectrum a shift in the 
peak from 171.5 to 202.18 confirmed the thionation of one carbonyl while other carbonyl 
appeared at 166.71. Compound 406 was confirmed as dithione by IR spectroscopy which 
showed shift in amide absorption of peaks from 1697 and 1636 to 1599 and 1508 cm-1. NMR 
spectroscopy further confirmed the structure with two new peaks at 193.89 and 199.39 ppm 
in the 13C NMR spectrum confirming the presence of two thiocarbonyls along with the loss of 
the two amide carbonyl signals at 168.15 & 171.50 ppm. HRMS data of both adducts 405a 
and 406 was also consistent with the assigned structures. The ability of δawesson’s reagent to 
thionate secondary amides in preference to tertiary amides is well established283,284. 
Thionation of adduct 397b resulted in the synthesis of the monothionated 405b in 69 % yield 
as yellow solid. 
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Scheme  2.83 
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Spectroscopic analysis of the product provided the evidence for the structure of the 
compound 405b.  1H NMR confirmed the structure of the product by showing an amide peak 
at 12.68 ppm, four aromatic protons and five aliphatic protons. 13C NMR evidenced the 
structure of the product with two quaternary peaks at 164.48 and 200.42 ppm to confirm the 
presence of one  carbonyl and one thiocarbonyl. IR spectrum showed peaks with absorptions 
at 3430 (NH), 1701 (C=O) and 1592 cm-1 for (C=S). HRMS further confirmed the structure 
of the product as the monothionated adduct. 
Compound 397c was thionated using LR in THF to afford monothionated product 405c in 66 
% yield. The IR spectrum confirmed the presence of an amide with peak at 3178 cm-1 (NH) 
with carbonyl and thiocarbonyl groups 1670 and 1536 cm-1 respectively. Amide groups were 
further confirmed by the 1H NMR spectrum with one peak at 8.83 ppm as a triplet with J = 
4.6 Hz showing its coupling with neighbouring two protons of the ring, and another peak at 
12.38 ppm. A shift in one carbonyl peak was evident in 13C NMR from 171.61 to 201.27 ppm 
which confirms thionation of this carbonyl whereas the other carbonyl appeared at 167.29 
ppm.  
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Scheme  2.84 
In another attempt thionation of 397c was performed by using freshly prepared P4S10-pyr. 
complex to afford compound 407 in 78 % yield as a dithione. Spectroscopic analysis 
evidenced for the double thionation of the starting material. Thus, the IR spectrum showed a 
shift in absorption of peaks from 1701 and 1670 to 1591 and 1547 cm-1. 13C NMR confirmed 
two quaternary carbons at 199.70 and 196.11 ppm for two thiocarbonyls with the 1H NMR 
spectrum also showed a shift in amide signals from 8.55 and 10.37 to 11.14 and 12.51 ppm 
showing the presence of amide protons in different medium hence supporting the assigned 
structure of the product. 
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Reactivity of 397d with P4S10-pyr. complex in dry pyridine afforded compound 405d in 27 % 
yield as a dithione, with the expected spectroscopic characteristics.  
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Scheme  2.85 
The reaction of adduct compound 397e with P4S10-pyr. complex resulted in the synthesis of 
two products, and again the structures of both products were confirmed by NMR & IR 
spectroscopy as the monothione and dithione, formed in yields of 58 and 21 %, respectively.  
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Scheme  2.86 
 
In the dithione, the two thiocarbonyls appeared at 195.31 and 201.78 ppm whereas, in the 
monothione, 13C NMR spectroscopy showed two quaternary carbons at 168.22 and 204.19 
ppm for the carbonyl and thiocarbonyl moieties respectively. HRMS gave the confirmation. 
Thionation of adduct 397f using LR in THF afforded the compound 405f in 97 % yield as a 
yellow solid. 
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Spectroscopic analysis provided the evidence for the structure of the product with the 13C 
NMR spectrum, again showing two peaks at 196.13 and 200.01 ppm for the presence of two 
thiocarbonyls. The IR spectrum showed a broad peak at 3169 cm-1 for the thioamide NH 
groups and two peaks at 1582 and 1520 cm-1 for the two thiocarbonyls. 
Finally, compound 409 was obtained as a yellow solid in 93 % yield, as a result of thionation 
of adduct 403 with LR. The structure of the product was confirmed through spectroscopic 
analysis, although the presence of only one amide group meant that selectivity was not an 
issue here. The 1H NMR spectrum showed a shift in the signal for NH to 9.06 ppm from 6.71 
ppm indicating that thionation was successful. This was confirmed by 13C NMR spectroscopy 
which showed a new signal at 203.43 ppm and loss of the signal at 172.62 ppm, consistent 
with C=O to C=S conversion. IR and HRMS confirmed the assignment. IR spectrum also 
showed loss of the C=O stretch. 
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Scheme  2.88 
No general pattern of reactivity for the thionations emerged and the process seems to be very 
starting material specific, at least for the benzodiazepines used here. 
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2.5.3 Alkylation of 1,4-benzodiazepine-thiones 
After thionation of the benzodiazepines, the next step was S-alkylation of the adducts. It was 
anticipated that this would give imine or diimine functions which could be used to react with 
cyclopropenones and 1,3-dipoles to form fused benzodiazepines and pyrrolobenzodiazepines. 
Because of its success in our previous work, alkylation was done by using εeerwein’s 
reagent in DCM and the reaction proceeded through the mechanism described before. 
Alkylation of 405a afforded the compound 410 in 56 % as yellow oil.  
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Scheme  2.89 
The IR spectrum showed the loss of the NH peak and the emergence of a new peak at 1573 
cm-1(C=N). 1H NMR spectroscopy confirmed the loss of an amide peak and emergence of a 
singlet at 2.42 ppm integrating to three protons that confirmed S-alkylation of the adduct 
405a. In the 13C NMR spectrum a methyl peak at 13.32 ppm confirmed the presence of SMe 
and a new peak at 167.99 ppm confirmed the new C=N, whereas the C=S signal was missing 
which confirmed the successful formation of compound 410. HRMS confirmed that 
methylation had occurred.  
Compound 411 was obtained as a result of alkylation of 405b in 50 % yield. The structure of 
the product was confirmed by spectroscopic analysis, which showed similar features to those 
just discussed for compound 410. 
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Scheme  2.90 
The reaction of adduct 405e with εeerwein’s reagent resulted in the double S-alkylation of 
adduct 405e to form compound 412 in 69 % as a yellow oil. 
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Scheme  2.91 
  
Spectroscopic analysis of both products confirmed their structures. In the 1H NMR spectrum 
of compound 412, two singlets appeared at 2.43 and 2.48 ppm both integrating to three 
protons each which confirmed the presence of two methyl groups. The 1H NMR spectrum 
also confirmed the loss of both amide NH peaks whereas the remaining signals confirmed the 
presence of the isobutyl chain and aromatic ring. In the 13C NMR spectrum, peaks for C=S 
were absent and two new quaternary carbon signals appeared at 166.49 and 169.63 ppm 
confirming the presence of the two C=N groups.  
Compound 413 was produced as a yellow oil in 93 % yield as a result of alkylation of both 
amides in compound 405f.  
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Scheme  2.92 
Spectroscopic analysis confirmed the presence of two SMe with two singlets at 2.44 and 2.49 
ppm in the 1H NMR spectrum, both integrating to three protons. 1H NMR spectroscopy also 
confirmed the loss of both amide protons. 13C NMR spectroscopy further confirmed the 
structure by showing two quaternary carbons at 166.22 and 168.23 ppm for the two new C=N 
carbons, whereas the two distinctive signals for C=S were missing. Two peaks at 13.40 and 
14.47 ppm confirmed the presence of two thiomethyls, hence confirming the double S-
alkylation of the adduct 405f. IR and HRMS data were also consistent with the assigned 
structure.    
Finally, alkylation of compound 409 afforded compound 414 in 60 % yield as a yellow oil.  
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                                                       Scheme  2.93 
Again, the 1H NMR spectrum confirmed the loss of the NH peak from 9.06 ppm and the 
emergence of a SMe peak as a singlet at 2.21 ppm. 13C NMR spectroscopic analysis 
confirmed the loss of the C=S signal and the emergence of a new quaternary carbon at 166.99 
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ppm to infer the presence of C=N. One signal at 12.16 ppm confirmed the presence of SMe, 
and all other signals were also consistent with the assigned structure.  
 
2.5.4 Attempted reactivity of 1,4-benzodiazepine with cyclopropenones. 
 
Based on the successes with other cyclic imines, it was envisaged that reaction of 
cyclopropenones with these cyclic imines and cyclic diimines could result in the synthesis of 
the pyrrolofused benzodiazepine and pyrrolobenzodiazepine heterocycles. 
All attempts to react the imines 410, 411, 412, 413, 414 with diphenylcyclopropenone in 
various solvents at various temperatures were unsuccessful.  
Finally, adducts 413 and 414 were also mixed with the parent cyclopropenone, under 
different conditions. For compound 414 the desired pyrrolobenzodiazepine 416 (Scheme 
2.94) was not formed, with only starting material being recovered. Compound 413 was 
similarly unreactive.  
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Scheme  2.94 
The failure of these imines, particularly compound 414, to react with cyclopropenones was 
very disappointing. However, with a route to the imines now established, we looked at their 
reactivity towards nitrile oxides.   
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2.5.5 Attempted reactivity of 1,4-benzodiazepine with 1,3-dipoles. 
 
Imines 410, 411, 412, 413 and 414 were already available and all were explored. Thus, for 
example, imine 413 was treated with p-methoxybenzonitrile oxide which was generated in 
situ from p-methoxybenzohydroximoyl chloride with the help of triethylamine (Scheme 
2.96). The reaction was monitored regularly but after purification the only new product 
detected was the dimer of the nitrile oxide. Other nitrile oxides behaved similarly toward 
imine 413, and the other imines, 410, 411, 412 and 414, were found to be similarly unreactive 
towards nitrile oxides. 
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2.6. Multicomponent reactions of o-azidobenzaldehyde 
 
Multi-component reactions (MCRs) are of considerable interest in present day research due to 
the ability they have of making complex target molecules of biological relevance efficiently, 
especially in drug discovery302. The use of aldehydes in such reactions has also created 
opportunities to make combinatorial libraries of compounds and complex molecules303. We 
had a large stock of o-azidobenzaldehyde available (which had been used to make o-
azidobenzonitrile oxide for previous studies in this work) and decided, in light of the 
disappointing results in the previous section, to explore its use as an aldehyde in 
multicomponent reactions.  
In terms of MCRs, the azide group offers an opportunity for new reactivity of the MCR 
products as azides have a lot of chemistry open to them246. The use of 2-azido benzaldehyde 
in multi-component reactions has begun to be explored by Ming-Wu Ding304, where 2-
azidobenzaldehyde, an isocyanide and carboxylic acids were mixed to make α-acyloxy 
carboxamide azides through the Passerini reaction. Subsequent Staudinger and intramolecular 
aza-Wittig reactions gave 4H-1,3-benzoxazines 421 (Scheme 2.97).     
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Scheme  2.97 
The same group305 also used 2-azido benzaldehyde in a Biginelli reaction (Scheme 2.98) with 
ethyl acetoacetate and a urea (or thiourea) to make dihydropyrimidinone azides. Again using 
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the Staudinger reaction, iminophosphoranes 425 were reacted with isocyanates, acyl 
chlorides or CS2 in the presence of K2CO3 or NEt3 to further synthesize pyrimido [1,6-c] 
quinazoline-4-ones 426. 
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Scheme  2.98 
 
2-Azido benzaldehyde has also been used in the Ugi reaction (Scheme 2.99) with a 
carboxylic acid, 2-acylaniline and isocyanide by the same group306 to make azides 428 which 
underwent tandem Staudinger-aza-Wittig reactions to give indolo[1,2-c]quinazolines 430.   
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Scheme  2.99 
In our approach, we searched for other MCRs involving aldehydes and looked to explore the 
use of 2-azidobenzaldehyde in such processes. We were particularly interested in reactions 
that had cyano groupings present so that the possibility of azido-nitrile 1,3-dipolar reactions 
could be explored, as this area is unexplored in MCR processes. Secondly, we had the 
additional aims of using the azide to generate imines (as per Ding) but then using the imines 
as starting materials for the cyclopropenone type [3+2] additions discussed in previous 
sections. A typical example of this aim is shown in Scheme 2.100 below, and will be 
discussed later. 
122 
 
 
N3
H
O
OEt
O O
+
O
EtO2C
H3C NH2
CN
N3
NC CN
OH3C NH2
O
EtO2C
H3C NH2
N
N
N
N
OH3C NH2
CN
N
EtO
CN
N
OEt
O
R
R
RR
O
210 422
431 432
433434
 
Scheme  2.100 
 
2.6.1  Synthesis of 6-amino-4-(2-azidophenyl)-3-methyl-2,4-dihydropyrano-[2,3-c]- 
pyrazole-5-carbonitrile307. 
A mixture of ethyl acetoacetate (EAA), hydrazine hydrate, 2-azidobenzaldehyde and 
malononitrile in water was refluxed for 20 minutes in the presence of L-proline as a catalyst 
to get the pyrazole as a product in 41 % yield which contains one cyano group and one 2-
azido benzyl as substituents at position 3 and 4 of the ring. This reaction is known with 
benzaldehyde307, but had not previously been attempted with 2-azidobenzaldehyde. 
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Scheme  2.101 
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Spectroscopic analysis was consistent for the assigned structure of the product. The IR 
spectrum confirmed the presence of azide group with a strong peak at 2123 cm-1. Nitrile and 
NH2/NH were also seen by IR spectroscopy. The 1H NMR spectroscopy confirmed the 
presence of one CH3 with a singlet at 1.77 ppm and another singlet at 4.86 ppm showed the 
proton of the pyran ring. Two singlets at 6.88 and 12.15 ppm confirmed the presence of the 
two protons of NH2 and the one proton of NH moieties, respectively. The presence of four 
aromatic protons confirmed the disubstituted benzene ring. In the 13C NMR spectrum, a 
signal at 10.03 ppm confirmed the methyl group, with four CH and seven quaternary signals 
confirming the presence of the benzene ring, pyrazole and pyranyl alkene carbons. 13C NMR 
data showed further peaks for the nitrile carbon and the sp3 pyranyl CH group.  
The mechanism proposed for this reaction307 begins with pyrazole 436 formation from EAA. 
Ionisation of L-proline in water then facilitates the formation of an enolate from the pyrazole. 
The enolate attacks the Knoevenagel product 440 of o-azidobenzaldehyde and malononitrile, 
to produce the Michael adduct 441 which undergoes Thorpe-Ziegler307 type intramolecular 
cyclization followed by tautomerization to give the final product 435. 
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Scheme  2.102 
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2.6.2. Reactivity of 6-amino-4-(2-azidophenyl)-3-methyl-2,4-dihydropyrano-[2,3-
c]pyrazole-5-carbonitrile : Synthesis of tetrazolo[1,5-a]quinoline-4-carbonitrile. 
In an attempt to achieve the intramolecular cyclization of azide and nitrile, adduct 435 was 
heated in refluxing toluene. After the purification the only product afforded was 
tetrazolo[1,5-a]quinoline-4-carbonitrile 442 in 75 % yield as a brown solid. 
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Scheme  2.103 
The structure of this product was confirmed through spectroscopic analysis. The IR spectrum 
confirmed the loss of azide group at 2121 cm-1 and the presence of a nitrile group with a peak 
at 2242 cm-1. 1H NMR spectroscopy confirmed the presence of four aromatic protons and a 
singlet at 9.24 ppm confirmed one proton of the alkene. 13C NMR spectroscopy showed four 
CH and two quaternary signals of the aromatic ring. A peak at 117.01 appeared for the CH of 
alkene and two quaternary carbons at 114.54 and 97.66 ppm appeared for the quaternary 
carbon of malononitrile and nitrile carbons, respectively. This compound is known in the 
literature and the data was fully consistent. MS data was also consistent with the assigned 
structure of the product.  
It is assumed that intramolecular cyclization of azide and nitrile produced the tetrazole ring 
and then pyrazole ring ring enter into the reverse of the mechanism described in Scheme 
2.102 to release the compound 442.  
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Scheme  2.104 
 
2.6.3. Synthesis of methyl tetrazolo[1,5-a]quinoline-4-carboxylate. 
Next, the same reaction was repeated with methyl cyanoacetate rather than malononitrile. 
Thus, a mixture of ethyl acetoacetate, hydrazine hydrate, 2-azidobenzaldehyde and methyl 
cyanoacetate in refluxing water in the presence of L-proline was set up. The only product that 
could be isolated was 447 in 19 % yield instead of the expected pyranopyrazole 446. After 
purification, structure of the compound 447 was confirmed by spectroscopic techniques.  
IR spectrum confirmed the absence of azide and nitrile moieties and the presence of carbonyl 
group was confirmed with peak 1714 cm-1. The 1H NMR spectrum confirmed the presence of 
a methoxy group with a singlet at 4.15 ppm and another singlet at 8.80 ppm confirmed one 
proton of alkene. The 13C NMR spectroscopy confirmed the presence of five quaternary 
carbons, and five CH between 163 & 117 ppm. The signal for the methoxy group appeared at 
53.04 ppm. Mass spectrometry further confirmed the structure of the product.  
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Scheme  2.105 
It was assumed that condensation product of aldehyde 210 and methyl cyanoacetate 
underwent an intramolecular azide to nitrile cyclisation to form the compound 447, and did 
not react with the enolate produced from the ethyl acetoacetate, hydrazine hydrate product 
436 after deprotonation by L-proline as described in Scheme 2.102. Alternatively, compound 
446 might have been produced and then undergone ring opening of the pyran as described in 
Scheme 2.104 followed by intramolecular cyclisation of azide and nitrile moieties to form the 
tetrazole ring, and finally the loss of fragment 445 to give compound 447.   
 
2.6.4. Synthesis of ethyl 6-amino-4-(2-azidophenyl)-5-cyano-2-methyl-4H-pyran-3-
carboxylate. 
The reaction of 2-azidobenzaldehyde with ethyl acetoacetate and malononitrile in the 
presence of triethylamine afforded the product 448 in 59 % yield. The reaction was done in 
EtOH at room temperature and after purification, spectroscopic analysis provided the 
evidence for the structure of the product. When benzaldehyde was used in the original 
literature, the corresponding 4-phenylpyran was formed308. 
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Scheme  2.106 
The IR spectrum showed peaks with absorptions at 2203, 2119 and 1704 cm-1 to confirm the 
presence of nitrile, azide and carbonyl moieties respectively.  
1H NMR spectroscopy confirmed the presence of four aromatic protons and one proton of the 
pyran ring which appeared as a singlet at 4.79 ppm. One singlet at 4.57 confirmed the 
presence of two amine protons and another singlet at 2.38 ppm confirmed three methyl 
protons. The two CH2 protons of the ethyl group appeared as a multiplet at 3.93-4.06 ppm, 
which together with a triplet at 1.06 ppm with a coupling constant of 7.0 Hz confirmed the 
presence of the ethyl chain. 13C NMR spectroscopy showed two quaternary carbons at 165.79 
and 157.84 ppm respectively for C=O and CN moieties. The ethyl group was confirmed by 
two signals at 33.47 and 18.45 ppm, whereas the peak for the other methyl appeared at 13.18 
ppm. Mass spectrometry further confirmed the structure of the product.  
It is assumed that the reaction proceeded through a mechanism where a Knoevenagel 
condensation between 2-azidobenzaldehyde and malononitrile 449 produced 2-
azidobenzylidene malononitrile which subsequently underwent Michael addition with ethyl 
acetoacetate in the presence of triethylamine leading to intermediate 450 which in turn 
produced the 4H-pyran 448 via the enol 451 and imine 452, as shown in Scheme 2.107, 
below. 
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Scheme  2.107 
2.6.5 Reactivity of ethyl 6-amino-4-(2-azidophenyl)-5-cyano-2-methyl-4H-pyran-3-
carboxylate. 
Ethyl 6-amino-4-(2-azidophenyl)-5-cyano-2-methyl-4H-pyran-3-carboxylate was heated in 
refluxing toluene in an attempt to achieve intramolecular cyclization between azide and 
nitrile moieties to get a tetrazole ring. After 24 hours of reflux the only product obtained in 75 
% yield was characterized as tetrazolo[1,5-a]quinoline-4-carbonitrile 442 (Scheme 2.108), 
identical to that isolated previously, and probably forming by a similar mechanism or 
possibly by a retro-Diels-Alder process, as shown below, in Scheme 2.109.     
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Scheme  2.108 
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Scheme  2.109 
Having established the intramolecular 1,3-dipolar cycloaddition, it was next decided to try an 
intramolecular aza-Wittig reaction to try and form an imine from the azide & ester functional 
groups. Thus, compound 448 was reacted with triphenylphosphine at room temperature in 
toluene, and then at reflux in order to attempt to produce an imine 454 via aza-Wittig reaction 
of intermediate 452. 
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                                                                  Scheme  2.110 
After confirming the consumption of azide 448, monitored by TLC, the reaction mixture was 
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hours. The disappearance of azide 448 at room temperature is consistent with the formation 
of intermediate 452, which was not isolated. Upon heating a new product was formed, which 
after purification and spectroscopic analysis, was assigned as compound 453 and not the 
desired 454. The structure of the product 453 was confirmed by spectroscopic analysis. The 
1H NMR spectrum of the product evidenced the presence of nineteen protons from 7.10 to 
7.93 ppm confirming the presence of the three phenyl groups of triphenylphosphine and the 
one aromatic ring of the benzylidene. One singlet at 8.15 ppm showed one proton of alkene. 
The 13C NMR spectrum showed two quaternary carbons at 160.97 and 160.91 ppm to 
confirm the presence of two nitrile moieties. One CH signal at 118.94 ppm evidenced the 
alkene carbon of the benzylidene-malononitrile. The presence of four aromatic rings with five 
quaternary carbons and thirteen CH signals was also seen in the 13C NMR spectrum. IR 
spectrum confirmed the loss of azide from the product and mass spectrometric data further 
confirmed the structure of the product. It is assumed that the same type of ring opening 
occurs with iminophosphorane 452 as occurred with the parent 448 (see Scheme 2.109) and 
that similar mechanisms can be drawn, but that the absence of the azide now prevents 
tetrazole formation. 
2.6.6. Synthesis of diethyl 4-(2-azidophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-
dicarboxylate.  
A mixture of 2-azidobenzaldehyde, two equivalents of ethyl acetoacetate and 20 % aqueous 
ammonia was mixed at room temperature to afford the compound 455 in 46 %. This is the 
classic Hantzsch dihydropyridine synthesis in which arylaldehyde has been used before309 but 
has not been reported with 2-azidobenzaldehyde. However, previous workers did not explore 
subsequent attempts to react aza-Wittig imine products with cyclopropenones, which was the 
intention in this work. 
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The 1H NMR spectrum showed a triplet at 1.20 ppm with J = 7.1 Hz, and a singlet at 2.29 
ppm each integrating to six protons and each confirming the presence of the two methyls of 
the ester and the two methyls of the dihydropyridine ring, respectively. A multiplet at 4.08 
ppm showed the four protons of two carboethoxymethylenes. The CH proton of the 
dihydropyridine ring appeared as a singlet at 5.18 ppm and the proton of NH appeared at 5.87 
ppm as a singlet. The presence of four aromatic protons provided evidence for the azidoaryl 
substituent. All other data was fully consistent with the assigned structure and with 
previously reported data.  
The reaction occurred according to the classic dihydropyridine synthesis mechanism 
described by Hantzsch. A Knoevenagel condensation of aldehyde and ethyl acetoacetate 
produced an intermediate and another intermediate produced by ammonia and ethyl 
acetoacetate underwent Michael addition followed by cyclization and tautomerization to form 
the product, as shown below in Scheme 2.112. 
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Scheme  2.112 
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Diethyl 4-(2-azidophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate 455 was 
reacted with triphenylphosphine at room temperature to form the iminophosphorane and then 
at reflux in a sequence of Staudinger-aza-Wittig reactions to afford compound 464 in 53 % 
yield. The reaction was monitored by TLC at regular intervals to confirm the formation of 
iminophosphorane followed by elimination of triphenylphosphine oxide to form the product.  
Spectroscopic analysis provided the evidence for the structure of the product, which was in 
fact found to be pyridine 464, the aromatised version of the expected dihydropyridine 463-
aromatisation must be easy in such highly conjugated systems. IR spectrum confirmed the 
loss of azide and a signal at 1714 cm-1 confirmed the presence of a carbonyl of the other 
ester. 
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Scheme  2.113 
The 1H NMR spectrum showed two triplets at 1.39 and 1.54 ppm with J = 7.2 and 7.0 Hz 
respectively to confirm two methyls of the carboethoxy and ethoxy moieties. Two singlets at 
2.70 and 3.13 ppm confirmed the two other methyl substituents. Two quartets at 4.53 and 
4.65 ppm with coupling constants of 7.0 Hz confirmed the presence of the two methylenes of 
ethyl moieties. The remaining signals confirmed four aromatic protons. The 13C NMR 
spectrum agreed with the assigned structure by showing eight signals for quaternary carbons 
and four CH signals for the carbons of the three rings. The CH at C-4 in dihydropyridine 463 
was not seen. The peak for the carbonyl appeared at 170.91 ppm and four methyl peaks and 
two methylene signals confirmed the structure of the product. Mass spectrometric data was 
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also consistent with the assigned structure, again showing that the product was the aromatised 
464 and not the initially formed 463. Unsurprisingly, the stable aromatic compound 464 
showed no reactivity towards cyclopropenones. 
 
2.6.7 Synthesis of 5-acetyl-4-(2-azidophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyridine-3-
carboxamide. 
The reaction of o-azidobenzaldehyde with acetylacetone and cyanoacetamide in the presence 
of triethylamine afforded the compound 467 in 65 % yield as yellow oil. Again this reaction 
is known with benzaldehyde310, but has not been reported with 2-azidobenzaldehyde. 
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Scheme  2.114 
The structure of the product was confirmed using spectroscopic techniques. The 1H NMR 
spectrum showed two singlets at 1.99 and 2.20 ppm integrating to three protons each 
confirming the presence of two methyl moieties. Two broad singlets at 3.26 and 4.58 ppm, 
respectively confirmed the two CH protons of the pyridinone ring. The three amide protons 
appeared as three different singlets at 7.22, 7.29 and 10.06 ppm. The presence of four 
aromatic protons completed the assignment of the structure of the product. The 13C NMR 
spectrum showed three carbonyl signals at 196.82, 168.80 and 167.45 ppm. The aromatic ring 
was confirmed by the presence of two quaternary and four CH signals. The two quaternary 
carbons of the pyridinone ring appeared at 147.58 and 137.57 ppm whereas the two CHs of 
pyridinone ring appeared at 54.00 and 37.45 ppm. The presence of two methyls was 
confirmed with two signals at 19.14 and 30.03 ppm. 
134 
 
The IR spectrum confirmed the presence of azide and carbonyl moieties and mass 
spectrometric data was also in accordance with the assigned structure of the product. 
Mechanistically, this reaction occurred following the same type of route as described above 
where a Knoevenagel condensation between 2-azidobenzaldehyde and acetylacetone 
produced an intermediate 468 which underwent a nucleophilic attack from cyanoacetamide 
which is a Michael donor, followed by intramolecular cyclization of the Michael adduct 469 
through a nucleophilic attack of NH2 on the carbonyl group of acetylacetone, and loss of 
water. Hydrolysis of compound 470 resulted in the synthesis of product 467. The presence of 
EtOH in the reaction mixture may have caused the conversion of the nitrile to amide via 
oxidative hydration311 or the nitrile may have been converted to the amide by the presence of 
water312,313.         
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Scheme  2.115 
As one goal of this project was to attempt intramolecular azide-nitrile cyclization or a 
Staudinger-aza-Wittig reaction to investigate the reactivity of MCR products, adduct 467 was 
reacted with triphenylphosphine at room temperature in toluene to form the Staudinger 
product 471 which was generated in situ and was then reacted at higher temperature to 
attempt aza-Wittig reaction between iminophosphorane and carbonyl group to form a new 
cyclic imine 472, whose reactivity, towards cyclopropenones could then be explored. 
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                                                                   Scheme  2.116 
Formation of iminophosphorane 471 was inferred by TLC showing loss of azide and so the 
reaction was continued on to reflux. After a few hours it was observed that adduct 471 had 
been decomposed without forming any single product. The TLC showed a multi-spot reaction 
which indicated widespread degradation. No products could be isolated from this reaction 
mixture. 
2.6.8. Synthesis of 2-(2-azidophenyl)-4-oxochroman-3-carbonitrile. 
3-(2-Hydroxyphenyl)-3-oxopropanenitrile 476 (Scheme 2.118) reacts with benzaldehyde to 
form chromanes substituted with nitriles314. We hoped to turn this into an MCR by using an 
azide which would form a tetrazole with the nitrile. 3-(2-Hydroxyphenyl)-3-
oxopropanenitrile 476 and 2-azidobenzaldehyde 210 in ethanol in the presence of a small 
amount of piperidine afforded 2-(2-azidophenyl)-4-oxochroman-3-carbonitrile 477 in 27 % 
yield as shown in Scheme 2.118. 3-(2-Hydroxyphenyl)-3-oxopropanenitrile 476 was 
synthesized from 2-hydroxyacetophenone 473, as shown in Scheme 2.117 below. 
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Scheme  2.117 
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In the first step, 2-hydroxyacetophenone 473 was converted into the corresponding 
dimethylamino methylene 474 as a result of condensation with DMF-DMA. Reaction of the 
adduct 474 with hydroxylamine hydrochloride in refluxing EtOH produced 2-hydroxyphenyl-
isoxazole 475 which underwent ring cleavage upon treatment with aqueous-ethanolic NaOH 
solution at room temperature to give product 476 in 30 % overall yield. The structure of the 
adduct 476 was confirmed by NMR spectroscopy, and by comparison to the known literature 
data314. 
The reaction of compound 476 with 2-azidobenzaldehyde gave the desired product 477 as a 
mixture of diastereoisomers. Azide to nitrile cycloaddition clearly had not occurred. 
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Scheme  2.118 
Mechanistically, compound 477 would be the product of the cyclisation of intermediate 478, 
where intermediate 478 forms from the condensation of the oxopropanenitrile 476 with 2-
azidobenzaldehyde as shown below. 
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Scheme  2.119 
Spectroscopic analysis provided evidence for the structure of the product 477. The IR 
spectrum confirmed the presence of nitrile, azide and carbonyl moieties with peaks showing 
absorptions at 2243, 2123 and 1700 cm-1, respectively. The 1H NMR spectrum showed 
sixteen aromatic protons confirming the product as a mixture of diastereoisomers. The two 
protons of the chromone ring appeared as two different sets of doublets. One set of doublets 
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appeared at 5.86 and 5.75 ppm with coupling constants of 12.2 and 2.4 Hz respectively, and 
the other set of doublets appeared at 4.42 and 3.99 ppm with coupling constants of 12.2 and 
2.6 Hz, respectively, confirming that the product was a mixture of diastereoisomers.  
The 13C NMR spectroscopy further confirmed the product as a mixture of diastereoisomers 
by showing every signal doubled. It showed the two sp2 carbons of the chromone ring as four 
signals at 43.37, 45.86, 74.57 and 76.05 ppm, and two quaternary carbons at 112.69 and 
112.91 ppm for the two CN moieties. All the aromatic signals were doubled; finally, two 
peaks at 182.17 and 182.62 ppm appeared for the carbonyl moiety.     
 
 2.6.9.  Reactivity of 2-(2-azidophenyl)-4-oxochroman-3-carbonitrile.  
2-(2-Azidophenyl)-4-oxochroman-3-carbonitrile was heated in refluxing toluene to afford the 
product 480a in 65 % yield as a result of intramolecular cyclization of azide and nitrile 
moieties to form a tetrazole ring. The expected product 479 was not isolated, but instead its 
presumably more stable tautomer 480a was isolated. 
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Scheme  2.120 
The structure of the product was confirmed through spectroscopic analysis. The IR spectrum 
showed the loss of azide and nitrile peaks and confirmed the presence of an NH and carbonyl 
moieties. The 1H NMR spectrum showed one broad singlet at 11.78 ppm to confirm one 
proton of NH and another singlet at 8.22 ppm showing the one proton of CH of the tetrazole 
ring. It has been deshielded probably because of being in a highly conjugated system and in a 
tetrazole ring. Other signals confirmed the presence of the eight aromatic protons of the two 
phenyl rings.  
The 13C NMR spectrum further confirmed the structure by showing a peak at 195.00 ppm to 
confirm the carbonyl group whereas the CH of the tetrazole ring appeared at 117.17 ppm. 
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The two quaternary carbons of the chromone ring appear at 145.85 and 163.60 ppm. The four 
quaternary and eight CH carbons of aromatic rings confirmed the structure of the product. 
Mass spectrometric data was also consistent with the assigned structure. 
The reaction mechanism is a straightforward [2+3] cycloaddition of azide to nitrile to form a 
five membered tetrazole ring. The tautomerisation is presumably driven by the extra 
conjugation that is allowed in isomer 480a compared to 479. Tetrazoles of this type are 
known in the literature and have remarkably deshielded CHs in NMR spectroscopy. At this 
stage we are unable to discant compound 480b as a possible product.   
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2.6.10.  Synthesis of 2,6-bis (cyclohexylamino)-3,7-bis (2-azidophenyl) benzofuro[5,6-
b]furan-4,8-dione. 
2,5-Dihydroxycyclohexa-2,5-diene-1,4-dione was reacted with 2-azidobenzaldehyde and 
cyclohexyl isocyanide to form the compound 483 (Scheme 2.121) in 13 % as a dark brown 
oil, again a reaction that was known to work with benzaldehyde315 but had never been 
attempted with 2-azidobenzaldehyde. 
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Scheme  2.121 
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Spectroscopic analysis provided the evidence for the proposed structure of the product which 
is assigned tentatively and may not be correct because it is difficult to get full data315 of 
compounds like 483. The 1H NMR spectrum of compound 483 showed twentytwo protons 
for two cyclohexyl rings as a series of multiplets between 1.06 to 3.75 ppm. Two amide 
protons appeared as doublets at 6.38 ppm with a coupling constant of 7.5 Hz. The remaining 
signals confirmed the presence of two aromatic rings. 13C NMR spectroscopy confirmed the 
presence of two cyclohexyl rings with five signals for CH2s and one for the aliphatic CH 
carbon, whereas the presence of four CH and seven quaternary carbons in the aromatic region 
confirmed the structure of the (symmetric) product. Although the 13C spectrum was 
complicated by lack of solubility and NMR invisibility seen in quinones. The IR spectrum 
confirmed the presence of NH showing an absorption at 3521 cm-1. Azide and carbonyl 
moieties showed absorptions at 2124 and 1739 cm-1, respectively.  
The reaction is thought to proceed through a condensation between 2,5-dihydroxycyclohexa-
2,5-diene-1,4-dione and 2-azidobenzaldehyde to produce the intermediate 485 which 
undergoes [1+4] cycloaddition with isocyanide to form intermediate 486. Imine to enamine 
tautomerization of intermediate 486 produces compound 487 which, under the same reaction 
conditions, reacts again with 2-azidobenzaldehyde and cyclohexylisocyanide to form the 
ultimate product 483, as shown in Scheme 2.122.  
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Scheme  2.122 
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The reactivity of adduct 483 towards triphenylphosphine was investigated in an attempt to 
form cyclic imines 488 as a result of Staudinger-aza-Wittig reactions. Adduct 483 was 
unreactive to triphenylphosphine at room temperature as monitored by TLC. The reaction 
mixture was then heated at reflux to result only in the decomposition of the starting material. 
No products could be isolated and neither the imine 483 nor the iminophosphorane 
intermediate 488 were detectable.      
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Scheme  2.123 
The reaction of 2,5-dihydroxycyclohexa-2,5-diene-1,4-dione with 2-azidobenzaldehyde and 
tert-butyl isocyanide was also explored and also resulted in the synthesis of 2,6-bis (tert-
butylamino)-3,7-bis (2-azidophenyl) benzofuro[5,6-b]furan-4,8-dione 490 in 15 % yield 
(Scheme 2.124). 
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Scheme  2.124 
The structure of the compound 490 was assigned tentatively and may not be correct because 
it is difficult to get full data315 of compounds like 490. The IR spectrum confirmed the 
presence of azide and carbonyl moieties with peaks at 2124 and 1737 cm-1, respectively. 1H 
NMR spectroscopy confirmed the presence of eighteen protons for six methyl groups as a 
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singlet at 1.32, and two protons of the NHs as a singlet at 6.29 ppm.  1H NMR spectroscopy 
also confirmed the presence of eight aromatic protons. 13C NMR spectroscopy further 
confirmed the structure by showing peaks at 28.19, 28.67 and 29.61 ppm for the methyl 
groups, whereas the presence of seven quaternary carbons and four CH peaks in the aromatic 
region confirmed the presence of the two aromatic rings and the symmetric tricyclic structure 
of the quinine 490, although the 13C spectrum was complicated by lack of solubility and 
NMR invisibility seen in quinones. 
The attempted reaction of adduct 490 with triphenylphosphine, like that with the cyclohexyl 
analogue 483, was unsuccessful and no iminophosphorane or imine 491 was formed. Again, 
the compound 490 was found to be unstable in toluene at reflux.   
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Scheme  2.125 
 
2.6.11. Synthesis of ethyl 3-(2-azidophenyl)-5-methylisoxazole-4-carboxylate. 
The reaction of ethylacetoacetate with the nitrile oxide derived from 2-
azidobenzohydroximoyl chloride 352 in the presence of triethylamine afforded the isoxazole 
492 (Scheme 2.126) as a yellow oil. The isoxazole 492 is known in the literature316 and was 
synthesized here because it might undergo reaction with DPP to produce the potential aza-
Wittig precursor 493. We hoped that this process might pave the way for a new MCR using 
2-azidobenzohydroximoyl chloride 352, active CH2 compounds and cyclopropenones.  
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Scheme  2.126 
The structure of the initial product 492 was deduced from its IR, NMR and mass 
spectrometric data and was also identical to that produced in the literature. The IR spectrum 
confirmed the presence of azide and carbonyl moieties with peaks at 2123 and 1717 cm-1. 
The 1H NMR spectrum showed a triplet at 1.03 and a quartet at 4.08 ppm with a coupling 
constant of 5.8 Hz confirming the ethyl ester. One singlet at 2.64 ppm showed three protons 
of COMe and the rest of signals confirmed the four aromatic protons of the phenyl ring. The 
13C NMR spectrum confirmed the presence of a carbonyl group with a peak at 174.78 ppm. 
Three signals at 161.56, 159.70 and 109.77 ppm showed the three quaternary carbons of the 
isoxazole ring, whereas one peak at 13.07 ppm was consistent with the methyl substituent of 
the isoxazole ring. All other signals in the 13C NMR spectrum and mass spectrometric data 
confirmed the structure of the product. The regiochemistry of the product was confirmed with 
HMBC and HSQC spectroscopic techniques, and by mechanistic analysis. 
In the proposed mechanism, the reaction of triethylamine with ethyl acetoacetate formed an 
enolate intermediate which underwent stepwise nucleophilic addition with the nitrile oxide 
followed by elimination of water to produce the isoxazole. 
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   Scheme  2.127 
The reactivity of adduct 492 was investigated by reacting it with diphenylcyclopropenone. It 
was envisaged that it would undergo Grigg’s reaction317 to form a pyridinone from the 
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isoxazole (as occurred with benzaldehyde) and that the presence of azide and carbonyl 
moieties in the anticipated product might lead to further reaction possibilities via a 
Staudinger-aza-Wittig reaction.   
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Scheme  2.128 
 
The reaction mixture was heated in toluene at reflux for 24 hours and the only significant 
product identified was the dimer of diphenylcyclopropenone and the desired pyridone 
compound could not be found. This brief investigation based on the chemistry in Scheme 
2.126 finished here.   
 
2.7. Conclusion and future prospects. 
 
A wide range of cyclic imines have been synthesized and their reactivity was examined 
against cyclopropenones and 1, 3-dipoles. Simple monocyclic 7-, 6- and 5-membered cyclic 
imines were reacted with different cyclopropenones to form examples of pyrroloazepine, 
indolizidine and pyrrolizidine products respectively. These bicyclic adducts were found to be 
stable in toluene at reflux and were unreactive towards dimethyl acetylenedicarboxylate. 
These reactions are currently being investigated in order to access pyrroloazepine, 
indolizidine and pyrrolizidine natural products.  
4-Membered cyclic imines (1-azetines) were synthesized and reacted with different 
cyclopropenones to make azabicyclo compounds and the reactivity of these azabicyclic 
adducts was explored. A new protocol for the synthesis of pyridines was thus developed 
using the reaction of cyclopropenones with 4-aryl-1-azetines, which forms 
144 
 
azabicyclo[3.2.0]hept-2-ene-4-ones. When heated in toluene, the resulting 
azabicyclo[3.2.0]hept-2-en-4-ones generated the proposed 3-azacyclopentadienones which 
underwent Diels-Alder reaction with styrenes followed by extrusion of carbon monoxide to 
generate pyridines. The potential of the proposed 3-azacyclopentadienones was investigated 
in preliminary fashion in this programme of work and is currently being investigated further. 
 
1,3-Dipolar cycloaddition of nitrile oxides to 4-aryl-2-alkylthio-1-azetines produced 
oxadiazabicyclo[3.2.0]heptenes that underwent formal [2+2] cycloreversion and loss of 
styrene to furnish stable 5-alkylthio-3-aryl-1,2,4-oxadiazoles in a similar process. In these 
reactions, a 2-alkylthio-1-azetine functions as a thiocyanate (R-S-CN) equivalent. The use of 
these oxadiazoles in Liebeskind style318 coupling processes is under current investigation. 
1,3-Dipolar cycloaddition of 2-azidobenzyl nitrile oxide to 2-methylthio-3,3,4,4-tetramethyl-
1-azetine gave a oxadiazabicyclo[3.2.0]heptene that reacted with DMAD to unexpectedly 
produce a pyrimidine. This reaction should be more thoroughly investigated in future. 
 
2-Methyl-3-phenyl-1-azirine, a 3-membered cyclic imine, was synthesized and reacted with 
diphenylcyclopropenone to furnish a mixture of pyridone and a pyrazine, a process that 
appeared to be catalysed by the diphenylcyclopropenone. This process warrants further 
investigation. 
 
Some benzodiazepines and pyrrolobenzodiazepines were synthesized and converted into a 
range of benzodiazepine based cyclic imines. These cyclic imines were treated with 
cyclopropenones and nitrile oxides and were found to be unreactive towards both. 
Due to this disappointment, 2-azidobenzaldehyde was synthesized and reacted in different 
multicomponent reactions to furnish a range of heterocyclic products that had azide, nitrile 
and/or carbonyl groups that might then undergo cycloaddition or aza-Wittig reaction. 
Staudinger-aza-Wittig reaction of diethyl 4-(2-azidophenyl)-2,6-dimethyl-1,4-
dihydropyridine-3,5-dicarboxylate produced an imine and azide nitrile intramolecular 
cyclization in 2-(2-azidophenyl)-4-oxochroman-3-carbonitrile furnished a tetrazole ring. 
Several tetrazoles have been produced and this aspect of the MCRs reported in this thesis is 
under active development. 
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General information 
Unless otherwise stated or unnecessary, all reactions were conducted under nitrogen dried 
through 4Å molecular sieves and delivered through a gas manifold using oven dried glass-
ware. Work-up procedures were carried out in air. All solvents were purchased from Fisher 
Chemicals and were of analytical grade. 
Anhydrous grade solvents were freshly distilled using a continuous still under nitrogen. 
Diethyl ether and THF were pre-dried over sodium wires, and then distilled over sodium 
wires (1-2 % w/v) and benzophenone (0.2-0.3 % w/v) as an indicator. Dichloromethane and 
toluene were dried over calcium hydride (5 % w/v) for 4-6 hours. Any other anhydrous 
solvents were purchased from Acros or Sigma-Aldrich, while deuterated solvents were 
purchased from Goss scientific. 
All reactions were monitored by TLC, which was carried out on 0.20 mm Macherey-Nagel 
Alugram® Sil G/UV254 silica gel-60 F254 precoated aluminium plates and visulisation was 
achieved using UV light and / or using vanillin stain. Column chromatography was conducted 
using Merck silica gel (0.063-0.200 mm, 60 Å). 
The NMR spectra were obtained on a Bruker DPX-400 or on a Bruker Avance 500 
instrument. IR spectra were recorded on a Nicolet 380 FT-IR instrument as a thin film for oils 
and neat for solids. Mass spectra were recorded on a Bruker Daltonics micrOTOF mass 
spectrometer operating at a positive ion mode under an electrospray ionisation (ESI +) 
method. High resolution mass spectra were also recorded on a Finnegan MAT 900 XTL 
instrument operated by EPSRC National Mass Spectrometry service at the University of 
Swansea.   
Melting points were measured by using a GallenKamp instrument. 
Crystallographic data were recorded on a Bruker Apex Duo instrument at the University of 
Huddersfield. 
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 3.  Experimental 
3.1  Synthesis and reactivity of pyrroloazepines, indolizidines and 
pyrrolizidines. 
3.1.1  Synthesis of pyrroloazepines, indolizidines and pyrrolizidines. 
3.1.1.1  Synthesis of pyrroloazepines. 
 
3.1.1.1.1  Synthesis of azepan-2-thione.                             
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Scheme  3.1 
To azepan-2-one (1 g, 8.85 mmol) in dry THF (15 ml) was added δawesson’s reagent (1.78 
g, 4.42 mmol, 1.5 eq.) under an inert atmosphere and the mixture was stirred at room 
temperature for 1 h and then at 60 °C for 1h. The solvent was removed in vacuo to yield the 
crude product as an orange oil. It was purified by column chromatography (hexane / EtOAc : 
4/1, Rf = 0.27) to yield as a white solid (1.08 g, 95 %) the azepan-2-thione, m.p. 117-120 °C. 
IR: max (cm-1) 3180 (m), 2928 (s), 1552 (s), 1439 (s), 1368 (m). 
1H NMR δ (400 MHz, CDCl3): 9.19 (1H, s, NH), 3.37 (2H, dd, J= 6.0, 10.1, NCH2), 2.97 
(2H, t, J= 5.4, SCCH2) 1.79 – 1.73 (2H, m, CH2), 1.72 – 1.66 (2H, m, CH2), 1.64 – 1.58 (2H, 
m, CH2). 
 
13C NMR δ (100 MHz, CDCl3): 210.31 (C=S), 47.25 (CH2), 45.16 (CH2), 30.52 (CH2), 
28.23 (CH2), 24.62 (CH2). 
Data is identical to literature 229. 
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3.1.1.1.2.  Synthesis of 2-methylthio-1-azepane 
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Scheme  3.2 
 
Dimethyl sulfate (0.485 ml, 5.11 mmol, 1.5 eq) was added in one portion to azepan-2-thione 
(440 mg, 3.41 mmol, 1 eq) and the mixture was stirred for 18 hours at ambient temperature 
under an atmosphere of dry nitrogen. The reaction mixture was diluted with diethyl ether (10 
ml), washed with 10 % aqueous potassium carbonate (20 ml) and extracted with 
dichloromethane (3 x 20 ml). The organic phase was dried over magnesium sulfate and 
filtered under gravity. Most of the solvent was removed in vacuo, to leave 2 ml of crude 
liquid which was used in the next step. (Note that 2-methylthio-1-azepane was found to be 
volatile and unstable)319,320. 
 
3.1.1.1.3  Synthesis of 5-methylthio-2,3-diphenyl-1-azabicyclo[5.3.0]dec-2-en-4-one 
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Scheme  3.3 
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Diphenylcyclopropenone (358 mg, 1.73 mmol, 1 eq) was added in one portion to a stirring 
solution of 2-methylthio-1-azepane (250 mg, 1.73 mmol, 1eq) dissolved in anhydrous 
acetonitrile (10 ml) at ambient temperature under an atmosphere of dry nitrogen. The reaction 
mixture was stirred for 72 hours, concentrated and purified by column chromatography 
(eluent: hexane: EtOAc, 4:1) to yield 5-methylthio-2,3-diphenyl-1- 
azabicyclo[5.3.0]dec-2-en-4-one (357 mg, 59 %) as a yellow oil. 
 
IR: max (cm-1) 3053 (w) 2920 (m), 2851 (m), 1656 (vs), 1599 (s), 1577 (w), 1540 (s). 
1H NMR δ (500 MHz, CDCl3): 7.53 – 7.46 (3H, m, Ar), 7.37 – 7.31 (2H, m, Ar), 7.13 – 
7.10 (4H, m, Ar), 7.04 – 6.98 (1H, m, Ar), 3.82 – 3.78 (1H, m, NCH2), 3.41 – 3.34 (1H, m, 
NCH2), 2.78 (1H, dd, J= 7.8, 14.4, CH2CSMe), 1.93 (3H, s, SMe), 1.77 – 1.64 (2H, m, CH2), 
1.71 (1H, dd, J= 11.4, 14.4, CH2CSMe), 1.52 – 1.45 (1H, dd, J= 1.7, 14.1, CH2), 1.31 – 1.21 
(1H, m, CH2), 1.18 – 1.10 (1H, m, CH2), 1.10 – 1.01 (1H, m, CH2). 
 
13C NMR δ (125 MHz, CDCl3): 197.63 (C=O), 174.29 (q), 131.71 (q), 130.90 (q), 130.51 
(CH), 129.37 (CH), 128.81 (CH), 128.51 (CH), 128.03 (CH), 125.66 (CH), 113.21 (q), 76.98 
(q), 43.32 (CH2), 37.27 (CH2), 29.71 (CH2), 29.53 (CH2), 23.95 (CH2), 11.56 (CH3). 
 
HRMS (ESI+): Found 372.1394 [M+Na]+, C22H23NNaOS requires 372.1392. 
 
 
3.1.1.2  Synthesis of Indolizidines 
 
 
3.1.1.2.1 Synthesis of piperidone-2-thione 
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Scheme  3.4 
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A solution of 2-piperidone (1 g, 10.58 mmol, 1 eq) and δawesson’s reagent (β.ββ g, 5.49 
mmol, 0.5 eq.) in anhydrous tetrahydrofuran (15 ml) was stirred under an atmosphere of dry 
nitrogen at ambient temperature for an hour. The mixture was heated at reflux and monitored 
by TLC. Upon completion of the reaction (two hours) the mixture was left to cool to reach 
ambient temperature, concentrated and purified by column chromatography (eluent: hexane: 
EtOAc 3:1, Rf = 0.24) to yield piperidine-2-thione (532 mg, 84 %) as white crystals, m.p. 
114-117 oC.  
1H NMR δ (400 MHz, CDCl3): 9.53 (1H, s, NH), 3.32 – 3.28 (2H, m, NCH2), 2.82 (2H, t, 
J= 6.3 Hz, SCCH2), 1.78 – 1.67 (4H, m, CH2CH2CH2CH2). 
 
13C NMR δ (100 MHz, CDCl3): 202.11 (C=S), 44.60 (CH2), 39.11 (CH2), 20.70 (CH2), 
20.09 (CH2). 
The data is identical to literature 229. 
 
3.1.1.2.2  Synthesis of 2-methylthio-1-piperidine 
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Scheme  3.5 
 
Dimethyl sulfate (611 mg, 0.46 mL, 4.78 mmol, 1.1 eq.) was added in one portion to 
piperidine-2-thione (500 mg, 4.34 mmol, 1 eq) and the mixture was stirred for 18 hours at 
ambient temperature under an atmosphere of dry nitrogen. The reaction mixture was diluted 
with ether (10 ml), washed with 10 % potassium carbonate (20 ml) and extracted with 
dichloromethane (3 x 20 ml). The organic phase was dried over magnesium sulfate and 
filtered under gravity. Most of the solvent was removed in vacuo, to leave 2 ml of liquid 
which was used crude in the next step. (Note that 2-methylthio-1-piperidine was found to be 
volatile and unstable)319,320. 
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3.1.1.2.3  Synthesis of 5-methylthio-2,3-diphenyl-1-azabicyclo[4.3.0]non-2-en-4-one 
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  Scheme  3.6 
  
Diphenylcyclopropenone (475 mg, 2.30 mmol, 1 eq) was added in one portion to a stirring 
solution of 2-methylthio-1-piperidine (300 mg, 2.30 mmol, 1 eq) dissolved in anhydrous 
acetonitrile (10 ml) at ambient temperature under an atmosphere of dry nitrogen. The reaction 
mixture was stirred for a week, concentrated and purified by column chromatography (eluent: 
hexane:EtOAc, 4:1, Rf = 0.32) to yield 5-methylthio-2,3-diphenyl-1-azabicyclo[4.3.0]non-2-
en-4-one (427 mg, 55 %) as an orange/ yellow oil. 
 
IR: max (cm-1) 3056 (w), 2941 (m), 2859 (w), 1655 (vs), 1599 (m), 1578 (w), 1537 (m). 
 
1H NMR δ (400 MHz, CDCl3): 7.52 – 7.45 (3H, m, Ar), 7.34 – 7.28 (2H, m, Ar), 7.15 – 
7.09 (4H, m, Ar), 7.05 – 7.00 (1H, m, Ar). 3.65 (1H, dd, J= 8.7 and 4.7 Hz, NCH2), 3.51 (1H, 
td, J= 3.2 and 9.8 Hz NCH2), 2.28 – 2.21 (1H, m, SCCH2), 1.98 (3H, s, SCH3), 1.97 – 1.74 
(3H, m), 1.73 – 1.65 (1H, m), 1.36 – 1.29 (1H, m). 
13C NMR δ (100 MHz, CDCl3): 198.75 (C=O), 170.55 (q), 131.65 (q), 130.34 (q), 130.30 
(CH), 129.17 (CH), 128.48 (CH), 128.19 (CH), 127.78 (CH), 125.23 (CH), 109.86 (q), 72.19 
(q), 41.40 (CH2), 32.62, (CH2), 27.37 (CH2), 20.45 (CH2), 10.56 (CH3). 
 
HRMS (ESI+): Found 358.1234 [M+H]+, C20H19NO2 requires 358.1236. 
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3.1.1.3  Synthesis of pyrrolizidines. 
 
3.1.1.3.1 Synthesis of pyrrolidine-2-thione 
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Scheme  3.7 
 
A solution of pyrrolidine-2-one (1 g, 11.75 mmol, 1 eq) and δawesson’s reagent (β.γ7 g, 5.87 
mmol, 0.5 eq.) in anhydrous tetrahydrofuran (15 ml) was stirred under an atmosphere of dry 
nitrogen at ambient temperature for an hour. The mixture was heated at reflux and monitored 
by TLC. Upon completion of the reaction (two hours) the mixture was left to cool to reach 
ambient temperature, concentrated and purified by column chromatography (eluent: hexane: 
EtOAc 3:1, Rf = 0.23) to yield pyrrolidine-2-thione (532 mg, 90 %) as white crystals, m.p. 
108-112 oC.  
 
IR: max (cm-1) 3139 (br, NH), 2916 (w), 2884 (w), 1533 (m, C=S), 1469 (w), 1445 (m), 
1291(s), 1214 (m). 
1H NMR δ (400 MHz, CDCl3): 8.74 (1H, s, NH), 3.63 (2H, t, J= 7.3 Hz, NCH2), 2.92 (2H, t, 
J= 8.0 Hz, SCCH2), 2.21 (2H, m, CH2CH2CH2). 
 
13C NMR δ (100 MHz, CDCl3): 206.07 (C=S), 49.86 (CH2), 43.21 (CH2), 22.87 (CH2). 
 
The data is identical to literature 229. 
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3.1.1.3.2  Synthesis of 5-(methylthio)-3,4-dihydro-2H-pyrrole 
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                                                                Scheme  3.8 
εeerwein’s reagent (878 mg, 5.94 mmol, 1.β eq.) was added in one portion to pyrrolidine-2-
thione (500 mg, 4.95 mmol, 1 eq) in anhydrous DCM (10 ml) and the mixture was stirred for 
1 hour at ambient temperature under an atmosphere of dry nitrogen and then heated at reflux 
for 1 hour. The solution was then added dropwise to a 50% aqueous solution of potassium 
carbonate (10 ml) at -10 oC. The solution was then filtered through Celite and the organic 
layer was separated. The aqueous layer was washed with dichloromethane (2x 10 ml), and the 
combined organic extracts were dried over magnesium sulfate. After filtration, the solvent 
was evaporated in vacuo to leave 2 ml of liquid product as dark orange oil which was used 
crude in the next step. (Note that 2-methylthio-1-piperidine was found to be volatile and 
unstable)319.  
 
3.1.1.3.3  Synthesis of 5-methylthio-1-azabicyclo[3.3.0]oct-2-en-4-one  
 
            
CH3CN
N
SMe
N
SMe O
O
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Scheme  3.9 
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Cyclopropenone (140 mg, 2.60 mmol, 1 eq) was added in one portion to a stirring solution of 
2-methylthio-1-pyrrolidine (300 mg, 2.60 mmol, 1 eq) dissolved in anhydrous acetonitrile (10 
ml) at ambient temperature under an atmosphere of dry nitrogen. The reaction mixture was 
stirred for 12 hours, concentrated and purified by column chromatography (eluent: 
hexane:EtOAc, 4:1, Rf = 0.36) to yield 5-methylthio-1-azabicyclo[3.3.0]oct-2-en-4-one (81 
mg, 18 %) as a yellow oil. 
 
IR: max (cm-1) 2980 (br), 2851 (m), 1681 (s), 1597 (m), 1533 (m), 1341 (m). 
1H NMR (400 MHz) (CDCl3) δ 7.77 (1H, d, J= 3.5 Hz, C=CH), 5.35 (1H, d, J= 3.6 Hz, 
C=CH), 3.49-3.56 (1H, m, NCH), 3.30-3.36 (1H, m, NCH), 2.05-2.22 (2H, m, CH2), 1.96 
(3H, s, SCH3), 1.85-1.93 (2H, m, CH2). 
13C NMR (100 MHz) (CDCl3) δ 203.54 (C=O), 169.00 (CH), 105.24 (CH), 79.46 (C), 48.46 
(CH2), 32.86 (CH2), 27.07 (CH2), 11.84 (CH3).  
HRMS (ESI+): Found 192.0454, C8H11NOSNa, requires 192.0454. 
 
 
3.1.2  Reactivity of pyrroloazepines, indolizidines and pyrrolizidines 
 
3.1.2.1 Reactivity of pyrroloazepines. 
 
 
3.1.2.1.1.   Reactivity of 5-methylthio-2,3-diphenyl-1-azabicyclo[5.3.0]dec-2-en-4-one. 
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Scheme  3.10 
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100 mg (0.28 mmol) of 5-methylthio-2,3-diphenyl-1-azabicyclo[5.3.0]dec-2-en-4-one was 
added to toluene (10 ml) and the mixture was heated at 115 oC overnight. The reaction was 
monitored by TLC and even after 72 hours of reflux no product could be identified.  
 
3.1.2.2  Reactivity of indolizidines. 
 
3.1.2.2.1.  Reactivity of 5-methylthio-2,3-diphenyl-1-azabicyclo[4.3.0]non-2-en-4-one. 
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Scheme  3.11 
100 mg (0.30 mmol) of 5-methylthio-2,3-diphenyl-1-azabicyclo[4.3.0]non-2-en-4-one was 
added to toluene (10 ml) and the mixture was heated at 115 oC overnight. The reaction was 
monitored by TLC and even after 72 hours of reflux no product could be identified.  
 
3.1.2.3  Reactivity of pyrrolizidines. 
 
3.1.2.3.1. Reactivity of 5-(methylthio)-1-azabicyclo[3.3.0]oct-2-en-4-one with DMAD 
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Scheme  3.12 
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5-(methylthio)-1-azabicyclo[3.3.0]oct-2-en-4-one (70 mg, 0.41 mmol) and DMAD (58.8 mg, 
0.3 ml, 1 eq.) were added to toluene (10 ml) and the mixture was heated at 115 oC for 24 
hours. The reaction was monitored by TLC and then mixture was refluxed for 12 hours and 
monitored again, no product could be identified.   
 
3.2  Synthesis and reactivity of 1-azetines 
3.2.1  Synthesis of 1-azetines 
3.2.1.1 Synthesis of 2-methylthio-4-phenyl-1-azetine 
3.2.1.1.1. Synthesis of 4-phenylazetidin-2-one 
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Scheme  3.13 
N-chlorosulfonyl isocyanate (CSI) (3.20 ml, 5.24g, 37.0 mmol, 1.2 eq.) was added drop wise 
to styrene (3.7 ml, 3.32g, 31.90 mmol) in dry diethyl ether (15 ml) under an inert atmosphere 
over 10 minutes. The mixture was stirred at room temperature for 2h and the solvent was 
removed in vacuo to give an oily residue, which was redissolved in diethyl ether (20 ml) and 
added over 10 minutes to a vigorously stirred solution of water (30 ml), sodium carbonate (9 
g, 107.1 mmol, 3.3 eq.), sodium sulfite (6 g, 47.6 mmol, 1.5 eq.) and ice (20 g). The solution 
was stirred for 1 hour and filtered under vacuum. The organic layer was separated, and the 
aqueous layer was washed with diethyl ether (5 x 20 ml). The combined organic extracts 
were dried over magnesium sulfate, filtered and the solvent evaporated under vacuum to yield 
the product as a white solid (3.70 g, 79 %, m.p. = 102-103 oC) 247. 
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IR: max (cm-1) 3207 (br, NH), 1737 (m), 1705 (s, C=O), 1491 (m), 1453 (m), 1404 (m) 1390 
(w), 1368 (m), 1282 (w), 1214 (w), 1185 (m), 1171 (m), 1007 (w), 979 (m), 962 (m), 783 
(w), 757 (s), 697 (s).              
1H NMR:   H (500 MHz, CDCl3) 7.34-7.27 (5H, m, Ph), 6.97 (1H, bs, NH), 4.67 (1H, dd, 
J= 5.2 and 2.3 Hz, CH), 3.38 (1H, ddd, J= 14.8, 5.2 and 2.3 Hz, CH2), 2.80 (1H, dd, J= 14.8 
and 2.3 Hz, CH2). 
13C NMR c (125 MHz, CDCl3) 168.48 (C=O), 140.13 (C), 128.44 (CH), 127.93 (CH), 
125.47 (CH), 50.15 (CH), 47.60 (CH2). 
MS (m/z): 170 (M+Na)+, 317 (2M+Na)+. 
 
3.2.1.1.2  Synthesis of 4-phenylazetidin-2-thione 
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Scheme  3.14 
To 4-phenylazetidine-2-one (3.70 g, β5.17 mmol) in dry THF (15 ml) was added δawesson’s 
reagent (5.08 g, 12.58 mmol, 0.5 eq.) under an inert atmosphere and the mixture was stirred 
at room temperature for 1 h and then at 60 oC for 20 minutes. The solvent was then removed 
by rotary evaporation to yield the crude product as orange oil. It was purified by column 
chromatography (PE 40-60 oC / EtOAc : 3/1, Rf = 0.24) to yield a white solid (1.97g, 48 %, 
m.p. = 117-118 oC) 247. 
IR: max (cm-1) 3136 (br, NH), 1486 (s, C=S), 1450 (s), 1403 (m), 1359 (m), 1263 (w), 1236 
(s) 1176 (m), 1146 (m), 1068 (w), 980 (m), 963 (s), 756 (s), 694 (s). 
1H NMR:   H (500 MHz, CDCl3) 8.28 (1H, bs, NH), 7.38-7.31 (5H, m, Ph), 5.18 (1H, dd, 
J= 4.6 and 1.8 Hz, CH), 3.51 (1H, ddd, J= 15.5, 4.6 and 2.1 Hz, CH2), 3.02 (1H, dd, J= 15.5 
and 1.8 Hz, CH2). 
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13C NMR c (125 MHz, CDCl3) 204.42 (C=S), 138.03 (C), 129.03 (CH), 128.82 (CH), 
125.77 (CH), 58.89 (CH), 51.26 (CH2). 
 
3.2.1.1.3  Synthesis of 2-methylthio-4-phenyl-1-azetine 
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Scheme  3.15 
To 4-phenylazetidin-2-thione (500 mg, γ.06 mmol) was added εeerwein’s reagent (785 mg, 
5.34 mmol, 1.5 eq.) in dry dichloromethane (10 ml) under a nitrogen atmosphere. The 
mixture was stirred at room temperature for 1 h and then at reflux for 1 h. The solution was 
then added dropwise to a 50% aqueous solution of potassium carbonate (10 ml) at -10 oC. 
The solution was then filtered through celite and the organic layer was separated. The 
aqueous layer was washed with dichloromethane (2 x 10 ml), and the combined organic 
extracts were dried over magnesium sulfate. After filtration the solvent was evaporated in 
vacuo to give the product as dark orange oil (237 mg, 43 %). 
IR: max (cm-1):  2940 (w), 1523 (s), 1500 (m), 1460 (m), 1225 (s), 1135 (w), 960 (m), 920 
(m). 
1H NMR: δ (400 MHz, CDCl3): 7.34 – 7.29 (5H, m, 5 x PhH), 5.25 (1H, dd, J = 4.3, 1.9, 
CH), 3.56 (1H, dd, J = 14.5 and 4.3, CH2), 2.95 (1H, dd, J = 14.5 and 1.9, CH2), 2.48 (3H, s, 
Me). 
 
13C NMR δ (100 MHz, CDCl3): 183.31 (C), 140.03(C), 127.48 (CH), 126.42 (CH), 125.37 
(CH), 64.17 (CH), 42.50 (CH2), 11.51 (Me). 
 
HRMS (m/z): calc for C10H11NS + H+ (M + H+), 178.0687, found 178.0689 
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3.2.1.2  Synthesis of 2-ethylthio-4-phenyl-1-azetine 
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Scheme  3.16 
To 4-phenylazetidin-2-thione (500 mg, γ.06 mmol) was added εeerwein’s reagent (1ε 
solution in DCM, 5 ml, 5 mmol, 1.6 eq.) in dry dichloromethane (10 ml) under a nitrogen 
atmosphere. The mixture was stirred at room temperature for 1 h and then at reflux for 1 h. 
The solution was then added dropwise to a 50% aqueous solution of potassium carbonate (10 
ml) at -10 oC. The solution was then filtered through celite and the organic layer was 
separated. The aqueous layer was washed with dichloromethane (2 x 10 ml), and the 
combined organic extracts were dried over magnesium sulfate. After filtration the solvent 
was evaporated in vacuo to give the product as dark orange oil (320 mg, 54 %). 
IR: max (cm-1):  3059 (w), 3030 (w), 2968 (w), 2926 (w), 1655 (m), 1554 (m), 1514 (m), 
1493, (m), 1450 (m), 1374 (m), 1325 (m), 1264 (m), 1029 (m), 972 (m), 755 (m), 697 (s). 
 
1H NMR:   H (400 MHz, CDCl3) 7.34-7.28 (5H, m, Ph), 5.02 (1H, dd, J = 4.3 and 2.0, CH), 
3.56 (1H, dd, J = 14.6 and 4.3, CH2), 3.06 (2H, q, J = 7.4, SCH2Me), 2.96 (1H, dd, J = 14.6 
and 2.0, CH2), 1.40 (3H, t, J = 7.4, SCH2CH3). 
 
13C NMR  (100 MHz, CDCl3) 183.56 (C), 140.82 (C), 128.37 (CH), 127.34 (CH), 125.96 
(CH), 65.10 (CH), 43.57 (CH2), 23.36 (CH2), 14.65 (CH3). 
 
MS (m/z): 192.1 ([M+H]+), 383.2 ([M2+H]+), 574.2 ([M3+H]+), 765.3 ([M4+H]+), 956.4 
([M5+H]+). 
HRMS (m/z): calc for C11H13NS + H+ (M + H+), 192.0843, found 192.0845. 
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3.2.1.3  Synthesis of 2-methylthio-4-tolyl-1-azetine 
3.2.1.3.1. Synthesis of 4-tolylazetidin-2-one 
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Scheme  3.17 
 
N-chlorosulfonyl isocyanate (CSI) (1.76 ml, 2.86 g, 20.30 mmol, 1.2 eq.) was added 
dropwise to vinyltoluene (2.2 ml, 2 g, 16.92 mmol) in dry diethyl ether (15 ml) under an inert 
atmosphere over 10 minutes. The mixture was stirred at room temperature for 2h and the 
solvent was removed in vacuo to give an oily residue, which was redissolved in diethyl ether 
(20 ml) and added over 10 minutes to a vigorously stirred solution of water (30 ml), sodium 
carbonate (4.5 g, 42.50 mmol, 2.5 eq.), sodium sulfite (3 g, 22.41 mmol, 1.3 eq.) and ice (20 
g). The solution was stirred for 1 hour and filtered under vacuum. The organic layer was 
separated, and the aqueous layer was washed with diethyl ether (5 x 20 ml). The combined 
organic extracts were dried over magnesium sulfate, filtered and the solvent evaporated under 
vacuum to yield the product as a white solid (2.27 g, 83 %, m.p. = 104-107 oC). 
IR: max (cm-1) 3216 (br, NH), 1769.5 (s, C=O), 1513.4 (m), 1417 (m), 1375 (m), 1351 (w), 
1275 (m), 1177 (w), 1114 (w), 966 (m), 814 (m), 774 (w), 623 (m), 556 (m), 486 (w), 408 (s).               
1H NMR:   H (500 MHz, CDCl3) 7.27 (2H, d, J= 8.1, Ph), 7.20 (2H, d, J= 8.3, Ph), 6.74 
(1H, bs, NH), 4.69 (1H, dd, J= 5.2 and 2.4 Hz, CH), 3.42 (1H, ddd, J= 14.8, 5.2 and 2.4 Hz, 
CH2), 2.84 (1H, dd, J= 14.8 and 2.0 Hz, CH2), 2.37 (3H, CH3). 
13C NMR c (125 MHz, CDCl3) 168.63 (C=O), 137.99 (C)), 137.25 (CH), 129.35 (CH), 
125.91 (CH), 50.37 (CH), 47.93 (CH2), 21.19 (CH3). 
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3.2.1.3.2.  Synthesis of 4-tolylazetidin-2-thione 
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Scheme  3.18 
To 4-tolylazetidine-2-one (1.1 g, 6.79 mmol) in dry THF (15 ml) was added δawesson’s 
reagent (1.37 g, 3.39 mmol, 0.5 eq.) under an inert atmosphere and the mixture was stirred at 
room temperature for 1 h and then at 60 oC for 20 minutes. The solvent was then removed by 
rotary evaporation to yield the crude product as an orange oil. It was purified by column 
chromatography (PE 40-60 oC / EtOAc : 3/1, Rf = 0.24) to yield a white solid ( 0.58 g, 52 %, 
m.p. = 114-117 oC). 
1H NMR:   H (500 MHz, CDCl3) 8.84 (1H, bs, NH), 7.33-7.26 (4H, m, Ph), 5.15 (1H, dd, 
J= 4.5 and 1.8 Hz, CH), 3.48 (1H, ddd, J= 15.5, 4.5 and 2.0 Hz, CH2), 3.97 (1H, dd, J= 15.6 
and 1.5 Hz, CH2), 2.37 (3H, CH3). 
13C NMR c (125 MHz, CDCl3) 204.48 (C=S), 138.71 (C), 135.05 (CH), 129.69 (CH), 
125.64 (CH), 58.97 (CH), 51.23 (CH2), 21.25 (CH3). 
 
3.2.1.3.3.  Synthesis of 2-methylthio-4-tolyl-1-azetine 
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Scheme  3.19 
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To 4-tolylazetidin-2-thione (500 mg, γ.56 mmol) was added εeerwein’s reagent (785 mg, 
5.34 mmol, 1.5 eq.) in dry dichloromethane (15 ml) under a nitrogen atmosphere. The 
mixture was stirred at room temperature for 1 h and then at reflux for 1 h. The solution was 
then added dropwise to a 50% aqueous solution of potassium carbonate (10 ml) at -10 oC and 
filtered through celite and the organic layer was separated. The aqueous layer was washed 
with dichloromethane (2 x 10 ml), and the combined organic extracts were dried over 
magnesium sulfate. After filtration the solvent was evaporated in vacuo to give the product as 
dark orange oil (220 mg, 41 %). 
IR υmax (cm-1): 2935 (w), 1523 (s), 1400 (w), 1224 (s), 1135 (m), 941 (m), 905 (m), 811 (s). 
 
1H NMR: δ (400 MHz, CDCl3): 7.27 (2H, d, J = 8.0, 2 x ArH), 7.19 (2H, d, J = 8.0, 2 x 
ArH), 5.01 (1H, dd, J = 4.3, 2.0, CH), 3.56 (1H, dd, J = 14.6 and 4.3, CH2), 2.96 (1H, dd, J = 
14.6 and 2.0, CH2), 2.49 (3H, s, Me), 2.37 (3H, s, Me). 
 
13C NMR δ (100 MHz, CDCl3): 183.12 (C), 137.10 (C), 136.44 (C), 128.47 (CH), 125.57 
(CH), 64.14 (CH), 42.38 (CH2), 20.53 (Me), 10.85 (Me). 
 
HRMS (m/z): calc for C11H13NS + H+ (M + H+), 192.0843, found 192.0843. 
 
3.2.1.4.  Synthesis of 2-ethylthio-4-tolyl-1-azetine 
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Scheme  3.20 
To 4-tolylazetidin-2-thione (500 mg, 2.80 mmol) was added εeerwein’s reagent (1 ε 
solution in DCM, 4.21 ml, 4.21 mmol, 1.5 eq.) in dry dichloromethane (10 ml) under a 
163 
 
nitrogen atmosphere. The mixture was stirred at room temperature for 1 h and then at reflux 
for 1 h. The solution was then added dropwise to a 50% aqueous solution of potassium 
carbonate (10 ml) at -10 oC. The solution was then filtered through celite and the organic 
layer was separated. The aqueous layer was washed with dichloromethane (2 x 10 ml), and 
the combined organic extracts were dried over magnesium sulfate. After filtration the solvent 
was evaporated in vacuo to give the product as dark orange oil (221 mg, 38 %). 
IR υmax (cm-1): 3251 (w), 1522 (s), 1440 (w), 1224 (s), 1134 (m), 940 (m), 911 (m), 811 (s). 
 
1HNMR: δ (400 MHz, CDCl3): 7.13 (2H, d, J = 8.0, 2 x ArH), 7.04 (2H, d, J = 8.0, 2 x 
ArH), 4.88 (1H, dd, J = 4.2, 1.9, CH), 3.47 (1H, dd, J = 14.5 and 4.2, CH2), 2.98 (2H, dq, J = 
7.2 and 1.8, SCH2), 2.86 (1H, dd, J = 14.5 and 1.9), 2.27 (3H, s, Me), 1.33 (3H, t, J = 7.2, 
SCH2CH3). 
 
13C NMR δ (100 MHz, CDCl3): 183.10 (C), 137.11 (C), 136.65 (C), 128.11 (CH), 124.07 
(CH), 64.97 (CH), 44.31 (CH2), 22.50 (Me), 20.10 (CH2), 13.43 (Me). 
 
HRMS (m/z): calc for C12H15NS + H+ (M + H+), 206.0999, found 206.1002. 
 
3.2.1.5  Synthesis of 2-methylthio-4-naphthyl-1-azetine 
3.2.1.5.1.  Synthesis of 4-naphthylazetidin-2-one 
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 Scheme  3.21 
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N-chlorosulfonyl isocyanate (CSI) (1.35 ml, 2.20 g, 15.55 mmol, 1.2 eq.) was added 
dropwise to 2-vinylnaphthalene (2 g, 12.96 mmol) in dry diethyl ether (15 ml) under an inert 
atmosphere over 10 minutes. The mixture was stirred at room temperature for 2h and the 
solvent was removed in vacuo to give an oily residue, which was redissolved in diethyl ether 
(20 ml) and added over 10 minutes to a vigorously stirred solution of water (30 ml), sodium 
carbonate (4.5 g, 42.50 mmol), sodium sulfite (3 g, 22.38 mmol) and ice (20 g). The solution 
was stirred for 1 hour and filtered under vacuum. The organic layer was separated, and the 
aqueous layer was washed with diethyl ether (5 x 20 ml). The combined organic extracts 
were dried over magnesium sulfate, filtered and the solvent evaporated under vacuum to yield 
the product as a white solid (1.64 g, 64 %, m.p. = 105-108 oC). 
IR: max (cm-1) 3152 (br, NH), 1709 (s, C=O), 1402 (s), 1266 (m), 1233 (s) 1168 (m), 1123 
(m), 941 (m), 926 (s), 866 (s), 822 (s). 
1H NMR:   H (500 MHz, CDCl3) 7.90-7.81 (5H, m, Ar), 7.48 (2H, dd, J= 8.4 and 1.7 Hz, 
Ar), 6.69 (1H, bs, NH), 4.85 (1H, dd, J= 4.9 and 2.1 Hz, CH), 3.52 (1H, ddd, J= 15.6, 5.6 and 
2.2 Hz, CH2), 2.84 (1H, dd, J= 14.8 and 1.8 Hz, CH2), 2.37 (3H, CH3). 
13C NMR c (125 MHz, CDCl3) 168.4 (C=O), 137.5 (C (Ar)), 134.0 (C (Ar)), 129.1 (C 
(Ar)), 128.5 (C (Ar), 128.1 (C (Ar), 127.8 (C (Ar), 127.1 (C (Ar), 126.3 (C (Ar)), 124.7 (C 
(Ar), 50.58 (CH), 47.90 (CH2). 
 
3.2.1.5.2.  Synthesis of 4-naphthylazetidin-2-thione 
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Scheme  3.22 
To 4-naphthylazetidine-2-one (750 mg, 3.81 mmol) in dry THF (15 ml) was added 
δawesson’s reagent (770 mg, 1.90 mmol, 0.5 eq.) under an inert atmosphere and the mixture 
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was stirred at room temperature for 1 h and then at 60 oC for 20 minutes. The solvent was 
then removed by rotary evaporation to yield the crude product as orange oil. It was purified 
by column chromatography (PE 40-60 oC / EtOAc : 3/1, Rf = 0.24) to yield a white solid 
(378 mg, 47 %, m.p. = 119-122 oC). 
IR: max (cm-1) 3132 (br, NH), 1499 (s, C=S), 1402 (s), 1263 (m), 1237 (s) 1168 (m), 1121 
(m), 941 (m), 916 (s), 866 (s), 820 (s). 
1H NMR:   H (500 MHz, CDCl3) 7.91-7.81 (3H, m, Ar), 7.54 (m, 2H, Ar), 7.48 (2H, dd, J= 
8.4 and 1.7 Hz, Ar), 7.3 (1H, bs, NH), 5.4 (1H, dd, J= 4.9 and 2.1 Hz, CH), 3.52 (1H, ddd, J= 
15.6, 5.6 and 2.2 Hz, CH2), 3.12 (1H, dd, J= 14.4 and 1.9 Hz, CH2). 
13C NMR c (125 MHz, CDCl3) 204.4 (C=O), 135.4 (C (Ar)), 133.3 (C (Ar)), 133.1 (C 
(Ar)), 129.2 (C (Ar), 128.1 (C (Ar), 127.8 (C (Ar), 126.6 (C (Ar), 122.9 (C (Ar)), 59.12 (CH), 
51.25 (CH2). 
"The assigned structure is consistent with the available data. It was not possible to obtain full 
data for this compound meaning that this assignment remains tentative". 
 
3.2.1.5.3.  Synthesis of 2-methylthio-4-naphthyl-1-azetine 
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Scheme  3.23 
To 4-naphthylazetidin-2-thione (300 mg, 1.40 mmol) was added εeerwein’s reagent (γ1β 
mg, 2.11 mmol, 1.5 eq.) in dry dichloromethane (10 ml) under a nitrogen atmosphere. The 
mixture was stirred at room temperature for 1 h and then at reflux for 1 h. The solution was 
then added dropwise to a 50% aqueous solution of potassium carbonate (10 ml) at -10 oC. 
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The solution was then filtered through celite and the organic layer was separated. The 
aqueous layer was washed with dichloromethane (2 x 10 ml), and the combined organic 
extracts were dried over magnesium sulfate. Filtration and solvent removal in vacuo gave the 
product as a dark orange oil (133 mg, 40 %). 
IR υmax (cm-1): 3023 (w), 2915 (w), 1604 (m), 1510 (w), 1490 (m), 1345 (m), 1165 (s), 1072 
(s), 819 (s), 749 (s). 
 
1H NMR: δ (400 MHz, CDCl3): 7.76 – 7.69 (4H, m, 4 x ArH), 7.31 – 7.39 (3H, m, 3 x 
ArH), 5.07 (1H, dd, J = 4.3, 2.0, CH), 3.51 (1H, dd, J = 14.6 and 4.3, CH2), 2.94 (1H, dd, J = 
14.6 and 2.0), 2.41 (3H, s, Me). 
 
13C NMR δ (100 MHz, CDCl3): 183.35 (C), 136.95 (C), 133.37 (C), 132.66 (C), 128.10 
(CH), 127.59 (CH). 127.44 (CH), 126.64 (CH), 126.25 (CH), 124.40 (CH), 123.17 (CH), 
64.87 (CH), 43.45 (CH2), 11.11 (SMe). 
 
"The assigned structure is consistent with the available data. It was not possible to obtain full 
data for this compound meaning that this assignment remains tentative". 
 
3.2.1.6.  Synthesis of 2-methylthio-3,3,4,4-tetramethyl-1-azetine 
 
3.2.1.6.1.  Synthesis of 3,3,4,4-tetramethylazetidin-2-one 
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Scheme  3.24 
N-chlorosulfonyl isocyanate (CSI) (1.75 ml, 2.83 g, 20 mmol, 1.2 eq.) was added dropwise to 
2,3-dimethyl-2-butene (1.4 g, 2 ml, 16.66 mmol) in dry diethyl ether (15 ml) under an inert 
atmosphere over 10 minutes. The mixture was stirred at room temperature for 2h and the 
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solvent was removed in vacuo to give an oily residue, which was redissolved in diethyl ether 
(20 ml) and added over 10 minutes to a vigorously stirred solution of water (30 ml), sodium 
carbonate (4.5 g, 42.5 mmol), sodium sulfite (3 g, 22.38 mmol) and ice (20 g). The solution 
was stirred for 1 hour and filtered under vacuum. The organic layer was separated, and the 
aqueous layer was washed with diethyl ether (5 x 20 ml). The combined organic extracts 
were dried over magnesium sulfate, filtered and the solvent evaporated under vacuum to yield 
the product as a white solid (1.51 g, 71 %, m.p. = 102-104 oC) 247. 
IR υmax (cm-1): 3186 (br, NH), 2984 (w), 1747 (m), 1703 (s, C=O), 1449 (w), 1393 (m), 1375 
(m), 1314 (m), 1252 (w). 
1H NMR: δ (500 MHz, CDCl3) 6.02 (1H, bs, NH), 1.32 (6H, s, 2 x CH3), 1.22 (6H, s, 2 x 
CH3). 
13C NMR δ (125 MHz, CDCl3) 174.91 (C=O), 58.18 (C), 54.51 (C), 24.40 (CH3), 19.06 
(CH3).  
MS (m/z) : 150.1 [M+Na]+, 255.2 [M2+H]+, 277.2 [M2+Na]+. 
 
3.2.1.6.2.  Synthesis of 3,3,4,4-tetramethylazetidin-2-thione 
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Scheme  3.25 
To 3,3,4,4-tetramethylazetidine-2-one (1 g, 7.87 mmol) in dry THF (15 ml) was added 
δawesson’s reagent (1.59  g, γ.9γ mmol, 0.5 eq.) under an inert atmosphere and the mixture 
was stirred at room temperature for 1 h and then at 60 oC for 20 minutes. The solvent was 
then removed by rotary evaporation to yield the crude product as orange oil. It was purified 
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by column chromatography (PE 40-60 oC / EtOAc : 3/1, Rf = 0.24) to yield a white solid 
(521 mg, 47 %, m.p. = 121-124 oC) 247. 
IR υmax (cm-1): 3117 (br, NH), 2988 (w), 1492 (s, C=S), 1455 (m), 1393 (w) 1367 (m), 1311 
(w), 1257. 
1H NMR: δ (500 MHz, CDCl3) 8.23 (1H, bs, NH), 1.38 (6H, s, 2 x CH3), 1.24 (6H, s, 2 x 
(CH3). 
13C NMR δ (125 MHz, CDCl3) 212.27 (C=S), 68.57 (C), 56.81 (C), 23.51 (CH3), 20.92 
(CH3). 
MS (m/z): 144.1 [M+H] , 166.1 [M+Na] , 309.1 [M2+Na] . 
 
3.2.1.6.3.  Synthesis of 2-methylthio-3,34,,4-tetramethyl-1-azetine 
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Scheme  3.26 
To 3,3,4,4-tetramethylazetidin-2-thione (500 mg, γ.5 mmol) was added εeerwein’s reagent 
(620 mg, 4.19 mmol, 1.2 eq.) in dry dichloromethane (15 ml) under a nitrogen atmosphere. 
The mixture was stirred at room temperature for 1 h and then at reflux for 1 h. The solution 
was then added dropwise to a 50% aqueous solution of potassium carbonate (10 ml) at -10 
oC. The solution was then filtered through celite and the organic layer was separated. The 
aqueous layer was washed with dichloromethane (2 x 10 ml), and the combined organic 
extracts were dried over magnesium sulfate. After filtration the solvent was evaporated in 
vacuo to give the product as dark orange oil, as reported previously157. 
 
169 
 
1H NMR: δ (500 MHz, CDCl3) 1.97 (3H, s, SCH3), 1.26 (6H, s, 2 x CH3), 1.12 (6H, s, 2 x 
CH3). 
 
13C NMR δ (125 MHz, CDCl3) 182.96 (C=N), 69.82 (C), 51.34 (C), 23.81 (CH3), 20.57 
(CH3), 10.58 (SCH2CH3).  
 
"The assigned structure is consistent with the available data. It was not possible to obtain full 
data for this compound meaning that this assignment remains tentative". 
 
3.2.1.7.  Synthesis of 2-ethylthio-3,3,4,4-tetramethyl-1-azetine 
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Scheme  3.27 
To 3,3,4,4-tetramethylazetidin-2-thione (γ80 mg, β.65 mmol) was added εeerwein’s reagent 
(1M soln. in DCM, 3.72 mmol, 1.4 eq.) in dry dichloromethane (10 ml) under a nitrogen 
atmosphere. The mixture was stirred at room temperature for 1 h and then at reflux for 1 h. 
The solution was then added drop wise to a 50% aqueous solution of potassium carbonate (10 
ml) at -10 oC. The solution was then filtered through celite and the organic layer was 
separated. The aqueous layer was washed with dichloromethane (2 x 10 ml), and the 
combined organic extracts were dried over magnesium sulfate. After filtration the solvent 
was evaporated in vacuo to give the product as dark orange oil, as reported previously157. 
 
1H NMR: δ (500 MHz, CDCl3) 2.94 (2H, q, J=7.3 Hz, SCH2CH3), 1.32 (3H, t, J=7.2 Hz 
(SCH2CH3), 1.25 (6H, s, 2 x CH3), 1.13 (6H, s, 2 x CH3). 
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13C NMR δ (125 MHz, CDCl3) 186.96 (C=N), 69.88 (C), 51.32 (C), 23.82 (CH3), 21.75 
(CH2), 20.61 (CH3), 14.48 (SCH2CH3).  
 
"The assigned structure is consistent with the available data. It was not possible to obtain full 
data for this compound meaning that this assignment remains tentative". 
 
 
3.2.2. Reactivity of 1-azetines with cyclopropenones 
3.2.2.1. Reactivity of 2-methylthio-4-phenyl-1-azetine with diphenylcyclopropenone : 
Synthesis of 5-methylthio-2,3,7-triphenyl-1-azabicyclo[3.2.0]hept-2-en-4-one 
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Scheme  3.28 
To a mixture of 4-phenyl-2-methylthio-1-azetine (300 mg, 1.69 mmol) in dry acetonitrile (10 
ml) was added diphenylcyclopropenone (DPP) (348 mg, 1.69 mmol, 1 eq.) under a  nitrogen 
atmosphere and the mixture was strirred at room temperature for 24 h. The solvent was 
evaporated in vacuo and the mixture was purified by silica gel chromatography using PE 40-
60 oC / EtOAc :  4/1, Rf = 0.21 to give the product as a yellow oil (380 mg, 59 %). 
1H NMR:   H (400 MHz, CDCl3) 7.61-6.81 (15H, m, Ph), 5.58 and 4.25 (2 x diastereo, 1H, 
2 x dd, J = 8.1, 8.1 and 5.5, 9.6, Ph-CH-CH2), 3.18 and 2.50 (2 x diastereo, 1H, 2 x dd, J = 
9.6, 12.6 and 5.5, 12.9, Ph-CH-CH2), 2.97 and 3.03 (2 x diastereo, 1H, 2 x dd, J = 8.1, 12.9 
and 8.1, 12.6, Ph-CH-CH2), 2.14 and 2.08 (2 x diastereo, 3H, s, S-CH3). 
13C NMR:   C (100 MHz, CDCl3) 202.89 & 202.56 (C), 177.64 and 175.38 (C), 141.39 (C), 
140.68 (CH), 135.26 (CH), 132.14 and 132.06 (C), 131.20 and 131.14 (C), 130.76 (CH), 
130.35 (CH), 130.07 (C), 129.67 (CH), 129.06 and 129.03 (CH), 128.81 (CH), 128.78 (CH), 
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128.73 (CH), 128.68 (CH), 128.46 (CH), 128.14 (CH), 128.04 (CH), 127.89 (CH), 127.56 
(CH), 127.22 (CH), 127.15 (CH), 126.33 (C), 124.03 (C), 66.63 and 66.16 (CH), 31.29 and 
29.90 (CH2), 11.92 and 11.69 (CH3). 
 
"The assigned structure is consistent with the available data. It was not possible to obtain full 
data for this compound meaning that this assignment remains tentative". 
 
3.2.2.2.  Reactivity of 5-methylthio-2,3,7-triphenyl-1-azabicyclo[3.2.0]hept-2-en-4-one : 
Synthesis of 2,3,4-triphenyl-6-methylthio-1-pyridine    
        
N
SMe
Ph
Ph
Ph
O
301
NMeS
Ph
Ph
Ph
toluene
302
 
Scheme  3.29 
100 mg (0.26 mmol) of 5-methylthio-2,3,7-triphenyl-1-azabicyclo[3.2.0]hept-2-en-4-one was 
added to toluene (8 ml) and the mixture was heated at reflux at 115 oC overnight. The solvent 
was evaporated in vacuo and after purification with column chromatography using PE 40-60 
oC / EtOAc : 4/1 product was obtained as white crystals (65 mg, 71 %), m.p. 170-173 oC.  
IR: max (cm-1):  2920 (s), 2852 (m), 1556 (s), 1519 (s), 1403 (m), 1353 (m), 1123 (m) 766 
(s), 750 (m), 693 (m), 609 (m). 
1H NMR:   H (400 MHz, CDCl3) 7.35-7.30 (2H, m, Ph), 7.23 (1H, s, pyrid-H), 7.22-7.18 
(6H, m, 7 x PhH), 7.09-7.04 (5H, m, 5 x Ph-H), 6.89 (1H, d, J = 8.0, Ph-H), 6.87 (1H, d, J = 
8.0, Ph-H), 2.7 (3H, s, CH3). 
13C NMR  (100 MHz, CDCl3) 158.02 (C), 157.48 (C), 150.05 (C), 140.55 (C), 139.32 (C), 
137.71 (C), 131.52 (CH), 130.24 (C), 130.09 (CH), 129.21 (CH), 127.86 (CH), 127.70 (CH), 
127.48 (CH), 127.42 (CH), 127.37 (CH), 126.49 (CH), 120.98 (CH), 13.39 (CH3).  
 
HRMS (m/z): calc for C24H19NS+H+ (M+H)+, 354.1311, found 354.1300. 
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3.2.2.3.  Reactivity of 5-methylthio-2,3,7-triphenyl-1-azabicyclo(3.2.0)hept-2-en-4-one 
with benzoquinone : Synthesis of 2,3,4-triphenyl-6-methylthio-1-pyridine and  5-
methylthio-4-phenyl-2-oxabicyclo[4.3.1]deca-1(9),4-diene-3,7-dione. 
N
SMe O
Ph
Ph
Ph
O
O
N
Ph
Ph
PhMeS
+
toluene
O
SMe
Ph
O
O
301 302338 339
 
Scheme  3.30 
100 mg (0.27 mmol) of 5-methylthio-2,3,7-triphenyl-1-azabicyclo [3.2.0] hept-2-en-4-one 
and benzoquinone (58 mg, 0.54 mmol, 2 eq.) were added to toluene (8 ml) and the mixture 
was heated at reflux at 115 oC overnight. The solvent was evaporated in vacuo and after 
purification with column chromatography (PE 40-60 oC / EtOAc : 4/1) two products were 
obtained, one pyridine as white crystals (52 mg, 65 %) and the tentatively assigned dione 
339, (24 mg, 31 %) . 
Pyridine 
1H NMR:   H (400 MHz, CDCl3) 7.28 (12H, m, Ph), 7.07 (2H, d, J= 7.8 Hz, Ph), 6.88 (2H, 
d, J= 8.0 Hz, Ph), 2.7 (3H, s, CH3). 
13C NMR  (100 MHz, CDCl3) 158.8 (C-N), 157.4 (C-N), 150.04 (C (Ar)), 140.5 (C (Ar)), 
139.3 (C (Ar)), 137.7 (C (Ar)), 131.5 (2C (Ar)), 130.2 (C (Ar)), 130.1 (2C (Ar)), 129.2 (2C 
(Ar)), 128.2 (C (Ar)), 127.88 (2C (Ar)), 127.72 (2C (Ar)), 127.50 (2C (Ar)), 127.45 (C (Ar)), 
127.39 (C (Ar)), 126.5 (C (Ar)), 120.98 (C (Ar)),  13.42 (C (S-CH3)). 
Dione 
IR υmax (cm-1): 3001, 1651, 1597, 1289, 1059. 
1H NMR:   H (400 MHz, CDCl3) 7.28 (1H, s), 7.23-7.17 (2H, m), 7.10 (1H, d, J= 6.1 Hz), 
6.83 (1H, d, J= 10.1 Hz), 6.74 (1H, dd, J= 7.5 and 2.6 Hz), 6.12 (1H, dd, J= 2.4 and 2.0 Hz), 
3.77 (2H, d, 1.9 Hz), 2.23 (3H, s, SCH3).  
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13C NMR  (100 MHz, CDCl3) 187.72 (C=O), 187.39 (C=O)), 148.31 (CH (Ar)), 136.72 (C 
(Ar)), 136.42 (C (Ar)), 134.25 (C (Ar)), 133.00 (C (Ar)), 130.72 (C (Ar)), 130.39 (C (Ar)), 
127.50 (C (Ar)), 126.51 (C (Ar)), 32.64 (CH2), 19.40 (CH3). 
"The assigned structure is consistent with the available data. It was not possible to obtain full 
data for this compound meaning that this assignment remains tentative". 
 
3.2.2.4.  Reactivity of 2-methylthio-4-phenyl-1-azetine with phenylcyclopropenone : 
Synthesis of 5-methylthio-3-phenyl-1-azabicyclo [3.2.0] hept-2-en-4-one 
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Scheme  3.31 
To a mixture of 4-phenyl-2-methylthio-1-azetine (200 mg, 1.13 mmol) in dry acetonitrile (10 
ml) was added phenylcyclopropenone (170 mg, 1.13 mmol, 1 eq.) under a nitrogen 
atmosphere and the mixture was stirred at room temperature overnight. The solvent was 
evaporated in vacuo and the mixture was purified by silica gel chromatography (PE 40-60 oC 
/ EtOAc :  4/1, Rf = 0.24) to give the product as light yellow oil (122 mg, 35 %). 
1H NMR:   H (400 MHz, CDCl3) 8.36 and 7.76 (2 x diastereo, 1H, 2 x s, vinyl-H), 7.85 – 
7.65 (3H, m, 3 x PhH), 7.50-7.26 (7H, m, 7 x PhH), 5.66 and 4.65 (2 x diastereo, 1H, 2 x dd, 
J = 7.6, 9.6 and 5.2, 10.5, Ar-CH-CH2), 3.06 and 3.00 (2 x diastereo, 1H, dd, J = 9.6, 12.6, 
and 9.6, 12.4, Ar-CH-CH2), 2.83 (diastereo 1, 1H, dd, J = 7.6, 12.4, Ar-CH-CH2), 2.48 
(diastereo 2, 1H, dd, J = 5.2, 12.6, Ar-CH-CH2), 2.04 and 2.03 (2 x diastereo, 3H, s, S-CH3). 
13C NMR  (100 MHz, CDCl3) 203.13 and 201.74 (C=O), 167.14 and 164.28 (C), 140.44 
(C), 135.20 (C), 130.61 (C), 130.13 (C), 129.48 (CH), 129.14 (CH), 128.75 (CH), 128.73 
(CH), 128.60 (CH), 128.45 (CH), 128.09 (CH), 127.96 (CH), 127.55 (CH), 127.27 (CH), 
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126.57 (CH), 126.52 (CH), 125.85 (CH), 125.56 (CH), 79.67 (CH), 65.34 (CH), 32.79 and 
32.32 (CH2), 12.08 and 11.55 (CH3). 
"The assigned structure is consistent with the available data. It was not possible to obtain full 
data for this compound meaning that this assignment remains tentative". 
 
3.2.2.5. Reactivity of 5-methylthio-3-phenyl-1-azabicyclo [3.2.0] hept-2-en-4-one : 
Synthesis of 2-methylthio-4,5-diphenylpyridine.     
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                                                                         Scheme  3.32 
5-Methylthio-3, 7-diphenyl-1-azabicyclo [3.2.0]  hept-2-en-4-one (120 mg, 0.39 mmol) was 
added to o-xylene (8 ml) and the mixture was heated at reflux at 155 oC overnight. The 
solvent was evaporated in vacuo and the mixture purified with column chromatography (PE 
40-60 oC / EtOAc : 4/1). The product was obtained as white crystals (68 mg, 62 %), m.p. 
153-155 oC. 
IR υmax (cm-1): 3035 (w), 3000 (w), 2910 (w), 1582 (m), 1568 (m), 1458 (m), 1443 (m), 1339 
(m), 1114 (s), 762 (s), 748 (s), 696 (s), 567 (s). 
1H NMR:   H (400 MHz, CDCl3) 8.51 (1H, s, pyrid-H), 7.31 - 7.24 (7H, m, 6 x PhH + 
pyrid-H), 7.18 - 7.12 (4H, m, 4 x PhH), 2.68 (3H, s, S-CH3), 2.31 (3H, s, CH3). 
13C NMR  (100 MHz, CDCl3) 159.01 (C), 150.44 (CH), 147.95 (C), 138.53 (C), 137.53 
(C), 131.86 (C), 129.78 (CH), 129.24 (CH), 128.27 (CH), 128.26, (CH), 127.93 (CH), 127.11 
(CH), 122.00 (CH), 13.48 (CH3).  
 
HRMS (m/z): calculated for C18H15NS+H+ (M+H)+, 278.0998, found 278.1000 
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3.2.2.6.  Reactivity of 2-ethylthio-4-phenyl-1-azetine with diphenylcyclopropenone : 
Synthesis of 5-ethylthio-2,3,7-triphenyl-1-azabicyclo[3.2.0]hept-2-en-4-one. 
  
N
SEt
Ph
N
SEt
Ph
O
CH3CN
+
O
Ph
Ph
Ph
Ph287b 300 312
 
Scheme  3.33 
To a solution of 4-phenyl-2-ethylthio-1-azetine (300 mg, 1.57 mmol) in dry acetonitrile (10 
ml) was added diphenylcyclopropenone (DPP) (324 mg, 1.57 mmol, 1 eq.) under a nitrogen 
atmosphere and the mixture was stirred at room temperature overnight. The solvent was 
evaporated in vacuo and the mixture was purified by silica gel chromatography using PE 40-
60 oC / EtOAc :  4/1, Rf = 0.21 to give the product as yellow oil (380 mg, 61 %). 
1H NMR:   H (400 MHz, CDCl3) 7.65-6.90 (15H, m, Ph), 5.60 and 4.28 (2 x diastereo, 1H, 
2 x dd, J = 8.3, 8.3 and 5.5, 9.6, Ph-CH-CH2), 3.16 and 2.52 (2 x diastereo, 1H, 2 x dd, J = 
9.6, 13.1 and 5.2, 12.6, Ph-CH-CH2), 2.90 - 3.05 (2H, m, 1 x S-CH2CH3 and 1 x Ph-CH-CH2 
from diastereo 1), 2.56 – 2.70 (2H, m, 1x S-CH2CH3 and 1 x Ph-CH-CH2 from diastereo 2), 
1.23 –1.30 (2 x diastereo, 3H, 2 x t, J = 7.2, S-CH2CH3). 
 
13C NMR  (100 MHz, CDCl3)  202.86 & 202.46 (C), 176.99 (C), 174.85 (C), 141.33 (C), 
135.18 (C), 132.00 (CH), 131.89 (CH), 131.14 (C), 131.07 (CH), 130.64 (C), 130.52 (CH), 
130.19 (CH), 130.01 (C), 129.67 (C), 129.50 (CH), 129.24 (C), 129.04 (C), 128.90 (CH), 
128.86 (CH), 128.61 (CH), 128.52 (CH), 128.29 (CH), 128.12 (CH), 127.93 (CH), 127.85 
(CH), 127.71 (CH), 127.36 (CH), 127.06 (CH), 127.03 (CH), 126.14 (C), 123.79 (C), 66.62 
and 65.98 (CH), 35.14 and 31.86 (CH2), 23.70 and 23.59 (CH2), 14.59 and 14.24 (CH3). 
"The assigned structure is consistent with the available data. It was not possible to obtain full 
data for this compound meaning that this assignment remains tentative". 
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3.2.2.7. Reactivity of 5-ethylthio-2,3,7-triphenyl-1-azabicyclo[3.2.0]hept-2-en-4-one : 
Synthesis of 2,3,4-triphenyl-6-ethylthio-1-pyridine    
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Scheme  3.34 
 
5-Ethylthio-2,3,7-triphenyl-1-azabicyclo[3.2.0]hept-2-en-4-one (100 mg, 0.25 mmol) was 
added to toluene (8 ml) and the mixture was refluxed at 115 oC overnight. The solvent was 
evaporated in vacuo and after purification with column chromatography using PE 40-60 oC / 
EtOAc : 4/1 the product was obtained as white crystals (68 mg, 75 %), m.p. 109-111 oC . 
IR: max (cm-1):  2955, (m), 2927 (M), 2870 (m), 1561 (s), 1490 (s), 1405 (m), 1359 (s), 
1219 (s), 1090 (s), 1013 (m), 824 (m), 766 (s), 697 (s), 611 (m). 
 
1H NMR:   H (400 MHz, CDCl3) 7.39-7.32 (2H, m, 2 x PhH), 7.28 – 7.18 (8H, m, 7 x PhH 
plus pyrid-H), 7.16-7.7.07 (4H, m, 4 x PhH), 6.98-6.92 (2H, m, 2 x PhH), 3.32 (2H, q, J = 
7.3, S-CH2-CH3), 1.51 (3H, t, J = 7.3, S-CH2-CH3). 
 
13C NMR  (100 MHz, CDCl3) 157.52 (C), 150.07 (C), 140.63 (C), 139.33 (C), 137.77 
(C),131.54 (CH), 130.29 (CH), 129.25 (CH), 128.52 (CH), 127.98 (CH), 127.88 (CH), 
127.74 (CH), 127.49 (CH), 127.41 (CH), 127.38 (CH), 126.51 (C), 121.62 (C), 24.52 (CH2), 
15.0 (S-CH3).  
 
HRMS (m/z): calc for C25H21NS+H+ (M+H)+, 368.1467, found 368.1460. 
 
177 
 
3.2.2.8.  Reactivity of 5-ethylthio-2,3,7-triphenyl-1-azabicyclo[3.2.0]hept-2-en-4-one with 
diphenyl acetylene : Synthesis of 2,3,4-triphenyl-1-pyridine 
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Scheme  3.35 
 
5-Ethylthio-2,3,7-triphenyl-1-azabicyclo[3.2.0]hept-2-en-4-one (50 mg, 0.13 mmol)  and 
diphenylacetylene (111 mg, 0.63 mmol, 4 eq.) were added to o-xylene (8 ml) and the mixture 
was heated at reflux at 155 oC overnight. The solvent was evaporated in vacuo and after 
purification with column chromatography (PE 40-60 oC / EtOAc : 4/1) the product was 
obtained as yellow crystals (20 mg, 50 %). 
1H NMR:   H (500 MHz, CDCl3) 8.75 (1H, d, J= 7.3 Hz), 7.36 (1H, d, J= 6.3 Hz), 7.30-7.27 
(3H, m, Ph-H), 7.24-7.20 (6H, m, Ph-H), 7.10-7.05 (4H, m, Ph-H), 6.90 (2H, dd, J= 7.8 and 
1.8 Hz, Ph-H).  
 
13C NMR  (125 MHz, CDCl3) 158.38 (C-N), 149.38 (C-N)), 148.26 (CH (Ar)), 140.70 (C 
(Ar)), 139.35 (C (Ar)), 137.70 (C (Ar)), 134.37 (2C (Ar)), 131.27 (C (Ar)), 129.85 (2C (Ar)), 
129.35 (2C (Ar)), 128.37 (C (Ar)), 127.93 (2C (Ar)), 127.73 (2C (Ar)), 127.62 (2C (Ar)), 
127.39 (C (Ar)), 127.37 (C (Ar)), 126.66 (C (Ar)), 123.69 (C (Ar)). 
"The assigned structure is consistent with the available data. It was not possible to obtain full 
data for this compound meaning that this assignment remains tentative". 
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3.2.2.9.  Reactivity of 5-ethylthio-2,3,7-triphenyl-1-azabicyclo[3.2.0]hept-2-en-4-one with 
4-chlorostyrene : Synthesis of 2,3,4-triphenyl-6-ethylthio-1-pyridine 
  
N
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Ph
Ph
Ph
Cl NEtS
Ph
Ph
Ph
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Scheme  3.36 
 
5-Ethylthio-2,3,7-triphenyl-1-azabicyclo[3.2.0]hept-2-en-4-one (100 mg, 0.25 mmol) and 
chlorostyrene (63.5 µl, 0.50 mmol, 2 eq.) were added to o-xylene (8 ml) and the mixture was 
refluxed at 155 oC overnight. The solvent was evaporated in vacuo and the mixture was 
purified with column chromatography (PE 40-60 oC / EtOAc : 4/1) to give 2,3,4-triphenyl-6-
ethylthio-1-pyridine as the only product. 
Data as above for the same compound.  
 
3.2.2.10  Reactivity of 5-ethylthio-2,3,7-triphenyl-1-azabicyclo[3.2.0]hept-2-en-4-one with 
methylfurate : Synthesis of 2,3,4-triphenyl-6-ethylthio-1-pyridine   
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Scheme  3.37 
5-Ethylthio-2,3,7-triphenyl-1-azabicyclo[3.2.0]hept-2-en-4-one (100 mg, 0.27 mmol) and 
methylfurate (172 µl, 1.07 mmol, 4 eq.) were added to o-xylene (8 ml) and the mixture was 
heated at reflux at 155 oC overnight. The solvent was evaporated in vacuo and after 
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purification with column chromatography (PE 40-60 oC / EtOAc : 4/1), the pyridine product 
was obtained as white crystals (80 mg, 75 %). No other products were isolated. Data for the 
pyridine was identical to that reported as above for the same compound. 
 
3.2.2.11.  Reactivity of 2-ethylthio-4-phenyl-1-azetine : Synthesis of 5-ethylthio-2,3-
dibutyl-7-phenyl-1-azabicyclo[3.2.0]hept-2-en-4-one 
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Scheme  3.38 
To a mixture of 4-phenyl-2-ethylthio-1-azetine (300 mg, 1.56 mmol) in dry acetonitrile (10 
ml) was added dibutylcyclopropenone (322 mg, 1.56 mmol, 1 eq.) under a nitrogen 
atmosphere and the mixture was strirred at room temperature overnight. The solvent was 
evaporated in vacuo and the mixture was purified by silica gel chromatography using PE 40-
60 oC / EtOAc :  4/1, Rf = 0.21 to give the product as dark yellow oil (318 mg, 57 %). 
 
1H NMR:   H (400 MHz, CDCl3) 7.59 (1H, d, J = 7.4, Ph), 7.45-7.28 (3H, m, Ph), 7.22 (1H, 
d, J = 7.4, Ph), 5.48 (diastero 1, 1H, dd, J = 8.5, 8.5, Ph-CH-CH2), 4.3 (diastereo 2, 1H, dd, J 
= 5.4 and 8.7, Ph-CH-CH2), 2.89 (diastereo 1, 1H, dd, J = 15.6, 8.5, CHCH2), 2.62-2.50 (1H, 
m, CH2), 2.49-2.40 (2H, m, CH2), 2.34-2.28 (1H, dd, J = 14.8, 5.4, CH2), 2.22-2.13 (2H, m, 
CH2), 2.04- 2.00 (diastereo 1, 1H, dd, J = 8.5, 12.5, CH2), 1.99-1.94 (diastereo 2, 1H, dd, J = 
8.5, 12.5, CH2), 1.56-1.48 (2H, m, CH2), 1.42-1.27 (6H, m, 3 x CH2), 1.21-1.17 (3H, 2 x t, 
both diastereo, J = 7.4, CH3), 0.94 (diastereo 1, 3H, t, J = 7.0, CH3), 0.92 (diastereo 2, 3H, t, J 
= 7.0, CH3), 0.86 (diastereo 1, 3H, t, J = 7.3, CH3), 0.77 (diastereo 2, 3H, t, J = 7.2, CH3). 
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13C NMR  (100 MHz, CDCl3) 205.44 and 204.96 (C=O), 182.78 and 180.98 (C), 141.71 
(C), 136.29 (C), 129.31 (CH), 128.90 (CH), 128.69 (CH), 128.61 (CH), 128.33 (C), 128.06 
(C), 127.68 (CH), 127.26 (C), 126.47 (CH), 126.22 (C), 75.45 and 75.11 (CH), 64.94 and 
64.58 (CH2), 33.88, 31.88, 31.29, 31.09, 29.96, 29.93, 29.24, 27.70 (8 x CH2), 23.12, 22.77, 
22.73, 22.63, 22.55, 22.49 (6 x CH2), 14.62, 14.47, 13.96, 13.93, 13.73, 13.65 (6 x Me). 
"The assigned structure is consistent with the available data. It was not possible to obtain full 
data for this compound meaning that this assignment remains tentative". 
 
3.2.2.12.  Reactivity of 5-ethylthio-2,3-dibutyl-7-phenyl-1-azabicyclo[3.2.0]hept-2-en-4-one 
: Synthesis of 2,3-dibutyl-4-phenyl-6-ethylthio-1-pyridine    
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Scheme  3.39 
5-ethylthio-2,3-dibutyl-4-phenyl-1-azabicyclo[3.2.0]hept-2-en-4-one (100 mg, 0.28 mmol) 
was added to toluene (8 ml) and the mixture was refluxed at 115 oC overnight. The solvent 
was evaporated in vacuo and after purification with column chromatography using PE 40-60 
oC / EtOAc : 4/1 product was obtained as a clear oil (67 mg, 73 %). 
IR υmax (cm-1): 2955 (s), 2925 (s), 2867 (m), 1569 (s), 1531 (m), 1456 (m), 1368 (m), 1120 
(w), 1075 (w), 962 (m), 824 (m), 766 (m), 700 (s). 
 
1H NMR:   H (400 MHz, CDCl3) 7.45-7.35 (3H, m, 3 x PhH), 7.31-7.23 (2H, m, 2 x PhH), 
6.84 (1H, s, pyrid-H), 3.2 (2H, q, J = 7.3, S-CH2-CH3), 2.82 (2H, dd, J = 7.5 and 11.4, CH2), 
2.54-2.47 (2H, m, CH2), 1.83-1.76 (2H, m, CH2), 1.45 (2H, q, J = 7.5, CH2), 1.4 (3H, t, J = 
181 
 
7.3, S-CH2-CH3), 1.35-1.28 (2H, m, CH2), 1.2 (2H, q, J = 7.3, CH2), 1.0 (3H, t, J = 7.3, CH3), 
0.78 (3H, t, J = 7.3, CH3). 
 
13C NMR  (100 MHz, CDCl3) 160.67 (C), 154.16 (C), 150.42 (C), 140.26 (C), 129.16 
(C),128.48 (CH), 128.11 (CH), 127.48 (CH), 120.35 (CH), 34.62 (CH2), 32.93 (CH2), 31.58 
CH2), 29.73 (CH3), 24.55 (CH2), 22.88 (CH2), 22.78 (CH2), 14.98 (CH3), 14.16 (CH2), 13.62 
(CH3). 
HRMS (m/z): calc for C21H29NS+H+ (M+H)+, 328.2093, found 328.2086. 
 
3.2.2.13.  Reactivity of 2-methylthio-4-tolyl-1-azetine : Synthesis of 5-methylthio-2,3-
diphenyl-7-tolyl-1-azabicyclo[3.2.0]hept-2-en-4-one 
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Scheme  3.40 
To a solution of 4-tolyl-2-methylthio-1-azetine (300 mg, 1.56 mmol) in dry acetonitrile (10 
ml) was added diphenylcyclopropenone (DPP) (322 mg, 1.56 mmol, 1 eq.) under a nitrogen 
atmosphere and the mixture was strirred at room temperature overnight. The solvent was 
evaporated in vacuo and the mixture was purified by silica gel chromatography using PE 40-
60 oC / EtOAc :  4/1, Rf = 0.21 to give the product as a yellow oil (388 mg, 63 %). 
 
1H NMR:   H (400 MHz, CDCl3) 7.53 – 7.32 (10H, m, PhH), 6.98 and 6.75 (2 x diastereo, 
2H, 2 x d, J = 8.1 and 8.1, Tol), 7.25 and 6.79 (2 x diastereo, 2H, 2 x d, J = 8.1 and 8.1, Tol), 
5.54 and 4.27 (2 x diastereo, 1H, 2 x dd, J = 8.1, 8.1 and 8.5, 5.1, ArCH), 3.16 and 2.49 (2 x 
diastereo, 1H, 2 x dd, J = 12.8, 9.6 and 12.8, 5.1, ArCHCH2), 3.02 and 2.95 (2 x diastereo, 
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1H, 2 x dd, J = 8.1, 12.8 and 12.8, 8.5, ArCHCH2), 2.41, 2.14, 2.12 and 2.07 (2 x diastereo, 
6H, 4 x s, ArMe and SMe). 
 
13C NMR  (100 MHz, CDCl3) 202.83 and 202.46 (C=O), 177.56 and 177.52 (C), 138.44 
and 138.29 (C), 137.69 (C), 132.18 (C), 132.03 (C), 131.92 (CH), 131.08 (C), 131.03 (CH), 
130.46 (CH), 130.23 (CH), 129.96 (C), 129.52 (CH), 129.31 (CH), 128.87 (CH), 128.75 
(CH), 128.60 (CH), 128.50 (CH), 128.44 (CH), 128.27 (CH), 128.12 (C), 127.52 (CH), 
127.35 (CH), 126.99 (CH), 126.95 (CH), 126.21 (C), 123.75 (C), 66.38 and 65.92 (CH), 
34.35 and 31.01 (CH2), 21.29 and 20.94 (CH3), 11.76 and 11.52 (CH3). 
"The assigned structure is consistent with the available data. It was not possible to obtain full 
data for this compound meaning that this assignment remains tentative". 
 
3.2.2.14. Reactivity of 5-methylthio-2,3-diphenyl-7-tolyl-1-azabicyclo[3.2.0]hept-2-en-4-
one : Synthesis of 2,3-diphenyl-4-tolyl-6-methylthio-1-pyridine    
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Scheme  3.41 
5-Methylthio-2,3-diphenyl-7-tolyl-1-azabicyclo[3.2.0]hept-2-en-4-one (100 mg, 0.25 mmol) 
was added to toluene (8 ml) and the mixture was heated at reflux at 115 oC overnight. The 
solvent was evaporated in vacuo and after purification with column chromatography using PE 
40-60 oC / EtOAc : 4/1 the product was obtained as white crystals (69 mg, 74 %), m.p. 179-
182 oC. 
183 
 
IR υmax (cm-1): 2918 (s), 2849 (m), 1560 (m), 1506 (m), 1410 (m), 1355 (s), 1120 (s), 1028 
(m), 818 (s), 765 (s), 697 (s), 612 (m). 
 
1H NMR:   H (400 MHz, CDCl3)  7.34 - 7.30 (3H, m, 3 x PhH), 7.24 - 7.18 (4H, m, 3 x PhH 
+ pyrid-H), 7.08 (2H, d, J = 7.8, 2 x PhH), 7.02 (2H, d, J = 8.1, 2 x Tol-H), 6.96 (2H, d, J = 
8.1, 2 x Tol-H), 6.88 (2H, dd, J = 1.8 and 6.0, 2 x PhH), 2.68 (3H, s, S-CH3), 2.31 (3H, s, 
ArCH3). 
 
13C NMR  (100 MHz, CDCl3) 157.97 (C), 157.50 (C), 149.99 (C), 140.64 (C), 137.86 (C), 
137.20 (C), 136.32 (C), 131.54 (CH), 130.22 (C), 130.09 (CH), 129.13 (CH), 128.61 (CH), 
127.73 (CH), 127.47 (CH), 127.37 (CH), 126.44 (CH), 121.03 (CH), 21.18 (CH3), 13.42 
(CH3).  
HRMS (m/z): calc for C25H21NS+H+ (M+H)+, 368.1467, found 368.1468 
 
3.2.2.15.  Reactivity of 2-ethylthio-4-tolyl-1-azetine : Synthesis of 5-ethylthio-2,3-diphenyl-
7-tolyl-1-azabicyclo[3.2.0]hept-2-en-4-one 
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Scheme  3.42 
To a solution of 4-tolyl-2-ethylthio-1-azetine (300 mg, 1.46 mmol) in dry acetonitrile (10 ml) 
was added diphenylcyclopropenone (DPP) (301 mg, 1.46 mmol, 1 eq.) under a nitrogen 
atmosphere and the mixture was strirred at room temperature overnight. The solvent was 
evaporated in vacuo and the mixture was purified by silica gel chromatography using PE 40-
60 oC / EtOAc :  4/1, Rf = 0.21 to give the product as a yellow oil (394 mg, 66 %). 
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1H NMR:   H (400 MHz, CDCl3)  7.52-7.12 (10H, m, 2 x Ph), 7.01, 6.94, 6.78, 6.72 (4H, 4 
x d, J = 8.2, 8.2, 8.1, 8.1, Tol: 2 x diastereo), 5.57 and 4.26 (2 x diastereo, 1H, 2 x dd, J = 8.4, 
8.4 and 9.6, 5.4, ArCH), 3.16 (diastereo 2, 1H, dd, J = 12.6 and 9.6, Ar-CH-CHH), 3.01 
(diastereo 1, 1H, dd, J = 13.1, 8.0, ArCHCHH), 2.93 (diastereo 1, 1H, dd, J = 8.4, 13.1, Ar-
CH-CHH), 2.65 (diastereo 2, 1H, dd, J = 12.6, 5.4, Ar-CH-CHH), 2.47-2.70 (2 x diastereo, 
2H, m, S-CH2CH3), 2.41 and 2.11 (2 x diastereo, 3H, 2 x s, ArCH3), 1.30 and 1.28 (2 x 
diastereo, 3H, 2 x t, J = 7.2, 7.2, S-CH2-CH3). 
 
13C NMR  (100 MHz, CDCl3) 202.95 and 202.50 (C=O), 177.08 and 175.15 (C), 138.40 
(C), 137.64 (C), 136.69 (C), 132.26 (C), 132.11 (C), 131.22 (C), 131.13 (C), 130.66 (CH), 
130.44 (CH), 130.23 (CH), 130.04 (C), 129.73 (C), 129.67 (CH), 129.51 (CH), 129.30 (CH), 
128.87 (CH), 128.76 (CH), 128.60 (CH), 128.51 (CH), 128.43 (CH), 128.28 (CH), 128.12 
(CH), 127.53 (CH), 127.28 (C), 127.00 (CH), 126.97 (CH), 126.14 (C), 123.65 (C), 66.54 
and 65.92 (CH), 35.15 and 31.74 (CH2), 23.70 and 23.57 (CH2), 21.29 and 20.95 (CH3), 
14.63 and 14.60 (CH3). 
"The assigned structure is consistent with the available data. It was not possible to obtain full 
data for this compound meaning that this assignment remains tentative". 
 
3.2.2.16.  Reactivity of 5-ethylthio-2,3-diphenyl-7-tolyl-1-azabicyclo[3.2.0]hept-2-en-4-one 
: Synthesis of 2,3-diphenyl-4-tolyl-6-ethylthio-1-pyridine    
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Scheme  3.43 
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5-Ethylthio-2,3-diphenyl-7-tolyl-1-azabicyclo[3.2.0]hept-2-en-4-one (100 mg, 0.24 mmol) 
was added to toluene (8 ml) and the mixture was heated at reflux at 115 oC overnight. The 
solvent was evaporated in vacuo and after purification with column chromatography using PE 
40-60 oC / EtOAc : 4/1 the product was obtained as white crystals (66 mg, 72 %), 140-143 
oC. 
IR υmax (cm-1): 2981 (m), 1556 (m), 1508 (m), 1365 (m), 1124 (m), 819 (s), 763 (m), 697 (s). 
 
1H NMR:   H (400 MHz, CDCl3) 7.36-7.34 (2H, m, 2 x PhH), 7.23-7.18 (4H, m, 3 x PhH + 
Pyrid-H), 7.12 – 7.06 (3H, m, 3 x Ph), 7.02 (2H, d, J = 8.2, 2 x Tol-H), 6.97 (2H, d, J = 8.2, 2 
x Tol-H), 6.90 (2H, dd, J = 8.0 and 1.8, 2 x PhH), 3.3 (2H, q, J = 7.3, S-CH2-CH3), 2.31 (3H, 
s, ArCH3) 1.5 (3H, t, J = 7.3, S-CH2-CH3) . 
 
13C NMR  (100 MHz, CDCl3) 157.53 (C), 157.44 (C), 150.02 (C), 140.73 (C), 137.93 (C), 
137.16 (C), 136.35 (C), 131.56 (CH), 130.29 (C), 130.10 (CH), 129.15 (CH), 128.61 (CH), 
127.74 (CH), 127.45 (CH), 127.32 (CH), 126.44 (CH), 121.68 (CH), 24.52 (CH2), 21.19 
(CH3), 14.99 (CH3).  
HRMS (m/z): calc for C26H23NS+H+ (M+H)+, 382.1624, found 382.1624. 
 
3.2.2.17.  Reactivity of 2-methylthio-4-naphthyl-1-azetine : Synthesis of 5-methylthio-2,3-
diphenyl-7-naphthyl-1-azabicyclo[3.2.0]hept-2-en-4-one 
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Scheme  3.44 
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To a solution of 4-naphthyl-2-methylthio-1-azetine (200 mg, 0.88 mmol) in dry acetonitrile 
(10 ml) was added diphenylcyclopropenone (DPP) (181 mg, 0.88 mmol, 1 eq.) under a  
nitrogen atmosphere and the mixture was strirred at room temperature overnight. The solvent 
was evaporated in vacuo and mixture was purified by silica gel chromatography using PE 40-
60 oC / EtOAc :  4/1, Rf = 0.23 to give the product as a yellow oil (192 mg, 51 %). 
1H NMR:   H (400 MHz, CDCl3) 7.98-7.85 (2H, m, Ar), 7.60-7.15 (10H, m, Ar), 7.0 (1H, 
dd, J = 1.7 and 8.4, Ar), 6.92 (2H, dd, J = 7.1 and 16.1, Ar), 6.72 (2H, dd, J = 7.6, 7.6, Ar), 
5.74 (diastereo 1, 1H, dd, J = 8.3 and 8.3, Ph-CH-CH2), 4.48 (diastereo 2, 1H, dd, J = 5.5 and 
8.7, Ph-CH-CH2), 3.26 (diastereo 1, 1H, dd, J = 9.6 and 12.6, Ph-CH-CH2), 3.18 (diastereo 2, 
1H, dd, J = 8.0 and 13.1, Ph-CH-CH2), 3.06 (diastereo 1, 1H, dd, J = 8.3 and 13.1, Ph-CH-
CH2), 2.59 (diastereo 2, 1H, dd, J = 5.5 and 12.6, Ph-CH-CH2), 2.13 and 2.07 (both diastereo, 
3H, 2 x s, S-CH3). 
 
13C NMR  (100 MHz, CDCl3) 202.78 and 202.40 (C=O), 177.43 and 175.45 (C), 138.65 
(C), 133.19 (C), 133.06 (C), 132.89 (C), 132.43 (C), 132.39 (C), 131.97 (C), 131.84 (CH), 
131.07 (C), 130.74 (C), 130.60 (C), 130.48 (C), 130.21 (CH), 129.93 (CH), 129.29 (CH), 
128.90 (C), 128.69 (CH), 128.65 (CH), 128.63 (CH), 128.56 (CH), 128.54 (CH), 128.29 
(CH), 128.18 (CH), 128.01 (CH), 127.84 (CH), 127.81 (CH), 127.69 (CH), 127.46 (CH), 
127.43 (CH), 127.40 (CH), 127.27 (CH), 127.02 (CH), 126.47 (CH), 126.37 (CH), 126.25 
(CH), 126.19 (CH), 126.04 (CH), 126.00 (C), 124.84 (CH), 123.95 (C), 66.66 and 66.22 
(CH), 34.37 and 30.98 (CH2), 11.79 and 11.59 (CH3). 
 
"The assigned structure is consistent with the available data. It was not possible to obtain full 
data for this compound meaning that this assignment remains tentative". 
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3.2.2.18.  Reactivity of 5-methylthio-2,3-diphenyl-7-naphthyl-1-azabicyclo[3.2.0]hept-2-en-
4-one : Synthesis of 2,3-diphenyl-4-naphthyl-6-methylthio-1-pyridine  
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  Scheme  3.45 
5-Methylthio-2,3-diphenyl-7-naphthyl-1-azabicyclo[3.2.0]hept-2-en-4-one (100 mg, 0.23 
mmol) was added to toluene (8 ml) and the mixture was heated at reflux at 115 oC overnight. 
The solvent was evaporated in vacuo and after purification with column chromatography 
using PE 40-60 oC / EtOAc : 4/1 the product was obtained as white crystals (59 mg, 64 %), 
m.p. 190-193 oC . 
IR υmax (cm-1): 2957 (s), 2922 (s), 2854 (m), 1553 (m), 1508 (m), 1462 (m), 1271 (s), 1119 
(s), 1071 (m), 962 (m), 824 (m), 743 (s), 690 (s), 671 (s). 
 
1H NMR:   H (400 MHz, CDCl3) 7.82-7.74 (2H, m, 2 x ArH), 7.71 (1H, d, J = 1.3, pyrid-
H), 7.59 (1H, d, J = 8.5, 1 x ArH), 7.48 (2H, m, 2 x ArH), 7.34 – 7.38 (3H, m, 3 x ArH), 7.19 
– 7.24 (3H, m, 3 x ArH), 7.00 – 7.07 (4H, m, 4 x ArH), 6.92 (2H, dd, J = 1.6 and 6.7, 2 x 
ArH), 2.7 (3H, s, SCH3). 
 
13C NMR  (100 MHz, CDCl3) 158.13 (C), 157.58 (C), 149.90 (C), 140.56 (C), 137.66 (C), 
137.01 (C), 133.00 (C), 132.33 (C), 131.57 (CH), 130.32 (C), 130.14 (CH), 128.39 (CH), 
28.09 (CH), 127.83 (CH), 127.62 (CH), 127.52 (CH), 127.47 (CH), 127.18 (CH), 127.10 
(CH), 126.57 (CH), 126.32 (CH), 126.22 (CH), 121.31 (CH), 13.42 (CH3). 
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HRMS (m/z): calc for C28H21NS+H+ (M+H)+, 404.1467, found 404.1479 
 
3.2.2.19.  Reactivity of 2-methylthio-3,3,4,4-teramethyl-1-azetine : Synthesis of 5-
methylthio-2,3-diphenyl-6,6,7,7-tetramethyl-1-azabicyclo [3.2.0] hept-2-en-4-one 
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Scheme  3.46 
To a mixture of 3,3,4,4-tetramethyl-2-methylthio-1-azetine (300 mg, 1.91 mmol) in dry 
acetonitrile (10 ml) was added diphenylcyclopropenone (DPP) (394 mg, 1.91 mmol, 1 eq.) 
under a nitrogen atmosphere and the mixture was strirred at room temperature overnight. The 
solvent was evaporated in vacuo and mixture was purified by silica gel chromatography (PE 
40-60 oC / EtOAc :  4/1, Rf = 0.23) to give the product as a yellow solid (427 mg, 62 %), 
m.p. 154-157 oC. 
1H NMR δ (400 MHz) (CDCl3) 7.54 (2H, d, J= 7.1 Hz, Ar), 7.44 (2H, dt, J= 7.4, 1.2 Hz, 
Ar), 7.33 (2H, t, J= 7.8 Hz, Ar), 7.27 (2H, d, J= 4.2 Hz, Ar), 7.22-7.19 (2H, m, Ar), 1.95 (3H, 
s, SCH3), 1.69 (3H, s, CH3), 1.33 (3H, s, CH3), 1.26 (3H, s, CH3), 0.73 (3H, s, CH3).  
13C NMR δ (100 MHz) (CDCl3) 202.31 (C=O), 175.63 (C), 133.55 (C), 131.37 (C), 131.28 
(CH), 129.47 (CH), 128.84 (CH), 128.53 (CH), 128.22 (CH), 126.68 (CH), 123.57 (C), 83.79 
(C), 70.30 (C), 41.93 (C), 27.96 (CH3), 23.19 (CH3), 22.54 (CH3), 19.66 (CH3), 10.60 
(SCH3). 
MS. (ESI, m/z), 386.15 (M+Na)+. 
HRMS (m/z): 386.1549 calculated for C23H25NNaOS, (M+Na)+, found 386.1531. 
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3.2.2.20.  Reactivity of 5-methylthio-2,3-diphenyl-6,6,7,7-tetramethyl-1-azabicyclo 
[3.2.0] hept-2-en-4-one : attempted synthesis of 2,3-diphenyl-4,4,5,5-tetramethyl-6-
methylthio-1-pyridine.  
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Scheme  3.47 
5-Methylthio-2,3-diphenyl—6,6,7,7-tetramethyl-1-azabicyclo[3.2.0]hept-2-en-4-one (100 
mg, 0.27 mmol) was added to o-xylene (8 ml) and the mixture was heated at reflux at 155 oC 
overnight. The reaction was monitored on TLC and even after 72 hours of reflux no product 
could be identified.  
 
3.2.2.21.  Reactivity of 2-ethylthio-3,3,4,4-teramethyl-1-azetine : Synthesis of 5-
ethylthio-2,3-diphenyl-6,6,7,7-tetramethyl-1-azabicyclo [3.2.0] hept-2-en-4-one 
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                                                                      Scheme  3.48 
To a solution of 3,3,4,4-tetramethyl-2-ethylthio-1-azetine (300 mg, 1.75 mmol) in dry 
acetonitrile (10 ml) was added diphenylcyclopropenone (362 mg, 1.75 mmol, 1 eq.) under a 
nitrogen atmosphere and the mixture was strirred at room temperature overnight. The solvent 
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was evaporated in vacuo and the mixture was purified by silica gel chromatography (PE 40-
60 oC / EtOAc :  4/1, Rf = 0.23) to give the product as a yellow solid (262 mg, 40 %), m.p. 
162-165 oC. 
IR υmax (cm-1): 2953, 2924, 1671, 1533, 1447, 1373, 1242, 1174. 
1H NMR δ (400 MHz) (CDCl3) 7.53 (2H, d, J= 7.0 Hz, ArH), 7.44 (2H, dt, J= 7.4, 1.3 Hz, 
ArH), 7.33 (2H, t, J= 7.7 Hz, ArH), 7.28 (2H, d, J= 5.6 Hz, ArH), 7.22-7.18 (2H, m, ArH), 
2.57-2.36 (2H, m, CH2), 1.70 (3H, s, CH3), 1.31 (3H, s, CH3), 1.24 (3H, s, CH3), 1.18 (3H, t, 
J= 7.5 Hz, CH3), 0.73 (3H, s, CH3).  
13C NMR δ (100 MHz) (CDCl3) 202.40 (C=O), 175.23 (C), 133.62 (C), 131.38 (C), 131.24 
(CH), 129.48 (CH), 128.84 (CH), 128.54 (CH), 128.23 (CH), 126.64 (CH), 123.33 (C), 84.26 
(C), 70.23 (C), 42.35 (C), 27.99 (CH2), 23.09 (CH3), 22.60 (CH3), 22.41 (CH3), 19.71 (CH3), 
14.40 (CH3).  
MS. (ESI, m/z), 400.17 (M+Na)+. 
HRMS (m/z): 400.1706 calculated for C24H27NNaOS, (M+Na)+, found 400.1707. 
3.2.2.22.  Reactivity of 5-ethylthio-2,3-diphenyl-6,6,7,7-tetramethyl-1-azabicyclo [3.2.0] 
hept-2-en-4-one :  attempted synthesis of 2,3-diphenyl-4,4,5,5-tetramethyl-6-ethylthio-1-
pyridine.  
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Scheme  3.49 
 
5-Ethylthio-2,3-diphenyl—6,6,7,7-tetramethyl-1-azabicyclo [3.2.0] hept-2-en-4-one (100 mg,  
0.26 mmol) was added to o-xylene (8 ml) and the mixture was heated at reflux at 155 oC 
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overnight. The reaction was monitored on TLC and even after 72 hours of reflux no product 
could be identified.  
 
3.2.3.  Reactivity of 1-azetines with nitrile oxides 
3.2.3.1. Synthesis of 2-(p-methoxy-phenyl)-5-(methylthio)-7-phenyl-4-oxa-1,3-
diazabicyclo[3.2.0]hept-2-ene. 
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Scheme  3.50 
To a mixture of 2-methylthio-4-phenyl-1-azetine (180 mg, 1.01 mmol) and 4-
methoxybenzohydroximoylchloride (1 eq. 188 mg) in dry diethyl ether (5 ml) was added 
triethylamine (1 eq. 102 mg, 134.2 µl) diluted in dry diethyl ether (30 ml) dropwise over 6-7 
h at room temperature. The mixture was stirred overnight and precipitates were filtered. After 
removing the solvent in vacuo the mixture was purified by column chromatography (PE 40-
60 oC / EtOAc : 5/1, Rf = 0.31) to give a yellow oil as product, 141 mg, 43 %.  
IR υmax (cm-1) 2905 (w), 1606 (s) 1510 (s), 1421 (m), 1347 (m), 1305 (m), 1256 (s), 1172 
(m), 1026 (m), 836 (m), 753 (m). 
1H NMR: 
 
(500 MHz, CDCl3) 7.64-7.38 (5H, m, Ph), 6.97 (2H, d,  J=7.0 Hz, Ar), 6.82 (2H, 
d, J=7.0 Hz, Ar), 4.83 (1H, dd, J=5.3, 9.3 Hz, PhCH), 3.8 (3H, s, OCH3), 3.67 (1H, dd,  
J=9.3, 13.2 Hz, PhCHCH2), 2.72 (1H, dd, J=13.2 and 5.3 Hz, PhCHCH2), 2.2 (3H, s, SCH3). 
13C NMR  (125 MHz, CDCl3) 161.7 (N=C-N), 160.6 (C, Ar), 140.6 (C, Ar), 137.5 (C, Ar), 
133.9 (CH, Ar), 128.7 (CH, Ar), 128.6 (CH, Ar), 126.9 (CH, Ar), 114.6 (CH, Ar), 114.4 (C-
SMe), 66.5 (CH), 55.3 (OCH3), 44.6 (CH2), 10.3 (SCH3). 
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MS (m/z) 349.1 [M+Na]+, 675.2 [M2 + Na]+.  
HRMS (m/z) [M+Na]+ for C18H18N2O2S calculated = 349.0164, measured = 349.0159. 
 
3.2.3.2.  Reactivity of 2-(4-methoxy-phenyl)-5-(methylthio)-7-phenyl-4-oxa-1,3-
diazabicyclo[3.2.0]hept-2-ene : Synthesis of 3-(p-methoxy-phenyl)-5-(methylthio)-1,2,4-
oxadiazole. 
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Scheme  3.51 
 
2-(4-Methoxy-phenyl)-5-(methylthio)-7-phenyl-4-oxa-1,3-diaza-bicyclo[3.2.0]hept-2-ene (80 
mg, 0.24 mmol) was added to toluene (10 ml) and the mixture was heated at reflux overnight. 
After the completion of reaction in 18 hours, monitored by TLC, the solvent was evaporated 
in vacuo and the mixture was purified with column chromatography (PE 40-60 oC / EtOAc : 
8/1, Rf = 0.52). The product was obtained as an oily solid (45 mg, 88 %). 
IR υmax (cm-1) 2919 (m), 1611 (s), 1509 (s), 1466 (m), 1422 (m), 1346 (m), 1297 (m), 1250 
(s), 1198 (m), 1117 (m), 1027 (m), 833 (s), 758 (s). 
1H NMR:   H (500 MHz, CDCl3) 7.99 (2H, d, J=8.0, ArH), 6.98 (2H, d, J=8.0, ArH), 3.85 
(3H, s, OMe), 2.78 (3H, s, SMe). 
 
13C NMR: C (125 MHz, CDCl3) 178.05 (C, oxadiazole), 168.33 (C, oxadiazole), 161.99 
(C, Ar), 129.09 (CH, Ar), 118.97 (C, Ar), 114.23 (CH, Ar), 55.38 (O-CH3), 14.20 (S-CH3). 
HRMS (m/z) [M+Na]+ for C10H10N2O2S calculated = 245.0355, measured = 245.0350. 
193 
 
3.2.3.3. Synthesis of 2-(4-methoxy-phenyl)-5-(methylthio)-7-p-tolyl-4-oxa-1,3-
diazabicyclo[3.2.0]hept-2-ene. 
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Scheme  3.52 
 
To a mixture of 2-methylthio-4-p-tolyl-1-azetine (110 mg, 0.57 mmol) and 4-
methoxybenzohydroximoylchloride (1 eq. 106 mg) in dry diethyl ether (5 ml) was added 
triethylamine (1 eq. 58 mg, 76.4 µl) diluted in dry diethyl ether (30 ml) dropwise over 6-7 h 
at room temperature. The mixture was stirred overnight and precipitates were filtered. After 
removing the solvent in vacuo the mixture was purified by column chromatography (PE 40-
60 oC / EtOAc : 5/1, Rf = 0.28) to give a yellow oil as product, 139 mg, 72 %. 
IR υmax (cm-1) 2893 (w), 1608 (s) 1512 (s), 1346 (s), 1306 (m), 1255 (s), 1172 (s), 1051 (m), 
1031 (m), 838 (m), 753 (m). 
1H NMR:  (500 MHz, CDCl3) 7.42-7.39 (4H, m, 2 x Ar1, 2 x Ar2), 7.14 (2H, d, J=8.0 Hz, 
Ar1), 6.71 (2H, d, J=7.2 Hz, Ar2), 4.68 (1H, dd, J=5.3 and 9.3 Hz, Ar1CH), 3.68 (3H, s, 
OCH3), 3.54 (1H, dd, J=9.3 and 13.2 Hz, Ar1CHCH2), 2.61 (1H, dd, J= 13.2 and 5.3 Hz, 
Ar1CHCH2), 2.30 (3H, s, SCH3), 2.13 (3H, s, CH3). 
13C NMR  (125 MHz, CDCl3) 161.8 (N=C-N), 160.7 (C, Ar), 138.1 (C, Ar), 137.9 (C, Ar), 
129.07 (CH, Ar), 128.7 (CH, Ar), 126.4 (CH, Ar), 116.9 (C, Ar), 114.7 (CH, Ar), 111.2 (C-
SMe), 66.5 (CH), 55.4 (OCH3), 44.7 (CH2), 21.1 (ArCH3), 10.4 (SCH3).   
MS (m/z) 341.1 [M+H+], 363.1 [M+Na]+. 
HRMS (m/z) [M+H]+ for C19H20N2O2S calculated = 341.0501, measured = 341.0503. 
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3.2.3.4. Reaction of 2-(4-methoxy-phenyl)-5-(methylthio)-7-p-tolyl-4-oxa-1,3-
diazabicyclo[3.2.0]hept-2-ene : Synthesis of 3-(p-methoxy-phenyl)-5-(methylthio)-1,2,4-
oxadiazole.        
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Scheme  3.53 
2-(4-Methoxy-phenyl)-5-(methylthio)-7-p-tolyl-4-oxa-1,3-diazabicyclo[3.2.0]hept-2-ene (100 
mg, 0.3 mmol) was added to toluene (10 ml) and the mixture was heated at reflux overnight. 
After the completion of reaction in 18 hours, monitored by TLC, the solvent was evaporated 
in vacuo and the mixture was purified with column chromatography (PE 40-60 oC / EtOAc : 
8/1, Rf = 0.54). The product was obtained as an oily solid (52 mg, 82 %). 
 
IR υmax (cm-1) 2919 (m), 1611 (s), 1509 (s), 1466 (m), 1422 (m), 1346 (m), 1297 (m), 1250 
(s), 1198 (m), 1117 (m), 1027 (m), 833 (s), 758 (s). 
1H NMR:   H (500 MHz, CDCl3) 7.99 (2H, d, J=8.0, ArH), 6.98 (2H, d, J=8.0, ArH), 3.85 
(3H, s, OMe), 2.78 (3H, s, SMe). 
 
13C NMR: C (125 MHz, CDCl3) 178.05 (C, oxadiazole), 168.33 (C, oxadiazole), 161.99 (C, 
Ar), 129.09 (CH, Ar), 118.97 (C, Ar), 114.23 (CH, Ar), 55.38 (O-CH3), 14.20 (S-CH3). 
 
HRMS (m/z) [M+Na]+ for C10H10N2O2S calculated = 245.0355, measured = 245.0350. 
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3.2.3.5. Synthesis of 2-(4-methoxy-phenyl)-5-(ethylthio)-7-p-tolyl-4-oxa-1,3-
diazabicyclo[3.2.0]hept-2-ene. 
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Scheme  3.54 
 
To a mixture of 2-ethylthio-4-p-tolyl-1-azetine (100 mg, 0.48 mmol) and 4-
methoxybenzohydroximoylchloride (1 eq. 92 mg) in dry diethyl ether (5 ml) was added 
triethylamine (1 eq. 50 mg, 70 µl) diluted in dry diethyl ether (25 ml) dropwise over 6-7 h at 
room temperature. The mixture was stirred overnight and precipitates were filtered. After 
removing the solvent in vacuo the mixture was purified by column chromatography (PE 40-
60 oC / EtOAc : 5/1, Rf = 0.30) to give a yellow oil as product, 80 mg, 48 %. 
IR υmax (cm-1) 2915 (w), 1608 (s), 1590 (m), 1512 (s), 1345 (m), 1256 (s), 1173 (m), 1030 
(m), 838 (m). 
1H NMR:  (500 MHz, CDCl3) 7.54-7.49 (2H, m, ArH), 7.29-7.24 (2H, m, ArH), 6.95 (2H, 
dd,  J=2.4 and 8.1 Hz, ArH), 6.83 (2H, d, J=7.2 Hz, ArH), 4.80 (1H, dd, J= 9.3 and 5.3 Hz, 
ArCH), 3.8 (3H, s, OCH3), 3.62 (1H, dd,  J= 13.2 and 9.3 Hz, ArCHCH2), 2.92-2.75 (2H, m, 
SCH2CH3), 2.71 (1H, dd, J= 13.2 and 5.3 Hz, ArCHCH2), 2.4 (3H, s, Ar-CH3), 1.36 (3H, t, 
J=7.0, SCH2CH3). 
13C NMR:  (125 MHz, CDCl3) 161.8 (N=C-N), 160.7 (C, Ar), 138.0 (C, Ar), 137.8 (C, Ar), 
129.4 (CH, Ar), 129.0 (CH, Ar), 126.4 (C, Ar), 114.4 (CH, Ar), 114.2 (CH, Ar), 111.5 (C, 
CSEt), 66.77 (CH), 55.3 (OCH3), 45.4 (ArCHCH2), 22.7 (SCH2), 21.1 (ArCH3), 14.8 
(SCH2CH3). 
MS (m/z) 377.1 [M+Na]+, 731.2 [M2 + Na]+. 
HRMS (m/z) [M+H]+ for C20H22N2O2S calculated = 355.0657, measured = 355.0657. 
196 
 
3.2.3.6.  Reaction of 2-(4-methoxy-phenyl)-5-(ethylthio)-7-p-tolyl-4-oxa-1,3-
diazabicyclo[3.2.0]hept-2-ene : Synthesis of 3-(p-methoxy-phenyl)-5-(ethylthio)-1,2,4-
oxadiazole.  
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Scheme  3.55 
2-(4-Methoxy-phenyl)-5-(ethylthio)-7-p-tolyl-4-oxa-1,3-diazabicyclo[3.2.0]hept-2-ene (80 
mg, 0.22 mmol) was added to toluene (10 ml) and the mixture was heated at reflux overnight. 
After the completion of reaction in 18 hours, monitored by TLC, the solvent was evaporated 
in vacuo and the mixture was purified by column chromatography (PE 40-60 oC / EtOAc : 
8/1, Rf = 0.51). The product was obtained as an oily solid (41 mg, 81 %). 
 
IR υmax (cm-1) 2920 (w), 1611 (s), 1505 (s), 1420 (m), 1348 (s), 1299 (m), 1250 (s), 1171 
(m), 1028 (m), 838 (m), 753 (m). 
1H NMR: H (500 MHz, CDCl3): 7.98 (2H, d, J=8.1 Hz, ArH), 6.96 (2H, d, J=8.1 Hz, ArH), 
3.86 (3H, s, OMe), 3.32 (2H, q, J=7.9 Hz, CH2CH3), 1.52 (3H, t, J=7.9 Hz, CH2CH3). 
13C NMR  (125 MHz, CDCl3): 177.64 (C, oxadiazole), 168.27 (C, oxadiazole), 161.97 (C, 
Ar), 129.04 (CH, Ar), 119.04 (C, Ar), 114.22 (CH, Ar), 55.38 (O-CH3), 27.25 (S-CH2), 14.82 
(S-CH2CH3). 
MS (m/z) 259.0 [M+Na]+, 731.2 [M2 + Na]+. 
HRMS (m/z) [M+Na]+ for C11H12N2O2S calculated = 259.0511, measured = 259.0518. 
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3.2.3.7. Synthesis of 2-(2-azidophenyl)-5-(ethylthio)-7-p-tolyl-4-oxa-1,3-
diazabicyclo[3.2.0]hept-2-ene. 
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Scheme  3.56 
To a mixture of 2-ethylthio-4-p-tolyl-1-azetine (120 mg, 0.58 mmol) and 2-
azidobenzohydroximoylchloride (1 eq. 114 mg) in dry diethyl ether (5 ml) was added 
triethylamine (1 eq. 58 mg, 81.3 µl) diluted in dry diethyl ether (25 ml) dropwise over 6-7 h 
at room temperature. The mixture was stirred overnight and precipitates were filtered off. 
After removing the solvent in vacuo the mixture was purified by column chromatography (PE 
40-60 oC / EtOAc : 5/1, Rf = 0.36) to give an orange oil as product, 84 mg, 40 %. 
IR υmax (cm-1) 2914 (w), 2103 (m), 1604 (s), 1592 (m), 1512 (s), 1345 (m), 1253 (s), 1173 
(m), 1031 (m), 838 (m). 
1H NMR:  (500 MHz, CDCl3) 8.15-8.17 (1H, m, ArH), 7.56-7.50 (2H, m, ArH), 7.46 (1H, 
d, J= 8.0 Hz), 7.39 (1H, d,  J= 7.7 Hz, ArH), 7.30-7.21 (2H, m), 7.17 (1H, d, J= 6.2 Hz, 
ArH), 4.79 (1H, dd, J= 9.3 and 5.3 Hz, ArCH), 3.67 (1H, dd,  J= 13.2 and 9.3 Hz, 
ArCHCH2), 2.92-2.82 (2H, m, SCH2CH3), 2.72 (1H, dd, J=5.3 and 13.2 Hz, ArCHCH2), 2.39 
(3H, s, Ar-CH3), 1.36 (3H, t, J=7.5, SCH2CH3). 
13C NMR:  (125 MHz, CDCl3) 155.1 (N=C-N), 139.3 (C, Ar), 138.5 (C, Ar), 132.2 (CH, 
Ar), 131.0 (CH, Ar), 130.8 (CH, Ar), 129.4 (C, Ar), 126.3 (C, Ar), 125.2 (CH, Ar), 118.8 
(CH, Ar), 115.3 (CH, Ar), 111.08 (C, CSEt), 66.9 (CH), 45.5 (ArCHCH2), 22.7 (SCH2), 21.2 
(ArCH3), 14.2 (SCH2CH3). 
HRMS (m/z) [M+Na]+ 388.1202 for C19H19N5OSNa, measured 388.1202. 
 
198 
 
3.2.3.8. Reaction of 2-(2-azidophenyl)-5-(ethylthio)-7-p-tolyl-4-oxa-1,3-
diazabicyclo[3.2.0]hept-2-ene. 
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Scheme  3.57 
2-(2-Azido-phenyl)-5-(ethylthio)-7-p-tolyl-4-oxa-1,3-diaza-bicyclo[3.2.0]hept-2-ene (85 mg, 
0.63 mmol) was added to toluene (10 ml) and the mixture was heated at reflux overnight. The 
reaction was monitored by TLC, no product could be identified due to the decomposition of 
starting material.  
3.2.3.9. Synthesis of 2-(4-methoxyphenyl)-5-(methylthio)-7-naphthyl-4-oxa-1,3-
diazabicyclo[3.2.0]hept-2-ene. 
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Scheme  3.58 
To a mixture of 2-methylthio-4-naphthyl-1-azetine (100 mg, 0.43 mmol) and 4-
methoxybenzohydroximoylchloride (1 eq. 81 mg) in dry diethyl ether (5 ml) was added 
triethylamine (1 eq. 44 mg, 61.5 µl) diluted in dry diethyl ether (25 ml) dropwise over 6-7 h 
at room temperature. The mixture was stirred overnight and precipitates were filtered. After 
removing the solvent in vacuo the mixture was purified by column chromatography (PE 40-
60 oC / EtOAc : 5/1, Rf = 0.37) to give an orange oil as product, 72 mg, 44 %. 
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IR υmax (cm-1) 2928 (w), 1608 (s), 1511 (s), 1404 (m), 1349 (m), 1256 (s), 1172 (m), 1028 
(m), 836 (m). 
1H NMR:  (500 MHz, CDCl3) 7.98 (2H, d, J=8.8 Hz, 4-MeOAr), 7.94-7.85 (2H, m, 
naphth), 7.57-7.47 (3H, m, naphth), 7.0-6.95 (2H, m, naphth), 6.80 (2H, d, J=8.8 Hz, 4-
MeOAr), 5.0 (1H, dd, J= 9.3 and 5.3 Hz, naphthCH), 3.77 (3H, s, OCH3), 3.74 (1H, dd, J= 
9.3 and 13.2 Hz, naphthCHCH2), 2.82 (1H, dd, J= 13.2 and 5.3 Hz, naphthCHCH2), 2.30 
(3H, s, SCH3). 
13C NMR  (125 MHz, CDCl3) 161.8 (N=C-N), 138.1 (C, Ar), 133.3 (C, Ar), 133.2 (C, Ar), 
130.2 (C, Ar), 130.0 (CH, Ar), 129.0 (CH, Ar), 128.4 (CH, Ar), 128.1 (CH, Ar), 126.8 (CH, 
Ar), 126.4 (CH, Ar), 125.2 (CH, Ar), 123.9 (CH, Ar), 116. 8 (CH, Ar), 114.4 (C, Ar), 111.3 
(C-SMe), 66.6 (CH), 55.3 (OCH3), 44.7 (CH2), 10.4 (SCH3). 
HRMS (m/z) [M + Na]+ for C22H20N2O2S calculated 399.1138 measured 399.1142.  
 
3.2.3.10. Reaction of 2-(4-methoxyphenyl)-5-(methylthio)-7-naphthyl-4-oxa-1,3-
diazabicyclo[3.2.0]hept-2-ene : synthesis of 3-methoxyphenyl-5-methylthio-1,2,4-
oxadiazole. 
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Scheme  3.59 
2-(4-Methoxyphenyl)-5-(methylthio)-7-naphthyl-4-oxa-1,3-diazabicyclo[3.2.0]hept-2-ene (70 
mg, 0.19 mmol) was added to toluene (10 ml) and the mixture was heated at reflux overnight. 
After the completion of reaction in 20 hours, monitored by TLC, the solvent was evaporated 
in vacuo and the mixture was purified by column chromatography (PE 40-60 oC / EtOAc : 
8/1, Rf = 0.53). The product was obtained as an oily solid (34 mg, 87 %). 
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IR υmax (cm-1) 2919 (m), 1611 (s), 1509 (s), 1466 (m), 1422 (m), 1346 (m), 1297 (m), 1250 
(s), 1198 (m), 1117 (m), 1027 (m), 833 (s), 758 (s). 
1H NMR:   H (500 MHz, CDCl3) 7.99 (2H, d, J=8.0, ArH), 6.98 (2H, d, J=8.0, ArH), 3.85 
(3H, s, OMe), 2.78 (3H, s, SMe). 
 
13C NMR: C (125 MHz, CDCl3) 178.05 (C, oxadiazole), 168.33 (C, oxadiazole), 161.99 
(C, Ar), 129.09 (CH, Ar), 118.97 (C, Ar), 114.23 (CH, Ar), 55.38 (O-CH3), 14.20 (S-CH3). 
HRMS (m/z) [M+Na]+ for C10H10N2O2S calculated = 245.0355, measured = 245.0350. 
 
3.2.3.11. Reaction of 2-methylthio-4-naphthyl-1-azetine with 2-azidobenzohydroximoyl 
chloride : Synthesis of 2-(2-azidophenyl)-5-(methylthio)-7-naphthyl-4-oxa-1,3-
diazabicyclo[3.2.0]hept-2-ene. 
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Scheme  3.60 
To a mixture of 2-methylthio-4-naphthyl-1-azetine (100 mg, 0.43 mmol) and 2-
azidobenzohydroximoylchloride (1 eq. 86.06 mg) in dry diethyl ether (5 ml) was added 
triethylamine (1 eq. 44 mg, 61.5 µl) diluted in dry diethyl ether (25 ml) dropwise over 6-7 h 
at room temperature. The mixture was stirred overnight and precipitates were filtered. After 
removing the solvent in vacuo the mixture was purified by column chromatography (PE 40-
60 oC / EtOAc : 5/1, Rf = 0.39) to give an orange oil as product, 74 mg, 44 %. 
IR υmax (cm-1) 2968 (m), 2918 (m), 2128 (s), 1597 (m), 1581 (m), 1447 (m), 1300 (m), 751 
(m). 
1H NMR:  (500 MHz, CDCl3) 7.95-7.85 (2H, m, Ar), 7.82 (1H, dd, J=7.0 and 1.5 Hz, Ar), 
7.58-7.50 (2H, m, Ar), 7.44-7.38 (2H, m, Ar), 7.28-7.23 (2H, m, Ar), 7.18 (1H, d, J=8.0 Hz, 
Ar), 6.96 (1H, td,  J=1.0 and 7.0 Hz, Ar), 5.0 (1H, dd, J= 9.3 and 5.3 Hz, ArCHN), 3.7 (1H, 
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dd, J= 13.2 and 9.3 Hz, ArCHCH2), 2.8 (1H, dd, J= 5.3 and 13.2 Hz, ArCHCH2) 2.3 (3H, s, 
SCH3). 
13C NMR  (125 MHz, CDCl3) 158.8 (N=C-N), 139.1 (C, Ar), 137.9, (C, Ar), 133.2 (C, Ar), 
132.2 (C, Ar), 132.0 (CH, Ar), 131.0 (CH, Ar), 130.2 (CH, Ar), 128.9 (CH, Ar), 128.4 (CH, 
Ar), 128.0 (CH, Ar), 126.4 (CH, Ar), 126.3 (CH, Ar), 124.8 (CH, Ar), 124.0 (CH, Ar), 119.6 
(CH, Ar), 118.8 (C, Ar), 116.1 (C-SMe), 66.8 (CH), 22.7 (CH2), 10.8 (CH3).  
HRMS (m/z) [M + Na]+ for C21H17N5OS calculated 410.1046, measured 410.1046.  
 
3.2.3.12. Reaction of 2-(2-azidophenyl)-5-(methylthio)-7-naphthyl-4-oxa-1,3-
diazabicyclo[3.2.0]hept-2-ene : Synthesis of 3-azidophenyl-5-methylthio-1,2,4-oxadiazole. 
              
N
N
O
SMe
N3
N
N
OMeS
toluene
reflux N3
351 d 350 e
 
Scheme  3.61 
2-(2-Azidophenyl)-5-(methylthio)-7-naphthyl-4-oxa-1,3-diazabicyclo[3.2.0]hept-2-ene (100 
mg, 0.25 mmol) was added to toluene (10 ml) and the mixture was heated at reflux overnight. 
After the completion of reaction (24h), monitored by TLC, the solvent was evaporated in 
vacuo and the mixture was purified by column chromatography (PE 40-60 oC / EtOAc : 8/1, 
Rf = 0.51). The product was obtained as an oily solid (41 mg, 68 %). 
IR υmax (cm-1) 2966 (w), 2128 (s), 1597 (m), 1578 (m), 1501 (m), 1300 (m), 750 (m). 
1H NMR: H (500 MHz, CDCl3) 7.97 (1H, dd, J=2.0 and 8.0 Hz, ArH), 7.55-7.45 (1H, m, 
ArH), 7.37 (1H, dd, J=2.0 and 8.0 Hz, ArH), 7.27-7.22 (1H, m, ArH), 2.7 (3H, s, SCH3). 
13C NMR  (125 MHz, CDCl3) 178.0 (C, oxadiazole), 166.7 (C, oxadiazole), 138.8 (C, Ar), 
132.1 (CH, Ar), 131.0 (CH, Ar), 124.9 (CH, Ar), 119.3 (CH, Ar), 118.9 (C, Ar), 15.3 (SCH3).  
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HRMS (m/z) [M+Na]+ for C9H7N5OS calculated 256.0264 measured 256.0273. 
 
 
3.2.3.13 Reactivity of 2-methylthio-4-naphthyl-1-azetine ; Synthesis of 2-methylthio-
benzoquinoline. 
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Scheme  3.62 
 
To 4-naphthylazetidin-2-thione (300 mg, 1.40 mmol) was added εeerwein’s reagent (γ1β.5 
mg, 2.11 mmol, 1.5 eq.) in dry dichloromethane (10 ml) under a nitrogen atmosphere. The 
mixture was stirred at room temperature for 1 h and then at reflux for 1 h. The solution was 
then added drop wise to a 50% aqueous solution of potassium carbonate (10 ml) at -10 oC. 
The solution was then filtered through celite and the organic layer was separated. The 
aqueous layer was washed with dichloromethane (2 x 10 ml), and the combined organic 
extracts were dried over magnesium sulfate. After filtration the solvent was evaporated in 
vacuo to give a dark orange oil which was kept at room temperature for 24 hour to give the 
product 294 as a yellow solid (112 mg, 35 %). 
IR υmax (cm-1): 3043 (w), 2955 (m), 1704 (m), 1587 (w), 1556 (w), 1493 (m), 1441 (m), 1391 
(m), 1144 (s), 1224 (m), 1073 (m), 835 (m), 748 (m). 
 
1H NMR: δ (400 MHz, CDCl3): 9.27 (1H, d, J = 7.6 Hz), 7.88 (2H, t, 3 J = 9.7 Hz), 7.71-
7.58 (4H, m), 7.36 (1H, d, J = 8.4 Hz), 2.83 (3H, s, SMe). 
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13C NMR δ (100 MHz, CDCl3): 158.51 (C), 146.18 (C), 135.31 (CH), 133.90 (C), 130.91 
(C), 128.02 (CH), 127.72 (CH), 126.67 (CH), 126.55 (CH), 125.46 (CH), 124.41 (CH), 
123.22 (C), 120.87 (CH), 13.26 (SMe). 
 
HRMS (m/z) [M+H]+ for C14H12N1S calculated 226.0692, measured 226.0684. 
 
3.2.3.14.  Reaction of 2-methylthio-3,3,4,4-tetramethyl-1-azetine with 2-
azidobenzohydroximoyl chloride : Synthesis of 2-(2-azidophenyl)-5-(methylthio)-6,6,7,7-
tetramethyl-4-oxa-1,3-diazabicyclo[3.2.0]hept-2-ene.  
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Scheme  3.63 
To a mixture of 2-methylthio-3,3,4,4-tetramethyl-1-azetine (250 mg, 1.57 mmol) and 2-
azidobenzohydroxyimoylchloride (1 eq. 308 mg) in dry diethyl ether (5 ml) was added 
triethylamine (1 eq. 159 mg, 218.8 µl) diluted in dry diethyl ether (30 ml) dropwise over 6-7 
h at room temperature. The mixture was stirred overnight and precipitates were filtered. After 
removing the solvent in vacuo the mixture was purified by column chromatography (PE 40-
60 oC / EtOAc : 10/1, Rf = 0.31) to give a yellow oil as product, 262 mg, 52 %.  
IR υ max (cm-1)  2959, 2925, 2127 and 2093 (N3), 1581 (CN), 1481, 1447, 1397. 
1H NMR (400 MHz) (CDCl3) į 7.66 (1H, d, J= 7.8 Hz, ArH), 7.56-7.43 (1H, m, ArH), 7.25 
(1H, d, J= 8.2 Hz, ArH), 7.22-7.14 (1H, m, ArH), 2.1 (3H, s, SCH3), 1.50 (3H, s, CH3), 1.32 
(3H, s, CH3), 1.26 (3H, CH3), 0.97 (3H, s, CH3). 
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13C NMR (100 MHz) (CDCl3) į 157.36 (CN), 138.36 (C), 131.54 (CH), 130.77 (CH), 
124.68 (CH), 119.83 (CH), 118.80 (C), 117.14 (C), 71.85 (C), 52.75 (C), 26.65 (CH3), 21.09 
(CH3), 20.52 (CH3), 20.13 (CH3), 9.69 (SCH3). 
MS. (ESI, m/z), 340.1203 (M+Na)+  calculated for  C15H19N5OSNa and found 340.1200. 
 
3.2.3.15.  Reaction of 2-(2-azidophenyl)-5-(methylthio)-6,6,7,7-tetramethyl-4-oxa-1,3-
diazabicyclo[3.2.0]hept-2-ene with DMAD : Synthesis of dimethyl 2-(2-azidophenyl)-6,6-
dimethyl-1-(2-methyl-3-oxobutan-2-yl)-1,6-dihydropyrimidine-4,5-dicarboxylate. 
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Scheme  3.64 
To a solution of 2-(2-azidophenyl)-5-(methylthio)-6,6,7,7-tetramethyl-4-oxa-1,3-
diazabicyclo[3.2.0]hept-2-ene (130 mg, 0.41 mmol) in dry toluene (10 ml) was added 
DMAD (1 eq. 58 mg, 50.3 µl) and the mixture was heated at reflux overnight in a nitrogen 
atmosphere. After the completion of reaction in 18 hours, monitored by TLC, the solvent was 
evaporated in vacuo and the mixture was purified by column chromatography (PE 40-60 oC / 
EtOAc : 4/1, Rf = 0.35). The product was obtained as an oily solid (68 mg, 36 %). 
IR υmax (cm-1) 2953 (w), 2928 (w), 2129 (N3), 1732 (s, C=O), 1665 (m, C=N), 1556 (m), 
1444 (m), 1361 (m), 1289(m), 1230 (m), 1203 (m), 1173 (m), 1127 (m), 1078 (m).1003 (m), 
825 (m), 765 (m). 
1H NMR δ (400 MHz, CDCl3) 8.26 (1H, d, J=7.5 Hz, CH (Ar)), 7.71 (1H, m, CH (Ar)), 7.56 
(1H, d, J=7.2 Hz, CH (Ar)), 7.27 (1H, m, CH (Ar)), 4.01 (3H, s, CO2Me), 3.74 (3H, s, 
CO2Me), 2.25 (3H, s, SCH3), 1.46 (6H, s, 2 x Me), 1.31 (6H, s, 2 x Me). 
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13C NMR δ (100 MHz, CDCl3) 204.66 (O=C-SMe), 165.18 (NC=N), 160.43 (C=O), 158.20 
(C=O) 136.40 (C (Ar)), 133.07 (C=C), 131.96 (C=C), 131.52 (CH, Ar), 130.12 (C, Ar), 
128.66 (CH, Ar), 127.27 (CH, Ar), 124.59 (C-Ar), 64.77 (C(CH3)2), 55.51 C(CH3)2), 53.30 
(CO2CH3), 52.71 (CO2CH3) 26.99 (CH3), 25.44 (CH3)2, 21.78 (CH3), 19.59 (CH3)2, 12.08 
(SCH3). 
HRMS (m/z) [M+Na]+ for C21H25N5O5SNa calculated 482.1468, measured 482.1472. 
 
3.2.3.16.  Reaction of 2-ethylthio-4-phenyl-1-azetine with α-chlorobenzaldehyde 
phenylhydrazine : Synthesis of 2,4,7-triphenyl-5-(ethylthio)-1,3,4-triazabicyclo[3.2.0]hept-
2-ene.  
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Scheme  3.65 
To a mixture of 2-ethylthio-4-phenyl-1-azetine (β00 mg, 1.05 mmol) and α-
chlorobenzaldehyde phenylhydrazine (1 eq. 241 mg) in dry diethyl ether (5 ml) was added 
triethylamine (1.1 eq. 116 mg, 165 µl) diluted in dry diethyl ether (30 ml) dropwise over 6-7 
h at room temperature. The mixture was stirred overnight and then heated at reflux for 3 h. 
After filtering and removing the solvent in vacuo the mixture was purified by column 
chromatography (PE 40-60 oC / EtOAc : 8/1, Rf = 0.31) to give a yellow oily solid as the 
product, 82 mg, 20 %.  
1H NMR δ (400 MHz) (CDCl3) 8.20 (2H, dd, J= 6.9 and 1.3 Hz, ArH), 7.52-7.46 (6H, m, 
ArH), 7.25-7.20 (7H, m, ArH), 4.54 (1H, dd, J= 9.3 and 5.3 Hz, Ph-CH), 3.45-3.27 (2H, m, 
CH2-ring), 2.33 (2H, 2x dq, J= 7.3 and 3.8 Hz, SCH2), 1.15 (3H, t, J= 7.3 Hz, CH3). 
13C NMR δ (100 MHz) (CDCl3) 161.58 (CN), 154.31 (C), 141.06 (C), 137.08 (C), 130.90 
(C), 129.39 (CH), 129.30 (CH), 129.16 (CH), 128.59 (CH), 128.56 (CH), 127.69 (CH), 
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127.46 (CH), 126.50 (CH), 125.85 (CH), 48.01 (CH), 33.85 (CH2), 25.54 (CH2), 14.39 
(CH3). 
 MS. (ESI, m/z), 408.15 (M+Na)+. 
HRMS (m/z): 408.1505 calculated for C23H25NNaOS, (M+Na)+, found 408.1517 
 
3.2.3.17.  Reactivity of 2,4,7-triphenyl-5-(ethylthio)-1,3,4-triazabicyclo[3.2.0]hept-2-ene : 
Attempted synthesis of 2,4-diphenyl-5-ethylthio-1,3,4-triazole. 
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Scheme  3.66 
5-Ethylthio-2,4,7-triphenyl-1,3,4-triazabicyclo[3.2.0]hept-2-en-4-one (100 mg, 0.26 mmol) 
was added to o-xylene (8 ml) and the mixture was heated at reflux at 155 oC overnight. The 
reaction was monitored on TLC and even after 72 hours of reflux no product could be 
identified.  
3.3  Synthesis and reactivity of 1-azirines 
3.3.1.  Synthesis of 2-methyl-3-phenyl-1-azirine[254]. 
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Scheme  3.67 
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To a mixture of phenyl acetone (1 g, 1 ml, 7.46 mmol) in MeOH (20 ml) and water (1 ml) 
was added hydroxylamine hydrochloride (1.5 eq. 778.5 mg) and sodium acetate (1.5 eq. 
918.4 mg) in a round bottom flask. After stirring the mixture for 4 h at room temperature, the 
solvent was removed in vacuo. The reaction mixture was dissolved in EtOAc and washed 
with water, saturated aqueous NaHCO3 solution and brine and dried over MgSO4. Distillation 
of the solvent resulted in the crude oxime (1.48 g) which was used directly in the next 
reaction. 
To a stirring mixture of crude oxime (1.48 g) in dry THF (30 ml) was added Et3N (11.2 
mmol, 1.13 g, 2.08 ml) and methanesulfonyl chloride (11.2 mmol, 1.28 g, 0.86 ml) 
sequentially at room temperature. The solution turned cloudy after the addition of 
methanesulfonyl chloride. After 30 min. of stirring, DBU (22.4 mmol, 3.4 g, 3.34 ml) was 
added over 1 min. and the mixture was stirred for a further 30 min. Then reaction mixture 
was passed through a pad of silica gel, and washed with EtOAc. After removing the solvent 
in vacuo the mixture was chromatographed (PE / EtOAc : 10/1, Rf = 0.68) to give the product 
as a colourless oil, 536 mg, 55 % from ketone271. 
1H NMR δ (400 MHz) (CDCl3) 7.30-7.18 (3H, m), 7.04 (2H, d, J= 8.2 Hz), 2.85 (1H, s, 
CH), 2.46 (3H, s, CH3). 
 
13C NMR δ (100 MHz) (CDCl3) 164.44 (CN), 141.31 (C), 128.85 (CH), 127.24 (CH), 
125.65 (CH), 33.39 (CH), 12.85 (CH3).  
3.3.2. Reactivity of 2-methyl-3-phenyl-1-azirine with diphenylcyclopropenone : 
Synthesis of 2,5-dimethyl-3,6-diphenylpyrazine and 2-methyl-3,5,6-triphenylpyridine-4-
(1H)-one [255]. 
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Scheme  3.68 
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To a solution of the azirine (160 mg, 1.22 mmol) in dry toluene (10 ml) was added 
diphenylcyclopropenone (1 eq. 252 mg) and the mixture was heated at reflux for 4 days. 
After completion of the reaction, the mixture was purified with flash chromatography (PE / 
EtOAc : 10/1, Rf = 0.42) to give the pyrazine (61 mg, 19 %) as a yellow solid, m.p. 157-161 
oC and the pyridone (Rf = 0.24) as a yellow solid (21 mg, 5 %), m.p. 250.5-253 oC. 
Pyrazine 
IR υmax (cm-1)  2907 (w), 1627(s), 1600 (s), 1507 (m), 1347 (s), 694 (m). 
1H NMR δ (400 MHz) (CDCl3) 7.63 (4H, d, J= 7.1 Hz, ArH), 7.42-7.51 (6H, m, ArH), 2.64 
(6H, s, 2xCH3). 
 
13C NMR δ (100 MHz) (CDCl3) 151.08 (C), 147.84 (C), 138.80 (C), 128.92 (CH), 128.35 
(CH), 128.24 (CH), 22.69 (2xCH3).  
HRMS (m/z): 261.1386 calculated for C18H17N2, (M+H)+, found 261.1388. 
Pyridone 
IR υmax (cm-1)  3400, 1687, 1600, 1493, 1447. 
1H NMR δ (400 MHz) (CDCl3) 8.1 (2H, d, J= 7.5 Hz, ArH), 7.95 (1H, s, NH), 7.88 (2H, t, 
J= 8.1 Hz, ArH), 7.61-7.22 (7H, m, ArH), 7.14 (2H, t, J= 7.7 Hz, ArH), 7.06 (2H, d, J= 7.5 
Hz, ArH), 2.63 (3H, s, CH3). 
 
13C NMR δ (100 MHz) (CDCl3) 172.64 (C=O), 166.97 (C), 165.88 (C), 148.10 (C), 142.25 
(CH), 135.45 (C), 134.36 (C), 133.65 (C), 131.62 (CH), 130.85 (CH), 130.18 (CH), 129.74 
(CH), 128.75 (CH), 128.46 (CH), 128.28 (CH), 126.30 (CH), 123.91 (C), 25.66 (CH3).  
The data is identical to literature272. 
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3.4.  Synthesis and reactivity of benzodiazepines 
 
3.4.1.  Synthesis of benzodiazepines 
 
3.4.1.1.  Synthesis of 1,2,3,11a-tetrahydro-10H-picolo[2,1-c][1,4]benzodiazepine-5,11-
dione 280. 
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Scheme  3.69 
Isatoic anhydride (4.1 g, 25 mmol) and pipecolic acid (1.61g, 1 eq.) were heated in DMSO 
(15 ml) for 5 h at 100 oC. The reaction mixture was cooled and added to iced water (150 ml), 
the precipitate was isolated and recrystallized from ethanol to give the product as light brown 
crystals 3.8 g, 66%. 
IR υmax (cm-1) 3246  (NH), 1697, 1636 cm-1 (2x C=O) 
1H NMR δ (500 MHz) (DMSO-d6) 10.4 (1H, s, NH), 7.78 (1H, dd, J= 7.9 and 1.5 Hz, ArH), 
7.55 (1H, dt, J= 8.1 and 1.2 Hz, ArH), 7.33 (1H, dt, J= 8.0 and 1.2 Hz, ArH), 7.24 (1H, d, J= 
8.0 Hz, ArH), 4.41 (1H, dd, J= 13.2, 3.1 Hz, CH), 4.26 (1H, dd, J= 6.7, 3.5 Hz, CH2), 2.71-
2.84 (1H, m, CH2), 2.35-2.15 (2H, m, CH2), 1.8-1.4 (4H, m, 2 x CH2). 
 
13C NMR δ (125 MHz) 171.5 (C=O), 168.15 (C=O), 137.37 (Ar), 132.33 (Ar), 130.93 (Ar), 
127.5 (Ar), 124.3 (Ar), 120.9 (Ar), 50.9 (CH), 39.05 (CH2), 25.28 (CH2), 23.30 (CH2), 19.3 
(CH2). 
 Data as reported280. 
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3.4.1.2. Synthesis of 1,2,3,10,11,11a(S)-Hexahydro-5H-thiazolo[4,3-
c][1,4]benzodiazepine-5,11-dione 280. 
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Scheme  3.70 
Isatoic anhydride (1.2 g, 7.36 mmol) and thiazoline-4-carboxylic acid (981 mg, 1 eq.) were 
heated in DMSO (10 ml) for 5 h at 100 oC. The reaction mixture was cooled and added to 
iced water (75 ml) which was extracted with ethyl acetate (2 x 25 ml). The organic layer was 
washed with water many times to remove the DMSO. After the mixture was dried with 
magnesium sulfate and evaporated, the product was obtained as yellow solid which was 
recrystallized from ethyl acetate and petroleum ether 60-80 oC to yield a cream crystalline 
solid 1.62 g, 94%. 
IR υmax (cm-1) 3430 (NH) 1701, 1636 cm-1 (2x C=O) 
1H NMR δ (400 MHz) (DMSO-d6) 8.58 (1H, s, NH), 8.02 (1H, d, J= 8.1 Hz, ArH), 7.52 
(1H, t, J= 7.4 Hz, ArH), 7.27 (1H, t, J= 7.4 Hz, ArH), 7.02 (1H, d, J= 8.2 Hz, ArH), 4.88 
(1H, d, J= 10.4 Hz, CHN), 4.74 (1H, d, J= 10.4 Hz, CHN), 4.32 (1H, dd, J= 3.3 and 6.8 Hz, 
CHCO), 3.85 (1H, dd, J= 3.3 and 12.3 Hz, CHS), 3.23 (1H, dd, J= 6.8 and 12.3 Hz, CHS).  
13C NMR δ (100 MHz) (DMSO-d6) 169.99 (C=O), 164.96 (C=O), 135.28 (Ar), 133.24 (Ar),  
131.67 (Ar), 126.49 (Ar), 125.53 (Ar), 121.28 (Ar), 58.62 (CH), 50.54 (CH2), 31.58 (CH2).  
Data as reported280. 
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3.4.1.3.  Synthesis of 3H-1,4-benzodiazepine-2,5(1H,4H)dione 280. 
NH
H
N
O
O
HO
H
N
O
O
+ DMSO
100 oC
H2N
O
O
H
395 499 397c
 
Scheme  3.71 
Isatoic anhydride (2 g, 0.012 mol) and the glycine ethyl ester HCl (1.71g, 1 eq.) in anhydrous 
pyridine (10 ml) were heated at reflux for 16 h. The cooled reaction mixture was poured on to 
iced water (200 ml) and the precipitate collected as a cream powder (1.67 g, 79%). 
IR υmax (cm-1) 3178 (NH) 1701, 1670 cm-1 (2x C=O) 
1H NMR δ (400 MHz) (DMSO-d6) 10.37 (1H, s, NH), 8.55 (1H, t, J= 5.8 Hz, NH), 7.74 
(1H, dd, J= 7.7 and 1.6 Hz, ArH), 7.52 (1H, dt, J= 7.2 and 1.6 Hz, ArH), 7.22 (1H, dt, J= 7.7 
and 1.2 Hz, ArH), 7.11 (1H, dd, J= 8.2 and 0.9 Hz, ArH), 3.56 (2H, d, J= 5.8 Hz, CHH).  
13C NMR δ (100 MHz) (DMSO-d6) 171.61 (C=O), 168.54 (C=O), 137.61 (Ar), 132.72 (Ar), 
131.27 (Ar), 125.98 (Ar), 124.35 (Ar), 121.37 (Ar), 44.92 (CH2).  
Data as reported280. 
 
3.4.1.4.   Synthesis of 3-methyl-3H-1,4-benzodiazepine-2,5(1H,4H)dione 280. 
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Scheme  3.72 
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Isatoic anhydride (2 g, 0.012 mol) and L-alanine methyl ester HCl (1.67g, 1 eq.) in anhydrous 
pyridine (10 ml) were heated at reflux for 16 h. The cooled reaction mixture was poured on to 
iced water (200 ml) and the precipitate collected as white powder (130 mg, 6%). 
IR υmax (cm-1) 3169 (NH) 1705, 1675 cm-1 (2x C=O) 
1H NMR δ (400 MHz) (DMSO-d6) 10.37 (1H, s, NH), 8.4 (1H, d, J= 5.1 Hz, NH), 7.74 (1H, 
d, J= 7.8 Hz, ArH), 7.52 (1H, dt, J= 7.4 and 1.6 Hz, ArH), 7.22 (1H, t, J= 7.7 Hz, ArH), 7.09 
(1H, d, J= 7.8 Hz, ArH), 3.82-3.76 (1H, m, CHCO), 1.23 (3H, d, J= 6.7 Hz, CH3).  
13C NMR δ (100 MHz) (DMSO-d6) 167.96 (C=O), 162.78 (C=O), 135.86 (Ar), 133.21 (Ar),  
131.85 (Ar), 126.46 (Ar), 124.33 (Ar), 121.23 (Ar), 52.51 (CH), 14.26 (CH3).  
Data as reported280. 
 
3.4.1.5.  Synthesis of 3-isobutyl-3H-1,4-benzodiazepine-2,5(1H,4H)dione 280. 
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Scheme  3.73 
Isatoic anhydride (2 g, 0.012 mol) and L-leucine methyl ester HCl (2.18 g, 1 eq.) in 
anhydrous pyridine (10 ml) were heated at reflux for 16 h. The cooled reaction mixture was 
poured on to iced water (200 ml) and the precipitate collected as white powder (1.83 g, 66%). 
IR υmax (cm-1)  3166 (NH) 1681, 1664 cm-1 (2x C=O) 
1H NMR δ (400 MHz) (DMSO-d6) 10.38 (1H, s, NH), 8.45 (1H, d, J= 5.8 Hz, NH), 7.74 
(1H, dd, J= 7.9 and 1.5 Hz, ArH), 7.50 (1H, dt, J= 8.6 and 1.5 Hz, ArH), 7.19 (1H, t, J= 6.9 
Hz, ArH), 7.10 (1H, d, J= 7.9 Hz, ArH), 3.63-3.56 (1H, m, CHCO), 1.75-1.69 (1H, m, CH), 
1.56 (2H, t,  J= 7.1 Hz, CH2), 0.84 (3H, d, J= 6.6 Hz, CH3), 0.76 (3H, d, J= 6.6 Hz, CH3).  
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13C NMR δ (100 MHz) (DMSO-d6) 172.12 (C=O), 168.22 (C=O), 137.20 (Ar), 132.68 (Ar), 
130.83 (Ar), 127.62 (Ar), 124.37 (Ar), 121.35 (Ar), 50.67 (CH), 36.60 (CH), 24.32 (CH2), 
23.29 and 21.99 (2 x CH3).  
Data as reported280. 
 
3.4.1.6.  Synthesis of 3-benzyl-3H-1,4-benzodiazepine-2,5(1H,4H)dione 280. 
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Scheme  3.74 
Isatoic anhydride (2 g, 0.012 mol) and L-phenylalanine ethyl ester HCl (2.75 g, 1 eq.) in 
anhydrous pyridine (10 ml) were heated at reflux for 16 h. The cooled reaction mixture was 
poured on to iced water (200 ml) and the precipitate collected as a cream powder (1.81 g, 
57%). 
IR υmax (cm-1)  3169 (NH) 1680, 1661 cm-1 (2x C=O) 
1H NMR (400 MHz) (DMSO-d6) δ 10.41 (1H, s, NH), 8.50 (1H, d, J= 6.2 Hz, NH), 7.66 
(1H, dd, J= 7.8 and 1.5 Hz, ArH), 7.51 (1H, dt, J= 7.4 and 1.5 Hz, ArH), 7.32-7.16 (6H, m, 
ArH), 7.10 (1H, d, J= 8.1 Hz, ArH), 3.89 (1H, m, J= 7.1 Hz, CHCO), 3.13 (1H, dd, J= 9.2 
and 3.2 Hz, PhCHH), 2.85 (1H, dd, J= 9.2 and 3.3 Hz, PhCHH).  
13C NMR (100 MHz)  (DMSO-d6) δ 171.30 (C=O), 167.70 (C=O), 137.94 (Ar), 136.75 
(Ar), 132.24 (Ar), 130.36 (Ar), 129.35 (Ar), 128.17 (Ar), 126.35 (Ar), 123.98 (Ar), 120.96 
(Ar), 53.87 (CH), 33.29 (CH2).  
The data is identical to the literature280.  
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3.4.1.7.  Synthesis of 2-phenylethyl-1,2,3,4-tetrahydroquinazoline-2-carboxylic acid 
ethyl ester 281. 
NH2
NH2
Ph CO2Et
O
+ HN NH
CO2Et
Ph
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120 oC
400 401
402
 
Scheme  3.75 
 
A solution of 2-aminobenzylamine (1.2 g, 10 mmol) and ethyl 2-oxo-4-phenylbutyrate (1.9 
ml, 10 mmol, 1 eq.) in 50 ml of toluene was heated at reflux for 18 h using a Dean-Stark 
apparatus for removal of water. The solvent was then removed under reduced pressure to give 
the ester crude product as a brown oil (4.20 g), which was used without further processing in 
the next step. 
1H NMR (400 MHz) (CDCl3) δ 7.34-7.20 ( 5H, m, ArH), 7.19 (1H, s, NH), 7.07 (1H, td,  J= 
6.4 and 1.0 Hz, ArH), 6.94 (1H d, J= 7.4 Hz, ArH), 6.74 (1H, td, J= 6.4 and 1.0 Hz, ArH), 
6.63 (1H, d, J= 7.4 Hz, ArH), 4.56 (1H, s, NH), 4.28-4.18 (2H, m, CH2CH3), 4.04 (1H, d, J= 
16.5 Hz, ArCH2NH), 3.99 (1H, d, J= 16.5 Hz, ArCH2NH), 2.87-2.63 (2H, m, CH2), 2.24-2.13 
(2H, m, CH2), 1.31 (3H, t, J= 7.1 Hz, CH2CH3).  
 
13C NMR (100 MHz) (CDCl3) δ 173.34 (C=O), 141.79 (C), 141.03 (C), 128.40 (CH), 
128.27 (CH), 127.41 (CH), 126.12 (CH), 125.34 (CH), 120.31 (CH), 118.52 (CH), 115.66 
(C), 61.91 (C), 42.56 (CH2), 41.03 (CH2), 30.98 (CH2), 29.56 (CH2), 14.33 (CH3).  
As reported in the literature281. 
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3.4.1.8.  Synthesis of 2-phenylethyl-2,3,4,5-terahydrobenzodiazepine-3-one 281. 
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Scheme  3.76 
To a stirred solution of crude tetrahydroquinazoline (4.20 g, 13.5 mmol) in 1,2-DCE (40 ml) 
was added TFA (10 ml) at 0 oC, followed by triethylsilane ( 4 ml, 25 mmol, 1.9 eq.), and the 
reaction mixture was allowed to warm to rt over 2 h. The solvent was then removed under 
reduced pressure and the residue was dissolved in methanol (50 ml). To this stirred solution 
at 0 oC was added 1N NaOH to adjust the pH to 13. After 18 h, the precipitates were 
collected to give the benzodiazepine as a yellow solid (1.4 g, 40 %), m.p. 143-146 oC.   
 
 IR: max (cm-1) 3262, 3014, 2893, 1666, 1600, 1487, 1450. 
1H NMR (400 MHz) (CDCl3) δ 7.34-7.21 (5H, m, ArH), 7.09 (1H, td, J= 7.2 and 1.0 Hz, 
ArH), 6.91 (1H, d, J= 7.2, Hz, ArH), 6.77 (1H, br, NHCO), 6.65 (1H, t,  J= 7.2 Hz, ArH), 
6.54 (1H, d, J= 7.9 Hz, ArH), 4.87 (1H, dd, J= 16.4 and 6.6 Hz, ArCH2NH), 4.36 (1H, t, J= 
6.3 Hz, CHCO), 3.87 (1H, dd, J= 16.4 and 6.6 Hz, ArCH2NH), 3.46 (1H, s, NH), 2.94-2.77 
(2H, m, PhCH2CH2), 2.40-2.31 (1H, m, PhCH2), 1.99-1.90 (1H, m, PhCH2).  
13C NMR (100 MHz) (CDCl3) δ 172.62 (C=O), 145.43 (C), 141.22 (C), 129.26 (CH), 
128.82 (CH), 128.57 (CH), 128.55 (CH), 126.17 (CH), 121.34 (CH), 118.39 (CH), 117.65 
(C), 53.81 (CH), 45.37 (CH2), 32.58 (CH2), 32.23 (CH2).  
MS. (ESI, m/z), 289.1311 (M+Na)+, calculated for C17H18N2ONa, measured 289.1301. 
Consistent with that reported in literature281. 
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3.4.1.9.  Synthesis of 1,2,3,11a-Tetrahydro-10H-picolo[2,1-c][1,4]benzodiazepine-5,11-
dithione and 1,2,3,11a-Tetrahydro-10H-picolo[2,1-c][1,4]benzodiazepine-5-one-11-thione. 
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Scheme  3.77 
To 1,2,3,11a-tetrahydro-10H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11-dione (500 mg, 2.18 
mmol) in dry THF (15 ml) was added δawesson’s reagent (88β mg, 2.18 mmol, 1 eq.) under 
an inert atmosphere and the mixture was stirred at room temperature for 1 h and then at 60 oC 
for 1h. The solvent was removed by rotary evaporation to yield the crude product mixture as 
an orange oil. It was purified by column chromatography (PE 40-60 oC / EtOAc : 3/1, Rf = 
0.24) to yield a yellow solid (250 mg, 50 %) as the monothionated product and a second solid 
(Rf = 0.48, 120 mg, 22 %) as the double thionated product. 
Monothione 
IR: max (cm-1) 3246  (NH), 1636 (C=O), 1599 (C=S). 
1H NMR δ (500 MHz) (DMSO-d6) 12.3 (1H, s, NH), 7.78 (1H, dd, J= 6.6 and 1.6 Hz, ArH), 
7.54 (1H, dt, J= 6.6 and 1.6 Hz, ArH), 7.32 (1H, dt, J= 6.9 and 1.0 Hz, ArH), 7.25 (1H, d, J= 
8.0, ArH), 4.40 (1H, dd, J= 13.2, 3.1 Hz, CH), 4.26 (1H, dd, J= 3.9, 12.7 Hz, NCHH), 2.78 
(1H, td,  J= 12.8 and 3.9, NCHH), 2.15-2.35 (2H, m, CH2), 1.44-1.82 (4H, m, 2 x CH2). 
 
13C NMR δ (125 MHz) 202.18 (C=S), 166.71 (C=O), 136.66 (Ar), 132.32 (Ar), 130.92 
(Ar), 128.64 (Ar), 126.08 (Ar), 121.39 (Ar), 54.72 (CH), 39.08 (CH2), 25.30 (CH2), 23.28 
(CH2), 18.93 (CH2). 
 HRMS. (ESI, m/z), 269.0719 (M+Na)+ 515.2 (2M+Na)+,  calculated for C13H14N2SONa and 
was measured 269.0704. 
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Dithione 
IR: max (cm-1) 3246  (NH), 1599, 1508 cm-1 (2x C=S) 
1H NMR δ (500 MHz) (DMSO-d6) 12.58 (1H, s, NH), 7.78 (1H, dd, J= 6.6 and 1.5 Hz, 
ArH), 7.56 (1H, dt, J= 6.6 and 1.6 Hz, ArH), 7.32 (1H, dt, J= 6.9 and 1.0 Hz, ArH), 7.24 (1H, 
d, J= 8.0, ArH), 5.30 (1H, dd, J= 10.1, 3.1 Hz, CH), 4.56 (1H, dd, J= 3.9, 12.8 Hz, NCHH), 
2.98 (1H, td,  J= 12.9 and 3.9, NCHH), 2.35-2.15 (2H, m, CH2), 1.82-1.44 (4H, m, 2 x CH2).  
13C NMR δ (125 MHz) 199.39 (C=S), 193.89 (C=S), 135.66 (Ar), 133.98 (Ar), 133.25 (Ar), 
132.0 (Ar), 125.88 (Ar), 121.08 (Ar), 60.12 (CH), 47.20 (CH2), 25.25 (CH2), 22.69 (CH2), 
17.95 (CH2). 
 MS. (ESI, m/z), 285.04626 (M+Na)+, measured for C13H14N2S2ONa while calculated was 
285.0451. 
3.4.1.10. Synthesis of 1,2,3,10,11,11a-hexahydro-5H-thiazolo[4,3-c][1,4]benzodiazepine-5-
one-11-thione. 
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Scheme  3.78 
To 1,2,3,10,11,11a-hexahydro-5H-thiazolo[4,3-c][1,4]benzodiazepine-5,11-dione (1 g, 4.26 
mmol) in dry THF (15 ml) was added δawesson’s reagent (β.067 g, 4.β6 mmol, 1.β eq.) 
under an inert atmosphere and the mixture was stirred at room temperature for 1 h and then at 
60 oC for 1h. The solvent was removed by rotary evaporation to yield the crude product as an 
orange oil. It was purified by column chromatography (PE 40-60 oC / EtOAc : 3/1, Rf = 0.24) 
to yield a yellow solid ( 780 mg, 69 %). 
IR: max (cm-1) 3430 (NH) 1701 (C=O), 1592 (C=S), 1500, 1470. 
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1H NMR (400 MHz) (DMSO-d6) δ 12.68 (1H, s, NH), 7.70 (1H, dd, J= 8.5 and 1.5 Hz, 
ArH), 7.48 (1H, td, J= 8.5 and 1.5 Hz, ArH), 7.29 (1H, td, J= 8.5 and 1.1 Hz, ArH), 7.08 (1H, 
d, J= 8.0 Hz, ArH), 4.90 (1H, d, J = 10.6 Hz, NCHH), 4.76 (1H, d, J = 10.6 Hz, NCHH), 4.34 
(1H, dd, J= 3.2 and 6.8 Hz, CHCO), 3.83 (1H, dd, J= 12.4 and 3.2 Hz, SCHH), 3.24 (1H, dd, 
J= 12.4 and 6.8 Hz, SCHH). 
 
13C NMR (100 MHz) (DMSO-d6) δ 200.42 (C=S), 164.48 (C=O), 136.81 (Ar), 133.30 (Ar), 
130.98 (Ar), 127.18 (Ar), 126.37 (Ar), 122.28 (Ar), 61.38 (CH2), 49.9 (CH2), 34.48 (CH2). 
 MS. (ESI, m/z), 273.012675 (M+Na)+  calculated for C11H10N2S2ONa and measured 
273.012717. 
 
3.4.1.11.  Synthesis of P2S5-Pyr. Complex 173. 
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Scheme  3.79 
 
Tetraphosphorus decasulfide (P4S10, 4.45g, 10 mmol) was added in portions to dry pyridine 
(56 ml) at 80 oC with stirring. After a period of reflux of 1h a clear yellow solution was 
obtained, which deposited light yellow crystals when the solution was allowed to cool. After 
2 h the crystals were collected, and washed with dry acetonitrile: yield (3.4 g, 45 %); m.p. 
167-169 oC 173.  
IR: max (cm-1) 3088, 3044, 1608, 1451, 1197, 1044, 723, 668 cm-1, as reported in 
literature173. 
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3.4.1.12.  Synthesis of 3H-1,4-benzodiazepine-2,5(1H,4H)dithione 173. 
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Scheme  3.80 
 
By using P2S5-pyr. complex (synthesis of dithione). 
To 3H-1,4-benzodiazepine-2,5(1H,4H)dione (500 mg, 2.84 mmol) in dry pyridine (10 ml) 
was added P2S5-Pyr. complex (544 mg, 1.42 mmol, 0.5 eq.) under an inert atmosphere and 
the mixture was heated at reflux for 2 h. The solvent was removed by rotary evaporation and 
water (15 ml) was added to the mixture. A solid was quickly formed which was filtered, and 
washed with water to yield the pure dithionated product as yellow powder (460 mg, 78 %).  
 
By using Lawesson’s reagent (synthesis of monothione). 
To 3H-1,4-benzodiazepine-2,5(1H,4H)dione (250 mg, 1.42 mmol) in dry THF (10 ml) was 
added δawesson’s reagent (β7β mg, 1.4β mmol, 1 eq.) under an inert atmosphere and the 
mixture was stirred at room temperature for 1 h and then at 60 oC for 1h. The solvent was 
removed by rotary evaporation to yield the crude product as orange oil. It was purified by 
column chromatography (PE 40-60 oC / EtOAc : 5/1, Rf = 0.24) to yield a yellow solid ( 180 
mg, 66 % ) as a monothione. 
Monothione 
IR: max (cm-1) 3178 (NH), 1670 (C=O), 1536 (C=S), 1474, 1449, 1409. 
1H NMR (400 MHz) (DMSO-d6) δ 12.38 (1H, s, NH), 8.83 (1H, t, J= 4.6 Hz, NH), 7.80 
(1H, dd, J= 5.2 and 1.1 Hz, ArH), ), 7.57 (1H, dt, J= 5.4 and 1.2 Hz, ArH), 7.34 (1H, dt, J= 
5.6 and 1.0 Hz, ArH), 7.25 (1H, d, J= 6.3 Hz, ArH), 3.96 (2H, d, J= 4.6 Hz, CH2).  
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13C NMR (100 MHz)  (DMSO-d6) δ 201.27 (C=S), 167.29 (C=O), 137.04 (Ar), 133.08 (Ar), 
130.85 (Ar), 126.72 (Ar), 125.67 (Ar), 121.26 (Ar), 51.58 (CH2). 
 Dithione 
IR: max (cm-1) 3178 (NH) 1591, 1547 (2x C=S), 1467, 1392. 
1H NMR (400 MHz) (DMSO-d6) δ 12.51 (1H, s, NH), 11.14 (1H, t, J= 5.6 Hz, NH), 8.08 
(1H, dd, J= 6.7 and 1.3 Hz, ArH), 7.55 (1H, dt, J= 6.8 and 1.5 Hz, ArH), 7.21 (1H, t, J= 7.2 
Hz, ArH), 7.18 (1H, d, J= 8.0 Hz, ArH), 3.58 (2H, d, J= 5.8 Hz, CH2).  
 
13C NMR (100 MHz) (DMSO-d6) δ 199.73 (C=S), 196.11 (C=S), 135.18 (Ar), 133.59 (Ar), 
132.73 (Ar), 126.04 (Ar), 124.41 (Ar), 121.77 (Ar), 56.25 (CH2). 
"The assigned structure is consistent with the available data. It was not possible to obtain full 
data for this compound meaning that this assignment remains tentative". 
 3.4.1.13.  Synthesis of 3-methyl-3H-1,4-benzodiazepine-2,5(1H,4H)dithione 173. 
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Scheme  3.81 
To 3-methyl-3H-1,4-benzodiazepine-2,5(1H,4H)dione (130 mg, 0.684 mmol) in dry pyridine 
(7 ml) was added P2S5-Pyr. complex (157 mg, 0.342 mmol, 0.5 eq.) under an inert 
atmosphere and the mixture was heated at reflux for 2 h. The solvent was removed by rotary 
evaporation and water (15 ml) was added to the mixture. A solid was quickly formed which 
was filtered, and washed with water to yield the pure product as a yellow powder (40 mg, 27 
%).  
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1H NMR (400 MHz) (DMSO-d6) δ 10.82 (1H, s, NH), 9.8 (1H, d, J= 5.3 Hz, NH), 7.76 (1H, 
d, J= 7.4 Hz, ArH), 7.56 (1H, dt, J= 7.2 and 1.6 Hz, ArH), 7.26 (1H, t, J= 7.4 Hz, ArH), 7.04 
(1H, d, J= 7.6 Hz, ArH), 3.77-3.72 (1H, m, CH), 1.24 (3H, d, J= 6.8 Hz, CH3). 
13C NMR (100 MHz) (DMSO-d6) δ 198.73 (C=S), 194.43 (C=S), 136.56 (Ar), 133.92 (Ar), 
132.17 (Ar), 126.88 (Ar), 124.74 (Ar), 121.56 (Ar), 54.36 (CH), 14.56 (CH3). 
"The assigned structure is consistent with the available data. It was not possible to obtain full 
data for this compound meaning that this assignment remains tentative". 
 
 3.4.1.14.  Synthesis of 3-isobutyl-3H-1,4-benzodiazepine-2,5(1H,4H)dithione 
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Scheme  3.82 
To 3-isobutyl-3H-1,4-benzodiazepine-2,5(1H,4H)dione (460 mg, 1.98 mmol) in dry THF (15 
ml) was added δawesson’s reagent (802 mg, 1.98 mmol, 1 eq.) under an inert atmosphere and 
the mixture was stirred at room temperature for 1 h and then at reflux for 1 h. The solvent 
was removed by rotary evaporation and the mixture was purified by column chromatography 
(PE 40-60 oC / EtOAc : 5/1, Rf = 0.24) to yield the pure products as light yellow crystals (330 
mg, 58 %, dithione) and 64 mg (13 % monothione).  
Dithione 
IR: max (cm-1)  3166 (NH) 1582, 1550 (2x C=S) 
1H NMR (400 MHz) (DMSO-d6) δ 12.57 (1H, s, NH), 10.95 (1H, d, J= 6.0 Hz, NH), 8.11 
(1H, d, J= 7.8 Hz, ArH), 7.59 (1H, t, J= 7.5 Hz, ArH), 7.36 (1H, t, J= 7.5 Hz, ArH), 7.25 
(1H, d, J= 8.0 Hz, ArH), 4.55 (1H, d, J= 7.6 Hz, CH), 2.02 (1H, m, CH), 1.81-1.73 (2H, d,  
J= 6.5 Hz, CH2), 0.92 (3H, d, J= 4.8 Hz, CH3), 0.78 (3H, d, J= 5.0 Hz, CH3). 
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13C NMR (100 MHz) (DMSO-d6) δ 201.78 (C=S), 195.31 (C=S), 134.63 (Ar), 133.56 (Ar), 
132.70 (Ar), 132.45 (Ar), 126.14 (Ar), 121.83 (Ar), 58.60 (CH), 55.65 (CH), 24.49 (CH2), 
23.36 and 21.87 (2x CH3). 
 HRMS. (ESI, m/z), 287.0647 (M+Na)+, calculated for C13H16N2S2Na , measured 287.06506. 
Monothione 
IR: max (cm-1) 3166 (NH) 1681 (C=O), 1551 (C=S) 
1H NMR (400 MHz) (DMSO-d6) δ 12.39 (1H, s, NH), 8.46 (1H, d, J= 5.7 Hz, NH), 7.74 
(1H, dd, J= 6.3 and 1.4 Hz), 7.51 (1H, td, J= 7.3 and 1.6 Hz), 7.21 (1H, t, J= 7.6 Hz), 7.10 
(1H, d, J= 8.1 Hz), 3.64-3.55 (1H, m), 1.74-1.67 (1H, m), 1.56 (2H, t,  J= 7.1 Hz), 0.85 (3H, 
d, J= 6.6 Hz), 0.76 (3H, d, J= 6.6 Hz).  
13C NMR (100 MHz) (DMSO-d6) δ 204.19 (C=S), 168.22 (C=O), 137.20 (Ar), 132.69 (Ar), 
130.83 (Ar), 126.72 (Ar), 124.38 (Ar), 121.35 (Ar), 50.63 (CH), 36.60 (CH), 24.31 (CH2), 
23.31 and 21.89 (2x CH3). 
"The assigned structure is consistent with the available data. It was not possible to obtain full 
data for this compound meaning that this assignment remains tentative". 
 3.4.1.15. Synthesis of 3-benzyl-3H-1,4-benzodiazepine-2,5(1H,4H)dithione 
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Scheme  3.83 
To 3-benzyl-3H-1,4-benzodiazepine-2,5(1H,4H)dione (160 mg, 0.60 mmol) in dry THF (10 
ml) was added δawesson’s reagent (β4γ mg, 0.60 mmol, 1 eq.) under an inert atmosphere and 
the mixture was stirred at room temperature for 1 h and then at 60 oC for 1h. The solvent was 
removed by rotary evaporation to yield the crude product as an orange oil. It was purified by 
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column chromatography (PE 40-60 oC / EtOAc : 5/1, Rf = 0.24) to yield a yellow solid ( 174 
mg, 97 % ).  
IR: max (cm-1) 3169 (NH) 1582, 1520 cm-1 (2x C=S), 1462, 1392. 
 
1H NMR (500 MHz) (CDCl3) δ 10.72 (1H, s, NH), 9.22 (1H, d, J= 7.0 Hz, NH), 7.67 (2H, 
dd, J= 6.4 and 1.4 Hz, ArH), 7.51 (2H, dt, J= 6.5 and 1.5 Hz, ArH), 7.32 (2H, d, J= 7.3 Hz, 
ArH), 7.22-7.17 (2H, m, ArH), 7.10 (1H, d, J= 7.7 Hz, ArH), 3.93-3.85 (1H, m, CH), 3.14 
(1H, dd, J= 9.3 and 5.0 Hz, PhCHH), 2.86 (1H, dd, J= 9.3 and 4.9 Hz, PhCHH). 
 
13C NMR (125 MHz) (CDCl3) δ 200.01 (C=S), 196.13 (C=S), 136.06 (Ar), 133.50 (Ar), 
132.98 (Ar), 129.25 (Ar), 129.11 (Ar), 127.90 (Ar), 127.43 (Ar), 127.09 (Ar), 126.50 (Ar), 
120.84 (Ar), 60.39 (CH), 36.96 (CH2). 
"The assigned structure is consistent with the available data. It was not possible to obtain full 
data for this compound meaning that this assignment remains tentative". 
3.4.1.16.  Synthesis of 2-phenylethyl-2,3,4,5-terahydrobenzodiazepine-3-thione 
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Scheme  3.84 
To 2-phenylethyl-2,3,4,5-tetrahydrobenzodiazepine-3-one (500 mg, 1.87 mmol) in dry THF  
(15 ml) was added δawesson’s reagent (γ78 mg, 0.9γ5 mmol, 0.5 eq.) under an inert 
atmosphere and the mixture was stirred for 1h at room temperature and then heated at 60 oC 
for 1 h. The solvent was removed by rotary evaporation and the crude mixture was purified 
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by column chromatography (PE/EA 3:1 ) to yield the pure product as light yellow crystals 
(350 mg, 93 %).  
IR: max (cm-1) 3264, 3022, 1601 (C=S), 1533, 1480, 1449. 
1H NMR (400 MHz) (CDCl3), δ 9.06 (1H, t, J= 5.5 Hz, NHCS), 7.20-7.08 (5H, m, ArH), 
6.93 (1H, td, J= 6.3 and 1.2 Hz, ArH), 6.71 (1H, d, J= 7.4 Hz, ArH), 6.52 (1H, t,  J= 7.1 Hz, 
ArH), 6.40 (1H, d, J= 8.1 Hz, ArH), 4.93 (1H, dd, J= 16.1 and 5.8 Hz, ArCH2NH), 4.39 (1H, 
t, J= 6.3 Hz, NHCH), 3.72 (1H, dd, J= 16.1 and 7.0 Hz, ArCH2NH), 3.66 (1H, d, J= 5.5 Hz, 
ArNHCH), 2.81-2.67 (2H, m, CH2), 2.42-2.33 (1H, m, CH2), 1.99-1.90 (1H, m, CH2). 
 
13C NMR (100 MHz) (CDCl3), δ 203.43 (C=S), 144.49 (C), 140.63 (C), 128.83 (CH), 
128.41 (CH), 127.83 (CH), 127.71 (CH), 125.49 (CH), 118.37 (CH), 117.78 (CH), 117.36 
(C), 55.40 (CH), 47.62 (CH2), 34.81 (CH2), 31.77 (CH2). 
 HRMS. (ESI, m/z), 305.1083 calculated for C17H18N2S1Na (M+Na)+, found 305.1082. 
 
3.4.1.17. Alkylation of 1,2,3,11a-Tetrahydro-10H-picolo[2,1-c][1,4]benzodiazepine-5-one-
11-thione 
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Scheme  3.85 
 
To a solution of 1,2,3,11a-tetrahydro-10H-pyrrolo[2,1-c] [1,4]benzodiazepine-5-one-11-
thione (200 mg, 0.8 mmol) in anhydrous dichloromethane (10 ml) was added 
trimethyloxonium tetrafluoroborate (118 mg, 1 eq.) and the reaction mixture was heated at 
reflux for 2 h. The reaction mixture was then added to an ice cooled 10 % aqueous solution of 
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potassium carbonate and filtered through celite. The organic phase was separated and the 
aqueous phase was extracted with DCM (3 x 10 ml) and combined organic phases were 
evaporated in vacuo. The product was purified by column chromatography using petroleum 
ether/ethyl acetate (2:1, Rf = 0.54) to yield product 110 mg, 56 %, as a yellow oil. 
IR: max (cm-1) 2901, 1631 (C=O), 1573 (C=N), 1488. 1397. 
1H NMR δ (500 MHz) (CDCl3) 7.86 (1H, dd, J= 7.8 and 1.5 Hz, ArH), 7.40 (1H, dt, J= 8.0 
and 1.5 Hz, ArH), 7.17 (1H, dt, J= 7.8 and 1.0 Hz, ArH), 7.14 (1H, dd, J= 8.0 and 1.0 Hz, 
ArH), 4.50 (1H, m, CH), 4.08 (1H, dd, J= 4.4, 7.1 Hz, CH2), 2.89 (1H, td,  J= 12.8 and 4.4, 
CH2), 2.42 (3H, s, SCH3), 2.29-2.15 (2H, m, CH2), 1.95-1.89 (1H, m, CH2), 1.83-1.73 (1H, 
m, CH2), 1.67-1.56 (2H, m, CH2). 
 
13C NMR δ (125 MHz) 170.28 (C=O), 167.99 (C=N), 145.52 (Ar), 131.34 (Ar), 130.18 
(Ar), 127.16 (Ar), 125.76 (Ar), 124.94 (Ar), 52.58 (CH), 39.10 (CH2), 23.01 (CH2), 23.00 
(CH2), 19.71 (CH2), 13.03 (CH3). 
 MS. (ESI, m/z), 283.1 (M+Na)+, 543.2 (2M+Na)+,  calculated for C14H16N2O1S1Na. 
"The assigned structure is consistent with the available data. It was not possible to obtain full 
data for this compound meaning that this assignment remains tentative". 
3.4.1.18.  Alkylation of 1,2,3,10,11,11a-hexahydro-5H-thiazolo[4,3-c][1,4]benzodiazepine-
5-one-11-thione 
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Scheme  3.86 
To a solution of 1,2,3,10,11,11a-hexahydro-5H-thiazolo[4,3-c] [1,4]benzodiazepine-5-one-
11-thione (100 mg, 0.4 mmol) in anhydrous dichloromethane (10 ml) was added 
trimethyloxonium tetrafluoroborate (91 mg, 1.5 eq.) and the reaction mixture was heated at 
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reflux for 2 h. The reaction mixture was then added to an ice cooled 10 % aqueous solution of 
potassium carbonate and filtered through celite. The organic phase was separated and the 
aqueous phase was extracted with DCM (3 x 10 ml) and the combined organic phases were 
evaporated in vacuo. The product was purified by column chromatography using petroleum 
ether/ethyl acetate 2:1 Rf = 0.40 to yield product 54 mg, 50 %, as a yellow oil. 
IR: max (cm-1) 2943, 1689 (C=N), 1636 (C=O), 1480, 1399. 
1H NMR (400 MHz) (CDCl3) δ 7.99 (1H, dd, J= 8.3 and 1.6 Hz, ArH), 7.52 (1H, td, J= 7.9 
and 1.6 Hz, ArH), 7.28-7.25 (2H, m, ArH), 4.86 (1H, d, J= 10.5 Hz, NCHH), 4.76 (1H, d, J= 
10.5 Hz, NCHH), 4.34 (1H, dd, J= 3.7 and 7.1 Hz, CHCH2), 3.73 (1H, dd, J= 12.9 and 3.7 
Hz, SCHH), 3.39 (1H, dd, J= 7.1 and 12.9 Hz, SCHH), 2.52 (3H, s, SCH3).  
13C NMR (100 MHz) (CDCl3) δ 167.70 (C=O), 165.10 (C=N), 145.70 (Ar), 132.11 (Ar), 
130.31 (Ar), 126.81 (Ar), 125.61 (Ar), 125.26 (Ar), 58.74 (CH), 49.94 (CH2), 32.28 (CH2), 
13.47 (CH3).  
"The assigned structure is consistent with the available data. It was not possible to obtain full 
data for this compound meaning that this assignment remains tentative". 
 
3.4.1.19. Synthesis of 3-isopropyl-2,5-bis(methylthio)-[1,4]-benzodiazepine. 
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Scheme  3.87 
To a solution of 3-isobutyl-3H-1,4-benzodiazepine-2,5(1H,4H)dithione (250 mg, 0.95 mmol) 
in anhydrous dichloromethane (10 ml) was added trimethyloxonium tetrafluoroborate (280 
mg, 1.89 mmol, 2 eq.) and the reaction mixture was heated at reflux for 2 h. The reaction 
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mixture was then added to an ice cooled 10 % aqueous solution of potassium carbonate and 
filtered through celite. The organic phase was separated and the aqueous phase was extracted 
with DCM (3 x 10 ml) and the combined organic phases were evaporated in vacuo. The 
product was purified by column chromatography using petroleum ether/ethyl acetate 3:1 to 
yield double alkylated product (Rf = 0.48, 192 mg, 69 %) as a yellow oil. 
1H NMR (400 MHz) (CDCl3) δ 7.81 (1H, d, J= 7.8 Hz, ArH), 7.47 (1H, t, J= 7.5 Hz, ArH), 
7.20 (1H, t, J= 7.0 Hz, ArH), 7.06 (1H, d, J= 8.0 Hz, ArH), 3.62 (1H, dd, J= 5.5 and 4.4 Hz, 
CH), 2.48 (3H, s, CH3), 2.43 (3H, s, CH3), 2.16 (1H, t, J= 9.0 Hz, CH), 1.93-1.82 (2H, m, 
CH2), 0.96 (3H, d, J= 5.9 Hz, CH3), 0.80 (3H, d, J= 5.9 Hz, CH3).  
13C NMR (100 MHz) (CDCl3) δ 169.63 (C=N), 166.49 (C=N), 136.13 (Ar), 131.92 (Ar), 
128.52 (Ar), 127.94 (Ar), 124.28 (Ar), 120.88 (Ar), 61.00 (CH), 39.62 (CH), 24.44 (CH2), 
23.55 (CH3), 21.88 (CH3), 14.27 (CH3), 13.44 (CH3).  
"The assigned structure is consistent with the available data. It was not possible to obtain full 
data for this compound meaning that this assignment remains tentative". 
 
3.4.1.20. Synthesis of 3-benzyl-2,5-bis(methylthio)-3H-[1,4]-benzodiazepine. 
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Scheme  3.88 
To a solution of 3-benzyl-3H-1,4-benzodiazepine-2,5(1H,4H)dithione (180 mg, 0.6 mmol) in 
anhydrous dichloromethane (10 ml) was added trimethyloxonium tetrafluoroborate (179 mg, 
1.20 mmol, 2 eq.) and the reaction mixture was heated at reflux for 2 h. The reaction mixture 
was then added to an ice cooled 10 % aqueous solution of potassium carbonate and filtered 
through celite. The organic phase was separated and the aqueous phase was extracted with 
DCM (3 x 10 ml) and the combined organic phases were evaporated in vacuo. The product 
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was purified by column chromatography using petroleum ether/ethyl acetate (3:1 Rf = 0.46) 
to yield the product (182 mg, 93 %) as a yellow oil. 
IR: max (cm-1) 2886, 1579 (2x C=N), 1205, 1127. 
1H NMR (400 MHz) (CDCl3) δ 7.80 (1H, d, J= 7.8 Hz, ArH), 7.48 (1H, td, J= 8.3 and 1.4 
Hz, ArH), 7.34-7.22 (6H, m, ArH), 7.15 (1H, td, J= 8.2 and 1.1 Hz, ArH), 3.68 (2H, m, CH2), 
3.46 (1H, d, J= 10.17 Hz, CH), 2.49 (3H, s, SCH3), 2.44 (3H, s, SCH3).  
13C NMR (100 MHz)  (CDCl3) δ 168.63 (C=N), 166.22 (C=N), 146.78 (C), 138.78 (C), 
130.92 (CH-Ar), 129.86 (CH-Ar), 128.17 (CH-Ar), 128.08 (CH-Ar), 127.46 (CH-Ar), 126.62 
(CH-Ar), 126.32 (CH-Ar), 123.83 (C), 64.98 (CH), 37.95 (CH2), 14.47 (CH3), 13.40 (CH3).  
MS. (ESI, m/z), 327.1 (M+H)+  calculated for C18H19N2S2. 
 
3.4.1.21. Synthesis of 3-methylthio-1-methyl-2-phenylethyl-4-dihydro-[1,4]-
benzodiazepine. 
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                                                                      Scheme  3.89 
To a solution of 2-phenylethyl-2,3,4,5-tetrahydrobenzodiazepine-3-thione (350 mg, 1.24 
mmol) in anhydrous dichloromethane (10 ml) was added trimethyloxonium tetrafluoroborate 
(239 mg, 1.3 eq.) and the reaction mixture was heated at reflux for 2 h. The reaction mixture 
was then added to an ice cooled 10 % aqueous solution of potassium carbonate and filtered 
through celite. The organic phase was separated and the aqueous phase was extracted with 
DCM (3 x 10 ml) and the combined organic phases were evaporated in vacuo. The product 
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was purified by column chromatography using petroleum ether/ethyl acetate (3:1 Rf = 0.51) 
to yield the product (220 mg, 60 %) as a yellow oil. 
1H NMR (400 MHz) (CDCl3), δ 7.21-7.12 (5H, m), 7.02 (1H, t, J= 7.2 Hz, ArH),  6.90 (1H, 
d, J= 8.0 Hz, ArH), 6.83 (1H, t, J= 7.3 Hz, ArH), 4.86 (1H, d, J= 15.1 Hz, ArCHHN), 4.80 
(1H, d, J= 15.0 Hz, ArCHHN), 3.84 (1H, t, J= 5.9 Hz, NCHCH2), 2.81 (3H, s, NCH3), 2.62-
2.53 (1H, m, PhCHH), 2.43-2.35 (1H, m, PhCHH), 2.21 (3H, s, SCH3), 2.04-1.85 (2H, m, 
CH2).  
13C NMR (100 MHz) (CDCl3), δ 166.99 (C=N), 148.68 (C-Ar), 140.90 (C-Ar), 130.69 (CH-
Ar), 128.61 (CH-Ar), 127.74 (CH-Ar), 127.42 (CH-Ar), 126.83 (CH-Ar), 125.20 (CH-Ar), 
120.96 (CH-Ar), 117.38 (C-Ar), 66.45 (CH), 55.21 (NCH3), 39.70 (CH2), 33.30 (CH2), 31.29 
(CH2), 12.16 (SCH3).  
"The assigned structure is consistent with the available data. It was not possible to obtain full 
data for this compound meaning that this assignment remains tentative". 
3.4.2.  Reactivity of benzodiazepines. 
3.4.2.1.  Reactivity of benzodiazepines with cyclopropenones. 
3.4.2.1.1. Reactivity of 1,2,3,10,11,11a-hexahydro-5H-thiazolo[4,3-c][1,4]benzodiazepine-
11-methylthio-5-one with diphenyl cyclopropenone. 
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                                                            Scheme  3.90 
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To the mixture of 1,2,3,10,11,11a-hexahydro-5H-thiazolo[4,3-c] [1,4]benzodiazepine-11-
methylthio-5-one (100 mg, 0.37 mmol) dry toluene (10 ml) was added 
diphenylcyclopropenone (DPP) (78 mg, 1 eq.) under a nitrogen atmosphere and the mixture 
was strirred at room temperature for 24 h. The solvent was evaporated in vacuo and the 
mixture was purified by silica gel chromatography using PE 40-60 oC / EtOAc :  4/1, Rf = 
0.21 to give 1,2,3,10,11,11a-hexahydro-5H-thiazolo[4,3-c] [1,4]benzodiazepine-5-one-11-
thione as a yellow oil (32 mg, 26 %) . 
Data as given above for the same compound. 
 
3.4.2.1.2. Reactivity of 3-benzyl-2,5-bis(methylthio)-[1,4]-benzodiazepine with 
diphenylcyclopropenone. 
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                                                            Scheme  3.91 
To 3-benzyl-2,5-bis(methylthio)-[1,4] -benzodiazepine (80 mg, 0.24 mmol) in dry acetonitrile 
(10 ml) was added diphenylcyclopropenone (DPP) (101 mg, 2 eq.) under a nitrogen 
atmosphere and the mixture was stirred at room temperature for 24 h and then at reflux for 24 
h. The solvent was evaporated in vacuo and the mixture was purified by silica gel 
chromatography using PE 40-60 oC / EtOAc :  4/1, Rf = 0.23 to give 3-benzyl-3H-1,4-
benzodiazepine-2-methylthio-5-thione as yellow oil (21 mg, 27 %). 
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3.4.2.1.3. Reactivity of 3-methylthio-2-phenylethyl-2,4-dihydro-1H-benzo-[e][1,4]-
benzodiazepine with cyclopropenone. 
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                                                              Scheme  3.92 
To a solution of 3-methylthio-2-phenylethyl-2,4-dihydro-[1,4] -benzodiazepine (70 mg, 0.23 
mmol) in dry acetonitrile (10 ml) was added cyclopropenone  (13 mg, 1 eq.) under a nitrogen 
atmosphere and the mixture was strirred at room temperature for 24 h. The reaction was 
monitored by TLC, but no product could be identified. Diphenylcyclopropenone was 
similarly unreactive. 
3.4.2.2. Reactivity of benzodiazepines with nitrile oxides 
3.4.2.2.1. Reactivity of 3-methylthio-2-phenylethyl-2,4-dihydro-[1,4]-benzodiazepine with 
p-methoxy benzohydroximoyl chloride. 
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                                                           Scheme  3.93 
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To a solution of 3-methylthio-2-phenylethyl-2,4-dihydro-[1,4] -benzodiazepine (70 mg, 0.23 
mmol) and 4-methoxybenzohydroximoylchloride (1 eq. 43.5 mg) in dry diethyl ether (5 ml) 
was added triethylamine (1 eq. 23 mg, 33 µl) diluted in dry diethyl ether (25 ml) dropwise 
over 6-7 h at room temperature. The mixture was stirred overnight and the precipitates were 
filtered. After removing the solvent in vacuo the mixture was purified by column 
chromatography (PE 40-60 oC / EtOAc) to give the dimer of 4-methoxyphenyl nitrile oxide 
as the only product. 
 
3.4.2.2.2. Reactivity of benzyl-2,5-dimethylthio-3H-1,4-benzodiazepine with p-methoxy 
benzohydroximoyl chloride. 
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                                                       Scheme  3.94 
 
To a mixture of benzyl-2,5-dimethylthio-3H-[1,4] -benzodiazepine (80 mg, 0.24 mmol) and 4-
methoxybenzohydroximoylchloride (2 eq. 88.8 mg) in dry diethyl ether (5 ml) was added 
triethylamine (2 eq. 48 mg, 67.3 µl) diluted in dry diethyl ether (25 ml) dropwise over 6-7 h 
at room temperature. The mixture was stirred overnight and the precipitates were filtered. 
After removing the solvent in vacuo the mixture was purified by column chromatography (PE 
40-60 oC / EtOAc) to give the dimer of 4-methoxyphenyl nitrile oxide as the only product. 
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3.5.  Multicomponent reactions : Reactivity of 2-azidobenzaldehyde.  
 
3.5.1.  Synthesis of 3-(2-hydroxyphenyl)-3-oxopropanenitrile314. 
CH3
O
OH OH
O
N
OH
NO
O
OH
CN
DMF-DMA
1 h
NH2OH.HCl
EtOH , 2 h
NaOH , EtOH/H2O
rt , 24 h
473 474 475
476       
                                                            Scheme  3.95 
A mixture of 2-hydroxyacetophenone (5 g, 36.7 mmol, 4.42 ml) and dimethylformamide 
dimethylacetal (DMF-DMA) (4.92 ml, 1 eq.) was heated at reflux for 1 h. On cooling down 
the precipitates were filtered and dissolved in EtOH and hydroxylamine hydrochloride was 
added. The mixture was heated at reflux for 2 h and on cooling down the solvent was 
evaporated under vacuum. A solution of sodium hydroxide in EtOH/H2O (1:3) was added to 
the mixture and stirred for 24 h at room temperature. The reaction was monitored by TLC 
and on completion the mixture was purified with column chromatography (PE/EtOAc : 5/1, 
Rf = 0.32) to give the product as a yellow oil, 295 mg.  
1H NMR (400 MHz) (CDCl3) δ 11.34 (1H, s, OH), 7.59-7.54 (2H, m, ArH x 2), 7.04 (1H, 
dd, J= 7.8 and 1.0 Hz, ArH), 6.96 (1H, td, J= 6.9 and 1.1 Hz, ArH), 4.16 (2H, s, CH2). 
 
13C NMR (100 MHz) (CDCl3) δ 192.56 (C=O), 162.67 (C), 138.13 (CH), 129.43 (CH), 
119.81 (CH), 119.25 (CH), 117.59 (C), 113.24 (CN), 29.47 (CH2). 
The data is identical to literature314. 
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3.5.2. Synthesis of 2-(2-azidophenyl)-4-oxochroman-3-carbonitrile314. 
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                                                    Scheme  3.96 
To a mixture of 3-(2-hydroxyphenyl)-3-oxopropanenitrile (150 mg, 0.93 mmol) and 2-
azidobenzaldehyde (1 eq. 136 mg) in EtOH, one drop of piperidine was added and the 
mixture was stirred for 30 min. monitoring the reaction with TLC. The solvent was distilled 
off and the residue was purified with column chromatography by using pet. ether-ethyl 
acetate (10:1, Rf = 0.42) to get the product as a yellow coloured oil, 72 mg, 27 % as a 
mixture of diastereoisomers. 
IR: max (cm-1) 2922, 2243 (CN), 2123 (N3), 1700 (C=O), 1640, 1489, 1462, 1297, 1220, 
1150, 1113, 1042, 974. 
1H NMR (400 MHz) (CDCl3) δ  7.99 (1H, d, J= 8.4 Hz, ArH), 7.94 (1H, d, J= 7.9 Hz, ArH), 
7.65-7.48 (6H, m, ArH), 7.37-7.24 (6H, m, ArH), 7.17 (1H, d, J= 7.9 Hz, ArH), 7.05 (1H, d, 
J= 8.4 Hz, ArH), 5.86 (diastereo, 1H, d, J= 12.2 Hz, CH), 5.75 (diastereo, 1H, d, J= 2.5 Hz, 
CH), 4.42 (diastereo, 1H, d, J= 12.2 Hz, CH), 3.99 (diastereo, 1H, d, J= 2.5 Hz, CH). 
13C NMR (100 MHz) (CDCl3) δ 182.62 (C=O), 182.17 (C=O), 161.13 (C-Ar), 160.89 (C-
Ar), 137.66 (C-Ar),137.48 (C-Ar), 131.50 (CH-Ar), 130.60 (CH-Ar),  128.68 (CH-Ar), 
128.43 (CH-Ar), 128.03 (CH-Ar), 127.90 (CH-Ar), 125.99 (CH-Ar), 125.84 (CH-Ar), 125.61 
(CH-Ar), 125.46 (CH-Ar), 123.06 (CH-Ar), 122.90 (CH-Ar), 119.02 (C-Ar), 118.51 (C-
Ar),118.23 (C-Ar), 117.91 (C-Ar),112.91 (CN), 112.69 (CN), 76.05 (CH), 74.57 (CH), 45.86 
(CH), 43.37 (CH). 
HRMS. (ESI, m/z), 313.069597 (M+Na)+  calculated for C16H10N4O2Na, measured 
313.069329. 
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3.5.3.  Reactivity of 2-(2-azidophenyl)-4-oxochroman-3-carbonitrile. 
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                                                        Scheme  3.97 
A solution of 2-(2-azidophenyl)-4-oxochroman-3-carbonitrile (70 mg, 0.24 mmol) in dry 
toluene (10 ml) was heated at reflux overnight. The reaction was monitored by TLC and on 
completion, the solvent was distilled off in vacuo and the mixture was purified by using 
column chromatography with pet. ether-ethyl acetate (5:1, Rf = 0.23) as eluent to give a 
yellow solid as the single product, 45 mg, 65 %, m.p. 196-200 oC. 
 
IR: max (cm-1)  3353, 2942, 1622, 1586, 1567, 1462, 1443, 1350, 1335, 1247, 1166, 1147, 
1093, 902, 844, 754. 
1H NMR (400 MHz) (CDCl3) δ 11.78 (1H, s, NH), 8.77 (1H, d, J= 8.3 Hz, ArH),  8.22 (1H, 
s, CH), 8.10 (1H, d, J= 8.0 Hz, ArH), 8.02 (1H, t, J= 7.8 Hz, ArH), 7.82 (1H, t, J= 7.6 Hz, 
ArH), 7.58 (1H, t, J= 7.9 Hz, ArH), 7.51 (1H, d, J= 8.0 Hz, ArH), 7.12 (1H, d, J= 8.4 Hz, 
ArH), 6.87 (1H, t, J= 7.6 Hz, ArH). 
13C NMR (100 MHz) (CDCl3) δ 195.00 (C=O), 163.60 (C), 145.85 (C), 137.93 (CH), 
134.80 (CH), 133.17 (CH), 132.83 (CH), 131.33 (C), 130.17 (CH), 128.75 (CH), 123.40 (C), 
122.81 (C), 119.27 (CH), 118.92 (C), 118.86 (CH), 117.17 (CH). 
 
MS. (ESI, m/z), 313.069597 (M+Na)+  calculated for C16H10N4O2 and found 313.068899. 
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3.5.4. Synthesis of 6-amino-4-(2-azidophenyl)-3-methyl-2,4-dihydropyrano-[2,3-c]pyrazole-
5-carbonitrile307. 
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                                                           Scheme  3.98 
To a mixture of ethyl acetoacetate (330 mg, 0.32 mL, 2.54 mmol) and hydrazine hydrate (1 
eq. 2.54 mmol), in water (5 ml) was added 2-azidobenzaldehyde (1 eq. 369 mg) and 
malononitrile (1 eq. 168 mg) followed by L-proline (10 mol %, 29.4 mg) and the mixture was 
heated at reflux for 20 min. On completion of the reaction, the mixture was cooled and then 
purified using column chromatography with DCM-methanol (5:1, Rf= 0.70) as eluent to 
afford the desired product as a brown solid, 302 mg, 41 %, m.p. 182-184 oC. 
IR: max (cm-1) 3323, 3147, 2213, 2125, 1722, 1668, 1594, 1483, 1403, 1291, 1217, 1159, 
1043, 925, 866, 845, 755.  
1H NMR (400 MHz) (DMSO-d6) δ 12.15 (1H, NH), 7.35-7.28 (2H, m, ArH), 7.15 (1H, t, J= 
7.1 Hz, ArH), 7.07 (1H, d, J= 7.5 Hz, ArH),  6.88 (2H, s, NH2), 4.86 (1H, s, CH), 1.77 (3H, s, 
CH3). 
 
13C NMR (100 MHz) (DMSO-d6) δ 161.73 (C), 155.42 (C), 137.03 (C),  135.87 (C), 135.51 
(C), 130.14 (Ar-CH), 129.02 (Ar-CH), 128.55 (Ar-CH), 125.99 (Ar-CH), 121.15 (C), 119.21 
(C),  97.53 (CN), 56.63 (CH), 10.03 (CH3).  
HRMS. (ESI, m/z), 316.091729 (M+Na)+, calculated for C14H11O1N7, measured 316.091879. 
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3.5.5. Reactivity of 6-amino-4-(2-azidophenyl)-3-methyl-2,4-dihydropyrano-[2,3-
c]pyrazole-5-carbonitrile : Synthesis of tetrazolo[1,5-a]quinoline-4-carbonitrile. 
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                                                     Scheme  3.99 
A solution of 6-amino-4-(2-azidophenyl)-3-methyl-2,4-dihydropyrano-[2,3-c]pyrazole-5-
carbonitrile (100 mg, 0.34 mmol) in dry toluene (10 ml) was heated at reflux overnight, and 
the reaction was monitored by TLC, and on completion the solvent was distilled off in vacuo 
and the mixture was purified by using column chromatography with pet. ether-ethyl acetate 
(5:1, Rf = 0.72) as eluent to give a brown solid as a product, 35 mg, 75 %, m.p. 267-271 oC. 
 
IR: max (cm-1) 3400, 2242, 2121, 1657, 1629, 1533, 1472, 1371, 1312, 1221, 1023, 990.   
 
1H NMR (400 MHz) (DMSO-d6) δ 9.24 (1H, s, CH), 8.74 (1H, d, J= 8.0 Hz, ArH),   8.38 
(1H, d, J= 8.0 Hz, ArH), 8.27 (1H, t, J= 7.7 Hz, ArH), 7.99 (1H, t, J= 7.7 Hz, ArH). 
 
13C NMR (100 MHz) (DMSO-d6) δ  146.12 (C), 143.86 (Ar-CH), 135.31 (Ar-CH), 131.89 
(C), 131.31 (Ar-CH), 129.42 (Ar-CH), 123.14 (C), 117.01 (CH), 114.54 (C-CN), 97.66 (CN).  
 
MS. (ESI, m/z), 218.043716 (M+Na)+  calculated for C10H5N5Na and found 218.043921. 
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3.5.6.  Synthesis of methyl tetrazolo[1,5-a]quinoline-4-carboxylate. 
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                                                       Scheme  3.100 
To a mixture of ethyl acetoacetate (330 mg, 0.32 ml, 2.54 mmol), hydrazine hydrate (1 eq. 
0.13 ml) in water was added 2-azidobenzaldehyde (1 eq. 369 mg) and methyl cyanoacetate (1 
eq. 252 mg, 022 ml) followed by L-proline (10 mol %, 29.4 mg) and the mixture was heated 
at reflux for 20 min. On completion of the reaction, the mixture was cooled and then purified 
by using column chromatography with PE / EtOAc : 1/1 (Rf= 0.41) as eluent to afford the 
product 447 as a yellow solid, 110 mg, 19 %. 
IR: max (cm-1) 3397, 1714, 1616, 1592, 1448, 1318, 1254. 
1H NMR (400 MHz) (CDCl3) δ 8.80 (1H, s, CH), 8.74 (1H, d, J= 8.0 Hz, ArH), 8.13 (1H, d, 
J= 7.9 Hz, ArH), 8.02 (1H, td, J= 7.3 and 1.1 Hz, ArH), 7.80 (1H, t, J= 7.3 Hz, ArH), 4.15 
(3H, s, CH3). 
13C NMR (100 MHz) (CDCl3) δ 163.20 (C=O), 145.58 (C), 138.54 (Ar-CH), 133.75 (Ar-
CH), 131.99 (C), 130.54 (Ar-CH), 128.68 (Ar-CH), 122.64 (C), 117.16 (CH),  116.57 (C), 
53.42 (CH3). 
MS. (ESI, m/z), 251.053947 (M+Na)+  calculated for C11H8O2N4 and found 251.054593. 
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3.5.7.  Synthesis of ethyl 6-amino-4-(2-azidophenyl)-5-cyano-2-methyl-4H-pyran-3-
carboxylate308. 
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                                                       Scheme  3.101 
To a mixture of 2-azidobenzaldehyde (180 mg, 1.25 mmol), ethyl acetoacetate (1 eq. 162 mg, 
0.15 mL, 1.25 mmol) and malononitrile (1 eq. 82.5 mg, 1.25 mmol) in DMF (10 ml) was 
added triethylamine (1.5 eq. 189 mg, 263 µl, 1.87 mmol) and the mixture was stirred for 48 h 
at room temperature. After completion of the reaction, the solvent was distilled under vacuum 
and the mixture was purified by using column chromatography with PE/EA (5:1, Rf = 0.19) 
as eluent to give a brown coloured oil as product, 212 mg, 59 %. 
IR: max (cm-1) 3322 (m), 2203 (m), 2119 (s), 1704 (s), 1672 (s), 1596 (m), 1485 (m), 1378 
(s), 1256 (m), 1214 (s), 1066 (s).  
1H NMR (400 MHz) (CDCl3) δ 7.25 (1H, t, J= 7.3 Hz, ArH), 7.14-7.06 (3H, m, ArH), 4.79 
(1H, s, CH), 4.57 (2H, bs, NH2), 4.06-3.93 (2H, m, OCH2CH3),  2.38 (3H, s, CH3), 1.06 (3H, 
t, J= 7.0 Hz, Me). 
 
13C NMR (100 MHz) (CDCl3) δ 165.79 (C=O), 157.84 (C), 157.79 (C), 137.42 (C), 135.08 
(C), 129.60 (Ar-CH), 128.50 (Ar-CH), 125.13 (Ar-CH), 118.91 (C), 118.42 (Ar-CH), 106.79 
(C), 61.12 (C), 60.62 (CH), 33.47 (CH2), 18.45 (CH3),13.18 (CH3). 
 
HRMS (ESI, m/z), 348.106710 (M+Na)+ calculated for C16H15N5O3Na, measured 
348.106892. 
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3.5.8.  Reactivity of ethyl 6-amino-4-(2-azidophenyl)-5-cyano-2-methyl-4H-pyran-3-
carboxylate : Synthesis of tetrazolo[1,5-a]quinoline-4-carbonitrile. 
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                                                         Scheme  3.102 
The mixture of ethyl 6-amino-4-(2-azidophenyl)-5-cyano-2-methyl-4H-pyran-3-carboxylate  
(80 mg, 0.24 mmol) in dry toluene (10 ml) was heated at reflux overnight and the reaction 
was monitored by TLC. On completion the solvent was distilled off in vacuo and the mixture 
was purified by using column chromatography with pet. ether-ethyl acetate (5:1, Rf = 0.72) 
as eluent to give a brown solid as a product, 35 mg, 75 %, m.p. 267-271 oC, identical to that 
reported above (Scheme 3.99). 
 
IR: max (cm-1) 3400, 2242, 1657, 1629, 1533, 1472, 1371, 1312, 1221, 1023, 990.   
1H NMR (400 MHz) (DMSO-d6) δ 9.24 (1H, s, CH), 8.74 (1H, d, J= 8.4 Hz, ArH), 8.38 
(1H, d, J= 8.0 Hz, ArH), 8.27 (1H, t, J= 7.7 Hz, ArH), 7.99 (1H, t, J= 7.7 Hz, ArH). 
 
13C NMR (100 MHz) (DMSO-d6) δ 146.12 (C), 143.86 (Ar-CH), 135.31 (Ar-CH), 131.89 
(C), 131.31 (Ar-CH), 129.42 (Ar-CH), 123.14 (C), 117.01 (CH), 114.54 (C-CN), 97.66 (CN). 
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3.5.9.  Reactivity of ethyl 6-amino-4-(2-azidophenyl)-5-cyano-2-methyl-4H-pyran-3-
carboxylate : Synthesis of 2-(2-aminotriphenylphosphinyl-benzylidene) malononitrile. 
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                                                           Scheme  3.103 
To a solution of ethyl 6-amino-4-(2-azidophenyl)-5-cyano-2-methyl-4H-pyran-3-carboxylate 
(100 mg, 0.30 mmol) in dry toluene (10 ml) was added triphenylphosphine (1 eq. 81 mg) and 
the mixture was stirred for 4 h at room temperature. After completion of the reaction, 
monitored by TLC, the mixture was heated at reflux overnight. The solvent was distilled 
under vacuum and the mixture was purified by using column chromatography with pet. ether-
ethyl acetate (8:1, Rf = 0.64) as eluent to give a white solid as the product, 82 mg, 64 %, m.p. 
194-197 oC. 
IR: max (cm-1) 3042, 2206, 1682, 1626, 1554, 1458, 1413, 1357, 1108, 1043, 730, 533. 
1H NMR (400 MHz) (CDCl3) δ 8.15 (1H, s, CH), 7.93 (6H, dd, J= 7.8 and 4.5 Hz, ArH), 
7.53-7.39 (11H, m, ArH), 7.20 (1H, d, J= 8.0 Hz, ArH), 7.10 (1H, t, J= 7.1 Hz, ArH). 
13C NMR (100 MHz) (CDCl3) δ 160.97 (C), 160.91 (C), 149.32 (C),  143.38 (CH), 143.35 
(CH), 133.45 (CH), 133.35 (CH), 131.97 (CH), 131.94 (CH), 131.25 (CH),  130.32 (CH), 
129.37 (C), 128.61 (CH), 128.49 (CH), 128.37 (CH), 127.74 (CH), 126.00 (CH), 122.22 
(CH),  121.41 (C), 118.94 (C),  105.00 (CN), 104.74 (CN). 
HRMS. (ESI, m/z), 430.146761 (M+H)+   calculated for C28H21N3P, measured 430.147653. 
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3.5.10  Synthesis of diethyl 4-(2-azidophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-
dicarboxylate321. 
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                                                          Scheme  3.104 
To a mixture of 2-azidobenzaldehyde (735 mg, 5.0 mmol) and ethyl acetoacetate (2 eq. 1.3 g, 
1.26 mL, 10 mmol) in MeOH (15 ml) was added 20 % ammonia soln. in water (5 ml) and the 
mixture was heated at reflux for 24 h. After completion of the reaction, the solvent was 
distilled under vacuum and the mixture was purified by using column chromatography with 
PE/EA (5:1, Rf = 0.25) as eluent to give a brown solid as the product, 861 mg, 46 %, m.p. 82-
85 oC. 
 
IR: max (cm-1) 3320, 2101, 1677, 1618, 1579, 1483, 1433, 1384, 1274, 1207, 1095.  
 
1H NMR (400 MHz) (CDCl3) δ 7.30 (1H, t, J= 7.0 Hz, ArH), 7.16 (1H, t, J= 7.6 Hz, ArH), 
7.08-6.99 (2H, m, ArH), 5.80 (1H, bs, NH), 4.08 (4H, m, 2xCH2), 3.61 (1H, s, CH), 2.29 (6H, 
s, 2xCH3), 1.20 (6H, t, J= 7.1 Hz, 2xCH3). 
 
 
13C NMR (100 MHz) (CDCl3) δ 167.73 (C=O), 144.24 (C), 139.84 (C), 136.57 (C), 131.11 
(CH), 127.55 (CH), 125.01 (CH), 118.20 (CH), 103.47 (C), 60.12 (CH), 59.73 (CH2), 19.52 
(CH3), 14.18 (CH3). 
 
MS. (ESI, m/z), 393.15513 (M+Na)+  calculated for C19H22N4O4Na and measured 393.15332. 
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3.5.11. Reactivity of diethyl 4-(2-azidophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-
dicarboxylate : Synthesis of ethyl 5-ethoxy-2,4-dimethyl-[2,7]-naphthyridine-1-
carboxylate. 
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                                                         Scheme  3.105 
To a solution of  diethyl 4-(2-azidophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-
dicarboxylate (240 mg, 0.64 mmol) in dry toluene (10 ml) was added triphenylphosphine (1 
eq. 170 mg) and the mixture was stirred for 4 h at room temperature. After completion of the 
reaction, monitored by TLC, the mixture was heated at reflux overnight. The solvent was 
distilled under vacuum and the mixture was purified using column chromatography with 
PE/EA (4:1, Rf = 0.38) as eluent to give a white solid as the product, 110 mg, 53 %, 106-109 
oC. 
IR: max (cm-1) 2922, 1714, 1582, 1573, 1550, 1455, 1306, 1237, 1143. 
1H NMR (400 MHz) (CDCl3) δ 8.01 (1H, d, J= 8.4 Hz, ArH), 7.81 (1H, d, J= 8.2 Hz, ArH), 
7.65 (1H, t, J= 7.3 Hz, ArH), 7.35 (1H, t, J= 7.5 Hz, ArH), 4.65 (2H, q, J= 7.1 Hz, CH2), 4.53 
(2H, q, J= 7.1 Hz, CH2), 3.13 (1H, s, CH3), 2.70 (3H, s, CH3), 1.54 (3H, t, J= 7.0 Hz, CH3), 
1.39 (3H, t, J= 7.2 Hz, CH3). 
13C NMR (100 MHz) (CDCl3) δ 170.91 (C=O), 160.01 (C),  159.09 (C), 153.66 (C), 145.31 
(C), 138.83 (C), 130.03 (CH), 127.84 (CH), 125.01 (CH), 124.05 (CH), 121.45 (C), 119.48 
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(C), 113.04 (C), 62.65 (CH2), 62.22 (CH2), 28.93 (CH3), 22.80 (CH3),14.51 (CH3), 13.91 
(CH3).  
MS. (ESI, m/z), 325.154669 (M+H)+  calculated for C19H21O3N2 and found 325.154339. 
 
3.5.12. Synthesis of 5-acetyl-4-(2-azidophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyridine-
3-carboxamide310. 
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                                                                 Scheme  3.106 
To a mixture of 2-azidobenzaldehyde (180 mg, 1.25 mmol), cyanoacetamide (840 mg, 10 
mmol) and acetyl acetone (750 mg, 08 ml, 7.5 mmol) in ethylene glycol (5 ml) and ethanol (5 
ml) was added triethylamine (1.5 eq. 15 mmol, 2.1 ml) and the mixture was stirred at 50 oC 
for 24 h. After completion of the reaction, the mixture was purified using column 
chromatography with PE/EA (3:1, Rf= 0.28) as eluent to afford the desired product as a 
brown oil, 242 mg, 65 %. 
IR: max (cm-1) 3361, 3212, 2979, 2124, 1703, 1680, 1581, 1483, 1386, 1365, 1275, 1205.  
1H NMR (400 MHz) (DMSO-d6) δ 10.06 (1H, s, NH), 7.39-7.30 (2H, m, ArH), 7.22 (2H, 
bs, NH2), 7.12 (1H, t, J= 7.2 Hz, ArH), 6.96 (1H, d, J= 7.7 Hz, ArH), 4.58 (1H, bs, CH), 3.26 
(1H, bs, CH), 2.20 (3H, s, CH3), 1.99 (3H, s, CH3). 
13C NMR (100 MHz) (DMSO-d6) δ 196.82 (C=O), 168.80 (C=O), 167.45 (C=O), 147.58 
(C), 137.57 (C), 131.49 (C), 129.27 (CH), 127.72 (CH), 125.61 (CH), 119.67 (CH), 112.45 
(C), 54.00 (CH), 37.45 (CH), 30.03 (CH3), 19.14 (CH3). 
MS. (ESI, m/z), 336.106710 (M+Na)+ calculated for C15H15O3N5 and found 336.106398. 
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3.5.13. Reactivity of 5-acetyl-4-(2-azidophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyridine-
3-carboxamide. 
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                                                   Scheme  3.107 
To a solution of 5-acetyl-4-(2-azidophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyridine-3-
carboxamide (100 mg, 0.39 mmol) in dry toluene (10 ml) was added triphenylphosphine (1 
eq. 89 mg) and the mixture was stirred for 4 h at room temperature. After completion of the 
reaction, monitored by TLC, the mixture was heated at reflux overnight and monitored by 
TLC which showed no product other than triphenylphosphine oxide confirming that 
compound had decomposed.  
3.5.14.  Synthesis of 2,6-bis (cyclohexylamino)-3,7-bis (2-azidophenyl) benzofuro[5,6-
b]furan-4,8-dione315. 
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                                                      Scheme  3.108 
To a stirred solution of 2,5-dihydroxycyclohexa-2,5-diene-1,4-dione (119 mg, 0.85 mmol) 
and 2-azidobenzaldehyde (2 eq. 250 mg) in ethanol (10 ml) was added cyclohexyl isocyanide 
(2 eq. 185 mg, 211 µl). After stirring the mixture at room temperature for 24 h, the solvent 
was removed under vacuum and the residue was purified by column chromatography using 
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PE/EA (4:1, Rf = 0.32) as eluent. After removal of the solvent, the product was obtained as a 
black oil, 70 mg, 13 %.  
IR: max (cm-1) 3421 (NH), 2933, 2854, 2124 (N3), 1739 (C=O), 1662, 1592, 1527, 1450, 
1274.   
1H NMR (400 MHz) (CDCl3) δ 7.41 (2H, d, J= 7.2 Hz, ArH), 7.34 (4H, m, ArH), 7.16 (2H, 
d, J= 7.7 Hz, ArH), 6.38 (2H, bs, 2 x NH), 3.75-3.70 (2H, m CH), 1.94-1.56 (8H, m), 1.42-
1.06 (12H, m). 
13C NMR (100 MHz) (CDCl3) δ 170.89 (C=O), 136.80 (C), 131.56 (C), 129.43 (C),  128.56 
(C), 128.07 (CH), 126.99 (CH), 125.53 (CH), 118.06 (CH), 48.48 (CH), 32.87 (CH2), 32.64 
(CH2), 25.41 (CH2), 24.60 (CH2), 24.54 (CH2). 
It is difficult to get exact 13C NMR of this and related compounds315, that’s why this assigned 
structure is proposed and may not be correct. 
 
3.5.15.  Reactivity of 2,6-bis (cyclohexylamino)-3,7-bis (2-azidophenyl) benzofuro[5,6-
b]furan-4,8-dione. 
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                                                     Scheme  3.109 
To a solution of 2,6-bis (cyclohexylamino)-3,7-bis (2-azidophenyl) benzofuro[5,6-b] furan-
4,8-dione (70 mg, 0.117 mmol) in dry toluene (10 ml) was added triphenylphosphine (2 eq. 
60 mg) and the mixture was stirred for 4 h at room temperature. After monitoring by TLC, 
which showed no reaction, the mixture was heated at reflux overnight and monitored by TLC 
which showed no product other than triphenylphosphine oxide confirming that the compound 
had decomposed at higher temperature. 
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3.5.16.  Synthesis of 2,6-bis (tert-butylamino)-3,7-bis (2-azidophenyl) benzofuro[5,6-
b]furan-4,8-dione315. 
O
O
HN NH
N3
N3O
OO
HO
O
H
O
N3
N C
EtOH , rt
24 h
+
OH
481 210
489
490
 
                                                                        Scheme  3.110 
To a stirred solution of 2,5-dihydroxycyclohexa-2,5-diene-1,4-dione (140 mg, 0.85 mmol) 
and 2-azidobenzaldehyde (2 eq. 250 mg) in ethanol (10 ml) was added tert-butylisocyanide (2 
eq. 141 mg ). After stirring the mixture at room temperature for 24 h, the solvent was 
removed under vacuum and the residue was purified by column chromatography using 
PE/EA (5:1, Rf = 0.42) as eluent. After removal of the solvent under vacuum, the product 
was obtained as dark brown oil, 72 mg, 15 %. 
IR: max (cm-1) 3452 (NH), 2963, 2126 (N3), 1737 (C=O), 1654, 1590, 1519, 1458, 1364, 
1293.   
1H NMR (400 MHz) (CDCl3) δ 7.43 (2H, d, J= 7.6 Hz, ArH), 7.35 (4H, m, ArH), 7.18 (2H, 
d, J= 7.4 Hz, ArH), 6.29 (2H, s, 2 x NH), 1.32 (18H, s, 6xCH3). 
13C NMR (100 MHz) (CDCl3) δ 170.87 (C=O), 136.83 (C), 131.54 (C), 129.41 (C), 128.54 
(C), 128.05 (CH), 126.96 (CH), 125.52 (CH), 118.08 (CH), 51.55 (C), 29.61 (CH3), 28.67 
(CH3), 28.19 (CH3). 
It is difficult to get exact 13C NMR of this and related compounds315, that’s why this assigned 
structure is proposed and may not be correct. 
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3.5.17.  Reactivity of 2,6-bis (tert-butylamino)-3,7-bis (2-azidophenyl) benzofuro[5,6-
b]furan-4,8-dione. 
O
O
HN NH
N3
N3O
O
toluene
reflux O
O
HN NH
N
N
490 491
PPh3
 
                                                        Scheme  3.111 
To a solution of compound 490 (70 mg, 0.12 mmol) in dry toluene (10 ml) was added 
triphenylphosphine (2 eq. 65 mg) and the mixture was stirred for 4 h at room temperature. 
After monitoring by TLC, which showed no reaction, the mixture was heated at reflux 
overnight and monitored by TLC which showed no product other than triphenylphosphine 
oxide confirming that the compound had decomposed at higher temperature. 
 
3.5.18.  Synthesis of 1-(3-(2-azidophenyl)-5-ethoxyisoxazole-4-yl)ethanone. 
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                                                         Scheme  3.112 
To a solution of ethyl acetoacetate (330 mg, 2.54 mmol) and dry triethylamine (2 eq. 513 mg, 
0.71 ml) in EtOH (10 ml) was added a solution of o-azidobenzohydroximoyl chloride (1 eq. 
500 mg) in EtOH (20 ml) dropwise over 4-5 h under a nitrogen atmosphere and the mixture 
was stirred overnight. The mixture was then concentrated in vacuo and the crude residue was 
purified by flash column chromatography (PE / EtOAc : 8/1, Rf = 0.38) to give the product as 
yellow oil, 224 mg, 32 %.      
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IR: max (cm-1) 2991 (m), 2123 (m, N3), 1717 (C=O), 1604 (s), 1578 (s), 1514 (s), 1458 (s), 
1310 (m), 1293 (m), 1173 9m), 1104 (m), 1018 (s), 980 (s), 889 (s), 788 (m), 756 (m). 
1H NMR (400 MHz) (CDCl3) δ 7.41 (1H, td, J= 5.0 and 1.3 Hz, ArH), 7.30 (1H, dd, J= 4.9 
and 1.2 Hz, ArH), 7.14-7.11 (2H, m, ArH), 4.08 (2H, q, J= 5.7 Hz, CH2), 2.64 (3H, s, CH3), 
1.03 (3H, t, J= 5.8 Hz, CH3). 
13C NMR (100 MHz) (CDCl3) δ 174.78 (C=O), 161.56 (C), 159.76 (C), 139.07 (C), 130.84 
(CH), 130.74 (CH), 124.48 (CH), 120.92 (C), 118.05 (CH), 109.77 (C), 60.38 (CH2), 13.73 
(CH3), 13.07 (CH3). 
MS. (ESI, m/z), 295.080161 (M+Na)+ calculated for C13H12N4O3Na and found 295.079985. 
 
3.5.19.  Reactivity of 1-(3-(2-azidophenyl)-5-ethoxyisoxazole-4-yl)ethanone317. 
ON
COMe
OEt
N3
Toluene
reflux
N
H
EtO2C
O
Ph
Ph
N3
O
Ph Ph
+
492 300 493
 
                                                              Scheme  3.113 
 
To a mixture of 1-(3-(2-azidophenyl)-5-ethoxyisoxazole-4-yl)-ethanone (100 mg, 0.37 mmol) 
in dry toluene (10 ml) was added diphenylcyclopropenone (DPP) (76 mg, 0.37 mmol, 1 eq.) 
under a nitrogen atmosphere and the mixture was refluxed for 48 hours. The reaction was 
monitored by TLC at regular intervals but no product could be identified.  
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3.6.  Synthesis of 1,3-dipoles 
 
3.6.1.  Synthesis of o-azidobenzylhydroximoyl chloride. 
3.6.1.1.  Synthesis of o-azidobenzyl alcohol 247 
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                                                            Scheme  3.114 
To a solution of o-aminobenzyl alcohol (5 g, 40.60 mmol, 1 eq.) in concentrated hydrochloric 
acid ( 40 ml) and water ( 40 ml) at 0 oC was added, with stirring, a solution of sodium nitrite 
(2.8 g, 41.16 mmol, 1.01 eq.) in water (10 ml), dropwise over 10 minutes. Stirring was 
continued for a further hour and the resulting mixture, maintaining its temperature at 0 oC, 
was added dropwise over an hour to an ice-cooled mixture of sodium azide (2.65 g, 40.755 
mmol, 1 eq.) and sodium acetate (37.5 g) in water (75 ml). The white precipitates formed 
were filtered, washed thoroughly with water (3 x 50 ml) and dried in vacuo for an hour to 
give o-azidobenzyl alcohol (5.3 g, 57 % yield) as a white crystalline solid, m.p.: 50-51 oC 247. 
IR: max (cm-1) 3600 (m), 3404 (bm), 2933 (w), 2881 (w), 2127 (s), 1585 (m), 1490 (s), 1452 
(m), 1282 (s), 1008 (m), 756 (s), 669 (s). 
1H NMR δ (400 MHz, d6-DMSO): 7.47 (1H, dd, J= 7.5, 0.8, Ar H), 7.35 ( 1H, td, J= 7.6, 
1.6, Ar H), 7.26-7.16 (2H, m, 2x Ar H), 5.21 (1H, s, br, OH), 4.44 (2H, s, CH2). 
13C NMR δ (100 MHz, d6-DMSO): 139.0 (q), 133.3 (q), 128.1 ( CH), 127.9 (CH), 118 
(CH), 58.3 (CH2).   
Data identical to literature 247. 
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3.6.1.2.  Synthesis of o-azidobenzaldehyde247 
 
                              
OH
N3 N3
OPCC , DCM
511 512
 
                                                        Scheme  3.115 
To o-azidobenzyl alcohol (3 g, 19.72 mmol,  1 eq.) in anhydrous dichloromethane (25 ml) 
was added freshly prepared pyridinium chlorochromate (20 g, 92.76 mmol, 4.7 eq. ) and the 
whole was stirred vigorously for 3 hours with occasional cooling in a water bath ( exothermic 
reaction). The dark reaction mixture was quenched with ether (100 ml) and the supernatant 
liquid was removed by decantation. The black tar residue was washed thoroughly with ethyl 
acetate (5 x 50 ml) and the combined organic layers were collected, dried (MgSO4), and 
filtered under gravity. Evaporation of the solvent gave a brown oil, which crystallised on 
cooling to give o-azidobenzaldehyde (2.8 g, 97 % yield) as brown needles, m.p. 33-35 oC. 
 
1H NMR δ (400 MHz, CDCl3): 8.84, (1H, s), 8.07 (1H, dd, J= 6.4, 1.2, Ar H), 7.08-7.20 
(2H, m, 2x Ar H), 7.41 ( 1H, td, J= 7.1, 1.5, Ar H). 
13C NMR δ (100 MHz, CDCl3): 156.5 (C=O), 139.5 (CH), 131.6 (CH), 127.2 (CH), 124.5 
(CH), 124.2 (C), 117.9 (C). 
The data is identical to literature 247. 
3.6.1.3.  Synthesis of o-azidobenzaldoxime247 
 
                                    
O
N3
N-OH
N3
NH2OH.HCl
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512 513
 
                                                             Scheme  3.116 
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To a mixture of hydroxylamine hydrochloride (6.367 g, 0.88 mmol, 4 eq.) and sodium acetate 
(11 g) in ethanol (150 ml) was added, at room temperature with vigorous stirring, o-
azidobenzaldehyde (3.366 g, 0.022 mmol, 1 eq). The reaction mixture was stirred for 5 hours, 
filtered in vacuo to remove the precipitates and the solvent evaporated off. The crude product 
was purified by flash column chromatography (eluent: PE:EtOAc/ 5:1) to yield o-
azidobenzaldoxime (2.27  g, 61 % yield) as pale yellow needles, m.p: 100-102 oC. 
IR: max (cm-1)  3576 (m), 3390 (bm), 2934 (m), 2127 (s), 1597 (m), 1573 (m), 1489 (s), 
1455 (m), 1290 (s), 1050 (m), 972 (m), 770 (s), 669 (s). 
1H NMR  δ (400 MHz, CDCl3): 9.25 (1H, s, br, OH), 8.40 (1H, s, HC=NOH), 7.73 (1H, dd, 
J= 7.8, 1.5, Ar H), 7.46-7.38 (1H, m, ArH), 7.19-7.11 (2H, m, 2x Ar H). 
13C NMR δ (100 MHz, CDCl3): 146.1 (HC=NOH), 138.5 (q), 131.2 (CH), 127.2 (CH), 
125.0 (CH), 123.2 (q), 118.6 (CH). 
The data is identical to literature247.  
 
3.6.1.4.  Synthesis of o-azidobenzohydroxyimoyl chloride247 
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                                                            Scheme  3.117 
To a solution of N-chlorosuccinimide (1.25 g, 9.343 mmol, 1.01 eq) in anhydrous 
dichloromethane (10 ml) and pyridine (0.1 ml, d= 0.978) was added o-azidobenzaldoxime 
(1.5 g, 9.25 mmol, 1 eq) at room temperature with stirring. The reaction mixture was left 
stirring overnight, then it was concenterated in vacuo and crude product was purified by flash 
column chromatography (eluent: PE:EtOAc/ 4:1) to yield o-azidobenzohydroxyimoyl 
chloride (1.52 g, 76 % yield) as a brown crystalline solid, m.p: 80-82 oC 247. 
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IR: max (cm-1) 3400 (bw), 2920 (w), 2131 (s), 1597 (s), 1578 (m), 1459 (m), 1420 (m), 1300 
(s), 1082 (w), 991 (w), 755 (s), 668 (m). 
1H NMR δ (400 MHz, CDCl3): 9.71 (1H, s, br, OH), 7.55 (1H, dd, J= 7.7, 1.1, ArH), 7.47 
(1H, dt, J= 7.8, 1.4, ArH), 7.30-7.16 (2H, m, 2xArH).  
13C NMR δ (100 MHz, CDCl3): 138.3 (q, C=N), 136.3 (q), 131.6 (CH), 131.2 (CH), 124.8 
(CH), 124.7 (q), 119.0 (CH). 
The data is identical to that previously reported 247. 
3.6.2.  Synthesis of benzohydroximoyl chloride. 
3.6.2.1.  Synthesis of benzaldoxime247 
 
                                    
O N-OHNH2OH.HCl
NaOAc ,EtOH
514 515
 
                                                             Scheme  3.118 
To a mixture of hydroxylamine hydrochloride (13.1 g, 0.19 mmol, 4 eq.) and sodium acetate 
(20 g) in ethanol (100 ml) was added, at room temperature with vigorous stirring, 
benzaldehyde (5 g, 47.16 mmol, 1 eq). The reaction mixture was stirred for 5 hours, filtered 
in vacuo to remove the precipitates and the solvent was evaporated off. The crude product 
was purified by flash column chromatography (eluent: PE:EtOAc/ 5:1) to yield benzaldoxime 
(6.57 g, 87 % yield) as pale yellow oil. 
1H NMR  δ (400 MHz, CDCl3): 10.01 (1H, s, br, OH), 8.26 (1H, s, CH=NOH), 7.63 (2H, 
dd, J= 6.8 and 1.1, 2x Ar H), 7.38-7.48 (3H, m, ArH). 
13C NMR δ (100 MHz, CDCl3): 150.3 (CH=NOH), 131.8 (Cq), 130.7 (CH), 128.9 (CH), 
127.4 (CH). 
The data is identical to that previously reported 247.  
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3.6.2.2.  Synthesis of benzohydroxyimoyl chloride247 
 
                                         
N-OH N-OH
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515 516
 
                                                               Scheme  3.119 
To a solution of N-chlorosuccinimide (2.24 g, 16.7 mmol, 1eq) in anhydrous 
dichloromethane (10 ml) and pyridine (0.1 ml, d= 0.978) was added benzaldoxime (2 g, 16.7 
mmol, 1 eq) at room temperature with stirring. The reaction mixture was left stirring 
overnight, then it was concentrated in vacuo and the crude product was purified by flash 
column chromatography (eluent: PE:EtOAc/ 4:1) to yield benzohydroxyimoyl chloride  (1.7 
g, 68 % yield) as a brown oil. 
1H NMR δ (400 MHz, CDCl3): 9.40 (1H, s, br, OH), 7.82 (2H, dd, J= 6.8 and 1.1, 2x Ar H), 
7.38-7.48 (3H, m, ArH). 
13C NMR δ (100 MHz, CDCl3): 140.2 (C=NOH), 132.3 (q), 130.6 (CH), 128.8 (CH), 127.5 
(CH). 
The data is identical to that previously reported 247. 
3.6.3.  Synthesis of p-methoxybenzohydroximoyl chloride. 
3.6.3.1.  Synthesis of p-methoxybenzaldoxime247 
 
                
O N-OHNH2OH.HCl
NaOAc ,EtOH
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517 518
 
                                                      Scheme  3.120 
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To a mixture of hydroxylamine hydrochloride (4.09 g, 58.8 mmol, 4 eq.) and sodium acetate 
(11 g) in ethanol (100 ml) was added, at room temperature with vigorous stirring, p-
methoxybenzaldehyde (2 g, 14.70 mmol, 1 eq). The reaction mixture was stirred for 5 hours, 
filtered in vacuo to remove the precipitates and the solvent was evaporated off. The crude 
product was purified by flash column chromatography (eluent: PE:EtOAc/ 5:1) to yield p-
methoxybenzaldoxime (2.72 g, 82 % yield) as a brown solid. 
 
1H NMR δ (400 MHz, CDCl3): 9.23 (1H, s, br, OH), 8.15 (1H, s, CH=NOH), 7.53 (2H, d, 
J= 8.7, 2x Ar-H), 6.92 (2H, d, J= 8.8, 2xAr-H), 3.8 (3H, s, OCH3). 
13C NMR δ (100 MHz, CDCl3): 161.1 (C), 149.8 (C=N), 128.6 (CH), 114.3 (CH), 113.7 
(C), 55.3 (OCH3). 
The data is identical to literature 247. 
 
3.6.3.2.  Synthesis of p-methoxybenzohydroxyimoyl chloride247 
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                                                Scheme  3.121    
To a solution of N-chlorosuccinimide (2.56 g, 19.20 mmol, 1.01 eq) in anhydrous 
dichloromethane (10 ml) and pyridine (0.1 ml, d= 0.978) was added p-methoxybenzaldoxime 
(2.9 g, 19.20 mmol, 1 eq) at room temperature with stirring. The reaction mixture was left 
stirring overnight, then it was concentrated in vacuo and the crude product was purified by 
flash column chromatography (eluent: PE:EtOAc/ 4:1) to yield p-
methoxybenzohydroxyimoylchloride  (2.7 g, 77 % yield) as a brown solid.  
1H NMR δ (400 MHz, CDCl3): 9.18 (1H, s, br, OH), 7.50 (2H, d, J= 7.8, 2x Ar-H), 6.97 
(2H, dd, J= 6.4 and 2.6, 2xAr-H), 3.8 (3H, s, OCH3). 
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13C NMR δ (100 MHz, CDCl3): 161.6 (C), 130.0 (C=N), 125.6 (CH), 114.4 (CH), 113.9 
(C), 55.4 (OCH3). 
Data was identical to literature247. 
 
3.6.4.  Synthesis of p-nitrobenzohydroximoyl chloride. 
3.6.4.1.  Synthesis of p-nitrobenzaldoxime247 
 
                        
O N-OHNH2OH.HCl
NaOAc ,EtOH
O2N O2N
519 520  
                                                            Scheme  3.122 
To a mixture of hydroxylamine hydrochloride (3.68 g, 52.98 mmol, 4 eq.) and sodium acetate 
(11 g) in ethanol (150 ml) was added, at room temperature with vigorous stirring, p-
nitrobenzaldehyde (2 g, 13.24 mmol, 1 eq). The reaction mixture was stirred for 5 hours, 
filtered in vacuo to remove the precipitates and the solvent was evaporated off. The crude 
product was purified by flash column chromatography ( eluent: PE:EtOAc/ 5:1) to yield p-
nitrobenzaldoxime (1.97 g, 90 % yield) as pale yellow needles, m.p: 100-102 oC. 
1H NMR δ (400 MHz, CDCl3): 8.28 (2H, d, J= 8.8, 2x Ar-H), 8.22 (1H, s, CH=NOH), 8.05 
(1H, s, br, OH), 7.78 (2H, d, J= 8.8, 2x Ar-H). 
13C NMR δ (100 MHz, CDCl3): 148.4 (C=N), 148.3 (C), 138.1 (C), 127.6 (CH), 124.0 
(CH). 
Data was identical to that previously reported247. 
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3.6.4.2.  Synthesis of p-nitrobenzohydroxyimoyl chloride247 
                          
N-OH N-OH
Cl
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                                                             Scheme  3.123 
To a solution of N-chlorosuccinimide (1.76 g, 13.13 mmol, 1 eq) in anhydrous 
dichloromethane (10 ml) and pyridine (0.1 ml, d= 0.978) was added p-nitrobenzaldoxime 
(2.19 g, 13.13 mmol, 1 eq) at room temperature with stirring. The reaction mixture was left 
stirring overnight, then it was concentrated in vacuo and the crude product was purified by 
flash column chromatography (eluent: PE:EtOAc/ 4:1) to yield p-nitrobenzohydroxyimoyl 
chloride  (1.2 g, 45 % yield) as a yellow crystalline solid.  
1H NMR δ (400 MHz, CDCl3): 8.42 (1H, s, br, OH), 8.38 (2H, d, J= 7.4, 2x Ar-H), 7.92 
(2H, d, J= 7.4, 2x Ar-H). 
13C NMR δ (100 MHz, CDCl3): 133.4 (CH), 130.5 (C), 128.3 (C), 124.3 (CH), 124.0 (C). 
Data was identical to literature247. 
 
3.6.5.  Synthesis of p-chlorobenzohydroximoyl chloride. 
3.6.5.1.  Synthesis of p-chlorobenzaldoxime247 
 
                      
O N-OHNH2OH.HCl
NaOAc ,EtOH
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522 523
 
                                                       Scheme  3.124 
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To a mixture of hydroxylamine hydrochloride (3.95 g, 56.93 mmol, 4 eq.) and sodium acetate 
(11 g) in ethanol (100 ml) was added, at room temperature with vigorous stirring, p-
chlorobenzaldehyde (2 g, 14.23 mmol, 1 eq). The reaction mixture was stirred for 5 hours, 
filtered in vacuo to remove the precipitates and the solvent was evaporated off. The crude 
product was purified by flash column chromatography ( eluent: PE:EtOAc/ 5:1) to yield p-
chlorobenzaldoxime (2.09 g, 95 % yield) as white needles.  
 
1H NMR δ (400 MHz, CDCl3): 8.56 (1H, s, br, OH), 8.14 (1H, s, CH=NOH), 7.54 (2H, d, 
J= 8.5, 2x Ar-H), 7.38 (2H, d, J= 8.5, 2x Ar-H). 
13C NMR δ (100 MHz, CDCl3): 149.3 (C=N), 136.0 (C), 130.3 (C), 129.1 (CH), 128.2 
(CH). 
The data is identical to that previously reported247. 
 
3.6.5.2.  Synthesis of p-chlorobenzohydroxyimoyl chloride247 
 
                         
N-OH N-OH
Cl
NCS, Pyridine
DCM ClCl
523 524
 
                                                         Scheme  3.125 
To a solution of N-chlorosuccinimide (1.97 g, 14.77 mmol, 1 eq) in anhydrous 
dichloromethane (10 ml) and pyridine (0.1 ml, d= 0.978) was added p-chlorobenzaldoxime 
(2.29 g, 14.77 mmol, 1 eq) at room temperature with stirring. The reaction mixture was left 
stirring overnight, then it was concentrated in vacuo and crude product was purified by flash 
column chromatography (eluent: PE:EtOAc/ 4:1) to yield p-chlorobenzohydroxyimoyl 
chloride  (2.4  g, 80 % yield) as a white crystalline solid. 
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1H NMR δ (400 MHz, CDCl3): 8.32 (1H, s, br, OH), 7.79 (2H, d, J= 8.7, 2x Ar-H), 7.40 
(2H, d, J= 8.8, 2x Ar-H). 
13C NMR δ (100 MHz, CDCl3): 139.3 (C=N), 136.7 (C), 130.8 (C), 128.8 (CH), 128.4 
(CH). 
Data as reported in literature247. 
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